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Abstract 
The  structurally  related  PM 94128  and  Ajudazols  A  and  B  exhibit  differing 
biological activities but share the isocoumarin core structure. PM 94128 belongs 
to a large family of compounds known as the aminodihydroisocoumarins and was 
isolated in 1997. It has been shown to be an inhibitor of DNA and RNA synthesis 
and have potent cytotoxic activity in vivo. The Ajudazols A and B were isolated 
in 2004 and have antifungal activity against several important food spoilers. 
 
The work that follows details the design and development of a novel method for 
the  generation  of  the  isocoumarin  core  from  isobenzofuran  utilizing  the 
Achmatowicz rearrangement of a hydroxyisobenzofurans.  
 
Spirocyclic pyrans such as Polymaxenolide are structurally complex molecules, 
containing  large  amounts  of  functionality.  The  biological  activity  of 
Polymaxenolide is unknown and there have been no total syntheses reported to 
date. iii 
  iii 
 
 
Also reported in this thesis is the design and synthesis of a model system of 
Polymaxenolide, using the Achmatowicz rearrangement of a hydroxyfurans. 
 iv 
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 Chapter 1 – Isocoumarins and Isochromanones  
  1 
1. Introduction 
1.1.  Isocoumarins 
The  isocoumarins,  to  which  PM 94128  1
1  belongs,  are  a  large  family  of 
compounds possessing the fused phenolactone (Figure 1.1). The recently isolated 
Ajudazols A 2 and B 3 (discussed in section 1.2) share the isocoumarin core, 
although the literature names this structure an isochromanone;
2 both compounds 
have complex functionality in their respective linear chains and as such have 
attracted  attention  from  the  synthetic  community  due  to  their  structural 
complexity and significant biological diversity within their respective families.  
 
Figure 1.1. PM 94128 and the Ajudazol A & B 
 
Three  common  bacterial  strains  have  been  found  to  produce  some  very 
interesting natural products. From Bacillus, Streptomyces and Xenorhabdus cell 
lines several isocoumarin containing natural product series have been isolated
3,4  
including the Amicoumacins
5 and the Xenocoumacins.
6 
1.1.1.  Bacillus isocoumarins 
The  Bacillus  strain  belongs  to  a  genus  of  rod shaped,  non  pathogenic  spore 
forming aerobic bacteria. Identifiable as gram positive cells, they can normally 
be  found  in  the  soil  and  gastro intestinal  (GI)  tracts  of  various  animals.  The 
Bacillus species includes both free living and pathogenic species (Figure 1.2).  Chapter 1 – Isocoumarins and Isochromanones.  
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Figure 1.2. Bacillus subtilis cells.
7,8 
 
The Bacillus strain of bacteria has yielded the greatest diversity and number of 
isocoumarins.                             
In 1997 Caňedo was able to extract PM 94128 1 from PhM PHD 090, a strain of 
Bacillus subtilis, isolated from marine sediment.
1 The closely related Y 05460M 
A 4 isocoumarin was isolated five years before from the Bacillus sp strain Y 
05460M,  while  the  AI 77  series  of  compounds  was  isolated  from  the  Bacillus 
pumillus cell line (AI 77).
9,10 Also from a Bacillus pumillus strain (BN 103) was 
isolated  the  Amicoumacin  series  of  antibiotics
5  whose  biological  activity  has 
been  studied  the  most  within  this  isocoumarin  family  of  compounds.
11 
Interestingly Bacillus subtilis strains also produce one of the very first antibiotics 
described in this family; Kristenin
12 and the recently characterised Bacilosarcins 
A 5 and B 6.
13   
Interestingly  of  the  many  Bacillus  species  two  are  considered  medically 
significant; Bacillus anthracis (causing Anthrax) and Bacillus cereus (causing food 
borne illness similar to that of Staphylococcus).
14,15                
1.1.2.  Streptomycetes isocoumarins 
The Streptomycetes are members of the bacterial order Actinomycetales; these 
bacteria  resemble  fungi  (they  have  a  branching  filamentous  structure). 
Streptomyces  species  are  found  worldwide  in  soil  and  are  important  in  soil 
ecology. It is widely accepted that their unique antibiotic production is to help 
the organism compete with other organisms in the relatively nutrient depleted 
environment of the soil by reducing competition. By far, the most successful 
genus  in  this  group  is  Streptomyces  with  over  500  species.  Few  species  of 
Streptomyces  are  pathogenic  to  animals,  although  a  few  species  cause  plant Chapter 1 – Isocoumarins and Isochromanones.  
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diseases.
16,17  Reticulol  (to  be  discussed  later)  is  produced  by  Streptomyces 
mobaraenis
18  and  Streptomyces  rubreticulae
19  along  with  many  other 
isocoumarin type natural products.  
1.1.3.  Xenorhabdus isocoumarins 
Xenorhabdus  spp.  is  a  Gram  negative  gamma  proteo bacterium  that  forms 
entomopathogenic  symbioses  with  soil  nematodes.  The  bacteria  produce 
antibiotics, intracellular protein crystals and numerous other products, of which 
Xenocoumacins 1 7 and 2 8 are important.
20  
 
Figure 1.3. Xenocoumacin 1 and 2. 
 
1.1.4.  Bachiphelacin 
One of the very first isocoumarins isolated was Bachiphelacin 9 (Figure 1.4).
21 It 
differs  from  other  isocoumarins  in  its  structure  as  it  has  an  elongated  linear 
chain and the terminal alkyl amino function does not originate from one of the 
20 common amino acids.  
 
Figure 1.4. Bachiphelacin, 9. 
 
Bachiphelacin  9  possesses  both  antibiotic  properties  and  cytotoxicity  against 
gram  positive  bacteria  (MIC  of  12  mM  against  S.aureus)  and  P 388  lymphatic 
leukaemia  cells  (IC50  15  mM)  respectively.  It  is  another  of  the  isocoumarins 
isolated  from  a  bacillus  strain  (Bacillus  thiaminolyticus  IFO  3967/B 1 7). 
Carrasco found that that Bachiphelacin had a potent toxic effect against HeLa 
cells.
22  Studies  of  its  mechanism  of  action  led  to  the  conclusion  that  this Chapter 1 – Isocoumarins and Isochromanones.  
  4 
antibiotic is an inhibitor of protein synthesis in eukaryotic cells. The antibiotic 
had no effect on protein synthesis in Saccharomyces cerevisiae or Escherichia 
coli, but inhibited the protozoan Trypanosoma brucei. In vitro protein synthesis 
in a rabbit reticulocyte cell free system was blocked by Bachiphelacin. Carrasco 
also identified a moderate, 5 mM antiherpetic activity in his screen for potential 
antiherpes compounds.
23  
Bachiphelacin  is  active  against  a  multi resistant  Staphylococcus  aureus  strain 
and a strain of Bacillus subtilis. It exhibits an antiviral activity against Newcastle 
Disease  (a  highly  contagious  disease  that  affects  domestic  poultry,  cage  and 
aviary birds and wild birds).
24,25 The likelihood of epidemics whenever a viral 
infection is recorded, makes this compound relevant across many sectors and 
interests.  
1.1.5.  PM-94128 and Y-05460M-A 
PM 94128 1 has been shown to be cytotoxic against several tumour cell lines in 
the  50  nM  activity  range  (Table  1.1).  The  activity  was  assessed  against  four 
different  tumour  cell  lines,  P 388  (lymphoid  leukaemia),  A 549  (human  lung 
carcinoma), HT 29 (human colon carcinoma) and MEL 28 (human melanoma) cell 
lines
1,26 using an adaptation of the method originally published by Bergeron.
27 
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Figure 1.5. PM 94128 and Y 05460M A. 
 
It was also discovered that PM 94128 1 had an inhibitory effect on DNA, RNA and 
protein  syntheses,
1,26  determined  by  measuring  T thymidine,  T uracil  and  T 
leucine  incorporation  from  P 388  culture  fluids  via  the  method  described  by 
Tomita.
28 PM 94128  was found to have an IC50 of 0.1  M in protein synthesis 
inhibition and an IC50 of 2.5 mM inhibiting DNA / RNA synthesis. The fact that 
these IC50s, compared with those against that of the whole cell line, are much Chapter 1 – Isocoumarins and Isochromanones.  
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lower than against protein synthesis, would seem to indicate the possibility of 
multiple targets.        More research into the biological activity and mechanism 
of action is consequently needed. 
The related and structurally similar isocoumarin Y 05460M A 4 (Figure 1.5), has 
the same spectrum, although less potent cytotoxic activity than PM 94128.2
9        
Y 05460M A was also tested against P 388 and L 1210 lymphoid leukaemia cell 
lines with IC50 values of 0.11  M and 0.32  M respectively.                      
The  biological  activity  assessment  (Table  1.1)  of  Y 05460M A  shows  strong 
cytotoxicity in vitro but it exhibits weak antitumour activity in vivo. 
Compound P 388 A 549 HT 29 MEL 28
PM 94128 1 50 nM 47 nM 47 nM 47 nM
Y 05460M A 4 11  M      
Amicoumacin A 10   1.7  M 3.5  M 0.35  M  
Table 1.1. Antitumour activities. 
 
1.1.6.  Amicoumacin A to C 
Amicoumacin A 10, B 11 and C 12 (Amicoumacin B is also known as AI 77 B) are 
structurally related to PM 94128 1 and they represent the largest quantity of 
biological  data  for  this  class  of  compound  (Figure  1.6).  They  exhibit 
antibacterial, anti inflammatory
30,31 and antiulcer activities.
32,33 while they show 
potent  gastoprotective  and  antiulcerogenic  activities  they  have  the  distinct 
property  of  being  non centrally  suppressive  and  non anticholinerigc  or 
histaminergic.  Their  significant  biological  activity  has  highlighted  them  as 
potential therapeutic leads.
34 Chapter 1 – Isocoumarins and Isochromanones.  
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Figure 1.6. Amicoumacin A, B and C.  
 
The antiulcerogenic activity of Amicoumacin A was investigated using a stress 
induced  gastric  ulceration  procedure.
5,35  The  ulcers  were  treated  with 
Amicoumacin A, a fairly substantial preventative ratio of 72% at 25 mg/kg was 
observed  (Amicoumacin B  and  C  had  greater  protective  effects  at  this  does, 
100% and 83% respectively). The control pro kinetic agent sulfiride achieved only 
34% protection at 30 mg/kg.                                  
In 2002 the antiulcerogenic activities of the Amicoumacins were described by 
Pinchuk,
32  it  was  found  that  the  Amicoumacins  were  potent  antiulcerogenic 
compounds but the doses administered to the rats to achieve protection were 
3.5  times  higher  than  lethal  doses  (LD50  values).  An  examination  of  chronic 
gastritis  and  peptic  ulcer  disease  causes  highlighted  Helicobacter  pylori  (H. 
pylori) infection. When tested against H. pylori Amicoumacin A exhibited potent 
antibacterial activity (significant activities were not observed in Amicoumacins B 
and C) and therefore an antiulcerogenic activity.         
Amicoumacin  A  was  tested  against  strains  of  pathogenic  and  non pathogenic 
intestinal bacteria. Entercoccus faecium, Shigella flexneri and Campylobacter 
Jejuni were sensitive to Amicoumacin A. These results are important because 
these 3 bacterial species represent three common human intestinal pathogens.
36 
“Enterococci  account  for  approximately  110,000  urinary  tract 
infections,  40,000  wound  infections,  25,000  cases  of  nosocomial 
bacteremia  and  1100  cases  of  endocarditis.  Furthermore,  the 
enterococci are among the most antibiotic resistant of all bacteria, 
with some isolates resistant to all known antibiotics”  Dr Gary Kaiser 
37 Chapter 1 – Isocoumarins and Isochromanones.  
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Shigella flexneri is a human intestinal pathogen, causing dysentery by invading 
the epithelium of the colon and is responsible, worldwide, for an estimated 165 
million episodes of shigellosis and 1.5 million deaths per year. Shigellosis is not 
only a significant cause of infant mortality in developing nations, but maintains 
endemic levels of infection worldwide.
38                  
C.jejuni (Campylobacter jejuni) is a highly prevalent food borne pathogen that 
causes diarrhoeal disease in humans.
39,40                   
The sensitivity E.faecium, S.flexneri and C.jejuni to Amicoumacin A has resulted 
in research into the use of Amicoumacin secreting bacteria (e.g. B.subtilis) as 
Pro biotics.
32,41 
Amicoumacin A has also been shown to have antitumour activity against a range 
of human cancer cell lines, with activities ranging from 0.35 to 1.7 mM. (See 
Table 1.1). 
Phosphorylative inactivation of antibiotics is a known process and is believed to 
be one of the resistance mechanisms used by bacteria.
42,43 As part of a screen 
for new antibiotics
44 against methicillin resistant Staphylococcus aureus (MRSA), 
Amicoumacin A was isolated along with Amicoumacin B (AI 77 B) and two novel 
phosphate  ester  derivatives  (Table  1.2),  from  a  strain  of  Bacillus  pumillus 
(MU313B).  Phosphorlyation  was  observed  to  be  exclusively  at  C8'  and  not  at 
either C9' or phenol positions 
 
Compound R
1 R
2
10 (Amicoumacin A) H NH2
13 H3PO4 NH2
11 (Amicoumacin B) H OH
14 H3PO4 OH  
Table 1.2.Phosphorylated derivatives of Amicoumacin A and B. 
 
Hashimoto and co workers analysed the fermentation broth by HPLC, monitoring 
the quantities of each compound.
44 Time course experiments showed that 13 Chapter 1 – Isocoumarins and Isochromanones.  
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was produced as concentrations of Amicoumacin A decreased. As production of 
14 increased amounts of Amicoumacin B decreased (although the scale of 11 
production was less than with 10).                      
To clarify the structure activity relationship of hydroxyl and amide/acid moiety 
of Amicoumacins, the antibacterial activity of the four compounds were tested 
against  Staphylococcus  aureus  (ATCC  43300)  with  Vancomycin  as  the  control. 
Amicoumacin  A  10  activity  was  similar  to  Vancomycin,  while  11,  13  and  14 
showed no activity at concentrations tested. The results suggested that the C8' 
hydroxyl  and  C12'  amide  group  of  Amicoumacin  A  plays  a  critical  role  for 
antiMRSA activity. 
Phosphorylation of Amicoumacins is an interesting finding, possibly in relation to 
self resistance and the export of Amicoumacins from a bacterial cell. 
Another  possible  insight  into  the  metabolism  of  the  isocoumarins  emerged 
recently when Bacilosarcin A 5 and B 6 were characterized.
13 They were isolated 
from the Bacillus subtilis strain TP B0611 and inhibit plant growth (Figure 1.7).  
 
Figure 1.7. Bacilosarcins A 5 and B 6. 
 
Structurally the Bacilosarcins are important because they contain a 2 hydroxy 
morpholine  (Bacilosarcin  B)  and  3 oxa 9 azabicyclo[3.3.1]nonan 7 one 
(Bacilosarcin A) substructures that are very rare in natural products.         
Bacilosarcin  A  5  is  the  more  active  of  the  two  molecules  and  showed  82% 
inhibition  (at  50   M)  of  barnyard  millet  sprouts  versus  98%  inhibition  by 
Amicoumacin A (Bacilosarcin B showed only very weak 7% inhibition at similar 
concentrations). 
This finding suggests Bacilosarcin A could be a prodrug of Amicoumacin A, as the 
Bacilosarcins appear to represent two metabolites in the cellular processing of 
some aminodihydroisocoumarins (Figure 1.8). Chapter 1 – Isocoumarins and Isochromanones.  
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Figure 1.8. Correlations between Bacilosarcins and Amicoumacin. 
 
1.1.7.  AI-77s and Sg17-1-4 
The AI 77 range of compounds (AI 77 A, B, C, D, F and G) were isolated from a 
soil  sample  that  was  classified  as  Bacillus  pumilis  AI 77  and  represents  the 
majority of synthetic research for this class of compound.
45 
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Figure 1.9. The AI 77 range of antibiotics.
46 
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As  a  major  product  in  the  fermentation  process,  AI 77 B  did  not  show  any 
antibacterial activity and exhibited only gastro protective activity. AI 77s C 16, 
D 17, F 18 and G 19 showed lower activities than 15.          
Pharmacological examination of the AI 77s showed antibacterial activity (7 to 
236  mM)  and  a  potent  gastro protective  activity,  together  with  an  inhibitory 
effect paw edema in rats.
34                   
A  possible  route  for AI 77 B  metabolism  was  hypothesized  upon  isolation  and 
characterisation of Sg17 1 4 20.
47 There is no account for the structure of Sg17 
1 4 but the distribution of compounds isolated could suggest a metabolic route 
as  one  can  expect  20to  be  derived  from  AI 77 B  11.  Cytotoxicities  were 
measured against cervical cancer HeLa cells, Sg17 1 4 has slightly lesser potency 
than AI 77 B. 
 
Figure 1.10. Sg17 1 4.  
 
Structurally  the  aminodihydroisocoumarins  are  composed  of  a  fusion  of  two 
modified  L amino  acid  residues.  The  eastern  (15C)  fragment  is  a  modified 
leucine molecule where the b carbon (C3 – based upon Shimojima’s numbering 
system
48) of the original amino acid, becomes incorporated into the isocoumarin 
ring system. The western C7' C11' fragment is comprised of the second amino 
acids, out of all the known aminodihydroisocoumarins, 7 are derived from the 20 
common  amino  acids  (Table  1.3),  the  others  are  derivatives  thereof.    In  all 
cases, the parent amino acid has been modified to include a new dihydroxy 
propanoic  acid  moiety  (connected  to  the  a/C10'  carbon).  The  difference  in 
biological activities between the aminodihydroisocoumarins is due to the side 
chains of the parent amino acid.
49  
  1Chapter 1 – Isocoumarins and Isochromanones.  
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Table 1.3. Isocoumarins derived from common amino acids. 
 
The absolute configurations, of the 5 stereocenters of AI 77 B were established 
through  X ray  crystallography  (Figure  1.11)  studies  by  Shimojima  and  co 
workers
9,10  in  the  early  1980’s.  The  centers  have  all  been  assigned  the  S 
configuration.  Nuclear  magnetic  resonance  and  synthetic  studies  have  been 
completed  on  PM 94128
50  and  AI 77 B
9,10  and  in  both  cases  they  support 
Shimojima’s proposed configurations (Figure 1.1).  
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Figure 1.11 The structure of AI 77 B as solved by Shimojima and collegues.
9,10 
 
The dihydroisocoumarin fragment 21 is found in a variety of natural products 
and  there  have  been  a  significant  number  of  methods  reported  for  their 
construction. The methods generally involve some form of nucleophilic attack 
onto  an  unsaturated  system,  whether  that  is  a  hydroxide  anion  attacking  an Chapter 1 – Isocoumarins and Isochromanones.  
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ester or amide 22
51,53 or an acid promoted ring closure of a carboxylate onto an 
adjacent olefin 23.
54 56  
CO2R
OH
R
OH O
O OH
R
OH
R
OH
O
Base Acid
22 21 23  
Scheme 1.1. The most common routes used to access isochromanone cores. 
 
There  have  also  been  reports  of  more  unusual  routes,  for  instance  radical 
chemistry
57  transition  metal  catalysed  reactions
58  and  Lewis  acid  ring 
expansions.
59  
1.1.8.  Shioiri’s synthesis of AI-77-B 
The  first  reported  synthesis  of  AI 77 B  was  reported  by  Shioiri  in  1989.
60      
Initially Shioiri attempted the intramolecular addition of a carboxylate 24 onto 
an adjacent olefin under acidic conditions. This approach suffered selectivity 
problems between desired 6 endo trig cyclisation product 25 and the favoured 
5 exo trig cyclisation product 26.  
 
Scheme 1.2. Shioiri’s initial attempts to synthesize the core of AI 77 B. 
 
A  second  approach  was  conceived;  involving  a  benzylic  anion  coupling  of 
partners 27 29 to a leucine derived aldehyde 30, thus a one step construction of 
the  aminodihydroisocoumarins  31  and  32,  by  diastereoselective  addition 
followed  by  spontaneous  lactonisation  was  achieved.  A  number  of  salicylate 
derived  starting  materials  were  studied  along  with  variations  in  the  reaction 
conditions (Scheme 1.3).  Chapter 1 – Isocoumarins and Isochromanones.  
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Scheme 1.3. General reaction scheme for aminodihydroisocoumarin formation.  
 
A chelation controlled model was proposed for the selectivity observed in the 
reaction with the nucleophile attacking the carbonyl from the least hindered 
face  (Scheme  1.3).  α Aminoaldehyde  30  is  deprotonated  (using  an  excess  of 
base) to give an N lithium derivative which seems to serve as an internal ligand 
for chelation control. When titanium tetrachloride was used as an additive, the 
reaction gave moderate yields, but the selectivity was reversed in favour of the 
syn aminodihydroisocoumarin 32. The optimal conditions were found to be with 
LDA (2.6 eq), which gave moderate yields, but most selectivity (4:1, anti:syn). 
H
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Figure 1.12. The model proposed by Shioiri et al 
 
Cyclisation of the isocoumarin molecule proved to be spontaneous and all that 
remained in the synthesis was cleavage of the phenolic and N protecting group, 
which was achieved by treatment with boron tribromide giving 33 and 34.    
Synthesis  of  the  linear  amino  diol  fragment  began  with  a  N O  benzylidene 
derivative of D pyroglutaminol 35 as reported by Thottathil.
61 Chapter 1 – Isocoumarins and Isochromanones.  
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Scheme 1.4. Thottathil’s synthesis of 43. 
 
α,β Unsaturated  lactam  39  was  produced,  by  oxidative  elimination  of  the 
seleninde derived from lactam 37. The newly installed olefin was oxidized via 
Upjohn conditions (OsO4/NMO) from the less hindered convex back face with a 
97% diastereotopic excess, followed by acetonide protection to yield ketal 40. 
Catalytic hydrogenation using palladium and hydrazine hydrate yielded the free 
alcohol 41. Conversion of the alcohol to a nitrile group was achieved according 
to  conditions established  within the  Shioiri  group  to  yield  cyanide  42.  tButyl 
carbamate  protection  followed  by  amide  hydrolysis  under  basic  conditions 
yielded acid 43(Scheme 1.5).  
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Scheme 1.5. Shioiri’s synthesis of the amino. 
 
The synthesis of AI 77 B was completed by coupling acid 43 and amine 33 with 
diethyl  phosphorocyanidate  (DEPC)  and  triethylamine.  A  Pinner  reaction 
(trimethylorthoformate  and  5%  hydrochloric  acid  in  methanol)  converted  the 
nitrile to the requisite carboxylate functionality, which cyclised spontaneously 
to generate the bis hydrochloric acid salt 45. Basic treatment of salt 45 with 0.1 
N lithium hydroxide followed by neutralization with 0.1 N hydrochloric acid gave 
the completed AI 77 B molecule 11 (Scheme 1.6). Chapter 1 – Isocoumarins and Isochromanones.  
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Scheme 1.6. Shioiri’s synthesis of AI 77 B. 
 
1.1.9.  Kotsuki’s synthesis of AI-77-B 
Another  more  recent  synthesis  of  AI 77 B  was  reported  by  Kotsuki  in  1999,
62 
wherein a novel salicyclic acid synthon was generated.                      
To begin, meta bromophenyl propargyl ether 46 was converted to benzofurans 
47  and  48  via  a  caesium  fluoride  mediated  rearrangement  in  good 
regioselectivity (Scheme 1.7) and the resulting bromides were converted into the 
corresponding Grignards 49 and 50. It was not possible to separate regioisomers 
of the CsF rearrangement until generation of aldehydes 55 and 56. 
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Scheme 1.7. Benzofuran generation. 
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The  remaining  carbon  framework  was  derived  from  D ribose; protected  as an 
acetonide to generate lactol 51. Wittig olefination of 51, gave the olefin that 
was reduced by catalytic hydrogenation and the free alcohol converted to the 
triflate 52. Coupling of Grignard reagents 49 and 50 to triflate 52 generated the 
key intermediates 53 and  54. Ozonolysis and base hydrolysis of the resulting 
acetates  gave  salicylaldehyde  aldehydes  55  and  56  that  were  separable  by 
chromatography. Benzyl protection of the phenol 56 was followed by acetonide 
deprotection gaving hemiacetal 57. Careful oxidation with sodium periodate and 
hydrogen peroxide gave lactone 58 that was transformed to 59 via mesylation of 
the secondary alcohol and displacement with sodium azide (Mitsunobu azidation) 
with SN2 inversion of the center. Catalytic hydrogenation of azide 59 gave the 
amine that was converted to the hydrochloride salt 33, by acidic work up to 
complete Kotsuki’s synthesis (Scheme 1.8). Vallee later used this approach in his 
synthesis of PM 94128 1.
50 Chapter 1 – Isocoumarins and Isochromanones.  
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Scheme 1.8. Kotsuki’s synthesis of the aminodihydroisocoumarin 39. 
 
Kotsuki’s synthesis of the linear section of AI 77 B began with acetal 60 (Scheme 
1.9) that was treated with PMB amine acetic anhydride/pyridine/DMAP to give 
lactam 61. A Sakurai type reaction of acetate 61, Allyl TMS and BF3OEt2 as the 
Lewis  acid  produced  62,  the  Allyl  group  adding  from  the  lower  face  of  the 
lactone  ring.  CAN  oxidative  removal  of  the  PMB  group  was  followed  by 
reprotection of the free amine to give the N Boc protected lactam 63. Lithium 
hydroxide promoted hydrolysis of the lactam ring produced desired acid 64. Chapter 1 – Isocoumarins and Isochromanones.  
  18 
 
Scheme 1.9. Kotsuki’s synthesis of the acetonide coupling partner 69. 
 
Coupling of isocoumarin 33 and acid 64 via DEPC mediated conditions proceeded 
in good yield to give amide 65. Oxidative cleavage of the terminal double bond 
gave acid 66. Global removal of the protecting groups was achieved by acid base 
acid reaction sequence yielding 11 ( 
Scheme 1.10). 
 
Scheme 1.10. Coupling of isocoumarin 33 and acid 64. 
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1.1.10.  Vallee’s sythesis of PM-94128 
Vallee described the synthesis of PM 92128 (the only full synthesis reported to 
date),  utilizing  the  common  disconnection  across  the  peptide  bond  (Scheme 
1.11).
50 The dihydroisocoumarin fragment 33 was synthesized following Kotsuki’s 
approach
62  while  the  dihydroxyamino  acid  portion  67  was  targeted  through 
diastereoselective  alkylation  of  a  chiral  nitrone  69  and  a  2,3 dihydro 
[1,2]oxazin 6 one dihydroxylation. 
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Scheme 1.11. The retrosynthesis of PM 94128 designed by Vallée. 
 
The nitrone 69, was synthesized (Scheme 1.12) by the selective O benzylation of 
valinol,  oxidation  to  the  hydroxylamine  71  and  condensation  with 
isovaleraldehyde producing the desired nitrone 69 in 49% yield.  
H2N
OBn
HOHN
OBn N
O OBn
1) PMBCHO, MgSO4,CH2Cl2,
2) mCPBA, CH2Cl2
3) NH2OH.HCl, CH3OH
68%, 3 steps
iBuCHO, MgSO4
CH2Cl2
79%
71 69  
Scheme 1.12. Generation of nitrone 74. 
 
Addition of tbutyl lithium propiolate to nitrone 69 was achieved successfully to 
give hydroxylamine 72 as a single product. Selective reduction of the alkyne unit 
using  Lindlar’s  conditions  gave  the  corresponding  Z olefin  73.  Hydroxylamine 
protection  was  necessary  at  this  point  to  avoid  nitrone  formation;  this  was 
achieved by ester saponification followed by cyclisation dehydration by reluxing 
in  toluene.  Dihydroxylation  of  the  Z olefin  was  accomplished  using  Shing’s Chapter 1 – Isocoumarins and Isochromanones.  
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dihydroxylation  protocol,  giving  syn  diol  75.
63  Protection  of  the  diol  75  with 
acidic dimethoxypropane produced the coupling partner 69. 
 
Scheme 1.13. Synthesis of coupling partner 68. 
 
Coupling  of  oxazinone  68  with  dihydroisocoumarin  33  was  performed  in  the 
presence  of  trimethylaluminium  (3.5  eq). Attempts  to  couple  (and  open)  the 
oxazinone  with  only  1.5  equivalents  of  33  and  sodium 2 ethyl hexanoate 
resulted in poor yields.                         
Removal of the chiral auxilliary involved concomitant hydrogenolysis of the O 
benzyl and N O bonds, to be followed by oxidative amino alcohol cleavage using 
palladium(II) acetate giving free amine. Acetyl group deprotection was achieved 
by 3% HCl in methanol to give PM 94128 1. Chapter 1 – Isocoumarins and Isochromanones.  
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Scheme 1.14. Coupling of aminodihydroisocoumarin 33 and 68. 
 
1.1.11.  Other notable syntheses 
Superchi,
64 presented his synthesis of the aminodihydroisocoumarin moiety of AI 
77 B, using a metallation/alkylation sequence followed by dihydroxylation/ring 
forming reactions.  
 
Scheme 1.15. Superchi’s approach to aminodihydroisocoumarin 39. 
 
Thomas, Russell and Davies and Durgnat and Vogel all recorded novel syntheses 
of  the  eastern  fragment  of  AI 77 B  while  using  Shioiri’s  procedure
60  or  a 
modification thereof (benzylic anion addition to leucine derived aldehyde) to 
generate isocoumarin coupling partner 33.  
Thomas’s  approach  to  lactam  82  was  via  olefination  of  lactam aldehyde  80 
derived  from  L aspartic  acid  then  syn dihydroxylation  of  4 alkenylazetidinone 
87, that was modified further to give 82.
65 Chapter 1 – Isocoumarins and Isochromanones.  
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Scheme 1.16. Thomas’s approach to lactam 82. 
 
Russell and Davies
66,67 were able to utilize their intramolecular acylnitroso Diels 
Alder  methodology  (taking  advantage  of  Shea’s
68  work  on  Type  II  Diels Alder 
chemistry  and  Craigs
69  studies  into  the  asymmetric  Diels Alder  chemistry)  to 
synthesize acid 91.  
 
Scheme 1.17. Synthesis of acid 85. 
 
Durgnat  and  Vogel
70  designed  their  synthesis  around  a  Diels Alder  approach 
between furan 86 and cyanovinyl acetate 87, the bridged ether 88 was modified 
to give the desired acid coupling partner 89. 
 
Scheme 1.18. Synthesis of furanoside 89 
 
Ghosh,  Bischoff  and  Cappiello
71  used  a  titanium  enolate  mediated  syn aldol 
reaction of 90, Curtius rearrangement and Dondoni aldehyde homologation to 
generate  the  acid  coupling  partner  92  via  ester  91.  While 
aminodihydroisocoumarin 100 was synthesized from 94 through alkylation and 
protection  giving  93  that  underwent  Diels Alder/Retro  Diels Alder  reaction 
sequence. Chapter 1 – Isocoumarins and Isochromanones.  
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Scheme 1.19. Synthesis of oxazolidine 92 and aminodihydroisocoumarin 94.  
 
Ward  and  Proctor  have  also  reported  several  syntheses  of 
aminodihydroisocoumarin family members. Bachiphelacins 9 amino diol fragment 
was synthesized via dihydroxylation of chiral allylsilane 95.
72  
 
Figure 1.13. Upjohn dihydroxylation of acid 101. 
 
Ward and Proctor were also able to synthesize AI 77 B 11 and Amicoumacin C 
12, using aspartic acid that could be diprotected as the benzyl ester 98 then 
converted  to  the  Cb aldehyde  99,  then  olefinated  with  Horner Wadsworth 
Emmons conditions giving 100, that was then dihydroxylated. 
 
Figure 1.14. Synthesis of olefin 100. 
 
Our  interest  in  the  aminodihydroisocoumarins  led  us  to  the  discovery  of  the 
isochromanones and the Ajudazols. The isocoumarins are structurally related to 
the isochromanones, they both have benzoic lactone structures with an alpha 
stereocenter. Biologically they have very different activities, making them very 
intersting targets within the Marquez research group. Chapter 1 – Isocoumarins and Isochromanones.  
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1.2.  Isochromanones 
1.2.1.  Ajudazol A and B 
Ajudazol A and B were discovered in 2004, during a screening of myxobacteria 
for new biologically active compounds.
2,73                            
The myxobacteria group of organisms was first described by Roland Thaxter in 
1892.  Myxobacteria  are  found  in  most  environments;  however  their  main 
habitats  are  temperate  topsoil  and  rotting  vegetation.  Physiologically  they 
exhibit several features that have made them the subject of significant scientific 
interest.
74 
As  prokaryotes,  Myxobacteria  show  a  unique  cooperative  social  behaviour,
74 
based  on  a  complex  communication  system  that  allows  colonies  a  swarming 
motility (they can move by gliding or creeping on surfaces) which enables them 
to coordinate in a predatory manner against other microbes 
 
Figure 1.15. Bacterial rods during gliding process.
75 
 
To complement their predatory activity, the bacteria produce lytic exo enzymes 
against their prey. The lysis products of ‘prey’ bacteria and fungi are sufficient 
to  sustain  the  Myxobacterias  growth  etc.  Under  starvation  conditions, 
Myxobacteria undergo a form of multicellular development where they are able 
to assemble fruiting bodies and more complex structures. Within these bodies 
resistant  cell  types  (myxospores)  are  produced.
76  Myxospores  are  resistant  to 
desiccation giving the organism a dormant stage to its life cycle. Myxobacteria 
also secrete an array of biologically active metabolites including antibiotics and 
antitumour agents. Chapter 1 – Isocoumarins and Isochromanones.  
  25 
A B
C D
 
Figure 1.16 Spore body of myxobacterium; B, C and D – Stages in the development of the 
'fruitbody' of the myxobacterium Chondromyces crocatus.
75 
 
The species Chondromyces crocatus has been particularly prolific at exhibiting 
high antifungal and cytotoxic effects. The activities have been ascribed to the 
large  number  of  secondary  metabolites  produced  by  the  species.  Of  these 
secondary  metabolites,  Adjudazols  A  2  and  B  3  were  observed  as  well  as 
Crocacin A to D and Chondramides A to D. The crocacins are a family of N acyl 
dipeptides, known to block electron flow in the third complex of the cytochrome 
bc1  segment of  the  eukaryotic  respiratory chain,  while  the  chondramides  are 
new  depsipeptides  structurally  related  to  jasplakinolide,
77,78  which  is  highly 
cytostatic against mammalian cell lines.
79,80 
The discovery of the Ajudazols came surreptitiously from further purification of 
crude extracts, also leading to the further discovery of the chondrochlorens, a 
new β amino styrene.
2 
The antimicrobial activity of the Ajudazols has been partially assessed; Ajudazol 
B  incompletely  inhibited  growth  of  several  important  fungi  including  Botrytis 
cinerea,  Ustilago  maydis.  It  has  also  displayed  weak  activity  against  several 
Gram positive  bacteria.  Ajudazol  A  showed  only  minor  activity  against  a  few Chapter 1 – Isocoumarins and Isochromanones.  
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fungi and Gram positive bacteria.                           
The  Ajudazols  antifungal  activity  is  significant  because  fungi  like  Botrytis 
cinerea  are  a  ubiquitous  fungal  pathogen  causing  gray  rot.  Botrytis  cinerea 
affects a large number of economically important agricultural and horticultural 
crops. It opportunistically infects wounds or senescing tissue and also invades 
young  tissues,  causing  necrosis.
81  While  Ustilago  maydis  (corn  smut)  infects 
maize (Zea mays) and teosinte (Euchlena mexicana) and can ruin whole harvests 
depending on level of infection. 
Studies, to investigate the mechanism of action and influence of the Ajudazols 
on the mitochondrial respiratory energy metabolism  were conducted in 2004. 
Nicotinamide  adenine  dinucleotide  (NADH)  oxidation  in  sub  mitochondrial 
particles (SMPs) (as determined by UV/VIS spectrophotometry) was inhibited by 
50%  at  a  concentration  of  22  nM  (Ajudazol  A)  and  18  nM  (Ajudazol  B), 
respectively.
73 
Faced  with  this  potent  activity  the  site  of  inhibition  within  the  electron 
transport chain was investigated. The results indicated that the site of inhibition 
of  Ajudazols  is  on  the  substrate  side  of  cytochrome  b.  Cytochromes  can  be 
reduced either by NADH via complex I (NADH: ubiquinone oxidoreductase) or by 
succinate.  To  determine  whether  the  Ajudazols  interfere  with  complex  I, 
complex II, or with both, the effect on reduction kinetics of cytochrome b using 
either NADH or succinate as the substrate was investigated. Ajudazol A and B 
inhibited  the  reduction  of  cytochrome  b  only  when  NADH  was  the  electron 
donor. The investigations on the mechanism of action of the Ajudazols suggest 
that the Ajudazols block the electron flow in SMPs specifically at the site of 
complex  I.  The  observation  is  supported  by  further  investigations  which 
demonstrated  that  the  new  compounds  block  the  electron  flow  in  SMPs 
specifically at the NADH: ubiquinone oxidoreductase complex 1 site. Chapter 1 – Isocoumarins and Isochromanones.  
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Figure 1.17. The NADH oxidation/reduction cycle. 
 
The Ajudazols A and B consist of an isochromanone (C1 C9) fragment and a C10 
C29 fragment (Figure 1.18). The isochromanone fragment possesses C8 hydroxyl 
and C9 alkyl groups, while the C10 C29 contains a Z diene (C17 C20) and an E 
olefin  (C23 C24)  which  is  linked  to  an  (E) 3 methoxy N methylbut 2 enamide. 
This  enamide  is  shared  among  other  compounds  isolated  from  Chondromyces 
bacteria  (for  example  the  Crocacins).  Another  feature  of  the  Ajudazol 
framework  is  the  (S) secpropyl  oxazole  fragment  that  connects  the 
isochromanone and the linear 18C tail portion. 
 
Figure 1.18. Ajudazols A 2 and B 3 
 
The sole difference between the Ajudazols is the C15 carbon. In Ajudazol B it is 
a methyl group (unassigned conformation) rather than an exo methylene olefin 
(as with Ajudazol A).                        
The  stereochemistry  of  the  Ajudazols  has  been  assigned  by  extensive  NMR 
studies although no crystallographic data has been reported.
82 The C9 carbon 
center has been assigned the S configuration, as has the C10 carbon, while the Chapter 1 – Isocoumarins and Isochromanones.  
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C8 hydroxyl center has the R conformation. The C15 carbon of Ajudazol B has 
not been assigned.  
The  isochromanone  functionality  is  one  of  only  a  few  examples  of  the  more 
common isocoumarin core 21, bearing C8 hydroxyl functionality. The literature 
contains  only  four  other  natural  products  containing  C8  hydroxyl 
isochromanones, with only two possessing an alkyl group in the C4 position.
83  
 
Figure 1.19. Examples of isochromanone natural products, bearing C4 oxygens. 
 
Other  than  the  C8  hydroxyl  and  C9  functionality  the  isochromanones  and 
isocoumarins differ only in ring stereochemistry. The aminodihydroisocoumarins 
are R configured while the Ajudazols have S configuration. 
To date there have been only two reported approaches towards the synthesis of 
the Ajudazols. Both of these are concerned with the synthesis of the C9/C15 C29 
eastern fragment of the molecule. There have been no publications detailing the 
synthesis of the isochromanone bicycle. 
1.2.2.  Taylor’s synthesis of the C15-C29 fragment, 104 
As part of his efforts towards the synthesis of Ajudazol A 2, Taylor presented the 
one pot double acetylene carbo cupration of a functionalised alkyl cuprate 109, 
that was trapped with 2,3 dibromopropene 110.
84                 
Taylor’s retrosynthesis (Scheme 1.20) is based on the key Stille disconnection of 
2 stannyl oxazole 103 and vinyl halide 104. Halide 104 was thought to come 
from the amide coupling of the amine derived from the Wittig olefination of 
aldehyde 105 and 3 methoxybutenoic acid 106. The aldehyde 105 could come 
from  alcohol  107,  which  in  turn  could  be  generated  through  the  key  double 
acetylene carbo cupration reaction and subsequent trapping with halide 108. Chapter 1 – Isocoumarins and Isochromanones.  
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Scheme 1.20. Taylor’s retrosynthesis of the Ajudazol A molecule. 
 
The forward synthesis began with the metal halogen exchange of iodide 111, 
followed by trans metallation to generate dialkyl cuprate. Reaction of cuprate 
with  acetylene  110  generated  the  Z,Z dienyl  intermediate  112  which  was 
trapped with 2,3 dibromopropene 108, to give triene 113. THP ether cleavage 
gave alcohol 107 (Scheme 1.21). 
 
Scheme 1.21. The first stages of the synthesis Chapter 1 – Isocoumarins and Isochromanones.  
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Oxidation of 107 and Wittig olefination of the resulting aldehyde 105 produced 
the tetrene 114, which was reduced and the allylic alcohol masked as the THP 
ether 115. Conversion of the bromide functionality to an iodide was achieved via 
a  metal halogen  exchange  process  with  tBuLi  and  the  resulting  alkyl lithium 
quenched with molecular iodine to give vinyl iodide 116. Cleavage of the THP 
group was followed by free alcohol conversion to the corresponding secondary 
amine 117 via the bromide intermediate. Coupling of amine 117 and acid 106 
completed the synthesis of Taylor’s C15 C29 104 fragment of Ajudazol (Scheme 
1.22). 
 
Scheme 1.22. The final reactions of the sequence 
 
The suitability of the vinyl iodide towards the planned Stille coupling reaction 
was  examined  see  Scheme  1.23.  Reacting  vinyl  iodide  104  with  2 oxazole 
stannane 118 produced in 60% yield the desired compound 119. Pd(PPh3)4 and 
PdCl2(MeCN)2  were  also  tested  for  this  coupling,  but  the  best  results  were 
obtained using PdCl2(PPh3)2.  Chapter 1 – Isocoumarins and Isochromanones.  
  31 
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Scheme 1.23. Stille reaction tests between vinyl iodide and oxazole 119  
 
1.2.3.  Rizzacasa’s synthesis of the C9-C29 fragment 121  
More recently, Rizzacasa reported his convergent approach to the synthesis of 
the  C9 C29  portion  of  the  Ajudazols.  Rizzacasa’s  approach  relies  on  a 
cyclodehydration/Sonogashira  coupling/alkyne  hydrogenation  reaction 
sequence.
85     
Retrosynthetically  the  C18 C19  bond  was  introduced  by  Sonogashira  cross 
coupling reaction between alkyne 120 and vinyl iodide 121. The alkyne could be 
seen to come from acid 123 followed by oxazole formation using a variant of the 
Wipf protocol.
86,87 Vinyl iodide 124 is thought to come from coupling of allylic 
amine 124 and acid 106. (Scheme 1.24) Chapter 1 – Isocoumarins and Isochromanones.  
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Scheme 1.24. The retrosynthesis designed by Rizzacasa. 
 
Rizzacasa’s  synthesis  of  the  C9 C29  segment  began  with  the  oxidation  and 
olefination of known alcohol 125, giving diene 126. The ester was reduced to 
the  allylic  alcohol  then  converted  to  the  bromide  and  displaced  with 
methylamine to give secondary amine 124. Peptide coupling between acid 106 
and amine 124 produced desired vinyl iodide 121 (Scheme 1.25). 
 
Scheme 1.25. Synthesis of the common coupling partner 
 
The oxazole fragment 132 was synthesized from dimethyl malonate 127, which 
was alkylated and then reduced to yield diol 128. Mono protection and oxidation 
produced the acid 129. Coupling of the acid with known racemic amine 130 Chapter 1 – Isocoumarins and Isochromanones.  
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afforded  amide  131.  Selective  silyl  ether  deprotection  of  the  tbutyldimethyl 
silyl group allowed Dess Martin Oxidation of the resulting alcohol that could be 
transformed to the desired oxazole 132 (Scheme 1.26). 
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Scheme 1.26 Production of the oxazole fragment corresponding to Ajudazol A. 
 
Coupling of alkyne 132 and vinyl iodide 121 under Sonogashira cross coupling 
conditions gave the desired ene yne 133. Partial hydrogenation of the alkyne 
followed by mesylation of the primary alcohol and elimination produced (Scheme 
1.27),  poly ene  134  as  Rizzacasa’s  model  system  for  the  synthesis  of  the 
Ajudazols. Chapter 1 – Isocoumarins and Isochromanones.  
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Scheme 1.27. Coupling of vinyl iodide 121 and oxazole 132. 
 
Rizzacasa then modified his synthesis of compound 132 (Scheme 1.28) in order 
to replicate the system present in Ajudazol B 2. This enantioselective approach 
allows for either enantiomer of oxazole 137 or 138 to be synthesized, simply by 
selecting the appropriate acid coupling partner 135 or 136 (Scheme 1.27). 
 
Scheme 1.28. Synthesis of both enantiomers of Ajudazol B. 
 Chapter 1 – Isocoumarins and Isochromanones.  
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1.3.  Other isocoumarin containing natural products  
There are a number of isocoumarin containing compounds that are structurally 
simpler, but are important due to their biological profile. 
Reticulol 139 was isolated from isolated from Steptomyces rubreticulae, a strain 
of soil actinomyces called streptoverticillium, NA 4803. Structurally, 139 is very 
similar to both Phytoalexin and Mellein but the compound is planar and lacks a 
stereocenter. 
 
Figure 1.20. Reticulol 139  
 
Reticulol 139, is important because it is a cyclic 3',5' monophosphodiesterase 
inhibitor. It has been shown that Topoisomerase 1 treated with 45  M Reticulol 
does not replicate or transcribe DNA.
19 
(R) ( ) Mellein 140 is widespread in nature having been isolated, inter alia, from 
many fungi and several insects in which it appears to play a pheromonal role.                  
(S) (+) Mellein  141  is  also  a  fungal  metabolite,  one  source  being  the  marine 
fungus Helicascus kanaloanus. 
 
Figure 1.21. Both enantiomers of Mellein. 
 
The differing activities of aminodihydroisocoumarins from antiinflammatory to 
antitumour would seem to indicate a wide range of different biological targets. 
However  compounds  like  AI 77 B  11  and  the  Xenocoumacins  have  not  been 
tested  for  any  antitumour  activities.  Although  AI 77 B  is  known  to  be  very 
cytotoxic when administered intraperitoneally. Combining this with observations 
in oncology, tumour cells have significantly increased uptake of minerals/sugars 
etc  from  their  extra cellular  matrices.  This  could  mean  that  others  in  the Chapter 1 – Isocoumarins and Isochromanones.  
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aminodihydroisocoumarin family of compounds have similar cytotoxicity to PM 
94128 that is as yet undiscovered. 
The first stereospecific synthesis of both enantiomers of Mellein was reported by 
Gill.
88 It began with alkylation of R propylene oxide 142 using propargyl bromide 
derived anion that gave alcohol 143. Silyl protection of the free alcohol was 
followed by alkylation of the terminal alkyne with methyl chloroformate in 81% 
yield. Diels Alder reaction between ester 145 and 1 methoxy 1,3 butadiene gave 
the salicylate derivate 146, that upon treatment with toluene sulfonic acid and 
hydrogen  bromide  gave  140.  The  opposite  S enantiomer  of  Mellein  141  was 
synthesized from S propylene oxide as per Scheme 1.29. 
 
Scheme 1.29. Gill’s synthesis of R Mellein 146. 
 
An  interesting  oxidative  approach,  to  the  synthesis  of  the  3,4 
dihydroisocoumarins  Mellein  140  and  metabolic  derivatives,  was  reported  by 
Watanabe  (Scheme  1.30).
89  Here  the  authors  report  a  novel  one pot 
esterification Michael  addition aldol  reaction  of  a  d hydroxy a,b unsaturated 
aldehyde 147 and a diketene 148. The product was aromatized to give R Mellein 
140.           
Interestingly, the step wise procedure was examined first in 47% overall yield 
while  the  one pot  version  gave  reproducible  yields  between  71%  and  74% 
reproducibly. Chapter 1 – Isocoumarins and Isochromanones.  
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Scheme 1.30. Watanbe’s synthesis. 
 
Treatment  of  alcohol  149  with  excess  amounts  of  Martin  Sulfurane  gave  R 
Mellein  140  unexpectedly,  via  a  two step  dehydration aromatisation  process, 
through intermediates 152 and 153 (Scheme 1.31). 
 
Scheme 1.31. Mechanism of aromatization by Martin Sulfurane. 
 
Finally Cho and Choo reported their interesting synthetic approach to sterically 
congested  cyclic  lactones,  through  palladium catalyzed  cyclisations  of  allenyl 
tetrahydrofurans bearing a carboxylic acid (Scheme 1.32).
90 Chapter 1 – Isocoumarins and Isochromanones.  
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Scheme 1.32. Synthetic route taken by Cho and Choo. 
 
Mechanistically, an aryl palladium halide intermediate adds to the center carbon 
of allene unit, resulting in the formation of a p allylpalladium intermediate. This 
intermediate  is  attacked  by  the  intramolecular  nucleophilic  carboxylate  to 
afford the observed tricyclic product 156, Scheme 1.33.  
 
Scheme 1.33. Proposed mechanism of palladium catalysed cyclisation. 
 
1.4.  Biosynthetic origin  
Before the 1990s, it was speculated that the aminodihydroisocoumarins were of 
mixed  polyketide  biosynthetic  origin.  In  1991,  McInerney  proposed  that  the 
aromatic portion of the bicycle is derived from leucine and four acetate units.
6    
The linear polyketide 157, is cyclised (and aromatized as water is eliminated) by 
a  polyketide  synthase  (PKS)  in  a  type  1  iterative  manner  (Figure  1.22). Chapter 1 – Isocoumarins and Isochromanones.  
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Bechthold’s work in to this area has helped provide mechanistic evidence of PKS 
activities.
91 
 
Figure 1.22. The orsellinic acid biosynthetic pathway.
92 
 
Isocoumarin 160, is formed as the product of a ring closing reaction of 158, 
giving 159. De oxygenation at C6 is followed by enantioselective reduction at 
the C3 C4 olefin. The free amine is then malonylated with a moeity derived from 
acetic  acid  and  the  requisite  amino  acid  giving  160.  Finally  oxidation  at  C8' 
takes place, presumably via water incorporation onto the linear chain. Reduction 
at C9' produces the final aminodihydroisocoumarin, Figure 1.23. 
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Figure 1.23. Formation of the dihydroisocoumarin system.
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McInerney’s proposed biosynthesis was corroborated some 17 years later, when 
Buntin et al. published their work into the biosynthesis of the Ajudazols, noting 
that the formation of the isochromanone is one of the last transformations to 
occur.
93  Although  the  research  showed  a  different  method  of  combining  the 
linear orsellinic acid and linear fragment, both papers agreed on the method of 
isocoumarin formation.                          
Buntin determined that the backbone of the Ajudazols molecule comes from a 
mixed system of type 1 polyketide synthase and a non ribosomal polypeptide 
synthetase (NRPS) multi enzyme.  
Generally, an acetyl transferase loads a dicarboxyl extender onto an acyl carrier 
protein (ACP) and then is condensed with a starter acyl unit, catalyzed by a Chapter 1 – Isocoumarins and Isochromanones.  
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ketosynthase, the resulting β ketoacyl intermediate remains thioester linked to 
the  ACP.  Ketoreductase  processing  of  the  b ketone  is  likely  followed  by 
dehydratase  and  then  enoyl  reductase  domains  to  yield  an  alcohol,  enoyl  or 
methylene group before the chain migrates to a ketosynthase and further cycles 
of extension. When the polyketide length is reached, termination occurs usually 
accompanied by cyclisation.  
Polyketide synthases, as a group, use a wide range of organic acids as starter 
units,  extenders  may  be  malonyl,  alkyl  malonyl  and  methoxy malonyl. 
Polyketide  structural  diversity  is  a  result  of  this  wider  substrate  tolerance. 
Chirality  is  introduced  through  branched  extender  units  and  asymmetric 
reduction  of  β ketones  to  alcohol,  chirality  as  a  result  increases  polyketide 
structural diversity.   Figure  1.24  and  Figure  1.25  show  the  sequence  of 
biochemical transformations that that result in the formation of the Ajudazols. 
 
S S
O O
O
S S
O O
N
O
O
N
O
O
OH
N
O
O
S
O
N
O
O
S
OH
O
N
O
O
S
O
N
O
O
S
O
AjuK AjuL AjuA AjuB AjuC
Acyl carrier protein
Peptidyl carrier protein
Subunit of multienzymes, these include Ketosynthase, Acyltransferase, o-Methyltransferase, Ketoreductase, Dehydrase,
Enoyl reductase, Thioesterase, N-Methyltransferase
 
Figure 1.24. The first 8 steps of Ajudazol biosynthesis by mixed PKS NRPS synthetase. 
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 Figure 1.25. The final 8 modifications of the Ajudazol biosynthesis model. 
 
Alcohol  stereochemistry  in  the  isochromanone  ring,  is  determined  by  specific 
ketoreductases.  Sequence  analysis  has  shown  few  consistent  differences 
between  the  ketoreductases  types.  Research  to  corroborate  and  properly 
examine reductase mechanisms of action is needed.  
Biosynthesis of aromatic molecules in bacteria is generally achieved with type I 
and II PKS systems. This means that there are 2 possible mechanisms for chain 
release,  coupled  to  the  formation  of  the  isochromanone  functionality. 
Mechanism A involves the attack of the C9 hydroxyl group onto the thioester 
161, catalysed by an appropriate thioesterase. Ejection of the peptide carrier 
bound thiol causes release of the 10 membered lactone 162, where we see a C2–
C9 aldol reaction followed by a ring aromatization reaction (Figure 1.26). Chapter 1 – Isocoumarins and Isochromanones.  
  42 
 
Figure 1.26. Proposed mechanism for 173 formation – Mechanism A. 
 
Mechanism B has an intramolecular aldol/aromatisation reaction of 171 before 
the  thioester  catalyzed  cleavage/lactonisation  reaction  of  intermediate  164. 
giving 165 (Figure 1.27). 
 
Figure 1.27. Proposed mechanism of 173 formation – Mechanism B. 
 
There are several post PKS modifications needed to complete the synthesis of 
Ajudazols  (C8  hydroxylation  and  exo methylene  formation).  Responsible  for 
these modifications are the enzymes AjuI and AjuJ (they have a great deal of 
homology  to  P450  enzymes)  The  product  released  from  AjuH  is  likely  to  be 
deshydroxyAjudazol, 166; which is a suitable substrate for AjuI and AjuJ. AjuI 
oxidizes the exo methyl group and AjuJ is responsible for C8 oxidation resulting 
in the complete Ajudazol A molecule. In the case of Ajudazol B, 3 is modified by 
AjuJ only. As Ajudazol A is the major metabolite, the former reaction sequence 
would appear to be the preferred pathway.  Chapter 1 – Isocoumarins and Isochromanones.  
  43 
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Figure 1.28. Buntin’s proposed post PKS modifications.  
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2. Results and discussion 
2.1.  Synthesis of PM-94128 
We  envisioned  PM 94128  1  as  having  come  from  the  amide  disconnection 
favoured by previous syntheses. The linear acid compound 168 was thought to 
be have arisen from the oxidation of ketone 169, this having come from the 
product of a proline catalyzed aldol reaction between hydroxyacetone 170 and 
from N–protected leucine derived aldehyde 171.                         
On  the  other  hand  aminodihydroisocoumarin  bicycle  167  was  thought  of  as 
originating from the aromatisation of allylic alcohol 172. 172 could in turn be 
the  product  of  the  Diels Alder  reaction  of  diene  174  and  a pyrone  173.  a 
Pyrone can come from the ring closing metathesis reaction of diene ester 175, 
which could be attained by stereoselective alkylation and esterification of  N–
protected leucinal 176 (Scheme 2.1). 
 
Scheme 2.1. Our retrosynthesis of PM 94128 
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2.1.1.  Proline organocatalysis 
Proline and proline derivatives have found widespread use as organocatalytical 
reagents in synthesis. 
“Proline  –  a  universal  asymmetric  catalyst?…there  are  various 
chemical reasons that contribute to prolines role in catalysis. Proline 
is bifunctional, with a carboxylic acid and amine portion. These two 
functional groups can act as both acid or base and facilitate chemical 
transformations  in  concert,  similar  or  enzymatic  catalysis  ”–  Dr 
Benjamin List
94 
Proline  has  been  reported  in  a  large  variety  of  reaction  types  ranging  from 
asymmetric transfer hydrogenation reactions,
95 97 to Bayliss Hillman chemistry
98 
and  even  Diels Alder  type  dimerisation  reactions.
99,100  Derivatives  have  also 
found  widespread  use;  Corey  has  applied  the  oxazaborolidine  deriviative  of 
proline  both  in  the  asymmetric  reduction  of  ketones  (Corey Bakshi Shibata 
reduction) and as an asymmetric catalyst for Diels Alder
 reactions.
101,102 
Proline was described as the catalyst for the Hajos, Parrish, Wiechert and Sauer 
reaction,  more  commonly  the  Hajos Parrish  reaction.
103 106  The  Hajos Parrish 
reaction has found widespread use in the enantioselective synthesis of complex 
bicycles.  In  its  original  application  the  reaction  saw  proline  catalysis  of  the 
conversion of trione 177 to the bicyclic dione 178 (Scheme 2.2).  
 
Scheme 2.2. Hajos Parrish reaction of 2 methyl 2 (3 oxobutyl)cyclopentane 1,3 dione. 
 
The  Hajos Parrish  reaction  is  essentially  an  intramolecular  application  of  the 
reaction that was envisioned for synthesis of the amino diol fragment 168. 
The  large  body  of  work  in  ‘direct  intermolecular  aldol  reactions’  made  us 
confident  its  application  would  be  successful.
107 110  Macmillan  (Scheme  2.3) 
reported the use of hydroxy carbonyl compounds 179 with aldehydes 180 in the 
presence of catalytic quantities of L proline, yielding anti diols 181 in good yield 
with excellent selectivities.
111 Chapter 2 – Isocoumarins and Isochromanones 
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Scheme 2.3. Macmillan’s method of generating anti diols. 
 
Further  literature  searches  of  proline  organocatalyzed  aldol  reactions, 
highlighted  the  paper  published  by  Ma,  in  which  they  detail  their  formal 
synthesis of the eastern fragment of PM 94128.
112 Their efforts were primarily 
concerned with reporting a method for the diastereoselective reaction of N,N 
dibenzyl α aminoaldehydes 182 with ketones 183 catalyzed by proline (Scheme 
2.5). This then was applied to the synthesis of PM 94128 1. 
 
Scheme 2.4. The reaction expanded by Ma et al. 
 
Ma  showed  that  L proline  catalyzed  the  direct  aldol  reactions  of  L 
aminoaldehyde  derived  dibenzyl  derivatives  with  a  range  of  ketones,  in 
moderate  to excellent  yields  and  stereoselectivites.  Ma’s  original  aim  was  to 
expand  the  scope  of  the  reaction  to  allow  for  the  use  of  functionalized 
aldehydes and/or ketones as well as a further demonstration of the benefits of 
the reaction methodology over more common approaches that use silyl ketene 
acetals, titanium homo enolates and boron enolates (these materials tend to be 
very moisture sensitive). Initial reactions between substituted  N phenylalanine 
and acetone showed good yields (48 to 98%) with up to 96% d.e. at the newly 
formed center. N Trityl phenylalanine was the best substrate for the reaction in 
terms  of  selectivity,  while  dibenzyl  phenylalaninal  had  near  quantitative 
conversion  but  selectivities  were  reduced  to  90%  d.e.  Table  2.1  highlights  a 
selection of Ma’s results.      Altering  the  stereochemistry  of  the  proline 
catalyst from  L to  D allowed the generation of the anti product. However the 
reaction  was  much  less  selective  for  the  anti product  and  the  diastereotopic 
excess was greatly reduced to 34%.  Chapter 2 – Isocoumarins and Isochromanones 
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Table 2.1. L Proline catalysed direct aldol reaction of dibenzyl aldehydes and ketones. 
 
The reaction of dibenzylleucinal and hydroxy acetone in HMPA (Entry 1) yielded 
anti diol (90%) and syn diol (4%).   Anti diol 185 was noted to resemble an 
advanced  intermediate  in  the  synthesis  of  PM 94128;  hence  the  ketone  was 
transformed into the corresponding acid via an oxidative cleavage reaction with 
sodium hypobromite then esterified to complete the synthesis of the diol ester, 
186 (Scheme 2.5)  
 
Scheme 2.5. Transformation of ketone 195 to ester 196. 
 
It  was  decided  that  Ma’s  work  represented  an  excellent  approach  to  the 
synthesis of the amino diol fragment of PM 94128, so it was decided to adopt 
this methodology with our bicycle synthesis. Chapter 2 – Isocoumarins and Isochromanones 
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2.1.2.  Initial synthetic efforts 
Our forward synthesis of 167 began with the esterification of Boc N Leucine 187. 
IBX oxidation of alcohol produced aldehyde 30 in 80% yield, it had been reported 
in  the  literature  that  Swern  oxidation  conditions  were  too  harsh  and 
epimerisation of the a carbon stereocenter would occur.
113 Attempts with the 
less basic/harsh SWERN like SO3.pyridine conditions failed to produce aldehyde 
30 (Scheme 2.6).         
Alkylation of aldehyde 30 was achieved using Grignard reagent (allyl magnesium 
bromide),  producing  the  homo allylic  alcohols  188  and  189  in  good  yield.
114 
However, the alkylation was non selective, with a ratio of 3:2 in favour of the 
anti diastereoisomer (188). Improvements to the selectivity were achieved by 
applying  Ghosh’s  conditions.
71  Allyl tributyltin  and  tin  tetrachloride  in 
dichloromethane gave, homo allylic alcohol 188 in much larger quantities than 
189 with a slight decrease in isolated yield (67%). The ratio of diatereoisomers 
could be improved from 5.8:1 to 10:1 in small scale experiments.              
 
Scheme 2.6. Generation of the homo allylic alcohols 199 and 200. 
 
The  inseparable  alcohols  188  and  189  were  treated  with  acrylic  acid  and 
dicyclohexylcarbodiimide (DCC) giving in 65% yield esters 190 and 191 that were 
separable  by  column  chromatography.
115 116  The  reaction  however  produced 
many side products, making purification difficult.  Chapter 2 – Isocoumarins and Isochromanones 
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Scheme 2.7. Esterification of homo allyic alcohols. 
An alternative approach was found using acryloyl chloride and triethylamine that 
generated esters 190 and 191, in much improved 96% yield (Scheme 2.8).
117,118 
Interestingly the reaction did not proceed with pyridine as solvent and base. 
 
Scheme 2.8. Acid Chloride esterification. 
 
In the 1960 and 1970s, interest in catalytic olefin metathesis reactions increased 
greatly.  In  its  simplest  form,  the  olefin  metathesis  reaction  consists  of  a 
redistribution  of  alkylidene  components.
119  In  1970,  Chauvin  and  Hérisson
120 
proposed  the  first  and  now  widely  accepted  cross metathesis  mechanism 
(Scheme  2.9).  The  mechanism  involves  the  [2+2]  cycloaddition  between  an 
alkene  double  bond  192  and  a  transition  metal  carbene  193  forming  a 
metallocycle intermediate 194. The metallocyclobutane intermediate produced, 
can  then  cyclorevert  reversibly  to  give  starting  material  or  a  new  metallo 
carbene  species  195,  which  can  then  under  go  a  second  [2+2]  cycloaddition 
giving  intermediate  196.  This  can  cyclo  revert  to  195  or  to  the  ring  closed 
alkene 197. The reaction is quicker than the uncatalyzed reaction because the 
activation energy is lowered through d orbital interactions on the metal. Chapter 2 – Isocoumarins and Isochromanones 
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Scheme 2.9. The mechanism for the ring closing metathesis reaction. 
 
Some 25 years later, Yves Chauvin, Robert Grubbs and Richard Schrock jointly 
won the Nobel prize for the development of the metathesis method in organic 
synthesis.  The  official  press release  contained  Figure  2.1  and  is  an  excellent 
analogy of the metathesis reaction. 
 
Figure 2.1. Schrock’s metathesis scheme.
121 
 
“Metathesis  can  be  viewed  as  a  dance  of  two  molecules,  with  a 
catalyst pair (left) that includes a metal (black) joining "hands" with 
an alkene (yellow/red) pair. The pair then join in a circle (center) and 
then go off with different partners (right)”. – Yves Chauvin
122 
Diene ester 190 had the correct stereochemistry so it was treated with 5 mol% 
Grubbs 1
st generation catalyst producing a pyrone 198 in good yield 78%.
115,117 
Using  Grubbs  2
nd  generation  catalyst  decreased  the  reaction  time  (48  to  36 
hours) and increased the yield to 79%. The structure was determined by NMR 
analysis and confirmed by X ray crystallography (Figure 2.2). Chapter 2 – Isocoumarins and Isochromanones 
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Scheme 2.10. Ring closing metathesis of diene ester 190. 
 
 
Figure 2.2. Xray structure of 198. 
 
Ester 191 was similarly treated with Grubbs 1
st generation catalyst, producing a 
pyrone 199 in 75% yield. 
The key step in our synthesis of the aminodihydroisocoumarin fragment 167 was 
the  Diels Alder  reaction  of  a pyrone  198  and  a  suitable  diene  174  (Scheme 
2.11). The choice of diene is key as it would allow us to set the second ring of 
the aminodihydroisocoumarin, but would also and provide significant scope for 
analogue generation. 
   
Scheme 2.11. The key Diels Alder reaction of our reaction sequence. Chapter 2 – Isocoumarins and Isochromanones 
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The  Diels Alder  reaction  is  the  cycloaddition  of  a  conjugated  diene  with  a 
dienophile (alkene or alkyne usually) involving the dienes 4p electrons and the 
dienophiles 2p electrons. The driving force of the reaction is the formation of 
new  s bonds, which are energetically more stable than the p bonds. For the 
reaction to proceed, an overlap of the molecular orbitals is required. It is the 
HOMO (Highest Occupied Molecular Orbital) of the diene which interacts with 
the LUMO (Lowest Unoccupied Molecular Orbital) of the dienophile. The Diels 
Alder reaction gives endo and exo adducts that arise from the reaction transition 
state, where the dienophile can adopt 2 orientations. The endo adduct is the 
kinetic product and is formed by a bonding interaction between the carbonyl of 
the dienophile and the developing p bond of the product. Figure 2.3 shows the 
molecular orbitals, HOMO and LUMO of the reactants and the expected endo and 
exo adducts. It is expected that the endo adduct will be the preferred product 
of the reaction, however a mixture of adducts would still give the same product 
upon aromatization (oxidation) in subsequent transformations.
123  
 
Figure 2.3. Diels Alder reaction. 
 
Initial  experiments  using  1 (trimethylsiloxy) 1,3 butadiene  201  and  a pyrone 
198  were  attempted  using  a  variety  of  solvents  and  Lewis  Acids  The  initial 
reactions were carried out in dichloromethane were unsuccessful, changing to 
higher boiling point solvents (i.e. benzene, toluene and xylenes) also failed to 
produce allylic alcohol 200.      Lewis acids have been reported to catalyse 
the  Diels Alder  reaction  so  it  was  decided  to  investigate  their  effect  on  our 
system.
124 127  The  use  of  Trimethylaluminium,  aluminium  trichloride  and 
diethylaluminium chloride was explored, however in all cases, no change to the 
reaction  outcome  was  observed.  The  use  of  higher  pressures  through  sealed 
tubes  also  failed  to  give  any  of  the  desired  products  (see  Appendix  1  for 
reaction conditions). Chapter 2 – Isocoumarins and Isochromanones 
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It was reasoned that a possible explanation for the lack of reactivity observed 
was  that  the  diene  was  not  electron  rich  enough  to  participate  in  the 
cycloaddition reaction, i.e. the HOMO and LUMO of the diene and dienophile 
were not close enough in energy. Hence we turned our attention to using a more 
electron rich diene and elected to use diene 202.                
202  is  a  modified  Brassard/Chan  diene,  where  the  C3  methoxy  group  of  the 
Brassard/Chan diene 203, has been moved to the C1 position. It also lacks the C3 
TMS ether of Danishefsky’s diene 204 (Figure 2.4). 
 
Figure 2.4. Comparisons between commonly used dienes. 
 
Diene 202 was made according to Molin’s procedure by treating freshly distilled 
methyl  crotonate  205  with  lithium  diisopropylamine  (LDA)  and  trapping  the 
resulting  enolate  with  trimethylsilyl  chloride  (Scheme  2.12).
128  When  the 
reaction was attempted using commercially available LDA and reagents straight 
from the bottle, no product was observed. Thus reagents had to be distilled and 
the LDA made fresh from nBuLi and iPr2NH. 
 
Scheme 2.12. Generating diene 202. 
 
The reaction between diene 205 dienophile 198, was attempted at relatively 
low  temperatures  (refluxing  dichloromethane),  but  no  reaction  could  be 
detected. Switching to higher boiling solvents (benzene, toluene or xylene) with 
and  without  aluminium  Lewis  acids  failed  to  change  the  reaction  outcome 
returning only a pyrone and diene degradation products. 
Faced with the lack of success the modified tbutyldimethylsilyl diene 206 was 
synthesized. It was thought that the presence of the TBDMS group would make 
the diene more stable than diene 202. This extra stability resulted in much less Chapter 2 – Isocoumarins and Isochromanones 
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degradation of the diene over the prolonged reaction times. To further combat 
the dienes instability problems, smaller batches of the diene were made on a 
regular  basis  so  as  to  avoid  degradation  during  storage  (see  Appendix  2  for 
details  of  reaction  conditions).  Frustratingly  there  remained  no  reaction 
progress. 
 
Scheme 2.13. Modifications to the Diels Alder reaction. 
 
Finally  we  turned  our  attention and efforts  to  microwave  chemistry  (Scheme 
2.14). Various conditions were examined in which equivalents, concentrations, 
reaction duration and importantly temperature were varied to try and achieve a 
favourable  reaction  outcome.  There  was  however,  no  successful  outcome 
observed (see Appendix 3 for reaction conditions). 
 
Scheme 2.14. Attempts to synthesize 200 
 
The use diphenyl ether as the reaction solvent gave what appeared to be a trace 
(by  TLC  analysis)  of  the  product.  Unfortunately,  further  exploration  of  the 
reaction using higher temperatures and various reaction times, returned only a 
pyrone 198 and diene degradation (see Appendix 3 for reaction conditions).  
Finally  the  reaction  was  attempted  without  solvent  increasing  the 
concentrations further (see Appendix 4 for reaction conditions) with no success. 
Faced with the continuous lack of success during the Diels Alder cycloadditions a 
new approach was developed. Chapter 2 – Isocoumarins and Isochromanones 
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2.2.  An alternate approach 
Our alternate approach was based on a modified version of the Achmatowicz 
rearrangement  which  if  successful  would  provide  access  to  a  number  of 
interesting targets including Ajudazol A (a synthetic target within the Marquez 
group).  
The  Achmatowicz  rearrangement  was  first  reported in  1971.  It  produces  a,b 
unsaturated  pyranones  208  from  a hydroxyfurans  209  under  epoxidising 
conditions.
129 131  
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Scheme 2.15. Conversion of hydroxy furans to pyranones. 
 
The  accepted  mechanism  for  the  rearrangement  involves  hydroxyl  directed 
epoxidiation of the allylic position of furan 208 across the C2 C3 olefin (Scheme 
2.16). A 6 electron movement occurs around the ring, opens epoxide 210, to 
yield zwitterion 211. Carbonyl formation causes the ring to open and generate 
1,4 diketone  212.  An  intramolecular  nucleophilic  attack  of  the  free  hydroxyl 
onto the adjacent ketone closes the ring and generates hemi acetal 209. The 
stereochemistry in the a hydroxyfuran is retained in the product. As expected 
the a anomer is the major product due to the anomeric effect. 
 
Scheme 2.16. Achmatowicz rearrangement 
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There have been many conditions reported for the rearrangement to date, the 
most  popular  being  N bromosuccinimide/water
132 134  and  vanadyl 
acetoacetonate/tertbutyl  hydrogen  peroxide.
135 137  Other  conditions  that  have 
also  been  reported  include  hydrogen  peroxide,
138,139  pyridinium 
chlorochromate,
141  meta chloroperoxybenzoic  acid
141  molecular  oxygen  (with 
tetraphenylporphine
142,143  or  rose  bengal
144,145).  Sharpless  asymmetric 
epoxidation conditions have also been reported introducing a resolution step as 
part of the rearrangement.
146 148 
The Achmatowicz rearrangement has found widespread use in organic chemistry, 
particularly in natural product synthesis, where it has been widely utilized to 
generate substituted pyrans.   The rearrangement can tolerate a wide range 
of substrates bearing complex functionality, being utilized in the syntheses of 
Isoaltholactone (A),
149 Yessotoxin (B)
150 and Mycopoxidene(C).
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Figure 2.5. The Achmatowicz rearrangement in natural product synthesis. 
 
While  the  reaction  has  gained  widespread  use  in  organic  chemistry  there  is 
further scope for its application, there are fewer than twenty examples (based 
upon SciFinder
® searches) where the furan has substituent’s at either the C3 or 
C4 positions. Only three examples have been reported where both the C3 and C4 
positions are substituted.                             
However  despite  the  lack  of  literature  precedence  it  was  reasoned  that  an 
Achmatowicz rearrangement reaction of an a hydroxyisobenzofuran 213 would 
provide bicyclic lactols 214, which could be further functionalised, to generate Chapter 2 – Isocoumarins and Isochromanones 
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isochromanones  (corresponding  to  the  Ajudazols)  and  Isocoumarins 
(corresponding to the PM 94128 family of molecules). 
 
Scheme 2.17. Our proposed application of the Achmatowicz rearrangement. 
 
Based on this hypothesis a new model system was designed in which both the 
Isocoumarin (PM 94128) 215 and Isochromanone (Ajudazol) 216 core structures 
could originate from reduction of keto lactone 217 (Scheme 2.18). Keto lactone 
217  could  be  obtained  through  the  oxidation  of  Achmatowicz  rearrangement 
product 214. Lactol 214 would in turn originate from the rearrangement of a 
hydroxyisobenzofuran  213  which  could  be  obtained  by  alkylation  of 
isobenzofuran 218. 
 
Scheme 2.18. Model synthesis design. 
 
2.2.1.  Model system synthesis 
Most  of  the  methods  reported  to  date  involve  the  generation  of  substituted 
isobenzofurans. 
Bis Grignard addition to phthalide 219 followed by treatment of the subsequent 
lactol with acid has been used to generate 1,3 diarylisobenzofurans 220. The Chapter 2 – Isocoumarins and Isochromanones 
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first alkylation is presumably at the anomeric position, displacing the methoxy 
group  as  a  result.  The  second  addition  at  the  lactone  gives  a  hemi acetal 
intermediate  that  upon  treatment  with  hydrochloric  acid  the  hydroxyl  is 
eliminated as water resulting in aromatisation.
152  
O
O
OMe
O
Ar
Ar
1) 3x ArMgBr, THF
2) HCl
43-99%
219 220  
Scheme 2.19. Double Grignard addition generating isobenzofuran 227 
 
Retro Diels Alder reactions of bridged ether type compounds 221 using pyridyl 
tetrazine  reagents  has  also  resulted  in  substituted  isobenzofuran  generation 
(Scheme  2.20).
153,154  221  is  synthesized  from  treatment  of  1,2,4,5 
tetrakis(trimethylsilyl)benzene with an iodonium triflate then further reaction 
with furan. 221 is then reacted with with 3,6 di 2 pyridyl 1,2,4,5 tetrazine in 
chloroform at reflux temperature generating isobenzofuran 222 via a retro Diels 
Alder reaction pathway.
155 
 
Scheme 2.20. Cycloaddition resulting in isobenzofuran formation.  
 
Cycloadditions between ketimines 224 and an excess of benzaldehyde 223 in the 
presence  of  a  Rhenium(I)  catalyst  have  been  used  successfully  to  generate 
isobenzofurans.
156 C H insertion of the rhenium and nucleophilic attack onto the 
benzaldehyde electrophile followed by cyclisation, gives an aminal intermediate 
that undergoes oxidative elimination of the N rhenium species resulting in 225 
formation (Scheme 2.21). 
 
Scheme 2.21. Rhenium catalyzed isobenzofuran synthesis. 
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Acidic elimination methods to achieve aromatisation have also been reported. 
Scheme 2.22 shows Da Ming’s synthesis of bis methoxyisobenzofuran 227 from 
lactol 226 which was treated with acetic acid in chloroform, resulting in the 
elimination of water and a proton.
157 
 
Scheme 2.22. Acidic dehydration resulting isobenzofuran formation. 
 
Similarly base mediated elimination methods can yield isobenzofuran compounds 
(Scheme 2.23). Treatment of methyl acetal 228 with lithium diisopropylamine 
has been used in its transformation to isobenzofuran 229. Deprotonation results 
in elimination of the methoxide and aromatization.
158 
 
Scheme 2.23. Synthesis of aromatic polycycle 236. 
 
A different method for generating isobenzofurans from methyl acetals 230 was 
reported by Mikami using palladium(0) catalysis.
159 Mechanistically there is an 
initial oxidative insertion of the palladium into the C O acetal bond, followed by 
elimination giving isobenzofuran 218 (Scheme 2.24). 
 
Scheme 2.24.Several Pd(0) catalysts were examined in this reaction.  
 
Despite the fact that there are a number of ways to generate isobenzofurans 
their synthetic use has largely been limited to their use as highly reactive dienes 
in Diels Alder reactions (Scheme 2.25).
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Scheme 2.25. Diels Alder reaction of isobenzofuran 225. 
 
But there are very few other examples of the use of these molecules, other than 
as reactants in Diels Alder reactions. 
Scheme  2.26.  shows  the  limited  use  isobenzofurans  have  received. 
Mohanakrishnan conducted a study of the optical and electrochemical properties 
of  diarylbenzo[c]selenophenes  and  their  subsequent  correlation  with  their 
structures.
163  A  series  of  selenophenes  232  was  synthesized  from  the 
corresponding isobenzofurans 220 in good yields using Woolin’s reagent (Scheme 
2.26  A).  The  photochemical  reactivity  of  substituted  isobenzofuran  233  was 
examined  by  Yoshida  in  1992  (Scheme  2.26  B),  whereby  irradiation  of 
isobenzofuran  233  gave  234  by  photovalence  isomerisation.
164  Carloni 
investigated  the  reactivity  of  isobenzofurans  towards  singlet  oxygen  (Scheme 
2.26 C), evaluating 225s suitability for biological radical detection. Oxygen and 
carbon centred radicals were reacted with 225 and the subsequent change in 
fluorescense  monitored.
165  Finally  aromatic  isobenzofurans  220  have  been 
transformed into thia naphthalenes in three separate studies. Dufraisse utilized 
thia napthalene compounds as a starting material in pyrolysis reactions with the 
aim  of  synthesizing  anthracene  (and  derivatives).
166  In  1960  Deana  and  co 
workers  synthesized  thia napthalene  derivatives  from  isobenzofurans  using 
carbon  disulfide  (as  Dufraisse  did  in  1937)  with  the  goal  of  generating 
benzocyclobutenes from pyrolysis of 236.
167 Swager reported in 2008 the use of 
thia napthalenes  (and  isobenzofurans)  as  potential  biological  chromophores 
using  in  vivo  near infrared  (NIR)  fluorescence.
168  It  was  also  found  that  236 
could be generated from 220 upon treatment with Lawesson’s reagent (Scheme 
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Scheme 2.26. Reported uses of isobenzofurans. 
 
For our approach the procedure of Crump and Rickborn was selected,
169 wherein 
isobenzofurans  are  generated  from  acetals  through  the  use  of  base.  This 
approach was ideal for our purposes, as mechanistically it involved the likely 
generation  of  the  isobenzofuran  anion.  Trapping  of  this  anion  with  an 
appropriate  aldehyde  would  provide  the  desired  alcohol  precursor  for  the 
rearrangement. 
Our  synthesis  began  with  phthalide  237  which  was  carefully  reduced  to  the 
corresponding lactol by treatment with 1 equivalent diisobutylaluminium hydride 
(Scheme 2.27). It was found that lactol 238 readily reacted with any excess of 
DiBAl H therefore reducing the reactive benzaldehyde intermediate 239 to the 
known  1,2 Benzenedimethanol  240.
170  The  isolation  and  purification  of  lactol 
238 proved problematic as the lactol opened readily to the aldehyde alcohol 
239.  Characterisation  proved  even  more  difficult  as  NMR  analysis  with  non 
hydrogen bonding deuterated solvents such as D6 benzene failed to resolve the 
spectra.  Hence  it  was  decided  to  alkylate  the  lactol  directly  and  bypass  the 
isolation  step.  Treatment  of  the  lactol  238  with  1.2  equivalents  of  sodium 
hydride and methyl iodide (filtered through basic alumina to remove traces of 
HI) at 0 
oC gave acetal 230. The acetal proved to be less prone to ring opening Chapter 2 – Isocoumarins and Isochromanones 
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and degradation; however it was made in small batches to avoid this problem all 
together. 
 
Scheme 2.27. Reduction of phthalide to methyl acetal 247. 
 
a Hydroxyisobenzofuran 249 was generated in one pot from methyl acetal 230 
by treatment with diisopropylamine and methyl lithium in tetrahydrofuran by 
modification of the protocol described by Crump and Rickborn.
169 It is believed 
that during the reaction an in situ catalytic quantity of LDA is generated which 
deprotonates  methyl  acetal  230.  The  subsequent  movement  of  electrons  (an 
aromatisation process) causes elimination of the methoxy group which leaves 
presumably  as  a  methoxide  ion.  Deprotonation  of  the  newly  generated 
isobenzofuran  molecule  218  gives  anion  240  which  upon  trapping  with 
isobutryaldehyde furnished the desired a hydroxyisobenzofuran 241. Crump and 
Rickborn quenched anion 240 with D2O and detected deuterium incorporation. 
 
Scheme 2.28. Synthesis of isobenzofuran alcohol 241.  
 
Attempts  to  isolate  isobenzofuranyl  alcohol  241  (via  silica  gel  and  neutral 
alumina  chromatography)  resulted  in  complete  degradation  of  the  highly Chapter 2 – Isocoumarins and Isochromanones 
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reactive  intermediate.  Thus  it  was  decided  to  react  the  crude  alcohol  241, 
under Achmatowicz rearrangement conditions (meta chloroperoxybenzoic acid in 
dichloromethane at 0 
oC) to avoid these purification issues. Thus lactol 242 was 
generated;  although,  the  lactol  also  proved  to  be  too  unstable  to  withstand 
purification. It was decided to oxidize the crude lactol 242 using Jones reagent 
gave  keto lactone  compound  243.  Unfortunately  purification  by  flash  column 
chromatography degraded 243 readily. Exchanging the solid phase for neutral 
alumina  greatly  reduced  decomposition,  however  the  molecule  could  not  be 
obtained  in  high  enough  purity.  At  this  point  it  was  decided  to  reduce  the 
ketolactone  243  to  the  more  stable  isochromanone  244  under  Luche 
conditions.
171 A facially selective (regioselective) reduction of the ketone was 
observed, to generate the syn diastereoisomer (Scheme 2.29).  
 
Scheme 2.29. Model system synthesis. 
 
The structure of 244 was assigned by NMR studies and later corroborated by X 
ray studies of the crystalline solid. 
 
Figure 2.6. The structure of 244 as solved by X ray analysis. 
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To assess the anomeric ratio of products from the Achmatowicz rearrangement, 
the  unstable  lactol  242  was  resynthesized  and  protected  immediately  as  the 
acetate  (Scheme  2.30).  A  4.6:1  ratio  of  anomers  was  observed  in  the  crude 
reaction mixture, with the a product the predominant anomer. This is consistent 
with other examples of the rearrangement in organic synthesis.
 149 151 
 
Scheme 2.30. Acetylation of lactol 250. 
 
To expand and explore the scope of the rearrangement the reaction sequence 
was carried out using a number of structurally diverse aldehydes as substrates 
(Table 2.2).  Chapter 2 – Isocoumarins and Isochromanones 
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Table 2.2. Table of aldehydes used in our reaction sequence. 
 
Keto lactones  243,  247  to  255  were  synthesized  as  per  the  4  step  reaction 
series described in Scheme 2.29 in good to excellent yields.  
Isochromanones 252 to 264 272 were then transformed from the corresponding 
lactones using the established Luche conditions, see Table 2.3. In all cases the 
expected chemo selectivity was observed (ketone reduction).         
Analysis of the isochromanone  syn:anti ratios showed that sterically hindered 
tertiary carbons and quaternary carbons provided complete selectivity, with the 
syn  product  being  the  preferred  diastereoisomer.  Linear,  unbranched  carbon 
chains were less selective, with no selectivity observed in the methyl example 
264 (Entry 2) in the R position while an increase in selectivity was observed as 
the alkyl chain increased in length (Entries 3 and 4)  Chapter 2 – Isocoumarins and Isochromanones 
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Table 2.3. Isochromanones 244, 256 264. 
 
The syn:anti relationships of the isochromanones were determined with 
1H NMR 
analysis.  Wherein  a  small  coupling  of  less  than  2.5  was  observed  for  syn 
compounds, while a larger coupling was observed for anti compounds (Jab syn ≤ 
2.5 Hz; Jab anti ≥ 6.0 Hz). 
X ray crystal structures were successfully obtained for the syn ethyl phenyl 264 
and  cyclohexyl  isochromanones  261.  264  was  separable  from  the  anti 
diastereoisomer by crystallisation (diethyl ether: petroleum spirits). The crystal 
structures  obtained  corroborated  the  success  of  the  isobenzofuran 
rearrangement as well as confirmed the syn relationship between the C8 and C9 
stereocenters.  Chapter 2 – Isocoumarins and Isochromanones 
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Figure 2.7. The structures of 261 and 264 as solved by X ray analysis. 
 
The  results  were  encouraging,  in  that  a  large  amount  of  functionality  was 
tolerated in the Achmatowicz rearrangement and subsequent transformations. 
Indeed phenyl and cyclohexyl groups, that would create steric tension at the 
newly  formed  stereocenter,  were  tolerated.  We  therefore  began  to  look  at 
synthetic applications of our methodology. 
2.2.2.  Studies towards the synthesis of Ajudazol A  
Retrosynthetically, we envisioned Ajudazol A 2 as originating from the palladium 
promoted coupling of bromide 266 and oxazole 265.  Chapter 2 – Isocoumarins and Isochromanones 
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Scheme 2.31. Retrosynthesis of the Ajudazols 
 
The  oxazole  substituted  isochroman 1 one  unit  265  was  thought  of  as  being 
obtained through the coupling of the isoxybenzofuran anion 267 and aldehyde 
268 followed by treatment of the resulting alcohol under our recently developed 
rearrangement conditions. The isobenzofuran anion 267 could be accessed from 
the methyl acetal 269, while the oxazole aldehyde 268 could originate from 
ester 270. Bromide 266 on the other hand could be formed by the condensation 
of  amine  271  and  methoxybutenoic  acid  106.  Bis alkyne  271  could  in  turn 
originate from the double acetlyation of butadiyne unit 272 (Scheme 2.31). 
In  order  to  assess  the  effect  of  the  aldehyde  C10  stereocenter  on  the 
stereochemical  outcome  of  the  isobenzofuran  alkylation  and  rearrangement 
sequence  a  further  model  system  was  designed.  2 (±) Methylbutyraldehyde 
(secbutyaldehyde) was chosen as the model as it represents the first 3 carbons of 
the Ajudazols aliphatic fragment.        Chapter 2 – Isocoumarins and Isochromanones 
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2 Methylbutyraldehyde was condensed with isobenzofuran anion 240 and then 
oxidised  using our  developed protocols  to  yield  the  consequent  keto lactones 
274 and 275 that were obtained in a 1.6:1 ratio of diastereoisomers with the 
anti compound (274) the preferred conformation (Scheme 2.32). 
 
Scheme 2.32. Formation of diastereoisomers, 283 and 284. 
 
The selectivity of the reaction can be explained using the Felkin Ahn model for 
addition to carbonyls.
172 The model predicts the 2 lowest energy non eclipsed 
conformations that the aldehyde can adopt. In both conformations the carbonyl 
is orientated perpendicular to Rlarge (in this case the ethyl group). Given that the 
nucleophile  (the  isobenzofuran  anion  240)  will  attack  the  aldehyde  carbonyl 
along  the  Burgi Dunitz  angle  of  ~107
o.  The  favoured  conformation  for  the 
aldehyde has the carbonyl orientated between Rlarge (ethyl group) and Rmedium 
(methyl  group)  such  that  the  nucleophile  (Nu
 )  will  ‘pass’  the  hydrogen 
(conformation  A)  rather  than  the  methyl  (conformation  B)  (Figure  2.8). 
Conformation A is the preferred conformation and the predicted product of this 
model will come via this orientation. 
 
Figure 2.8. Felkin Ahn conformations for the addition of the isobenzofuran anion. 
 
When either enantiomer of 2 methylbutyraldehyde adopts conformation A the 
product of the addition reaction has the syn relationship. This opposite is true 
when the aldehyde adopts conformation B, the result with either enantiomer is 
the anti product.  Chapter 2 – Isocoumarins and Isochromanones 
 
  70 
It is hypothesized the anti product is present because the substituents Rsmall and 
Rmedium  (hydrogen  and  methyl  respectively)  are  not  sufficiently  size 
differentiated for there to be full steric control over the addition. 
When  274  and  275  where  reacted  under  our  established  Luche  reduction 
conditions 2 products were obtained, this is consistent with the facially selective 
reduction observed before. The relative stereochemistry of these products was 
determined by NMR analysis of coupling between C8 and C9 hydrogens. As before 
couplings  of  ≤  2.5  Hz  were  observed  in  both  276  and  277  indicating  a  syn 
relationship between these groups.  
 
Scheme 2.33. Synthesis of 276 and 277.  
 
This relationship was later confirmed by X ray crystallographic analysis of the 
syn:anti  compound  276  (Figure  2.9)  as  276  was  separable  from  277  by 
recrystallisation (diethyl ether: petroleum ether). 
 
Figure 2.9. The structure of 276. 
 
With  the  desired  syn:anti  compound  in  hand  we  were  confident  that  this 
methodology could be applied to the synthesis of the Ajudazols as stereocenter 
inversion is a well documented transformation (see section 2.2.3). Chapter 2 – Isocoumarins and Isochromanones 
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Synthesis of the oxazole coupling partner began with D,L Serine methyl ester 278 
which was converted to oxazoline 279 by cycloaddition reaction in moderate 
yield  according  to  Leahy’s  protocol.
173  Unfortunately  aromatisation  of  the 
oxazoline using Leahy’s method (copper(II) bromide, hexamethyl tetraamine and 
1,8 Diazabicyclo[5.4.0]undec 7 ene) gave poor conversion (up to 28% yield). The 
low yield is most likely due to the difficult work up caused by the copper salt by 
products  of  the  reaction.  The  work up  involved  treatment  of  the  reaction 
mixture with aqueous ammonium salts that resulted in dark blue aqueous and 
organic phases that were very close in colour and therefore difficult to separate. 
Nicolaou’s  conditions
174  bromotrichloromethane  and  1,8 
Diazabicyclo[5.4.0]undec 7 ene,  increased  the  yield  to  55%  and  made  the 
reaction considerably easier to work up and purify. 
 
Scheme 2.34. Synthesis of oxazole 270 
 
Oxazole ester 270 was then reduced with diisobutylaluminium hydride to the 
corresponding  alcohol  in  good  yield.  Interestingly  lithium  aluminium  hydride 
proved to be too strong/harsh a reagent as reduction of the oxazole heterocycle 
was  observed  along  with  the  desired  alcohol  280.  Oxidation  of  the  primary 
alcohol  gave  aldehyde  281  in  good  yield,  both  IBX  and  Swern  oxidation 
conditions produced the same quantities of the desired aldehyde (Scheme 2.35).  
 
Scheme 2.35. Oxidation to aldehyde 281. 
 
Wittig  olefination  reaction  of  aldehyde  281  gave  ester  282,  interestingly  it 
required  higher  temperatures  (vigorously  refluxing  toluene  at  120 
oC)  to 
proceed.  The  use  of  dichloromethane  and  benzene  gave  no  reaction  product 
whatsoever.  This  is  not  surprising  considering  the  hindered  natured  of  the 
phosphonate used.  Chapter 2 – Isocoumarins and Isochromanones 
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[1,2] Reduction of the ester yielded allylic alcohol 283 that was further reduced 
with palladium on carbon to give racemic alcohol 284. Simultaneous [1,2] and 
[1,4]  reduction  of  the  a,b  unsaturated  ethyl  ester  282  was  attempted  using 
lithium aluminium hydride, unfortunately gave mixtures of allylic hydroxyl 283, 
saturated alcohol  284 and what appeared to oxazole reduction side products 
(reduction in a [1,6] fashion).                
Finally  oxidation  of  alcohol  284  under  Swern  conditions  yielded  the  desired 
aliphatic aldehyde 285. Oxidation of the alcohol using IBX gave the aldehyde in 
similar yields. Ease of purification and safety concerns during scale up made the 
Swern oxidation the preferred procedure. 
 
Scheme 2.36. Synthesis of aldehyde 285. 
 
Coupling of aldehyde 285 with isobenzofuran anion 240, as per our procedure, 
gave a lactol 286 that were oxidised immediately to the corresponding lactones 
287 and 288. Reduction of the lactones under Luche conditions gave the 289 
(syn:anti) and 290 (syn:syn) diastereoisomers in 3:2 ratio respectively. Chapter 2 – Isocoumarins and Isochromanones 
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Scheme 2.37. Synthesis of the Ajudazol model system. 
 
As  with  previous  examples  complete  syn  selectivity  during  the reduction  was 
observed.  The  structure  and  stereochemistries  were  corroborated  by  X ray 
analysis  of  the  major  diastereoisomer  289,  which  could  be  selectively 
crystallized. 
 
Figure 2.10. Crystal structure of Ajudazol model system. 
 
2.2.3.  Mitsunobu inversion 
The Ajudazol isochromanone ring system has the anti:anti relationship between 
groups.  To  examine  the  feasibility  of  inverting  the  hydroxyl  group,  289  was 
treated  with  4 nitrobenzoic,  diisopropylazadicarboxylate  and  triphenyl 
phosphine as per Mitsunobu conditions. The reaction successfully produced the 
benzoate ester 291 matching the stereochemistry present in the western section 
of the Ajudazols.
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When  diethylazadicarboxylate  (DEAD)  was  used  as  the  acid  activation  agent, 
none of the benzoate product was observed. 4 Nitrobenzoic acid was used as the 
nucleophile in the hope that the nitro benzoate 291 might have been induced to 
crystallize. 
 
Scheme 2.38. Mitsunobu inversion of alcohol 299. 
 
The Mitsunobu reaction works by phosphorous addition to the weak N=N p bond 
of  diisopropylazodicarboxylate  giving  an  anion  292  that  is  basic  enough  to 
remove the alcohol proton. The alkoxide intermediate 293 can then attack the 
phosphonium cation 294, displacing the amine. The final step is displacement of 
the phosporous oxonium 295 by the nucleophile (4 nitrobenzoic acid) in an Sn2 
manner giving ester 291. 
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Scheme 2.39. Mitsunobu mechanism 
 
Removal of the nitro benzoate group was not attempted at this point as there 
was insufficient material to conduct the experiment. Chapter 2 – Isocoumarins and Isochromanones 
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Having successfully generated nitro benzoate 290, it was possible to compare its 
NMR against that of Ajudazol A  2. The analysis  showed that  290 had almost 
identical coupling constants (± 0.1 Hz) to that observed in 2 and therefore the 
correct stereochemistry. 
 
                Ajudazol A 2                  p  NO2 ester 290
Atom d =  J ab =  d =  J ab = 
C8 4.8 6.5 6.4 6.4
C9 4.4 6.7 4.6 6.8  
Table 2.4. C8 C9 proton couplings in 2 and 290. 
 
Having successfully achieved the synthesis of the Ajudazol model system it was 
decided to investigate whether reduction of the C8 ketone could be achieved 
where the  anti product was favoured rather than the  syn reduction products 
observed so far. Keto lactone 251 was selected as a test substrate as it had 
previously  given  only  one  syn product.  Unfortunately  treatment  of  251  with 
borane  (as  tetrahydrofuran  and  dimethyl  sulfide  complexes)  gave  only 
degradation  products  with  none  of  the  starting  material  or  desired 
isochromanone  products  recovered.  Catecholborane  was  unreactive  with  this 
substrate (Scheme 2.40).  
 
Scheme 2.40. Attempted borane reduction of keto lactone 251.  
 
2.2.4.  An unexpected product 
As part of our aldehyde screening (Table 2.2 andTable 2.3), tiglic aldehyde was 
chosen  to  test  our  methodology.  Tiglic  aldehyde  is  a  potentially  very  useful 
substrate  but  also  potentially  dangerous  from  a  side  reaction  point  of  view Chapter 2 – Isocoumarins and Isochromanones 
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(Scheme 2.41). Utilizing tiglic aldehyde as per our conditions gave 1 product in 
8% yield. The product observed, was believed to be 296 and 297. However, on 
closer examination of the NMR data it was noticed that there were no signals 
corresponding  to  an  olefin  in  the 
13C  NMR  spectra.  There  where  however,  4 
signals between 42 and 57 ppm, which based on other similar compounds, no 
signals in this region were expected.  
 
Scheme 2.41. The expected products using tiglic aldehyde. 
 
Mass spectrometry of the product showed a peak at 301 m/z in both FAB and CI 
modes, while infrared spectroscopy showed no absorptions corresponding to a 
hydroxyl group. There was an absorption in the IR spectra at 820 cm
 1 which 
could potentially be attributed to an epoxide. Crystallization of the unknown 
product allowed  the use  of  X ray analysis  that  revealed  a  very  different  and 
unexpected bridged tetracycle 298 (Figure 2.11).  
 
Figure 2.11. The unexpected product. 
 
Mechanistically we believe that the isobenzofuran anion 240 was formed and 
coupled with tiglic aldehyde as expected. At this point the isobenzofuran 299 
undergoes a Diels Alder reaction with the excess tiglic aldehyde present, giving Chapter 2 – Isocoumarins and Isochromanones 
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the endo product 300 solely; this then lactonizes to give 301. Treatment with 
mCPBA  then  epoxidizes  the  dimethyl double  bond  giving  302,  finally  Jones 
reagent oxidises  the lactol  to  give  the  observed  lactone epoxide  298  via  the 
oxygen cation 303 and the chromate diol 304 intermediates. 
 
Scheme 2.42. Proposed mechanism for the generation of bridged ether 298. 
 
2.2.5.  Studies towards the Ajudazol A C15-C29 fragment. 
Our synthesis began with propane 1,3 diol 305 which was mono protected as the 
THP  ether  306  under  mildly  acidic  conditions
84  in  acceptable  55%  yield.  The 
alcohol functionality was then to either a bromide 307
178(via an Appel reaction 
in 29% yield), or to the corresponding tosylate 308
179 (68% yield), Scheme 2.43. 
 
Scheme 2.43. Synthesis of coupling partners 307 and 308. 
 
Treatment of TMS butadiyne 309 with methyllithium lithium bromide complex 
gave  the  mono desilylated  anion  that  was  treated  with  bromide  307,  then 
potassium carbonate to give the mono alkylated alkyne 310. Using bromide 307 Chapter 2 – Isocoumarins and Isochromanones 
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as  coupling  partner  proved  highly  problematic,  as  during  the  reaction  an 
insoluble black material was formed that made extractions/filtration difficult. It 
was  also  discovered  that  a  dihalide  containing  impurity  was  present  in  the 
bromide  coupling  partner,  resulting  in  poor  38%  yield  when  compared  to 
Fiandanese’s
180 or Hennies
181 procedure that obtained 56% yield of 310.  
Changing  the  leaving  group  to  a  tosylate  resulted  in  a  much  more  efficient 
reaction as yields were improved to 78% and did not result in the formation of 
the problematic side products (Scheme 2.44). 
OTHP
TMS TMS
1) MeLi. LiBr, THF
2) X(CH2)3OTHP
3) K2CO3, MeOH
X = Br, 39%
X = OTs, 78%
309 310
 
Scheme 2.44. Synthesis of the Ajudazol side chain. 
 
Unfortunately  attempts  to  further  alkylate  the  terminal  alkyne  have  been 
unsuccessful. Initially the alkyne 314 was treated with nbutyl lithium then 2,3 
dibromopropene, the conditions were altered to include larger quantities of base 
and  longer  deprotonation  times,  with  no  success,  returning  only  unreacted 
starting material.  
 
Scheme 2.45.Alkylation attempts of 310  
 
Upon examination of the literature, Tuyét’s copper catalysed allylic substitution 
of  terminal  alkynes  was  found.
182  Tuyét  reports  that  treatment  of  various 
terminal alkynes with a variety of allylic halides in the presence of copper(I) 
salts,  tetrabutylammonium  chloride  and  potassium  carbonate  gave  allyl 
substituted  acetynic  compounds;  thus  alkyne  310  was  applied  to  Tuyét’s 
conditions.  Unfortunately  none  of  the  desired  bromo compound  311  was 
obtained, so the temperature of the reaction was increased incrementally to 
much higher temperatures (up to 140 
oC), with no change (Scheme 2.46). Due to Chapter 2 – Isocoumarins and Isochromanones 
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time  constraints  there  has  been  no  time  to  further  investigate  this  alkyne 
allylation step. 
 
Scheme 2.46.Tuyét’s alkylation conditions. 
 
2.3.  Future work 
Despite  the  success  in  having  shown  that  isobenzofurans  are  reactive 
intermediates with significant potential, there are still a number of issues that 
still need to be addressed. 
2.3.1.  Introduction of the C8 hydroxyl 
The  first  obstacle  to  overcome  will  be  the  introduction  of  the  hydroxyl 
functionality; this can be achieved by several means. 
Treatment  of  phthalic  anhydride  312  with  zinc  borohydride  according  to 
Kayser’s procedure,
183 results in complete reduction at the A position, Scheme 
2.47.  The  selectivity  observed  is  due  to  chelation  of  the  zinc  borohydride 
between the carbonyl and methyl ether group. The opposite selectivity can be 
achieved using L selectride, which because of steric hindrance cannot reduce 
the A position carbonyl, resulting in the formation of 314. This method would be 
particularly useful because it allows the generation of both phthalides 313 and 
314.  
 
Scheme 2.47. Introduction of the hydroxyl. 
 
The  choice  of  protecting  group  is  also  important  here,  a  sterically  large 
protecting  group  is  likely  to  block  that  face  of  the  anhydride,  preventing Chapter 2 – Isocoumarins and Isochromanones 
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reduction of the anhydride 312 at the A position. It is also likely that reduction 
of the lactone 314 to the desired lactol would be impeded by the protecting 
group.  We  believe  a  large  protecting  group  is  needed  for  alkylation 
regioselectivity  (see  2.3.2),  should  problems  be  encountered  perhaps  a 
protecting group exchange sequence could be required. 
Hydroxy phthalide 316 can also be obtained from the formylation of diol 315 
upon  treatment  with  tin  tetrachloride,  triethylamine  and  formaldehyde.  The 
reaction proceeds by reaction of diol 315 with tin to give the phenoxide salt 
that gives intermediate 317 upon treatment with formaldehyde. Enolisation to 
the corresponding phenol is followed by oxidation with a second molecule of 
formaldehyde giving intermediate 318 which undergoes lactonisation and a third 
oxidation step to give phthalide 316 (Scheme 2.48).
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Scheme 2.48. Synthesis of phthalide 316. 
 
Protected  salycilate  319  can  be  functionalised  to  obtain  phthalide  321. 
Conversion of the acid functionality to the corresponding amide using diethyl 
amine  and  thionyl  chloride  would  then  give  the  substrate  for  a  formylation 
reaction. Reduction of the aldehyde group in 320 by sodium borohydride would 
allow lactonisation to occur, giving phthalide 321.
185 
 
Scheme 2.49.Vilsmeier reaction of salicylate 319. Chapter 2 – Isocoumarins and Isochromanones 
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2.3.2.  Alkylation regioselectivity 
During the aromatization of acetal 230, the second deprotonation can occur on 
either  face  of  the  isobenzofuran  molecule.  When  the  isobenzofuran  is 
desymmetrized (i.e. incorporating the C8 hydroxyl functionality), deprotonation 
at the isobenzofuran C3 position is preferred. It is hoped that a sterically bulky 
protecting group on the hydroxyl would enhance the regiochemistry by blocking 
the C1 hydrogen from the methyl anion leaving the C3 proton unhindered. A 
trityl  (Tr)  or  triisopropylsilyl  (TIPS)  ether  group  should  provide  the  necessary 
steric bulk required for selectivity. Using a trityl group would have the added 
bonus  of  not  requiring  a  deprotection  step  as  the  Jones  oxidation  conditions 
would be acidic enough to facilitate cleavage of the group. 
 
Scheme 2.50. Regioselective contol of alkylation. 
 
2.3.3.  Enantiopure Aldehyde 
Having addressed the region chemistry of isobenzofuran alkylation, enantiopure 
aldehyde  268  will  be  incorporated  into  our  synthesis  as  per  Scheme  2.29. 
Aldehyde 268 will be synthesized by one of two means from a,b unsaturated 
ester  323,  depending  on  where  in  the  sequence  the  chirality  need  be 
introduced. Treatment of 323 with Stryker’s reagent (chiral cuprate reagent), 
should give optically pure ester 324,
186 that could be further reduced to the 
corresponding alcohol then oxidised to give aldehyde 268.                          
Treatment of 323 with DiBAl H should give allylic alcohol 325. Hydroxyl directed 
reduction of the olefin through an iridium (Crabtree like) catalyst should also 
provide the chiral alcohol that could then be oxidised,
187 giving 268. Chapter 2 – Isocoumarins and Isochromanones 
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Scheme 2.51. The approach to the desired chiral aldehyde. 
 
2.3.4.  Completion of the C1-C14 fragment 
Having  already  demonstrated  that  isobenzofuran  addition  to  an  aldehyde  is 
selective, giving the anti configuration between C9 and C10, it is anticipated 
that aldehyde 268 (optically pure with the S configuration) will enhance these 
results. Should there be a need, Yamamoto’s MAD (MethylAluminium bis(2,6 Di 
tertbutyl 4 methylphenoxide)  chemistry  should  provide  the  necessary 
enhancement to selectivity (Scheme 2.52).
188 The sterically hindered MAD Lewis 
acid has been shown to favour anti Felkin Ahn control. Applied to our system it 
will enhance the selectivity already observed. 
 
Scheme 2.52. Yamamoto’s MAD additive. 
 
2.3.5.  Further work 
The  final  steps  in  the  total  synthesis  of  Ajudazol  A  would  begin  with  the 
palladium mediated coupling between the vinyl bromide bearing C1 C14 ‘eastern 
fragment’  266  and  oxazole  containing  C15 C29  ‘western  unit’  265.  Although 
there  is  no  previous  precedence  for  this  type  of  coupling,  we  believe  that 
Bellina’s  conditions  for  the  coupling  of  unfunctionalised  oxazoles  and  aryl 
iodides  could  be  successfully  extrapolated  into  our  system  to  produce  diyne 
327.
189  Removal  of  the  protecting  group  would  then  generate  phenol,  which Chapter 2 – Isocoumarins and Isochromanones 
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upon  a  double  selective  syn hydrogenation  would  complete  our  synthesis  of 
Ajudazol A 2.
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Scheme 2.53. Completion of Ajudazol A 
 
There is the very real possibility that the proposed palladium coupling between 
vinyl bromide 266 and oxazole 265 might fail. Should this be the case, several 
alternative  approaches  have  been  conceived.  Reverting  to  a  more  traditional 
Stille coupling either between vinyl stannane 329 and a 2 chloro oxazole unit 
328 is feasible. This would require a switch in starting material from the simple 
oxazole ester 270 to the C2 chloro substituted analogue.
191,192 Similarly we could 
revert to a Suzuki coupling between C2 halogen substituted oxazole  328 and 
boronic acid 330 using Greaney’s microwave conditions (Scheme 2.54).
193 
 
Scheme 2.54. An alternate approach that could be utilized. 
 
Ajudazol B 3 will be synthesized in a different manor. The two natural products  
2 and 3 differ in only one aspect, 3 has a CH methyl at the C15 position while Chapter 2 – Isocoumarins and Isochromanones 
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Ajudazol A 2 has an exo methylene group.   To  account  for  the  difference, 
terminal alkyne 310 can be alkylated with R or S propylene oxide, that would 
give  secondary  alcohol  332.  Conversion  of  alcohol  332  to  a  suitable  leaving 
group would allow it to be coupled with a suitable oxazole coupling partner. The 
reason for using R or S enantiomers of propylene oxide is due to the fact that 
Ajudazol  B  was  not  assigned  C15  stereochemistry  upon  isolation  and 
characterisation.
2 Utilizing both enantiomers will allow us to both confirm the 
configuration of  the natural  product,  by comparison of  physical  data (optical 
rotations etc) and simultaneously synthesize an anologue.  
 
Scheme 2.55. Proposed synthesis of Ajudazol B. 
 
Ajudazol A could be similarly synthesized should it be required. Alkylation of 
terminal alkyne 310 with ethylene oxide would give primary alcohol 335 that 
could  be  oxidised  to the corresponding  ester.  Alkylation  of ester  336  with  a 
suitable  oxazole  derived  nucleophile  would  give  a  ketone  intermediate  that 
could be olefinated under Petassis or Tebbe conditions to yield the desired exo 
olefin functionality in 337 (Scheme 2.56). 
 
Scheme 2.56. Modified approach to Ajudazol A. 
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3. Experimental 
All  reactions  were  performed  in  oven dried  glassware  under  an  inert  argon 
atmosphere unless otherwise stated. Tetrahydrofuran (THF), diethyl ether and 
dichloromethane  (DCM)  were  purified  through  a  Pure  Solv  400 5MD  solvent 
purification  system  (Innovative  Technology,  Inc).  All  reagents  were  used  as 
received,  unless  otherwise  stated.  Solvents  were  evaporated  under  reduced 
pressure at 40°C using a Buchi Rotavapor. IR spectra were recorded as thin films 
on NaCl plates using a JASCO FT/IR410 Fourier Transform spectrometer. Only 
significant  absorptions  (νmax)  are  reported  in  wavenumbers  (cm
 1).  Proton 
magnetic resonance spectra (
1H NMR) and carbon magnetic resonance spectra 
(
13C NMR) were respectively recorded at 400MHz and 100MHz using a Bruker DPX 
Avance400  instrument.  Chemical  shifts  (δ)  are  reported  in  parts  per  million 
(ppm) and are referenced to the residual solvent peak. The order of citation in 
parentheses is (1) number of equivalent nuclei (by integration), (2) multiplicity 
(s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, b = broad, dm = 
double  multiplet,  dd  =  double  doublet,  dt  =  double  triplet)  and  (3)  coupling 
constant (J) quoted in Hertz to the nearest 0.1Hz. High resolution mass spectra 
were recorded on a JEOL JMS 700 spectrometer by electrospray and chemical 
ionisation mass spectrometer operating at a resolution of 15000 full widths at 
half height. Where a 100% peak was not observed in Low resolution mass spectra 
the highest peak was taken to be 100%. Flash chromatography was performed 
using silica gel (Apollo Scientific Silica Gel 60, 40 63 mm) as the stationary phase. 
TLC was performed on aluminium sheets precoated with silica (Merck Silica Gel 
60 F254). The plates were visualised by the quenching of UV fluorescence (λmax 
254 nm) and/or by staining with either anisaldehyde, potassium permanganate, 
iodine or cerium ammonium molybdate followed by heating.  
Methyl (S) 2 (tertbutoxycarbonylamino) 4 methylpentanoate.
113 
 
A solution of (S) 2 (tertbutoxycarbonylamino) 4 methylpentanoic acid 197 (15.0 
g,  60.2  mmol)  in  anhydrous  dimethylformamide  (150  mL),  was  treated Chapter 3 – Experimental  
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sequentially with potassium hydrogen carbonate (13.3 g, 132 mmol) and methyl 
iodide (previously alumina filtered) (5.99 mL, 96.1 mmol), reaction mixture was 
stirred  completion  by  TLC  analysis  and  quenched  with  water  (50  mL).  The 
mixture  was  extracted  with  ethyl  acetate  (2x  50  mL)  the  organic  layer  was 
washed with saturated sodium chloride (50 mL). Combined organic layers were 
dried over sodium sulfate and concentrated in vacuo, to yield 15.8 g (99%) of the 
desired ester as a clear oil, further purification was not necessary.  .            
1H (CDCl3, 400 MHz) δ: 4.90 (1H, d, J = 8.2, CHNH), 4.25 4.24 (1H, m, CHNH), 
3.66 (3H, s, OCH3), 1.65 1.39 (3H, m, CH2CH), 1.37 (9H, s, C(CH3)3), 0.87 (6H, m, 
CH(CH3)2).                             
13C (CDCl3, 100 MHz) δ: 172.2 (CO), 154.9 (NHCO), 81.7 (C(CH3)3),54.6 (OCH3), 
52.8 (CHNH), 43.2 (CHCH2CH), 29.5 (C(CH3)3), 26.4 (CH(CH3)2), 23.5 (CH(CH3)2), 
21.6 (CH(CH3)2).                        
m/z [CI
+ (+ve), isobutane]  246.2 [M+H]
+ (100%), HRMS found 246.1704, C12H24NO4 
requires 246.1705 [M+H]
+.                          
υmax (neat)/cm
 1: 2916, 1749, 1682.                  
27 ] [ D a  =  54.8 (CHCl3, c = 1.1), Lit. 
113 
20 ] [ D a =  11.6 (CHCl3) 
tertButyl (S) 1 hydroxy 4 methylpentan 2 yl carbamate.
113 
 
A solution of (S) methyl 2 (tertbutoxycarbonylamino) 4 methylpentanoate (15.8 
g,  60.0  mmol)  in  anhydrous  tetrahydrofuran  (150  mL)  was  treated  with 
anhydrous lithium chloride (5.09 g, 120 mmol), sodium borohydride (4.54 g, 120 
mmol) and the mixture was stirred for 20 minutes. Ethanol (200 mL) was added 
slowly and the resulting opaque white solution was  stirred for 12 hours. The 
reaction mixture was cooled to 0 
oC, then acidified to pH 4 with 10% aqueous 
citric  acid  (45  mL)  and  concentrated  in  vacuo.  The  residue  was  dissolved  in 
diethyl ether (100 mL) and washed with water (3x 50 mL). The organic phase 
was  dried  over  anhydrous  sodium  sulfate  and  concentrated  in  vacuo,  to  give 
crude residue which was purified by flash column chromatography (silica gel, 
elution with 25% ethyl acetate in petroleum spirit) to yield 12.6 g (96% yield) of 
the desired alcohol as a clear oil.                       
1H (CDCl3, 400 MHz) δ: 4.49 (1H, bs, CHNH), 3.70 3.58 (2H, m, CH2OH), 3.47 3.42 Chapter 3 – Experimental  
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(1H, m, CHNH), 2.42 (1H, bs, OH), 1.62 1.56 (1H, m, CH(CH3)2), 1.38 (9H, s, 
C(CH3)3), 1.25 1.18 (2H, m, CH2CH), 0.86 (6H, m, CH(CH3)2).               
13C  (CDCl3,  100  MHz)  δ:  156.9  (NHCO),  79.8  (C(CH3)3),  66.9  (CH2OH),  51.2 
(CHNH),  40.6  (CHCH2CH),  28.6  (C(CH3)3),  24.9  (CH(CH3)2),  23.3  (CH(CH3)2), 
22.5(CH(CH3)2).                        
m/z [CI
+ (+ve), isobutane]  218.2 [M+H]
+ (100%), HRMS found 218.1754, C11H24NO3 
requires 218.1756 [M+H]
+.                      
υmax (neat)/cm
 1: 3455, 2978, 1675.                  
26 ] [ D a  =  53.60 (CHCl3, c = 1.0), Lit. 
72  D a] [ =  27.9 (MeOH, c = 2.1) 
tertButyl (S) 4 methyl 1 oxopentan 2 yl carbamate, 30.
71 
 
A solution of Boc N leucinol (12.6 g, 58.0 mmol) in DMSO (150 mL) was treated 
with a solution of IBX (19.5 g, 69.6 mmol) in DMSO (140 mL). The reaction was 
stirred at 40 
oC for 16 hours until completion by TLC. The reaction was quenched 
with water (100 mL) and diethyl ether (50 mL) was added, the organic layer was 
washed with water (3x 75 mL) and the organic extracts combined and dried over 
sodium sulfate. The solution was concentrated in vacuo to give 10.4 g aldehyde 
197 (83% yield) a colourless, viscous oil, further purification was not required.                  
1H (CDCl3, 400 MHz) δ: 9.52 (1H, s, CHO), 4.88 (1H, bs, CHNH), 4.22 4.15 (1H, m, 
CHNH), 1.70 1.45 (2H, m, CH2CH), 1.38 (9H, s, C(CH3)3), 1.18 (1H, m, CH(CH3)2), 
0.88 (6H, m, CH(CH3)2).                           
13C (CDCl3, 100 MHz) δ: 199.6 (CHO), 162.4 (NHCO), 81.2 (C(CH3)3), 53.6 (CHNH), 
39.4  (CHCH2CH),  28.7  (C(CH3)3),  24.9  (CH(CH3)2),  23.6  (CH(CH3)2),  21.6 
(CH(CH3)2). 
tertButyl 5 hydroxy 2 methyloct 7 en 4 ylcarbamate,188 and 189.
71 
 
To  a  stirred  solution  of  Boc N Leucinal  30  (10.4  g,  48.3  mmol)  in 
dichloromethane  (240  mL)  at   78 
oC,  was  added  tin  chloride  (96.6  mL,  96.6 Chapter 3 – Experimental  
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mmol, 1 M in dichloromethane) and the resulting solution stirred for 10 minutes. 
The reaction was treated with allyl tributyltin (22.5 g, 72.5 mmol) and stirred 
for 3 hours, then allowed to attain room temperature and stirred for a further 7 
hours. The reaction was quenched with ammonium chloride solution (50 mL) and 
diluted  with  dichloromethane  (100  mL).  The  combined  organic  extracts  were 
dried over anhydrous sodium sulfate and concentrated in vacuo. The resulting 
grey  residue  was  dissolved  in  anhydrous  methanol  (65  mL)  and  treated  with 
sodium  borohydride  (1.83  g,  48.3  mmol)  and  stirred  for  5  minutes.  The  grey 
suspension formed was treated with saturated sodium carbonate (50 mL) and 
diethyl ether (100 mL) and extracted into diethyl ether. Organic extracts were 
combined and washed with water (2x 50 mL) and brine (50 mL) then dried over 
anhydrous sodium sulfate and concentrated in vacuo Purification by flash column 
chromatography (silica gel, elution with 20% diethyl ether in petroleum spirits) 
gave 8.32 g (67% yield) of homo allylic alcohols 188 and 189 as a clear oil and as 
an 7:1 mixture of anti:syn diastereoisomers. 
tertButyl (4S,5S) 5 hydroxy 2 methyloct 7 en 4 ylcarbamate, 188.  
 
1H NMR (CDCl3, 400 MHz) δ: 5.89 5.79 (1H, m, CH2CHCH2), 5.17 5.13 (2H, m, 
CH2CHCH2), 4.64 (1H, d, J = 9.0 Hz, NH), 3.66 3.63 (1H, m, CHNH), 3.60 3.57 
(1H, m, CHOH), 2.33 2.29 (2H, m, CHCH2CH), 2.01 (1H, d, J = 2.9 Hz, OH), 1.69 
1.59 (2H, m, CHCH2CH), 1.44 (9H, s, C(CH3)3), 1.36 1.25 (1H, m, CH(CH3)2), 0.86 
(6H, m, CH(CH3)2).                          
13C NMR (CDCl3, 100 MHz) δ: 156.2 (NHCO), 134.6 (CH2CHCH2), 118.4 (CH2CH), 
79.2  (C(CH3)3),  72.8  (CH2CHOH),  52.0  (CHCHNH),  41.9  (CHCH2CH),  39.2 
(CH2CHNH), 28.6 (C(CH3)3), 24.8 (CH(CH3)2), 23.2 (CH(CH3)2), 22.2 (CH(CH3)2). 
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tertButyl (4S,5R) 5 hydroxy 2 methyloct 7 en 4 ylcarbamate, 189. 
 
1H NMR (CDCl3, 400 MHz) δ: 5.89 5.79 (1H, m, CH2CHCH2), 5.17 5.13 (2H, m, 
CH2CHCH2), 4.64 (1H, d, J = 9.0 Hz, NH), 3.66 3.63 (1H, m, CHNH), 3.60 3.57 
(1H, m, CHOH), 2.33 2.29 (2H, m, CHCH2CH), 2.01 (1H, d, J = 2.9 Hz, OH), 1.69 
1.59 (2H, m, CHCH2CH), 1.44 (9H, s, C(CH3)3), 1.36 1.25 (1H, m, CH(CH3)2), 0.79 
(6H, m, CH(CH3)2).                          
13C NMR (CDCl3, 100 MHz) δ: 156.2 (NHCO), 135.0 (CH2CHCH2), 117.9 (CH2CH), 
78.8  (C(CH3)3),  73.9  (CH2CHOH),  53.2  (CHCHNH),  38.5  (CHCH2CH),  37.2 
(CH2CHNH),  28.5  (C(CH3)3),  23.7  (CH(CH3)2),  22.7  (CH(CH3)2),  20.5  (CH(CH3)2). 
m/z  [CI
+  (+ve),  isobutane]    258.3  [M+H]
+  (100%),  HRMS  found    258.2071, 
C14H28NO3 requires 258.2069 [M+H]
+.                                
υmax (neat)/cm
 1: 3438, 2957, 1687, 1170. 
(4S,5S) 5 (tertButoxycarbonylamino) 7 methyloct 1 en 4 yl acrylate, 190. 
 
Homoallylic  alcohols  188  and  189  (5.34  g,  20.7  mmol)  were  dissolved  in 
dichloromethane (104 mL) and cooled to 0 
oC. Acryloyl chloride (2.95 mL, 36.3 
mmol) and triethylamine (10.1 mL, 72.6 mmol) were added sequentially and the 
reaction was stirred for 10 hours. Once complete by TLC analysis the solution 
was  neutralised  using  1  M  hydrochloric  acid  solution.  The  organic  phase  was 
separated then washed sequentially with water (2x 30 mL) and brine (30 mL) 
then  dried  over  anhydrous  sodium  sulfate  and  concentrated  in  vacuo. 
Purification by flash column chromatography (silica gel, elution with 10 % diethyl 
ether in petroleum spirits) gave 190 5.30 g (82% yield) and 191 883 mg (14% 
yield) as a clear oil         .                         
1H NMR (CDCl3, 400 MHz) δ: 6.45 (1H, d, J = 17.3 Hz, COCHCH2), 6.15 (1H, dd, J 
= 16.0, 8.1 Hz, COCHCH2), 5.88 (1H, d, J = 10.4 Hz, COCHCH2), 5.83 5.75 (1H, m, 
CH2CHCH2), 5.16 5.04 (2H, m, CH2CHCH2), 5.03 5.00 (1H, m, CHOC), 4.51 (1H, d, Chapter 3 – Experimental  
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J = 10.0 Hz, NH), 3.96 3.91 (1H, m, CHNH), 2.42 2.40 (2H, m, C(O)CH2CH), 1.71 
1.63 (1H, m, CH(CH3)2), 1.47 (9H, s, C(CH3)3), 1.31 1.24 (2H, m, CH2CH(CH3)2), 
0.94 (3H, m, CH(CH3)2), 0.92 (3H, m, CH(CH3)2).                
13C NMR (CDCl3, 100 MHz) δ: 165.6 (CHCO), 155.6 (NHCO), 133.1 (CH2CH), 131.2 
(CH2CH),  128.1  (CH2CH),  118.4  (CH2CH),  79.3  (CH2CH),  75.4  (C(CH3)3),  50.3 
(CHCHNH), 42.0 (CH2CH), 36.3 (CHCH2CH), 28.3 (C(CH3)3), 24.7 (CH(CH3)2), 23.1 
(CH(CH3)2), 22.1 (CH(CH3)2).                      
m/z [CI
+ (+ve), isobutane]  312.2 [M+H]
+ (100%). HRMS found 312.2176, C17H30NO4 
requires 312.2175 [M+H]
+.                      
25 ] [ D a  =  1.9 (CHCl3, c = 1.0) 
(4S,5R) 5 (tertButoxycarbonylamino) 7 methyloct 1 en 4 yl acrylate, 191. 
 
1H NMR (CDCl3, 400 MHz) δ: 6.33 (1H, dd, J = 17.3 , 1.1 Hz, COCHCH2), 6.15 (1H, 
dd, J = 17.3, 10.4 Hz, COCHCH2), 5.88 (1H, d, J = 12.0 Hz, COCHCH2), 5.78 5.65 
(1H,  m,  CH2CHCH2),  5.05 4.98  (2H,  m,  CH2CHCH2),  4.94  (1H,  d,  J  =  8.0  Hz, 
CHOC), 4.36 (1H, d, J = 10.0 Hz, NH), 3.87 3.80 (1H, m, CHNH), 2.37 2.25 (2H, 
m, C(O)CH2CH), 1.63 1.57 (1H, m, CH(CH3)2), 1.36 (9H, s, C(CH3)3), 1.24 1.19 
(2H, m, CH2CH(CH3)2), 0.86 (3H, m, CH(CH3)2), 0.84 (3H, m, CH(CH3)2).          
13C NMR (CDCl3, 100 MHz) δ: 165.4 (CHCO), 155.8 (NHCO), 133.1 (CH2CH), 131.3 
(CH2CH),  128.2  (CH2CH),  118.4  (CH2CH),  80.1  (CH2CH),  75.1  (C(CH3)3),  51.3 
(CHCHNH), 42.2 (CH2CH), 36.1 (CHCH2CH), 28.4 (C(CH3)3), 24.4 (CH(CH3)2), 23.2 
(CH(CH3)2), 21.8 (CH(CH3)2).                    
m/z [CI
+ (+ve), isobutane]  312.2 [M+H]
+ (100%), HRMS found 312.2178, C17H30NO4 
requires 312.2175 [M+H]
+.                          
υmax (neat)/cm
 1: 3367, 3079, 2959, 1689, 1639, 1169.           
[a]
25
D  =  4.3 (CHCl3, c = 1.0) 
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tertButyl (S) 3 methyl 1 ((S) 6 oxo 3,6 dihydro 2H pyran 2 yl) 
butylcarbamate, 198. 
 
Diene 190 (3.76 g, 12.1 mmol) was dissolved in dichloromethane (120 mL), to 
this was added Grubbs second generation catalyst 5 mol% (518 mg, 0.61 mmol), 
heated to reflux and stirred for 48 hours. Once complete the black solution was 
concentrated  in vacuo and suspended in diethyl ether (100 mL) then filtered 
through florisil. The filtrate was concentrated in vacuo and purification by flash 
column chromatography (elution with 20% diethyl ether and petroleum spirits) 
gave 2.67 g (78%) of a pyrone 198 as a crystalline solid (m.p. 55 57 
oC)             
1H NMR (CDCl3, 400 MHz) δ: 6.91 (1H, ddd, J = 9.6, 6.4, 2.1 Hz, COCHCH), 5.99 
(1H, dd, J = 9.8, 2.4 Hz, COCHCH), 4.59 (1H, d ,J = 9.9 Hz, NH), 4.42 (1H, dd, J 
=  12.8,  1.5  Hz,  CH2CHCH),  3.87 3.81  (1H,  m,  CHNH),  2.56 2.48  (1H,  m, 
CHCHCH2), 2.27 (1H, ddd, J = 18.6, 5.6, 3.9 Hz, CHCHCH2), 1.73 1.62 (2H, m, 
CH2CH(CH3)2), 1.43 (9H, s, C(CH3)3), 1.39 1.35 (1H, m, CH(CH3)2), 0.92 (3H, d, J 
= 6.3 Hz, CH(CH3)2), 0.92 (6H, d, J = 6.3 Hz, CH(CH3)2).                
13C  NMR  (CDCl3,  100  MHz)  δ:  164.1  (CHCO),  155.8  (NHCO),  145.9  (CHCHCO), 
120.8  (CHCHCO),  79.9  (CHCH2CH),  79.6  (C(CH3)3),  50.4  (CHCHNH),  41.1 
(CHCHCH2), 28.3 (CH2CH(CH3)2), 26.9 (C(CH3)3), 24.8 (CH(CH3)2), 23.0 (CH(CH3)2), 
22.0 (CH(CH3)2).                         
25 ] [ D a  =  5.7 (CHCl3, c = 1.0) 
tertButyl (S) 3 methyl 1 ((R) 6 oxo 3,6 dihydro 2H pyran 2 yl) 
butylcarbamate, 199. 
 
Diene 191 (869 mg, 2.79 mmol) was dissolved in dichloromethane (28 mL), to 
this was added Grubbs second generation catalyst 5 mol% (118 mg, 0.14 mmol), 
heated to reflux and stirred for 44 hours. Once complete the black solution was Chapter 3 – Experimental  
 
  92 
concentrated  in  vacuo  and  suspended  in  diethyl  ether  (20  mL)  then  filtered 
through florisil. The filtrate was concentrated in vacuo and purification by flash 
column chromatography (elution with 20% diethyl ether and petroleum spirits) 
gave 593 mg (75 %) of a pyrone 199 as a crystalline solid (m.p.103 104 
oC).          
1H NMR (CDCl3, 400 MHz) δ: 6.92 (1H, m, COCHCH), 6.03 (1H, dt, J = 9.6, 1.8 Hz, 
COCHCH), 4.72 (1H, d ,J = 8.3 Hz, NH), 4.44 (1H, d, J = 11.6 Hz, CH2CHCH), 
3.86 3.79  (1H,  m,  CHNH),  2.51 2.35  (2H,  m,  CHCHCH2),  1.76 1.69,  1H,  m, 
CH(CH3)2), 1.50 1.44 (2H, m, CH2CH(CH3)2), 1.45 (9H, s, C(CH3)3), 0.96 (3H, d, J 
= 6.7 Hz, CH(CH3)2), 0.94 (3H, d, J = 6.5 Hz, CH(CH3)2).                     
13C  NMR  (CDCl3,  100  MHz)  δ:  164.1  (CHCO),  155.5  (NHCO),  145.2  (COCHCH), 
121.2  (COCHCH),  80.6  (CHCH2CH),  79.7  (C(CH3)3),  50.9  (CHCHNH),  38.1 
(CHCHCH2), 28.4 (CH2CH(CH3)2), 26.4 (C(CH3)3), 24.6 (CH(CH3)2), 23.7 (CH(CH3)2), 
21.4 (CH(CH3)2). m/z [CI
+ (+ve), isobutane]  284.4 [M+H]
+ (100%), HRMS found 
284.1865, C15H26NO4 requires 284.1862 [M+H]
+.                           
υmax (neat)/cm
 1: 3447, 2958, 1686, 1167.                 
26 ] [ D a  =  3.9 (CHCl3, c = 1.0) 
(E) (1 Methoxybuta 1,3 dienyloxy)trimethylsilane, 202.
128 
 
A  solution  of  freshly  distilled  diisopropylamine  (3.07  mL,  21.9  mmol)  in 
anhydrous tetrahydrofuran (50 mL) at 0 
oC was treated with nBuLi (14.0 mL, 21.9 
mmol, 1.56 M in hexanes) and stirred for 15 minutes. The reaction was cooled to 
 78 
oC and stirred for 30 minutes; hexamethyl phosphoramide (4.29 mL, 23.9 
mmol) followed by methyl crotonate 205 (2.11 mL, 19.9 mmol) were added and 
the reaction was stirred for a further 40 minutes. A solution of trimethylsilyl 
chloride (4.09 mL, 31.9 mmol) in anhydrous tetrahydrofuran (20 mL) was then 
added  slowly  and  the  resulting  yellow  solution  was  allowed  to  attain  room 
temperature over 1 hour. Cold pentane (50 mL) was added, followed by water 
(30 mL) and the organic phase was separated then washed with water (3x 20 
mL), dried over anhydrous sodium sulfate and concentrated in vacuo. The brown 
residue was purified by short pass vacuum distillation (88 
oC at 32 mm Hg) giving 
4.61 g silyl enolate 202 in 67% yield.                     Chapter 3 – Experimental  
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1H NMR (CDCl3, 400 MHz) δ: 6.42 (1H, sext, J = 7.6 Hz, CHCHCH2), 4.78 (1H, d, J 
= 17.2 Hz, CHCHCH2), 4.54 (1H, d, J = 10.4 Hz, Ha), 4.43 (1H, d, J = 10.3 Hz, 
Hb), 3.5 (3H, s, OCH3), 0.17 (9H, s, (Si(CH3)3).                 
13C NMR (CDCl3, 100 MHz) δ: 166.7 (COCH3), 132.2 (CHCHCH2), 106.8 (CHCHCH2), 
80.4 (CHCHCH2), 54.5 (OCH3), 0.4 (Si(CH3)3). 
(E) tertbutyl(1 methoxybuta 1,3 dienyloxy)dimethylsilane, 206. 
 
A  solution  of  freshly  distilled  diisopropylamine  (3.07  mL,  21.9  mmol)  in 
anhydrous tetrahydrofuran (50 mL) at 0 
oC was treated with nBuLi (14.0 mL, 21.9 
mmol, 1.56 M in hexanes) and stirred for 15 minutes. The reaction was cooled to 
 78 
oC and stirred for 30 minutes; hexamethyl phosphoramide (4.29 mL, 23.9 
mmol) followed by methyl crotonate 205 (2.11 mL, 19.9 mmol) were added and 
the reaction was stirred for a further 40 minutes; hexamethyl phosphoramide 
(4.29 mL, 23.9 mmol) then methyl crotonate (2.11 mL, 19.9 mmol) were added 
and  the  reaction  stirred  for  a  further  30  minutes.  A  solution  of  dimethyl 
tertbutylsilyl chloride (3.61 g, 23.9 mmol) in anhydrous tetrahydrofuran (13 mL) 
was then added slowly and the resulting yellow solution allowed to attain room 
temperature over 1 hour. Cold pentane (50 mL) was added, followed by water 
(30 mL) and the organic phase was separated then washed with water (3x 20 
mL). The brown residue was purified by short pass vacuum distillation (96 
oC at 
28 mm Hg) giving 2.27 g silyl enolate 206 in 53% yield.                            
1H NMR (CDCl3, 400 MHz) δ: 6.35 (1H, sext, J = 7.6 Hz, CHCHCH2), 4.67 (1H, dd, J 
= 17.2, 0.9 Hz, CHCHCH2), 4.42 (1H, dd, J = 10.4, 0.9 Hz, Ha), 4.30 (1H, d, J = 
10.4 Hz, Hb), 3.39 (3H, s, OCH3), 0.77 (9H, s, SiC(CH3)3), 0.00 (6H, s, Si(CH3)2).          
13C NMR (CDCl3, 100 MHz) δ: 173.6 (COCH3), 135.3 (CHCHCH2), 107.6 (CHCHCH2), 
80.2 (CHCHCH2), 57.3 (OCH3), 24.9 (C(CH3)3), 19.3 (C(CH3)3),  1.9 (Si(CH3)2). 
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1 Methoxy 1,3 dihydro isobenzofuran, 230.
159  
 
To  a   78 
oC  solution  of  phthalide  237  (10.0  g,  74.7  mmol)  in  anhydrous 
dichloromethane (370 mL) was added slowly diisobutylaluminium hydride (78.4 
mL, 78.4 mmol, 1 M in hexanes) and stirred until completion by TLC analysis (4 
h). The reaction was warmed to 0 
oC, diluted with diethyl ether (200 mL) and 
quenched by the successive addition of water (3.1 mL), 15% aq sodium hydroxide 
(3.1 mL) and water (7.8 mL). The resultant slurry was stirred for 30 minutes, 
sodium  sulfate  was  added  and  the  resulting  slurry  stirred  for  a  further  30 
minutes.  The  solids  were  removed  by  filtration  and  the  solution  evaporated 
under vacuum.                         
The crude residue was dissolved in anhydrous tetrahydrofuran (170 mL) and was 
cannulated  to  a  solution  of  sodium  hydride  (3.75  g,  93.4  mmol)  in 
tetrahydrofuran (200 mL) at 0 
oC and stirred for an hour. Methyl iodide (filtered 
through basic alumina previously) was added (23.3 mL, 375 mmol) to reaction 
mixture  and  stirred  for  a  further  4  hours.  Once  complete  according  to  TLC 
analysis, water (50 mL) was added to quench and diluted with diethyl ether (100 
mL). Combined organic extracts were washed with water (2x 50 mL), brine (50 
mL) and dried over sodium sulfate. Purification by flash column chromatography 
(20%  elution  with  diethyl  ether  and  petroleum  spirits)  gave  8.83  g  (78%)  of 
methyl acetal 230 as a clear oil.                              
1H NMR (CDCl3, 400 MHz) δ: 7.41 7.26 (4H, m, Ar H), 6.19 (1H, d, J = 2.2 Hz, 
CH), 5.22 (1H, d, J = 12.8 Hz, CH2O), 5.08 (1H, d, J = 12.8 Hz, CH2O), 3.44 (3H, 
s, OCH3).                             
13C NMR (CDCl3, 100 MHz) δ: 139.9 (Ar C), 137.3 (Ar C), 129.2 (Ar C), 127.7 (Ar 
C), 122.9 (Ar C), 121.0 (Ar C), 107.6 (CH), 72.2 (CH2), 54.3 (OCH3).                  
m/z [CI
+ (+ve), isobutane]  151.1 [M+H]
+ (100%). HRMS found 151.0756, C9H11O2 
requires 151.0760 [M+H]
+.                  
υmax (neat)/cm
 1: 3049, 2859, 1615, 1192. 
General procedure for the preparation of lactones 243, 247 to 255.                
A 0 
oC solution of methyl acetal 230 in anhydrous tetrahydrofuran at was treated 
with diisopropylamine and stirred for 10 minutes. Methyl lithium solution (1.6 M Chapter 3 – Experimental  
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in diethyl ether) was added slowly and the reaction stirred for 30 minutes. The 
reaction mixture was cooled to  78 
oC and the freshly distilled aldehyde was 
added. The resulting solution was then stirred for a further 2 hours at  78 
oC 
before being quenched with water at 0 
oC.  The mixture was extracted with 
diethyl ether and the combined organic extracts were then washed with water, 
saturated  sodium  chloride  solution  and  dried  over  sodium  sulfate.    Solvent 
removal  under  reduced  pressure  then  afforded  the  desired  a hydroxy 
isobenzofuran  intermediate  which  was  used  in  the  next  step  without  further 
purification.                          
The  crude  α hydroxy  isobenzofuran  unit  was  then  dissolved  in  anhydrous 
dichloromethane and cooled to 0 
oC.  The solution was then treated with 3 
chloroperoxybenzoic  acid  and  the  resulting  mixture  stirred  at  0 
oC  until 
completion.    The  reaction  was  quenched  with  saturated  sodium  hydrogen 
carbonate  solution  and  extracted  with  ethyl  acetate  and  dried  over  sodium 
sulfate. The solvent was removed under reduced pressure and the crude residual 
lactol was taken on crude without the need of further purification.     The newly 
prepared lactol was dissolved in acetone and treated with freshly made 2.5 M 
Jones reagent. The resulting red/brown solution was then stirred for 2 hours or 
until complete consumption of starting material (as by TLC analysis on alumina 
plates). The reaction was quenched with water and the aqueous layer extracted 
with  diethyl  ether.  The  combined  organic  extracts  were  washed  sequentially 
with water (3x), saturated sodium bicarbonate solution and brine.  The organic 
layer was dried over sodium sulfate and the solvent evaporated under reduced 
pressure. The crude keto lactones obtained could then be taken on crude to the 
next step. 
General procedure for the reduction of lactones to isochroman 1 ones (244, 
256 264).                           
The  freshly  obtained  crude  lactones  (243,  247  to  255)  were  dissolved  in 
anhydrous dichloromethane and cooled to  78 
oC. The mixture was treated with 
a solution of cerium (III) chloride in anhydrous methanol (0.4 M in methanol, 2 
equivalents) and the resulting suspension was stirred for 10 minutes followed by 
addition of 1.5 equivalents sodium borohydride and stirred until completion as 
indicated  by  TLC  analysis.  The  reaction  solution  was  warmed  to  room 
temperature,  diluted  with  dichloromethane  and  quenched  with  10%  aqueous Chapter 3 – Experimental  
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citric acid solution (10 mL).  The biphasic mixture was stirred for 20 minutes and 
the aqueous phase was extracted into dichloromethane and washed sequentially 
with  water  (2x)  and  brine.  The  combined  organic  extracts  were  dried  over 
sodium sulfate and concentrated under reduced pressure. The crude residues 
were purified by flash column chromatography (silica gel). 
4 Hydroxy 3 isopropylisochroman 1 one, 244. 
 
Keto lactone 243 was prepared using the general procedure for the preparation 
of  lactones,  starting  from  a  solution  of  acetal  230  (1.01  g,  6.73  mmol)  in 
tetrahydrofuran  (34  mL)  and  diisopropylamine  (189   L,  1.35  mmol);  methyl 
lithium  (9.25  mL,  14.8  mmol);  isobutyraldehyde  (733   L,  8.08  mmol).    The 
oxidative rearrangement was performed using 3 chloroperoxybenzoic acid (1.81 
g,  8.08  mmol);  in  dichloromethane  (34  mL).    Oxidation  was  achieved  on  a 
solution of crude lactol (1.31 g, 6.36 mmol); in acetone (32 mL) using 2.5 M 
Jones (5.08 mL, 12.7 mmol) to afford 1.16 g of the desired keto lactone 243 
(85%) without further purification.                
Isochroman 1 one,  244  was  prepared  using  the  general  procedure  for  the 
reduction of lactones to iso chroman 1 ones, starting from a solution of keto 
lactone 18 (200 mg, 0.98 mmol) in dichloromethane (5 mL) and using cerium(III) 
chloride (4.90 mL, 1.96 mmol, 0.4 M in methanol) and sodium borohydride (56 
mg, 1.47 mmol).  Purification  by  flash  column  chromatography  (silica  gel, 
diethyl ether in dichloromethane in petroleum spirits 30:20:70) afforded 194 mg 
of  the  desired  isochromanone  244  (96%)  as  a  clear  oil  and  as  a  sole  syn 
diastereoisomer.                             
1H NMR (CDCl3, 400 MHz) d: 8.11 (1H, dd, J = 8.0, 0.8 Hz, Ar H), 7.65 (1H, td, J = 
7.6, 1.2 Hz, Ar H), 7.51 (1H, td, J = 7.6, 1.2 Hz, Ar H), 7.45 (1H, dm, J = 7.6 Hz, 
Ar H), 4.74 (1H, dd,  J = 7.6, 1.6 Hz,  CHOH), 3.99 (1H, dd,  J = 9.6, 1.6 Hz, 
CHCH), 2.39 2.30 (1H, m, CH(CH3)2), 2.18 (1H, d, J = 7.2 Hz, OH), 1.19 (3H, d, J 
= 6.8 Hz, CH(CH3)2), 1.09 (3H, d, J = 6.8 Hz, CH(CH3)2).               
13C NMR (CDCl3, 100 MHz) δ: 165.1 (CO2CH), 140.3 (Ar C), 134.4 (Ar C), 130.4 
(Ar C), 129.9 (Ar C), 128.1 (Ar C), 124.3 (Ar C), 86.6 (CHOH), 65.2 (CHCH), 28.7 Chapter 3 – Experimental  
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(CH(CH3)2), 19.4 (CH(CH3)2), 18.2 (CH(CH3)2).             
m/z:  [CI
+  Isobutane]:  207  [M+H]
+  (100%),  189  [M+H H2O]
+  (35%).  HRMS  found 
207.1018 C12H15O3 requires 207.1022 [M+H]
+.             
υmax (neat)/cm
 1; 3446, 2852, 1699, 1558, 1267. 
3 Isopropyl 1 oxoisochroman 4 yl acetate, 245 and 246. 
 
Lactol  242  was  prepared  using  general  procedure  for  the  preparation  of 
lactones,  starting  from  a  solution  of  acetal  230  (1.07  g,  7.10  mmol)  in 
tetrahydrofuran  (35  mL)  and  diisopropylamine  (199   L,  1.42  mmol);  methyl 
lithium  (9.7  mL,  15.6  mmol);  isobutyraldehyde  (773   L,  8.52  mmol).    The 
rearrangement  was  performed  using  3 chloroperoxybenzoic  acid  (1.91  g,  8.52 
mmol); in dichloromethane (35 mL).      A portion of the previously crude lactols 
(279 mg, 1.36 mmol) were dissolved in anhydrous dichloromethane (7 mL) and 
cooled to 0 
oC. The 0 
oC solution was treated with triethylamine (284  L, 2.03 
mmol) and N, N’ dimethylaminopyridine (17 mg, 136  mmol) and stirred for 30 
minutes. Acetic anhydride (192  L, 2.03 mmol) was then added to the reaction 
and the resulting mixture stirred until completion by as indicated by TLC analysis 
(2 h). The reaction was quenched with saturated sodium carbonate (5 mL) and 
diluted with dichloromethane (5 mL). The organic phase was washed with water 
(2 x 5 mL) and brine (5 mL). The combined organic extracts were dried over 
sodium sulfate and concentrated in vacuo.  Purification of the crude residue by 
flash column chromatography (silica gel, 20% diethyl ether in petroleum spirits) 
gave 65 mg (19%) of the desired acetates 245 and 246 as a 4.6:1 (a:b) mixture 
of anomers. 
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Acetic acid (1R,3R) 3 isopropyl 4 oxo isochroman 1 yl ester, 246. 
       
1H NMR (CDCl3, 400 MHz) d: 8.02 (1H, dd, J = 8.0, 1.6 Hz, Ar H), 7.63 (1H, td, J = 
7.6, 1.2 Hz, Ar H), 7.53 (1H, td, J = 7.6, 1.2 Hz, Ar H), 7.40 (1H, d, J = 6.8 Hz, 
Ar H), 7.13 (1H, s, CHOAc), 4.54 (1H, d, J = 2.8 Hz, COCH), 2.61 2.52 (1H, m, 
(CH(CH3)2), 2.09 (3H, s, COCH3), 1.08 (3H, d, J = 6.8 Hz, (CH(CH3)2)), 0.88 (3H, 
d, J = 6.8 Hz, (CH(CH3)2)).                       
13C NMR (CDCl3, 100 MHz) d: 195.1 (CO), 169.6 (COCH3), 137.9 (Ar C), 134.4 (Ar 
C), 129.9 (Ar C), 129.4 (Ar C), 126.3 (Ar C), 126.1 (Ar C), 90.5 (CHOCO), 79.8 
(CHO), 30.2 (CH(CH3)2), 21.1 (COCH3), 19.1 (CH(CH3)2), 16.1 (CH(CH3)2). 
Acetic acid (1S,3R) 3 isopropyl 4 oxo isochroman 1 yl ester, 245. 
O
O
O O
 
1H NMR (CDCl3, 400 MHz) d: 8.01 (1H, m, Ar H), 7.64 (1H, td, J = 7.6, 1.6 Hz, Ar 
H), 7.52 (1H, m, Ar H), 7.35 (1H, d, J = 7.6 Hz, Ar H), 7.04 (1H, s, CHOAc), 4.14 
(1H, d, J = 5.2 Hz, COCH), 2.51 2.48 (1H, m, (CH(CH3)2), 2.24 (3H, s, COCH3), 
1.05  (3H,  d,  J  =  7.2  Hz,  (CH(CH3)2)),    0.99  (3H,  d,  J  =  6.8  Hz,  (CH(CH3)2)).        
13C NMR (CDCl3, 100 MHz) d: 198.2 (CO), 169.6 (COCH3), 139.1 (Ar C), 134.4 (Ar 
C), 129.9 (Ar C), 129.5 (Ar C), 126.5 (Ar C), 124.8 (Ar C), 90.2 (CHOCO), 84.8 
(CHO),  29.6  (CH(CH3)2),  21.2  (COCH3),  19.0  (CH(CH3)2),  17.6  (CH(CH3)2).          
m/z [CI
+ (+ve), isobutane] 189 [M+H OAc]
+ (100%).                       
υmax (neat)/cm
 1; 3442, 2925, 1699, 1558, 1287. 
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4 Hydroxy 3 methylisochroman 1 one, 256.  
 
Keto lactone 247 was prepared using general procedure for the preparation of 
lactones,  starting  from  a  solution  of  acetal  230  (1.03  g,  6.92  mmol)  in 
tetrahydrofuran  (35  mL)  and  diisopropylamine  (194   L,  1.38  mmol);  methyl 
lithium  (9.5  mL,  15.2  mmol)  and  acetaldehyde  (1.02  g,  8.28  mmol).    The 
oxidative rearrangement was performed using 3 chloroperoxybenzoic acid (1.86 
g,  8.30  mmol);  in  dichloromethane  (35  mL).    Oxidation  was  achieved  on  a 
solution of crude lactol (1.20 g, 6.74 mmol); in acetone (34 mL) using 2.5 M 
Jones (5.39 mL, 13.5 mmol) to generate 1.16 g of the desired keto lactone 247 
(94%) without further purification. Isochromanone, 256 was prepared using the 
general procedure for the reduction of lactones to iso chroman 1 ones, starting 
from a solution of keto lactone 247 (1.16 g, 6.58 mmol) in dichloromethane (33 
mL) and using cerium(III) chloride (32.9 mL, 13.16 mmol, 0.4 M in methanol) and 
sodium borohydride (373 mg, 9.87 mmol).     Purification was achieved by flash 
column chromatography (silica gel, 20 % ethyl acetate in petroleum spirits) to 
afford 1.05 g of isochromanone 256 (90%) as a clear oil and as 1:1 mixture of 
diastereoisomers. 
4 Hydroxy (3R,4R) 3 methyl isochroman 1 one, 256syn. 
 
1H NMR (CDCl3, 400 MHz) δ: 8.07 (1H, dd, J = 7.8, 1.2 Hz, Ar H), 7.59 (1H, td, J = 
7.5, 1.5 Hz, Ar H), 7.47 (1H, td, J = 7.6, 1.2 Hz, Ar H), 7.42 (1H, dd, J = 7.4, 1.2 
Hz, Ar H), 4.64 4.59 (1H, m, CHOH), 4.54 (1H, dd, J = 7.2, 1.9 Hz, CHCH), 1.99 
(1H, d, J = 7.3 Hz, OH), 1.51 (3H, d, J = 6.6 Hz, CH3).               
13C NMR (CDCl3, 400 MHz) δ: 164.4 (CO2CH), 141.3 (Ar C), 134.4 (Ar C), 130.3 
(Ar C), 128.9 (Ar C), 125.2 (Ar C), 123.6 (Ar C), 79.1 (CHOH), 69.5 (CHCH), 18.1 
(CHCH3). 
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4 Hydroxy (3R,4S) 3 methyl isochroman 1 one, 256anti. 
 
 
1H NMR (CDCl3, 400 MHz) δ: 8.01 (1H, dd, J = 7.8 Hz, Ar H), 7.60 (1H, td, J = 
7.4, 1.2 Hz, Ar H), 7.54 (1H, d, J = 7.6 Hz, Ar H), 7.44 7.39 (1H, m, Ar H), 4.63 
(1H, t, 7.6 Hz, CHOH), 4.49 4.43 (1H, m, CHCH), 2.48 (1H, d, J = 7.3 Hz, OH), 
1.57 (3H, d, J =  6.8 Hz, CH3).                      
13C NMR (CDCl3, 400 MHz) δ: 164.9 (CO2CH), 141.3 (Ar C), 134.5 (Ar C), 130.3 
(Ar C),  128.9  (Ar C),  125.3  (Ar C),  123.6  (Ar C),  79.2  (CHOH),  67.5  (CHCH), 
18.1(CHCH3).                          
υmax (neat)/cm
 1; 3440, 2849, 1652, 1286. 
3 Ethyl 4 hydroxyisochroman 1 one, 257. 
 
Keto lactone 248 was prepared using general procedure for the preparation of 
lactones,  starting  from  a  solution  of  acetal  230  (1.00  g,  6.66  mmol)  in 
tetrahydrofuran  (35  mL)  and  diisopropylamine  (137   L,  1.33  mmol);  methyl 
lithium (9.2 mL, 14.66 mmol) and propionaldehyde (577  L, 8.00 mmol).  The 
oxidative rearrangement was performed using 3 chloroperoxybenzoic acid (1.79 
g,  8.00  mmol);  in  dichloromethane  (35  mL).    Oxidation  was  achieved  on  a 
solution of crude lactol (1.12 g, 5.83 mmol); in acetone (29 mL) using 2.5 M 
Jones (4.66 mL, 11.7 mmol) to generate 1.08 g of the desired keto lactone 248 
(84%) without further purification.                 
Isochroman 1 one, 257 was prepared using general the general procedure for 
the  reduction  of  lactones  to  iso chroman 1 ones,  starting  from  a  solution  of 
keto lactone  248  (1.08  g,  5.66  mmol)  in  dichloromethane  (28  mL)  and  using 
cerium(III)  chloride  (28.3  mL,  11.3  mmol,  0.4  M  in  methanol)  and  sodium 
borohydride (321 mg, 8.49 mmol).                   
Purification by flash column chromatography (silica gel, 30 % ethyl acetate in 
petroleum  spirits)  afforded  771  mg  of  isochromanone  257  (71%)  as  a  non 
separable mixture of diastereoisomers in a 60:40 ratio (syn:anti). Chapter 3 – Experimental  
 
  101 
3 Ethyl (3R,4R) 4 hydroxy isochroman 1 one, 257syn. 
 
1H NMR (CDCl3, 400 MHz) δ: 8.11 8.09 (1H, m, Ar H), 7.64 (1H, td, J = 7.5, 1.3 
Hz, Ar H), 7.52 (1H, dt, J = 7.6, 1.3 Hz, Ar H), 7.47 (1H, dm, Ar H), 4.65 (1H, d, 
J =  1.0 Hz, CHOH ), 4.39 1.35 (1H, m, CHCH), 2.22 (1H, bs, OH), 2.09 1.99 (1H, 
m, CH2), 1.98 1.89 (1H, m, CH2), 1.12 (3H, t, J = 7.5 Hz, CH2CH3).                 
13C NMR (CDCl3, 400 MHz) δ: 165.0 (CO2CH), 140.3 (Ar C), 134.4 (Ar C), 130.4 
(Ar C), 129.9 (Ar C), 127.9 (Ar C), 124.4 (Ar C), 82.6 (CHOH), 66.2 (CHCH), 23.5 
(CH2CH3), 9.7 (CH2CH3). 
3 Ethyl (3R,4S) 4 hydroxy isochroman 1 one, 257anti. 
 
1H NMR (CDCl3, 400 MHz) δ: 7.89 (1H, d, J = 7.6 Hz, Ar H), 7.63 7.58 (1H, m, Ar 
H), 7.52 7.45 (1H, m, Ar H), 7.41 (1H, m, Ar H), 5.38 (1H, d, J = 5.2 Hz, CHOH), 
4.39 4.35 (1H, m, CHCH), 2.22 (1H, bs, OH), 2.09 1.99 (1H, m, CH2), 1.98 1.88 
(1H, m, CH2), 1.05 (3H, t, J = 7.4 Hz, CH2CH3).                  
13C NMR (CDCl3, 400 MHz) δ: 165.0 (CO2CH), 140.3 (Ar C), 134.0 (Ar C), 129.4 
(Ar C), 125.8 (Ar C), 123.2 (Ar C), 122.4 (Ar C), 82.6 (CHOH), 74.2 (CHCH), 25.6 
(CH2CH3), 9.9 (CH2CH3).                      
m/z [CI
+ (+ve), isobutane]  193 [M+H]
+ (100%), HRMS found 193.0863, C12H13O3 
requires 193.0865 [M+H]
+.                        
υmax (neat)/cm
 1; 3433, 2975, 1697, 1607, 1275. 
3 Butyl 4 hydroxyisochroman 1 one, 258. 
 
Keto lactone 249 was prepared using general procedure for the preparation of 
lactones,  starting  from  a  solution  of  acetal  230  (930  mg,  6.18  mmol)  in Chapter 3 – Experimental  
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tetrahydrofuran  (31  mL)  and  diisopropylamine  (173   L,  1.24  mmol);  methyl 
lithium  (8.5  mL,  13.6  mmol)  and  valeraldehyde  (788   L,  7.41  mmol).    The 
oxidative rearrangement was performed using 3 chloroperoxybenzoic acid (1.66 
g,  7.41  mmol);  in  dichloromethane  (31  mL).    Oxidation  was  achieved  on  a 
solution of crude lactol (1.31 g, 6.82 mmol); in acetone (34 mL) using 2.5 M 
Jones (5.46 mL, 13.6 mmol) to generate the 1.10 g of the desired keto lactone 
249 (82%) without further purification.              
Isochroman 1 one, 258 was prepared using general the general procedure for 
the  reduction  of  lactones  to  iso chroman 1 ones,  starting  from  a  solution  of 
keto lactone 249 (973 mg, 5.12 mmol) in dichloromethane (26 mL) and using 
cerium(III)  chloride  (25.6  mL,  10.2  mmol,  0.4  M  in  methanol)  and  sodium 
borohydride (290 mg, 7.68 mmol).               
Purification by flash column chromatography (silica gel, 40 % diethyl ether in 
petroleum spirits) yielded 630 mg of isochromanone 258 (56%) as a yellow solid 
and as a 9:1 mixture of diastereoisomers (syn:anti). 
3 Butyl (3R,4R) 4 hydroxy isochroman 1 one, 258syn. 
 
 
1H NMR (CDCl3, 400 MHz) δ: 8.06 (1H, dt, J = 7.8, 1.8 Hz, Ar H), 7.58 (1H, td, J 
= 7.5, 1.4 Hz, Ar H), 7.46 (1H, td, J = 7.6, 1.2 Hz, Ar H), 7.40 (1H, dd, J = 7.5, 
0.5 Hz, Ar H), 4.57 (1H, d, J = 1.8 Hz, CHOH), 4.42 4.38 (1H, m, CHCH), 2.03 
(1H,  bs,  OH),  1.99 1.91  (1H,  m,  CH2CH2CH2CH3),  1.86 1.76  (1H,  m, 
CH2CH2CH2CH3),  1.56 1.49  (1H,  m,  CH2CH2CH2CH3),  1.43 1.32  (3H,  m, 
CH2CH2CH2CH3), 0.98 (3H, t, J = 7.2 Hz, CH2CH2CH2CH3).              
13C NMR (CDCl3, 400 MHz) δ: 164.9 (CO2CH), 140.3 (Ar C), 134.4 (Ar C), 130.5 
(Ar C), 129.9 (Ar C), 127.9 (Ar C), 124.2 (Ar C), 81.2 (CHOH), 66.6 (CHCH), 30.1 
(CH2CH2CH2CH3),  27.2  (CH2CH2CH2CH3),  22.6  (CH2CH2CH2CH3),  13.9 
(CH2CH2CH2CH3). 
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3 Butyl (3R,4S) 4 hydroxy isochroman 1 one, 258anti.  
 
1H NMR (CDCl3, 400 MHz) δ: 8.02 (1H, dd, J = 7.7, 1.1 Hz, Ar H), 7.58 (1H, td, J = 
7.5, 1.4 Hz, Ar H), 7.46 (1H, td, J = 7.6, 1.2 Hz, Ar H), 7.40 (1H, dd, J = 7.5, 0.5 
Hz, Ar H), 4.67 (1H, d, J = 7.5 Hz, CHOH), 4.37 4.32 (1H, m, CHCH), 2.03 (1H, 
bs, OH), 1.99 1.91 (1H, m, CH2CH2CH2CH3), 1.86 1.76 (1H, m, CH2CH2CH2CH3), 
1.70 1.62 (1H, m, CH2CH2CH2CH3), 1.66 1.58 (3H, m, CH2CH2CH2CH3), 0.85 (3H, 
t, J = 7.2 Hz, CH2CH2CH2CH3).                         
13C NMR (CDCl3, 400 MHz) δ: 164.9 (CO2CH), 140.3 (Ar C), 134.4 (Ar C), 130.5 
(Ar C), 129.9 (Ar C), 127.9 (Ar C), 124.2 (Ar C), 82.9 (CHOH), 68.1 (CHCH), 31.9 
(CH2CH2CH2CH3),  27.0  (CH2CH2CH2CH3),  22.7  (CH2CH2CH2CH3),  13.9 
(CH2CH2CH2CH3).                               
m/z:  [CI
+  Isobutane]:  221.1  [M+H]
+  (100%),  HRMS  found  221.1180  C13H17O3 
requires 221.1178 [M+H]
+.                          
υmax (neat)/cm
 1; 3420, 2972, 1685, 1279. 
4 Hydroxy 3 isobutylisochroman 1 one, 259.  
 
Keto lactone 250 was prepared using general procedure for the preparation of 
lactones,  starting  from  a  solution  of  acetal  230  (1.01  g,  6.71  mmol)  in 
tetrahydrofuran  (33  mL)  and  diisopropylamine  (188   L,  1.34  mmol);  methyl 
lithium (9.2 mL, 14.8 mmol) and isovaleraldehyde (863  L, 8.05 mmol).  The 
oxidative rearrangement was performed using 3 chloroperoxybenzoic acid (1.80 
g,  8.05  mmol);  in  dichloromethane  (33  mL).    Oxidation  was  achieved  on  a 
solution of crude lactol (1.42 g, 6.45 mmol); in acetone (33 mL) using 2.5 M 
Jones (5.16 mL, 12.9 mmol) to generate 1.06 g of the desired keto lactone 250 
(72%) without further purification.                 
Isochroman 1 one, 259 was prepared using general the general procedure for 
the  reduction  of  lactones  to  iso chroman 1 ones,  starting  from  a  solution  of 
keto lactone  250  (1.06  g,  4.88  mmol)  in  dichloromethane  (26  mL)  and  using Chapter 3 – Experimental  
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cerium(III)  chloride  (24.4  mL,  9.75  mmol,  0.4  M  in  methanol)  and  sodium 
borohydride (277 mg, 7.31 mmol).                 
Purification  by  flash  column  chromatography  (silica  gel,  40%  diethyl  ether  in 
petroleum spirits) gave 848 mg of isochromanone 259 (80%) as a clear oil and as 
a 75:25 mixture of diastereoisomers (syn:anti). 
4 Hydroxy (3R,4R) 3 isobutyl isochroman 1 one, 259syn. 
 
1H NMR (CDCl3, 400 MHz) δ: 7.96 (1H, d, J = 7.4 Hz, Ar H), 7.58 (1H, dt, J = 7.3, 
1.1 Hz, Ar H), 7.44 7.40 (2H, m, Ar H), 4.55 (1H, d, J = 1.8 Hz, CHOH), 4.49 (1H, 
ddd, J =  8.6, 4.6, 1.9 Hz, CHCH), 3.54 (1H, bs, OH), 1.94 1.88  (2H, m, CH2CH), 
1.60 1.52 (1H, m, CH(CH3)2), 0.93 (6H, t, m, CH(CH3)2).                        
13C NMR (CDCl3, 400 MHz) δ: 165.2 (CO2CH), 141.4 (Ar C), 134.3 (Ar C), 130.3 
(Ar C), 128.8 (Ar C), 128.8 (Ar C), 125.8 (Ar C), 81.3 (CHOH), 66.9 (CHCH), 39.1 
(CH2CH), 23.9 (CH(CH3)2), 23.1 (CH(CH3)2), 21.5 (CH(CH3)2). 
4 Hydroxy (3R,4S) 3 isobutyl isochroman 1 one, 259anti. 
 
1H NMR (CDCl3, 400 MHz) δ: 7.81 7.78 (1H, m, Ar H), 7.58 (1H, td, J = 7.3, 1.1 
Hz, Ar H), 7.44 7.40 (2H, m, Ar H), 4.49 (1H, d, J = 7.3 Hz, CHOH), 4.47 (1H, dd, 
J = 13.3, 7.2 Hz, CHCH), 3.54 (1H, bs, OH), 1.85 1.79 (2H, m, CH2CH), 1.60 1.52 
(1H, m, CH(CH3)2), 0.90 0.84 (1H, m, CH2CH), 0.93 (6H, m, CH(CH3)2).          
13C NMR (CDCl3, 400 MHz) δ: 165.3 (CO2CH), 140.4 (Ar C), 134.3 (Ar C), 130.1 
(Ar C), 129.7 (Ar C), 124.1 (Ar C), 123.7 (Ar C), 79.6 (CHCH), 68.3 (CHOH), 41.0 
(CH2CH) 24.1 (CH(CH3)2), 23.1 (CH(CH3)2), 22.2 (CH(CH3)2).             
m/z [CI
+ (+ve), isobutane]  221 [M+H]
+ (100%), HRMS found 221.1176, C13H17O3 
requires 221.1178 [M+H]
+.                        
υmax (neat)/cm
 1; 3442, 2925, 1699, 1558, 1287. 
 Chapter 3 – Experimental  
 
  105 
3 tertButyl (3R,4R) 4 hydroxy isochroman 1 one, 260.  
 
Keto lactone 251 was prepared using general procedure for the preparation of 
lactones,  starting  from  a  solution  of  acetal  230  (1.09  g,  7.24  mmol)  in 
tetrahydrofuran  (36  mL)  and  diisopropylamine  (203   L,  1.45  mmol);  methyl 
lithium (9.9 mL, 15.9 mmol) and trimethylacetaldehyde (940  L, 8.68 mmol).  
The oxidative rearrangement was performed using 3 chloroperoxybenzoic acid 
(1.95 g, 8.68 mmol); in dichloromethane (36 mL).  Oxidation was achieved on a 
solution of crude lactol (1.32 g, 6.00 mmol) in acetone (30 mL) using 2.5 M Jones 
(4.79 mL, 11.9 mmol) to give 1.31 g (83%) of the unstable keto lactone 251 after 
filtration  through  a  short  plug  of  silica  gel.    The  keto lactone  was  used 
immediately.                        
Isochroman 1 one, 260 was prepared using general the general procedure for 
the  reduction  of  lactones  to  iso chroman 1 ones,  starting  from  a  solution  of 
keto lactone  251  (220  mg,  1.01  mmol)  in  dichloromethane  (5  mL)  and  using 
cerium(III)  chloride  (5.05  mL,  2.02  mmol,  0.4  M  in  methanol)  and  sodium 
borohydride (172 mg, 4.55 mmol).                    
Purification by flash column chromatography (silica gel, 20% diethyl ether in 10% 
dichloromethane  in  petroleum  spirits)  yielded  171  mg  of  isochromanone  260 
(77%) as a clear oil and as a single syn diastereoisomer.                 
1H NMR (CDCl3, 400 MHz) d: 8.10 (1H, d, J = 8.0 Hz, Ar H), 7.65 (1H, dt, J = 7.2, 
1.2 Hz, Ar H), 7.52 (1H, dt, J = 7.6, 1.2 Hz, Ar H), 7.45 (1H, d, J = 7.6 Hz, Ar H), 
4.87 (1H, d, J = 1.2 Hz, CHOH), 4.06 (1H, d, J = 1.6 Hz, CHCH), 1.93 (1H, bs, 
OH), 1.21 (9H, s, C(CH3)3).                        
13C NMR (CDCl3, 100 MHz) d: 165.6 (CO2CH), 141.0 (Ar C), 134.4 (Ar C), 130.4 
(Ar C), 129.8 (Ar C), 127.5 (Ar C), 124.1 (Ar C), 87.2 (CHOH), 66.4 (CHCH), 34.6 
(C(CH3)3), 26.6 (C(CH3)3)                      
m/z [CI
+ (+ve), isobutane]  221.3 [M]
+ (100%), HRMS found 221.1176, C13H16NO3 
requires 221.1178 [M+H]
+.                        
υmax (neat)/cm
 1; 3424, 2960, 1700, 1606, 1282. 
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3 Cyclohexyl (3R,4R) 4 hydroxy isochroman 1 one, 261.   
 
Keto lactone 252 was prepared using general procedure for the preparation of 
lactones,  starting  from  a  solution  of  acetal  230  (1.00  g,  6.66  mmol)  in 
tetrahydrofuran  (34  mL)  and  diisopropylamine  (187   L,  1.33  mmol);  methyl 
lithium  (9.2  mL,  14.8  mmol)  and  cyclohexanecarboxaldehyde  (1.01  mL,  8.07 
mmol).    The  oxidative  rearrangement  was  performed  using  3 
chloroperoxybenzoic  acid  (1.81  g,  8.07  mmol);  in  dichloromethane  (34  mL).  
Oxidation  was  achieved  on  a  solution  of  crude  lactol  (1.52  g,  6.18  mmol)  in 
acetone (31 mL) using 2.5 M Jones (4.94 mL, 12.4 mmol) to give 927 mg (57%) of 
the unstable keto lactone 252 after filtration through a short plug of silica gel.  
The keto lactone was used immediately.            
Isochroman 1 one, 261 was prepared using general the general procedure for 
the  reduction  of  lactones  to  iso chroman 1 ones,  starting  from  a  solution  of 
keto lactone  252  (410  mg,  1.68mmol)  in  dichloromethane  (8  mL)  and  using 
cerium(III)  chloride  (8.40  mL,  3.36  mmol,  0.4  M  in  methanol)  and  sodium 
borohydride (95 mg, 2.52 mmol).                    
Purification  by  flash  column  chromatography  (silica  gel,  30%  ethyl  acetate  in 
petroleum  spirits)  afforded  339  mg  of  isochromanone  261  (82%)  as  a  white 
crystalline  solid  and  as  a  sole  syn  diastereoisomer  (mp.  163 
oC     166 
oC).                    
1H NMR (CDCl3, 400 MHz) d: 8.12 (1H, dt, J = 7.7, 0.7 Hz, Ar H), 7.64 (1H, td, J = 
7.5, 1.4 Hz, Ar H), 7.52 (1H, dt, J = 7.6, 1.3 Hz, Ar H), 7.45 (1H, dd, J = 7.4, 1.2 
Hz, Ar H), 4.69 (1H, d, J = 5.3 Hz, CHOH), 4.09 (1H, dd, J = 9.8, 1.7 Hz, CHCH), 
2.33  (1H,  dm,  CycHex H),  2.09 2.03  (1H,  m,  CycHex H),  1.99 1.94  (1H,  dm, 
CycHex H),  1.84 1.78  (1H,  m,  CycHex H),  1.75 1.71  (1H,  m,  CycHex H),  1.59 
(1H,  bs,  OH),  1.45 1.15  (4H,  m,  CycHex H),  1.13 0.99  (2H,  m,  CycHex H).            
13C NMR (CDCl3, 100 MHz) d: 165.0 (CO2CH), 140.3 (Ar C), 134.4 (Ar C), 130.5 
(Ar C), 129.9 (Ar C), 128.1 (Ar C), 124.5 (Ar C), 85.4 (CHOH), 64.8 (CHCH), 37.9 
(CycHex H), 29.5 (CycHex H), 28.1 (CycHex H), 26.3 (CycHex H), 25.7 (CycHex 
H), 25.5 (CycHex H).                       
m/z [CI
+ (+ve), isobutane]  247 [M+H]
+ (100%), HRMS found 247.1335, C15H19O3 Chapter 3 – Experimental  
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requires 247.1335 [M+H]
+.                               
υmax (neat)/cm
 1; 3442, 2925, 1699, 1558, 1287. 
Cyclohexylacetaldehyde.                    
Anhydrous dichloromethane (80 mL) was treated with  oxalyl chloride solution 
(23.4 mL, 46.8 mmol, 2 M in dichloromethane) at  78 
oC. Dimethylsulfoxide (6.6 
mL, 93.6 mmol) was then added to the reaction and the resulting mixture stirred 
for 1 hour. The reaction was then treated with through the slow addition of a 
solution  of  cyclohexyl  ethanol  (3.26  mL,  23.4  mmol)  in  anhydrous 
dichloromethane (40 mL). The reaction was stirred for 1 hour at  78 
oC, warmed 
to  room  temperature  and  then  treated  with  triethylamine  (26.1  mL,  187.2 
mmol).  The reaction was stirred for a further 1 hour before being quenched at 
0
oC through the addition of 1 M hydrochloric acid (20 mL). The resulting biphasic 
mixture was stirred for 20 minutes and extracted with dichloromethane (50 mL). 
The combined organic extracts were washed with sat. aq. sodium bicarbonate 
(20 mL), water (2x 30 mL), brine (30 mL), dried over sodium bicarbonate and 
concentrated in vacuo. The crude residue 2.89 g (98%) was taken on without 
further purification. 
3 (Cyclohexylmethyl) 4 hydroxyisochroman 1 one, 262.  
 
Keto lactone 253 was prepared using general procedure for the preparation of 
lactones,  starting  from  a  solution  of  acetal  230  (1.01  g,  6.71  mmol)  in 
tetrahydrofuran  (34  mL)  and  diisopropylamine  (188   L,  1.34  mmol);  methyl 
lithium (9.23 mL, 14.8 mmol) and cyclohexyl acetaldehyde (1.02 g, 8.06 mmol).  
The oxidative rearrangement was performed using 3 chloroperoxybenzoic acid 
(1.81 g, 8.06 mmol); in dichloromethane (34 mL).  Oxidation was achieved on a 
solution of crude lactol (1.52 g, 6.18 mmol) in acetone (30 mL) using 2.5 M Jones 
(4.86 mL, 12.15 mmol) to generate 1.16 g of the desired keto lactone 253 (67%) 
without further purification.                  
Isochroman 1 one, 262 was prepared using general the general procedure for 
the  reduction  of  lactones  to  iso chroman 1 ones,  starting  from  a  solution  of 
keto lactone  253  (1.06  g,  4.11  mmol)  in  dichloromethane  (20  mL)  and  using Chapter 3 – Experimental  
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cerium(III)  chloride  (20.5  mL,  8.21  mmol,  0.4  M  in  methanol)  and  sodium 
borohydride (233 mg, 6.17 mmol).                   
Purification was achieved by flash column chromatography (silica gel, 30 % ethyl 
acetate in petroleum spirits) to afford 615 mg of isochroman 1 one, 262 (58%) as 
a clear oil and as a 1:1 mixture of diastereoisomers. 
3 Cyclohexylmethyl (3R,4R) 4 hydroxy isochroman 1 one, 262syn.  
 
1H NMR (CDCl3, 400 MHz) d: 7.84 (1H, d, J = 7.6 Hz, Ar H), 7.64 7.60 (1H, m, Ar 
H), 7.51 7.48 (1H, m, Ar H), 7.41 (1H, m, Ar H), 5.31 (1H, d, J = 3.6 Hz, CHOH), 
4.56 4.52 (1H, m, CHCH), 2.00 (1H, bs, OH), 1.77 1.53 (8H, m, Alkyl H), 1.23 
1.08 (5H, m, Alkyl H).                         
13C NMR (CDCl3, 400 MHz) d: 170.5 (CO2CH), 146.9 (Ar C), 134.2 (Ar C), 134.1 
(Ar C), 129.5 (Ar C), 125.9 (Ar C), 124.2 (Ar C), 83.7 (CHOH), 70.4 (CHCH), 39.7 
(Alkyl C),  34.3  (Alkyl C),  33.8  (Alkyl C),  32.9  (Alkyl C),  26.5  (Alkyl C),  26.3 
(Alkyl C), 26.0 (Alkyl C). 
3 Cyclohexylmethyl (3R,4S) 4 hydroxy isochroman 1 one, 262anti.            
 
1H NMR (CDCl3, 400 MHz) d: 8.06 (1H, dt, J = 8.0, 1.6 Hz), 7.58 (1H, dt, J = 7.2, 
1.2 Hz), 7.46 (1H, dt, J = 7.6, 1.2 Hz), 7.41 (1H, d, J = 7.6 Hz), 4.56 4.52 (1H, 
m), 4.05  (1H, bs), 2.00 (1H, bs), 1.77 1.53 (8H, m, CycHex), 1.23 1.08 (5H, m, 
CycHex).                               
13C NMR (CDCl3, 400 MHz) d: 165.0 (CO2CH), 140.3 (Ar C), 134.4 (Ar C), 130.5 
(Ar C), 129.9 (Ar C), 127.8 (Ar C), 123.0 (Ar C), 84.0 (CHOH), 67.2 (CHCH), 37.9 
(Alkyl C),  33.9  (Alkyl C),  33.1  (Alkyl C),  32.5  (Alkyl C),  32.3  (Alkyl C),  26.4 
(Alkyl C), 26.2 (Alkyl C).                      
m/z [CI
+ (+ve), isobutane] 261 [M+H]
+ (100%), HRMS found 261.1490, C15H19O3 Chapter 3 – Experimental  
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requires 261.1491 [M+H]
+.                        
υmax (neat)/cm
 1; 3446, 2925, 1637, 1286. 
4 Hydroxy (3R,4R) 3 phenyl isochroman 1 one, 263.  
 
Keto lactone 254 was prepared using general procedure for the preparation of 
lactones,  starting  from  a  solution  of  acetal  230  (1.02  g,  6.82  mmol)  in 
tetrahydrofuran  (34  mL)  and  diisopropylamine  (191   L,  1.36  mmol);  methyl 
lithium  (9.4  mL,  15.0  mmol)  and  benzaldehyde  (827   L,  8.18  mmol).    The 
oxidative rearrangement was performed using 3 chloroperoxybenzoic acid (1.83 
g,  8.18  mmol);  in  dichloromethane  (34  mL).    Oxidation  was  achieved  on  a 
solution of crude lactol (1.61 g, 6.69 mmol) in acetone (33 mL) using 2.5 M Jones 
(5.35 mL, 13.4 mmol) to give 1.04 g (64%) of the unstable keto lactone 254 after 
filtration  through  a  short  plug  of  silica  gel.    The  keto lactone  was  used 
immediately.                           
Isochroman 1 one, 263 was prepared using general the general procedure for 
the  reduction  of  lactones  to  iso chroman 1 ones,  starting  from  a  solution  of 
keto lactone  254  (1.05  g,  4.40  mmol)  in  dichloromethane  (22  mL)  and  using 
cerium(III)  chloride  (22.0  mL,  8.80  mmol,  0.4  M  in  methanol)  and  sodium 
borohydride (249 mg, 6.60 mmol).                    
Purification was achieved by flash column chromatography (silica gel, 20% ethyl 
acetate in petroleum spirits) to afford 507 mg of isochroman 1 one, 263 (48%) as 
a yellow solid (m.p. 60.5 63.7 
oC) and as a single syn diastereoisomer.               
1H NMR (CDCl3, 400 MHz) δ: 8.05 (1H, dd, J = 8.0, 1.2 Hz, Ar H), 7.57 (1H, td, J = 
7.6, 1.2 Hz, Ar H), 7.56 7.51 (2H, m, Ar H), 7.48 7.35 (5H, m, Ar H), 5.50 (1H, 
d,  J  =  1.6  Hz,  CHOH),  4.72  (1H,  d,  J  =  1.9  Hz,  CHCH),  2.55  (1H,  bs,  OH).            
13C NMR (CDCl3, 100 MHz) δ: 164.9 (CO2CH), 139.4 (Ar C), 135.2 (Ar C), 134.5 
(Ar C), 130.5 (Ar C), 130.0 (Ar C), 128.8 (Ar C), 128.7 (Ar C), 128.2 (Ar C), 126.6 
(Ar C), 124.0 (Ar C), 81.8 (CHOH), 68.2 (CHCH).              
m/z [CI
+ (+ve), isobutane]  241.3 [M+H]
+ (100%), HRMS found 241.0866, C15H13O3 
requires 241.0865 [M+H]
+.                        
υmax (neat)/cm
 1; 3430, 3064, 2919, 1708, 1605, 1284. Chapter 3 – Experimental  
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4 Hydroxy 3 phenethylisochroman 1 one, 264. 
 
Keto lactone 255 was prepared using general procedure for the preparation of 
lactones,  starting  from  a  solution  of  acetal  230  (1.03  g,  6.84  mmol)  in 
tetrahydrofuran  (34  mL)  and  diisopropylamine  (192   L,  1.37  mmol);  methyl 
lithium  (9.38  mL,  15.0  mmol);  3 phenylpropanal  (1.08  mL,  8.21  mmol).    The 
oxidative rearrangement was performed using 3 chloroperoxybenzoic acid (1.84 
g,  8.21  mmol);  in  dichloromethane  (34  mL).    Oxidation  was  achieved  on  a 
solution of crude lactol (1.85 g, 6.53 mmol) in acetone (33 mL) using 2.5 M Jones 
(5.22 mL, 13.1 mmol) to give 1.69 g (93%) of the unstable keto lactone 255 after 
filtration  through  a  short  plug  of  silica  gel.    The  keto lactone  was  used 
immediately.                        
Isochroman 1 one, 264 was prepared using general the general procedure for 
the  reduction  of  lactones  to  iso chroman 1 ones,  starting  from  a  solution  of 
keto lactone  255  (248  mg,  0.93  mmol)  in  dichloromethane  (5  mL)  and  using 
cerium(III)  chloride  (4.65  mL,  1.86  mmol,  0.4  M  in  methanol)  and  sodium 
borohydride (53 mg, 1.40 mmol).                    
Purification of the crude residue by flash column chromatography (silica gel, 20% 
ethyl acetate in petroleum spirits) gave 225 mg of isochromanone 264 as a white 
solid  in  90%  yield  and  as  a  1:1  mixture  of  diastereoisomers  that  could  be 
separated by recrystallisation (diethyl ether: petroleum spirits). 
4 Hydroxy (3R,4R) 3 phenethyl isochroman 1 one, 264syn.  
 
1H NMR (CDCl3, 400 MHz) δ: 8.06 (1H, dd, J = 7.6, 1.2 Hz, Ar H), 7.60 7.55 (1H, 
m, Ar H), 7.50 7.36 (2H, m, Ar H), 7.24 7.11 (5H, m, Ar H), 4.53 (1H, bs, CHOH), 
4.35 (1H, ddd, J = 9.1, 4.7, 1.9 Hz, CHCH), 2.94 2.91 (1H, m, CH2CH2Ph), 2.81 
2.76  (1H,  m,  CH2CH2Ph),  2.20 2.14  (1H,  m,  CH2CH2Ph),  2.12 1.95  (1H,  m, 
CH2CH2Ph), 1.92 (1H, bs, OH).               
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13C NMR (CDCl3, 400 MHz) δ: 164.8 (CO2CH), 141.5 (Ar C), 140.8 (Ar C), 134.4 
(Ar C), 130.5 (Ar C), 129.9 (Ar C), 128.6 (Ar C), 128.5 (Ar C), 127.8 (Ar C), 126.2 
(Ar C),  125.2  (Ar C),  79.8  (CHOH),  68.1  (CHCH),  31.9  (CH2CH2Ph),  31.0 
(CH2CH2Ph). 
4 Hydroxy (3R,4S) 3 phenethyl isochroman 1 one, 264anti. 
 
1H NMR (CDCl3, 400 MHz) δ: 8.03 (1H, dd, J = 7.7, 1.1 Hz, Ar H), 7.60 7.55 (1H, 
m, Ar H), 7.50 7.36 (2H, m, Ar H), 7.24 7.11 (5H, m, Ar H), 4.68 (1H, t, J = 6.8 
Hz, CHOH), 4.32 4.27 (1H, ddd, J = 9.2, 8.1, 3.1 Hz, CHCH), 2.94 2.91 (1H, m, 
CH2CH2Ph), 2.81 2.76 (1H, m, CH2CH2Ph), 2.20 2.14 (1H, m,  CH2CH2Ph), 2.12 
1.95 (1H, m, CH2CH2Ph), 1.92 (1H, bs, OH).                              
13C NMR (CDCl3, 100 MHz) δ: 164.3 (CO2CH), 140.8 (Ar C), 140.1 (Ar C), 134.4 
(Ar C), 130.3 (Ar C), 128.9 (Ar C), 128.6 (Ar C), 128.5 (Ar C), 127.8 (Ar C), 126.2 
(Ar C),  125.2  (Ar C),  81.7  (CHOH),  66.9  (CHCH),  33.6  (CH2CH2Ph),  30.9 
(CH2CH2Ph).                           
m/z [CI
+ (+ve), isobutane]  269.1 [M+H]
+ (100%), HRMS found 269.1180, C17H17O3 
requires 269.1178 [M+H]
+.                        
υmax (neat)/cm
 1; 3445, 2924, 1698, 1576, 1282.. 
3 secButyl 4 hydroxyisochroman 1 one, 276 and 277. 
 
Keto lactones  274  and  275  were  prepared  using  general  procedure  for  the 
preparation  of  lactones,  starting  from  a  solution  of  acetal  230  (1.00  g,  6.69 
mmol) in tetrahydrofuran (33 mL) and diisopropylamine (187  L, 1.34 mmol); 
methyl lithium (9.19 mL, 14.7 mmol) and (+/ ) 2 methylbutanal (859  L, 8.03 
mmol).    The  oxidative  rearrangement  was  performed  using  3 
chloroperoxybenzoic  acid  (1.79  g,  8.03  mmol);  in  dichloromethane  (33  mL).  
Oxidation was achieved on a solution of crude lactol (1.32 g, 6.00 mmol); in 
acetone (35 mL) using 2.5 M Jones (4.79 mL, 11.9 mmol) to yield 1.39 g of the Chapter 3 – Experimental  
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desired  keto lactones  274  and  275  (95%)  as  a  1.6:1.0  mixture  of  anti:syn 
diastereoisomers without further purification. Isochroman 1 ones 276 (syn,anti) 
and 277 (syn,syn) were prepared using general the general procedure for the 
reduction of lactones to iso chroman 1 ones, starting from a solution of keto 
lactones 274 and 275 (1.39 g, 6.41 mmol) in dichloromethane (26 mL) and using 
cerium(III)  chloride  (32.1  mL,  12.8  mmol,  0.4  M  in  methanol)  and  sodium 
borohydride (363 mg, 9.62 mmol).                   
Purification was achieved by flash column chromatography (silica gel, 30% ethyl 
acetate in petroleum spirits) to afford 1.07 g of isochromanones 276 and 277 
(76%)  as  a  yellow  solid  and  as  a  1.6:1.0  mixture  of  diastereoisomers 
(syn,anti:syn,syn) that were separable by recrystallisation from diethyl ether: 
petroleum spirits. 
3 (R) secButyl (3R,4R) 4 hydroxy isochroman 1 one, 276 (syn,anti).  
 
1H NMR (CDCl3, 400 MHz) δ: 8.08 (1H, d, J = 7.8 Hz, Ar H), 7.65 7.61 (1H, m, Ar 
H), 7.65 7.61 (1H, m, Ar H), 7.46 (1H, d, J = 7.5 Hz, Ar H), 4.79 (1H, d, J = 1.3 
Hz, CHOH), 4.11 (1H, dd, J = 2.0, 1.8 Hz, CHCH), 2.37 (1H, bs, OH), 2.21 2.13 
(1H, m, CHCH3), 1.80 1.70 (1H, m, CH2CH3), 1.37 1.24 (1H, m, CH2CH3), 1.16 
(3H, d, J = 6.6 Hz), 0.98 (3H, t, J = 7.4 Hz).                     
13C NMR (CDCl3, 100 MHz) δ: 165.3 (CO2CH), 140.1 (Ar C), 134.4 (Ar C), 130.3 
(Ar C), 129.9 (Ar C), 128.1 (Ar C), 124.3 (Ar C), 85.4 (CHOH), 65.2 (CHCH), 34.6 
(CHCH2), 24.8 (CHCH2), 14.9 (CHCH3), 10.7 (CH2CH3). 
3 (R) secButyl (3S,4S) 4 hydroxy isochroman 1 one, 277 (syn,syn). 
 
1H NMR (CDCl3, 400 MHz) δ: 7.88 (1H, d, J = 8.2 Hz, Ar H), 7.71 7.67 (1H, m, Ar 
H), 7.65 7.61 (1H, m, Ar H), 7.46 (1H, d, J = 7.5 Hz, Ar H), 4.74 (1H, d, J = 1.3 
Hz, CHOH), 4.09 (1H, dd, J = 2.5, 1.8 Hz, CHCH), 2.37 (1H, bs, OH), 2.21 2.13 
(1H, m, CHCH3), 1.98 1.90 (1H, m, CH2CH3), 1.37 1.24 (1H, m, CH2CH3), 1.07 Chapter 3 – Experimental  
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(3H, d, J = 6.8 Hz), 0.95 (3H, t, J = 7.5 Hz, ).                    
13C NMR (CDCl3, 100 MHz) δ: 165.2 (CO2CH), 140.1 (Ar C), 134.4 (Ar C), 130.3 
(Ar C), 129.9 (Ar C), 128.1 (Ar C), 124.3 (Ar C), 84.6 (CHOH), 65.2 (CHCH), 34.5 
(CHCH2), 24.8 (CHCH2), 14.2 (CHCH3), 10.4 (CH2CH3).             
m/z [CI
+ (+ve), isobutane] 221 [M+H]
+ (100%), HRMS found 221.1179, C13H17O3 
requires 221.1179 [M+H]
+.                        
υmax (neat)/cm
 1; 3426, 2967, 1696, 1285. 
2 Methyl 4,5 dihydro oxazole 4 carboxylic acid methyl ester, 279.
173  
 
A  solution  of  DL serine  methyl  ester  278  (2.00  g,  16.8  mmol)  and  ethyl 
acetimidate (2.08 g, 16.8 mmol) in dichloromethane (65 mL) was treated with 
triethylamine (4.90 mL, 35.2 mmol) (3x 1.63 mL) over 30 minutes. The resulting 
cloudy solution was then stirred at room temperature until completion by TLC 
analysis (18 h). The crude reaction was filtered through celite and washed with 
diethyl ether (3x 100 mL).  The organic layer was concentrated in vacuo and the 
crude residue purified by short path distillation (151 
oC) to give 1.76 g (75%) of 
2 methyl 4,5 dihydro oxazole 4 carboxylic acid methyl ester 279 as a clear oil.          
1H NMR (CDCl3, 400 MHz) d: 4.71 4.67 (1H, m, COCH), 4.45 (1H, dd, J = 8.6, 8.0 
Hz, CHCH2), 4.37 (1H, dd, J = 10.6, 8.8 Hz, CHCH2), 3.76 (3H, s, OCH3), 1.99 (3H, 
d, J = 1.2 Hz, CCH3).                         
13C NMR (CDCl3, 100 MHz) d: 171.7 (CO2CH3), 167.8 (NCCH3), 69.4 (COCHN), 51.7 
(OCH3), 36.4 (CH2CH2), 26.5 (CH2CH2), 13.8 (NCCH3).               
υmax (neat)/cm
 1; 2955, 1743, 1669, 1438. 
2 Methyl oxazole 4 carboxylic acid methyl ester, 270.
173,174 
 
Procedure A.                            
To a suspension of copper (II) bromide (6.86 g, 30.7 mmol) and hexamethylene 
tetraamine  (4.30  g,  30.7  mmol)  in  anhydrous  dichloromethane  (65  mL)  was 
added a solution of 2 methyl 4,5 dihydro oxazole 4 carboxylic acid methyl ester 
279 (1.75 g, 12.29 mmol) in dichloromethane (20 mL). The resulting solution was Chapter 3 – Experimental  
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stirred at room temperature for 30 minutes to give a brown suspension that was 
treated  with  1,8 diazabicyclo[5.4.0]undec 7 ene  (4.59  mL,  30.7  mmol)  and 
stirred  for  2  hours.  The  reaction  was  concentrated  in  vacuo  and  the  crude 
residue was diluted with ethyl acetate (200 mL). The solution was treated by the 
slow addition of an ammonium chloride: ammonium hydroxide mixture (1:1) (200 
mL).  The organic phase was separated and washed again with the ammonium 
chloride: ammonium hydroxide solution (2x 100 mL), water (50 mL) and brine 
(50  mL)  sequentially.  The  organic  layer  was  dried  over  sodium  sulfate  and 
concentrated under  vacuum.  The crude  residue  was  purified  by  flash  column 
chromatography (silica gel, 50% diethyl ether in petroleum ether) to yield 502 
mg (28%) of known oxazole 270 as a white solid. 
Procedure B.
                      
A 0 
oC solution of 2 methyl 4,5 dihydro oxazole 4 carboxylic acid methyl ester 
279 (11.5 g, 80.3 mmol) in dichloromethane (250 mL) was treated with 1,8 
diazabicyclo[5.4.0]undec 7 ene  (23.9 mL,  160 mmol) and stirred for 10 min. 
Trichlorobromomethane (8.68 mL, 88 mmol), was then added to the reaction 
mixture and the resulting solution stirred at 0 
oC for 1 hour. The mixture was 
then warmed to room temperature and stirred until completion as indicated by 
TLC  analysis  (9  h).  The  solvent  was  evaporated  under  reduced  pressure  and 
crude  residue  was  purified  by  flash  column  chromatography  (silica  gel,  50% 
diethyl ether in petroleum ether) to give 6.49 g (55%) of oxazole 270 as a white 
solid.                                       
1H NMR (CDCl3, 400 MHz) d: 8.07 (1H, s, Ar H), 3.84 (3H, s, (Ar H), 2.45 (3H, s, 
Ar H).                             
13C NMR (CDCl3, 100 MHz) d: 162.4 (CO2CH3), 161.7 (Ar C), 143.8 (Ar C), 120.2 
(Ar C), 52.2 (CO2CH3), 13.9 (Ar CH3).                      
m/z  [EI
+]  141.07  [M]
+  (76%),  110.04  [M CH3O]
+  (100%).  HRMS  found  141.0423, 
C6H7NO3 requires 141.0426 [M]
+.                     
υmax (neat)/cm
 1; 2923, 1734, 1639, 1440. 
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(2 Methyloxazol 4 yl)methanol, 280.
173 
 
To  a   78 
oC  solution  of  2 methyl oxazole 4 carboxylic  acid  methyl  ester  270 
(5.44 g, 38.5 mmol) in dichloromethane (200 mL) was added diisobutylaluminium 
hydride (78.9 mL, 78.9 mmol, 1.0 M in dichloromethane) and stirred for 3 hours. 
The reaction mixture was warmed up to 0 
oC then diluted with diethyl ether (100 
mL) and treated with the sequential addition of water (3.2 mL), 15% aq sodium 
hydroxide (3.2 mL) and water (6.3 mL). The resulting suspension was stirred at 0 
oC  for  30  minutes  and  then  treated  with  sodium  sulfate.  The  mixture  was 
warmed to room temperature and then stirred for a further 30 minutes. The 
solids were filtered off and the solvent evaporated in vacuo.  The crude residue 
obtained  was  purified  by  flash  column  chromatography  (silica  gel,  60%  ethyl 
acetate  in  petroleum  spirits)  to  yield  3.51  g  (82%)  of  2 methyl oxazole 4 
methanol 280 as a clear oil.                         
1H NMR (CDCl3, 400 MHz) d: 7.41 (1H, s, Ar H), 4.8 (2H, s, CH2OH), 3.66 (1H, bs, 
OH), 2.38 (3H, s, Ar CH3).                        
13C  NMR  (CDCl3,  100  MHz)  d:  162.2  (Ar C),  140.2  (Ar C),  134.8  (Ar C),  56.1 
(CH2OH), 13.8 (Ar CH3).                       
m/z [CI
+ (+ve) isobutane]  114.15 [M+H]
+ (100%), 96.14 [M+H H2O)]
+ (16%). HRMS 
found  114.0556, C5H8NO2 requires 114.0556 [M+H]
+.                 
υmax (neat)/cm
 1; 3387, 2933, 1648, 1443. 
2 Methyl oxazole 4 carbaldehyde, 281.
173 
 
A   78 
oC  solution  of  oxalyl  chloride  (0.73  mL,  1.46  mmol)  in  anhydrous 
dichloromethane  (5  mL)  was  treated  with  dimethylsulfoxide  (0.21  mL,  2.92 
mmol)  and  stirred  for  30  minutes.  A  solution of  2 methyl oxazole 4 methanol 
280 (110 mg, 1.46 mmol) in dichloromethane (5 mL) was then cannulated slowly 
into  the  reaction  mixture  and  the  reaction  stirred  for  1  hour  at   78 
oC. 
Triethylamine (0.61 mL, 4.38 mmol) was then added to the reaction, which was 
allowed to warm to room temperature and stirring continued for a further 2 
hours.         The reaction was diluted with dichloromethane (5 mL) and quenched Chapter 3 – Experimental  
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by the addition of 2 M HCl (5 mL).  The resulting biphasic mixture was extracted 
into dichloromethane (5 mL) and the combined organic phases were washed with 
saturated aqueous sodium sulfate (10 mL), water (2 x 10 mL), brine (10 mL) and 
dried  over  sodium  bicarbonate.  Solvent  removal  in  vacuo  followed  by 
purification of the crude residue by flash column chromatography (silica gel, 30% 
ethyl acetate in petroleum spirits) yielded 87 mg (81%) of aldehyde 281 as a 
brown solid (m.p. 65 69 
oC).                         
1H NMR (CDCl3, 400 MHz) d: 9.90 (1H, s, CHO), 8.16 (1H, s, Ar H), 2.54 (3H, s, Ar 
CH3).                              
13C NMR (CDCl3, 100 MHz) d: 183.8 (CHO), 163.1 (Ar C), 144.5 (Ar C), 140.9 (Ar 
C), 13.8 (Ar CH3).                        
m/z  [EI
+(+ve)]  111.06  [M]
+  (100%).  HRMS  found  111.0318,  C8H11NO2  requires 
111.0320 [M]
+.                            
υmax (neat)/cm
 1; 2983, 1690, 1647, 1444, 1107. 
2 Methyl (E) 3 (2 methyl oxazol 4yl) acrylic acid ethyl ester, 282.  
 
To  a  refluxing  solution  of  2 methyl oxazole 4 carbaldehyde,  281  (2.31  g,  24 
mmol)  in  toluene  (100  mL)  was  added  (carbethoxyethylidene) 
triphenylphosphorane (17.25 g, 47.6 mmol) in three portions over 30 min. The 
resulting reaction mixture was refluxed for 3 hours before it was cooled down to 
room  temperature  and  the  solvent  evaporated  under  reduced  pressure.    The 
crude residue was then loaded directly onto silica and purified by flash column 
chromatography (silica gel, 20% ethyl acetate in petroleum spirits) to give 3.15 g 
(96%)  of  the  desired  olefin  282  as  a  yellow  oil  and  as  a  single  E  isomer.               
1H NMR (CDCl3, 400 MHz) d: 7.68 (1H, s, Ar H), 7.43 (1H, d, J = 0.7 Hz, CHCCH3), 
4.24 (2H, q, J = 7.1 Hz, CH2CH3), 2.48 (3H, s, Ar CH3), 2.20 (3H, d, J = 1.2 Hz, 
CCH3), 1.32 (3H, t, J = 7.1 Hz, CH2CH3).                    
13C NMR (CDCl3, 100 MHz) d: 168.3 (CO2CH2), 161.5 (Ar C), 138.9 (Ar C), 137.6 
(Ar C), 128.8 (CCH3), 127.3 (CHCCH3), 60.9 (CH2CH3), 14.5 (Ar CH3), 14.3 (CCH3), 
13.9 (CH2CH3).                           
m/z [CI
+ (+ve), isobutane] 196.25 [M]
+ (100%). HRMS found 196.0976, C10H14NO3 Chapter 3 – Experimental  
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requires 196.0974 [M+H]
+.                         
υmax (neat)/cm
 1; 2983, 1690, 1647, 1444, 1107 
2 Methyl (E) 3 (2 methyl oxazol 4 yl) prop 2 en 1 ol, 283.  
 
(E) 2 Methyl 3 (2 methyl oxazol 4yl) acrylic  acid ethyl  ester  282  (2.74  g,  14.4 
mmol) was dissolved in anhydrous dichloromethane (75 mL) and cooled to  78 
oC. 
The solution was treated with diisobutylaluminium hydride (30.9 mL, 1.0 M soln. 
in dichloromethane, 30.9 mmol) and stirred at  78 
oC for 2 hours. The reaction 
mixture was warmed up to 0 
oC and diluted with diethyl ether (75 mL) before 
being quenched by the sequential addition of water (1.1 mL), 15% aq sodium 
hydroxide  (1.1  mL)  and  water  (2.7  mL).  The  resulting  cloudy  suspension  was 
stirred for 30 minutes, treated with sodium sulfate and then stirred for a further 
30  minutes.  The  resulting  suspension  was  filtered  through  celite  and  washed 
with diethyl ether (3x 50 mL).  The combined organic phases were concentrated 
in vacuo and the residual clear oil was purified by flash column chromatography 
(silica gel, 30% ethyl acetate in petroleum spirits) to yield 2.10 g (98%) of the 
desired (E) 2 methyl 3 (2 methyl oxazol 4 yl) prop 2 en 1 ol 283 as a colourless 
oil.                               
1H NMR (CDCl3, 400 MHz) d: 7.48 (1H, s, Ar H), 6.29 (1H, s, CHCCH3), 4.17 (2H, s, 
CH2OH),  2.46  (3H,  s,  Ar CH3),  1.98  (3H,  s,  CCH3),  1.89  (H,  bs,  OH).                    
13C NMR (CDCl3, 100 MHz) d: 160.9 (Ar C), 139.6 (CCH3), 137.7 (CHCCH3), 135.3 
(Ar C), 114.2 (CHCCH3), 68.3 (CH2OH), 16.1 (Ar C), 13.8 (CCH3).         
m/z [EI
+(+ve)]  153.13 [M]
+ (100%), 135.12 [M H2O]
+(90%). HRMS found 153.0793, 
C8H11NO2 requires 153.0790 [M]
+.                      
υmax (neat)/cm
 1; 3607, 1642, 1442. 
2 Methyl 3 (2 methyl oxazol 4 yl) propan 1 ol, 284. 
 
Procedure A                       
A solution of (E) 2 methyl 3 (2 methyl oxazol 4 yl) prop 2 en 1 ol 283 (142 mg, 
0.93 mmol) in methanol (30 mL) was placed in an H Cube flow hydrogenator over Chapter 3 – Experimental  
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10% palladium on carbon catalyst, at 40 bar and 35 
oC.  The reaction was cycled 
for 3 hours before the hydrogenation was stopped and the solvent evaporated 
under  reduced  pressure  to  yield  140  mg  (97%)  of  the  desired  2 methyl 3 (2 
methyl oxazol 4 yl) propan 1 ol  284  as  a  colourless  oil,  which  could  be  used 
without the need of further purification. 
Procedure B                       
A solution of (E) 2 methyl 3 (2 methyl oxazol 4 yl) prop 2 en 1 ol 283 (2.05 g, 
13.39 mmol) in absolute ethanol (130 mL) was charged with palladium on carbon 
(10% Pd on activated carbon, 134 mg).  The reaction was then placed under a 
hydrogen atmosphere and stirred until completion as indicated by TLC analysis 
(2 h).  The suspension was filtered through celite and the filtrate concentrated 
under vacuum.  The crude residue was purified via flash column chromatography 
(silica gel, elution gradient 50% to 70% diethyl ether in petroleum spirits) to give 
1.99 g (96%) of the desired 2 methyl 3 (2 Methyl oxazol 4 yl) propan 1 ol 284 as 
a colourless oil. 
Procedure C                      
A solution of (E) 2 methyl 3 (2 methyl oxazol 4 yl) prop 2 en 1 ol 283 (8.93 g, 
45.7 mmol) in tetrahydrofuran (280 mL) was cooled to 0 
oC and treated with 
lithium aluminium hydride (18.3 mL, 64 mmol, 3.5 M  in tetrahydrofuran) and 
stirred for 4 hours. The reaction mixture was diluted with diethyl ether (75 mL) 
before being quenched by the sequential addition of water (2.4 mL), 15% aq 
sodium hydroxide (3.0 mL) and water (7.3 mL). The resulting cloudy suspension 
was stirred for 30 minutes, treated with sodium sulfate and then stirred for a 
further  30  minutes.  The  resulting  suspension  was  filtered  through  celite  and 
washed  with  diethyl  ether  (3  x  50  mL).    The  combined  organic  phases  were 
concentrated under vacuo and the residual clear oil was purified by flash column 
chromatography (silica gel, 30% ethyl acetate in petroleum spirits) to yield 3.63 
g (50%) of the desired alcohol 2 methyl 3 (2 Methyl oxazol 4 yl) propan 1 ol 284 
as a colourless oil.                           
1H NMR (CDCl3, 400 MHz) d: 7.32 (1H, t, J = 0.9 Hz, Ar H), 3.59 (1H, dd, J = 11.2, 
4.9 Hz, CH2OH), 3.48 (1H, dd, J = 11.7, 6.8 Hz, CH2OH), 2.64 (1H, bs, OH), 2.54 
(2H, dd, J = 6.3, 0.9 Hz, CHCH2 ), 2.46 (3H, s, Ar H), 2.07 1.99 (1H, m, CHCH3), 
0.95 (3H, d, J = 6.8 Hz, Ar CH3).                      Chapter 3 – Experimental  
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13C  NMR  (CDCl3,  100  MHz)  d:  161.4  (Ar C),  138.4  (Ar C),  134.6  (Ar C),  67.3 
(CH2OH),  35.1  (CH2CH),  29.9  (CHCH2),  16.7  (CHCH3),  13.9  (C CH3).                   
m/z [EI
+(+ve)] 155.15 [M]
+ (100%), 138.15 [M OH]
+ (16%). HRMS found 155.0943, 
C8H13NO2 requires 155.0946 [M]
+.                             
υmax (neat)/cm
 1; 2992, 1638, 1461. 
2 Methyl 3 (2 methyl oxazol 4 yl) propionaldehyde, 285 
 
Procedure A                      
A   78 
oC  solution  of  oxalyl  chloride  (17.07  mL,  34.14  mmol)  in  anhydrous 
dichloromethane  (50  mL)  was  treated  with  dimethylsulfoxide  (5.27  mL,  68.1 
mmol) and stirred for 30 minutes. A solution of 2 methyl 3 (2 methyl oxazol 4 
yl) propan 1 ol 284 (3.53 g, 22.7 mmol) in dichloromethane (50 mL) was then 
cannulated slowly into the reaction mixture and the reaction stirred for 1 hour 
at  78 
oC. Triethylamine (14.2 mL, 102.15 mmol) was then added to the reaction 
and  stirring  was  continued  at  room  temperature  for  a  further  2  hours.  The 
reaction  was  diluted  with  dichloromethane  (50  mL)  and  quenched  by  the 
addition  of  2  M  hydrochloric  acid  solution  (50  mL).    The  resulting  biphasic 
mixture was extracted with dichloromethane (50 mL) and the combined organic 
phases were washed with saturated aqueous sodium bicarbonate (50 mL), water 
(2x  50  mL),  brine  (50  mL)  and  dried  over  sodium  sulfate.  The  solvents  were 
removed under educed pressure and the crude residue was purified via flash 
column  chromatography  (silica  gel,  elution  50%  diethyl  ether  in  petroleum 
spirits) to give 1.82 g (52%) of the desired aldehyde 285 as a colourless oil. 
Procedure B                              
A  stirred  solution  of  iodoxybenzoic  acid  (542  mg,  1.94  mmol)  in 
dimethylsulfoxide (5 mL) was treated with a solution of 2 methyl 3 (2 methyl 
oxazol 4 yl) propan 1 ol 284 (201 mg, 1.29 mmol) in dimethylsulfoxide (2 mL) 
and stirred until completion (3 hours) by TLC analysis. The reaction was diluted 
with diethyl ether (10 mL) and quenched by the addition of water (5 mL) and 
extracted  into  diethyl  ether.  The  combined  organic  extracts  were  washed 
sequentially  with  water  (3  x  10  mL),  saturated  aqueous  sodium  bicarbonate Chapter 3 – Experimental  
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solution (10 mL) and brine (10 mL). The organic layer was dried over sodium 
sulfate  and  the  solvents  were  removed  under  reduced  pressure.  The  crude 
residue  obtained  was  purified  via  flash  column  chromatography  (silica  gel, 
elution  with  50%  diethyl  ether  in  petroleum  spirits)  to  give  169  mg  (85%)  of 
aldehyde 285 as a colourless oil.                      
1H NMR (CDCl3, 400 MHz) d: 9.72 (1H, d, J = 1.3 Hz, CHO), 7.29 (1H, t, J = 0.9 
Hz,  Ar H),  2.90  (1H,  ddd,  J  =  14.7,  6.5,  1.0  Hz,  CHCH2),  2.82 2.73  (1H,  m, 
CHOCH), 2.52 (1H, ddd, J = 14.7, 7.0, 0.9 Hz, CHCH2), 2.41 (3H, s, Ar CH3), 1.12 
(3H, d, J = 7.1 Hz, CHCH3).                       
13C NMR (CDCl3, 100 MHz) d: 204.1 (CHO), 161.5 (Ar C), 137.6 (Ar C), 134.7 (Ar 
C), 45.4 (CHCH3), 27.0 (CH2), 13.9 (Ar CH3), 13.3 (CHCH3).             
υmax (neat)/cm
 1, 2975, 2934, 1719, 1652, 930. 
4 Hydroxy 3 ((S) 1 (2 methyloxazol 4 yl)propan 2 yl)isochroman 1 ones, 289 
and 290.  
 
Keto lactones 287 and 288 were prepared using the general procedure for the 
preparation  of  lactones,  starting  from  a  solution  of  acetal  230  (1.36  g,  9.04 
mmol) in tetrahydrofuran (45 mL) and diisopropylamine (254  L, 1.81 mmol); 
methyl  lithium  (12.4  mL,  19.9  mmol);  2 methyl 3 (2 methyl oxazol 4 yl) 
propionaldehyde,  285 (1.8  g, 11.8 mmol).  The oxidative rearrangement was 
performed  using  3 chloroperoxybenzoic  acid  (2.43  g,  10.9  mmol);  in 
dichloromethane (45 mL).  Oxidation was achieved on a solution of crude lactol 
(2.46 g, 8.28 mmol); in acetone (41 mL) using 2.5 M Jones (6.62 mL, 16.6 mmol) 
to generate 1.57 g of the desired keto lactone intermediates 287 (anti) and 288 
(syn) (61%) in a 3:2 ratio of diastereoisomers.             
Isochroman 1 ones, 289 and 290 were prepared using the general procedure for 
the reduction of lactones to iso chroman 1 ones, starting from a solution of the 
keto lactones 287 and 288 (1.46 g, 5.08 mmol) in dichloromethane (25 mL) and 
using cerium(III) chloride (25.4 mL, 10.2 mmol, 0.4 M in methanol) and sodium 
borohydride  (288  mg,  10.2  mmol).  Purification  was  achieved by  flash  column 
chromatography (silica gel, 50% ethyl acetate in petroleum spirits) to afford 1.26 Chapter 3 – Experimental  
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g (86%) of the desired isochromanones 289 and 290 as a 3:2 (syn,anti:syn,syn) 
mixture of diastereoisomers from which the (syn,anti) diastereoisomer could be 
crystallized  out  (diethyl  ether:  petroleum  spirits).    It  must  be  noted  that 
extended exposure to silica gel resulted in extensive compound decomposition. 
(3S,4S) 4 Hydroxy 3 [(S) 1 methyl 2 (2 methyl oxazol 4 yl) ethyl] 
isochroman 1 one, 289 (syn,anti). 
 
1H NMR (CDCl3, 400 MHz) d: 8.10 (1H, dd, J = 7.3 Hz, Ar H), 7.64 (1H, dt, J = 7.5, 
1.2 Hz, Ar H), 7.51 (1H, dt, J = 7.7, 1.3 Hz, Ar H), 7.48 (1H, d, J = 7.5 Hz, Ar H), 
7.31 (1H, s, Ar H), 4.77 (1H, s, CHOH), 4.20 (1H, dd, J = 8.9, 1.4 Hz, CHCH), 
3.83  (1H,  bs,  OH),  3.16  (1H,  dd,  J  =  14.4,  2.9,  CHCH2),  2.64 2.28  (1H,  m, 
CHCH3), 2.48 (1H, dd, J = 14.4, 8.7 Hz, CHCH2), 2.24 (3H, s, Ar CH3), 1.09 (3H, 
d, J = 6.8 Hz, CHCH3).                                 
13C (CDCl3, 100 MHz) d: 164.8 (CO2CH), 161.3 (Ar C), 140.4 (Ar C), 138.4 (Ar C), 
134.9 (Ar C), 134.2 (Ar C), 130.4 (Ar C), 129.8 (Ar C), 128.0 (Ar C), 124.5 (Ar C), 
84.3 (CHOH), 65.5 (CHCH), 33.4 (CHCH2), 28.2 (CHCH3), 15.5 (CHCH3), 13.7 (Ar 
CH3). 
(3R,4R) 4 Hydroxy 3 [(S) 1 methyl 2 (2 methyl oxazol 4 yl) ethyl] 
isochroman 1 one, 290 (syn,syn). 
 
1H NMR (CDCl3, 400 MHz) d: 8.09 (1H, d, J = 7.5 Hz, Ar H), 7.64 7.59 (1H, m, Ar 
H), 7.50 7.46 (2H, m, Ar H), 7.29 (1H, s, Ar H), 4.98 (1H, m, CHOH), 4.13 (1H, 
dd, J = 9.3, 1.2 Hz, CHCH), 2.71 (1H, dd, J = 14.5, 4.3 Hz, CHCH2), 2.56 2.51 
(1H, m, CHCH3), 2.46 (1H, dd, J = 14.4, 7.1 Hz, CHCH2), 2.21 (3H, s, Ar CH3), 
1.16 (3H, d, J = 6.6 Hz, CHCH3).                      
13C NMR (CDCl3, 100 MHz) d: 165.1 (CO2CH), 161.9 (Ar C), 140.6 (Ar C), 137.7 
(Ar C), 134.8 (Ar C), 134.5 (Ar C), 130.1 (Ar C), 129.4 (Ar C), 128.0 (Ar C), 124.6 Chapter 3 – Experimental  
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(Ar C), 84.9 (CHOH), 64.6 (CHCH), 32.9 (CHCH2), 28.4 (CHCH3), 15.4 (CHCH3), 
13.6 (Ar CH3).                         
m/z [CI
+ (+ve), isobutane]  288 [M+H]
+ (100%). HRMS found 288.1238, C16H18O4N 
requires 288.1236 [M+H]
+.                                 
υmax (neat)/cm
 1; 3423, 2930, 1707, 1605, 1460, 1277, 911. 
(3S,4R) 3 ((S) 1 (2 methyloxazol 4 yl)propan 2 yl) 1 oxoisochroman 4 yl 4 
nitrobenzoate, 290.  
 
A solution of isochroman 1 one 289 in tetrahydrofuran (2 mL) was treated with 
triphenylphosphine  (82  mg,  0.31  mmol)  and  4 nitrobenzoic acid  (52  mg,  0.31 
mmol) and stirred for 10 minutes at room temperature. The resulting solution 
was treated dropwise with diisopropylazodicarboxylate (61  L, 0.31 mmol) and 
stirred  for  a  further  12  hours.  The  solvent  were  evaporated  under  reduced 
pressure and the crude residue purified by flash column chromatography (silica 
gel, 20% to 60% ethyl acetate in petroleum spirits) to give 53 mg of 4 nitrobenzyl 
ester 290 (62%) as a clear oil.                                 
1H NMR (CDCl3, 400 MHz) d: 8.24 (2H, d, J = 8.8 Hz, Ar H), 8.17 (2H, d, J = 9.2 
Hz, Ar H), 8.11 (1H, d, J = 7.6 Hz, Ar H), 7.57 (1H, dt, J = 9.6, 2.0 Hz, Ar H), 
7.48 (1H, m, Ar H), 7.30 (1H, d, J = 8.0 Hz, Ar H), 7.28 (1H, s, Ar H), 6.41 (1H, 
d, J = 6.4 Hz, CHOCO), 4.61 (1H, dd, J = 6.8, 4.8 Hz, CHCH), 2.67 (1H, dd, J = 
14.8, 7.2 Hz, CHCH2),2.32 (1H, m, CHCH3), 2.25 2.19 (1H, m, CHCH2), 2.12 (3H, 
s, Ar CH3), 0.97 (3H, d, J = 6.8 Hz, CHCH3).                   
13C NMR (CDCl3, 100 MHz) d: 164.9 (CO2CH), 163.6 (PhCO2), 161.7 (Ar C), 150.9 
(Ar C), 137.5 (Ar C), 136.3 (Ar C), 135.2 (Ar C), 134.4 (Ar C), 134.3 (Ar C), 131.2 
(Ar C), 130.6 (Ar C), 129.9 (Ar C), 126.7 (Ar C), 124.5 (Ar C), 123.8 (Ar C), 82.4 
(CHOH), 68.1 (CHCH), 33.6 (CHCH2), 29.7 (CHCH3), 14.4 (CHCH3), 13.9 (Ar CH3). 
m/z [CI
+ (+ve), isobutane]  437 [M+H]
+ (100%). HRMS found 437.1346, C23H21O7N2 
requires 437.1349 [M+H]
+.                       
υmax (neat)/cm
 1; 2981, 1726, 1607, 1530, 1266. Chapter 3 – Experimental  
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4 Ethyl 1 (3 hydroxy 2 methyl oxiranyl) 3a propyl 5,9b oxa 3a,4,5,9b 
tetrahydro 1H naphtho[1,2 c]furan 3 one, 298. 
O
O
O
O
 
298  was  prepared  using  general  procedure  for  the  preparation  of  lactones, 
starting from a solution of acetal 230 (876 mg, 5.83 mmol) in tetrahydrofuran 
(30 mL) and diisopropylamine (164  L, 1.17 mmol); methyl lithium (8.01 mL, 
12.8 mmol); tiglic aldehyde (676  L, 6.99 mmol). The oxidative rearrangement 
was  performed  using  3 chloroperoxybenzoic  acid  (1.57  g,  6.99  mmol);  in 
dichloromethane (30 mL).  Oxidation was achieved on a solution of crude lactol 
(1.28 g, 5.89 mmol); in acetone (30 mL) using 2.5 M Jones (4.71 mL, 11.8 mmol). 
The crude residues were reacted using general the general procedure for the 
reduction  of  lactones  to  iso chroman 1 ones,  starting  from  298  (1.10  g,  5.06 
mmol) in dichloromethane (25 mL) and using cerium(III) chloride (25.3 mL, 10.1 
mmol,  0.2  M  in  methanol)  and  sodium  borohydride  (287  mg,  7.59  mmol). 
Purification of the crude residue by flash column chromatography (silica gel, 20% 
ethyl acetate in petroleum spirits) gave 152 mg of 298 as a yellow solid (m.p. 
87 94 
oC) in 8% yield.                                        
1H NMR (400 MHz, CDCl3): δ 7.52 7.49 (1H, m, Ar H), 7.31 7.27 (3H, m, Ar H), 
5.14 (1H, d, J = 4.6 Hz, ArCHCH), 4.54 (1H, s, CHOCO), 3.16 (1H, q, J = 5.5 Hz, 
CHCHCH3), 2.91 (1H, oct, J = 3.8 Hz, CH3CHC), 1.59 (3H, s, CCH3), 1.45 (3H, d, J 
= 5.4 Hz, CH3CH), 0.74 (3H, s, epoxideCH3), 0.69 (3H, d, J = 7.3 Hz, CHCHCH3). 
13C NMR (100 MHz, CDCl3): δ 179.6 (CO2C), 142.9 (Ar C), 139.1 (Ar C), 127.3 (Ar 
C),  127.2  (Ar C),  122.4  (Ar C),  121.8  (Ar C),  97.5  (CCO),  85.8  (ArCO),  82.1 
(ArCO),  59.5  (CHCCH3),  57.5  (CH3CHO),  52.5  (OCCH),  42.1  (CHCHCH3),  16.5 
(OCCH3), 14.6 (CH3CH), 13.7 (COCCH3), 11.7 (CHCH3).              
m/z [CI
+ (+ve), (isobutane)] 301.3 [M+H]
+ (100%), [FAB
+ (NOBA)] 301.3 [M+H]
+ 
(100%).                              
vmax (film)/ cm
−1: 2913, 1747, 1571, 1109, 1059.  
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3 (tetrahydro 2H pyran 2 yloxy)propan 1 ol, 306.
179 
 
To  a  stirred  solution  of  1,3 propane  diol  305  (5.01  g,  65.7  mmol)  in 
tetrahydrofuran (165 mL) at 0 
oC was added para toluene sulfonic acid (2.53 g, 
13.1  mmol)  and  stirred  for  10  minutes.  The  resulting  opaque  solution  was 
treated with dihydropyran (6.1 mL, 67.0 mmol) in 3 portions over 30 minutes. 
The solution was stirred for 12 hours and then quenched with saturated aqueous 
sodium hydrogen carbonate solution (10 mL). Diethyl ether (50 mL) was added 
and the biphasic mixture stirred for 30 minutes. The organic layer was extracted 
and  washed  with  water  (2x  40  mL),  dried  over  saturated  sodium  sulfate  and 
concentrated in vacuo. Purification by flash column chromatography (silica gel, 
elution  with  60%  diethyl  ether  in  petroleum  spirit)  yielded  5.82  g  (55%)  THP 
ether 306 as a clear oil.                    
1H NMR (CDCl3, 400 MHz) δ: 4.58 (1H, bs, OCHO), 3.94 3.76 (4H, m, HOCH2 & 
CHOCH2), 3.60 3.48 (2H, m, CH2CH2CH), 2.77 (1H, bs, OH), 1.87 1.69 (4H, m, 
Alkyl H), 1.57 1.52 (4H, m, Alkyl H).                      
13C NMR (CDCl3, 100 MHz) δ: 99.1 (OCHO), 66.1 (CH2CH2O), 62.6 (CHOCH2), 61.3 
(HOCH2),  32.1  (HOCH2CH2),  30.6  (CHCH2CH2),  25.3  (CH2CH2CHO),  19.7 
(CHCH2CH2).                                 
m/z [CI
+ (+ve), isobutane] 161.3 [M+H]
+ (100%). HRMS found 161.1175, C8H17NO3 
requires 161.1178 [M+H]
+.                      
υmax (neat)/cm
 1: 3433, 2943, 1137, 1074 
2 (3 bromopropoxy)tetrahydro 2H pyran, 307. 
 
A solution of 3 (tetrahydro 2H pyran 2 yloxy)propan 1 ol, 306.82 g, 36.4 mmol) 
in  dichloromethane  (360  mL)  was  treated  with  carbon  tetrabromide  (36.2  g, 
109.2  mmol)  and  triphenylphosphine  (28.6  g,  109.2  mmol)  and  stirred  for  3 
hours.  Once  complete  by  TLC  analysis,  the  solvent  was  evaporated  under 
reduced  pressure  and  the  solids  formed  were  adsorbed  directly  onto  silica. 
Purification  by  flash  column  chromatography  (silica  gel,  40 50  % 
dichloromethane in petroleum spirits) gave 2.40 g (29%) of alkylbromide 307.           
1H  NMR  (CDCl3,  400  MHz)  δ:  4.61  (1H,  t,  J  =  Hz,  OCHO),  3.90 3.84  (2H,  m, Chapter 3 – Experimental  
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CHOCH2), 3.56 3.49 (4H, m, BrCH2CH2 & CH2CH2O), 2.14 (2H, quint, J = 6.2 Hz, 
CH2CH2CH2), 1.83 1.79 (1H, m, CHCH2CH2), 1.74 1.69 (1H, m CHCH2CH2), 1.59 
1.52 (4H, m, Alkyl H).                   
13C NMR (CDCl3, 100 MHz) δ: 98.9 (OCHO), 64.9 (CH2CH2O), 62.2 (CHOCH2), 32.9 
(BrCH2), 30.7 (BrCH2CH2), 30.6 (CHCH2CH2), 25.4 (CH2CH2CHO), 19.5 (CHCH2CH2). 
m/z [CI
+ (+ve), isobutane] 223.3 [M+H]
+ (100%).                   
υmax (neat)/cm
 1: 2861, 1381, 1126, 1201 
Toluene 4 sulfonic acid 3 (tetrahydro pyran 2 yloxy) propyl ester, 308.
179 
 
To  a  stirred  solution  of  3 (tetrahydro 2H pyran 2 yloxy)propan 1 ol,  306  (998 
mg, 6.23 mmol) in diethyl ether (31 mL) 0 
oC was added tosyl chloride (1.3 g, 6.5 
mmol) and stirred for 10 minutes. Freshly powdered potassium hydroxide (699 
mg, 12.5 mmol) was added in 3 portions over 30 minutes, then stirred for 12 
hours. Water (10 mL) and diethyl ether (10 mL) were added to quench and the 
organic layer separated washed with water (2x 20 mL), dried over anhydrous 
sodium  sulfate  and  concentrated  in  vacuo.  Purification  by  flash  column 
chromatography (elution with 30% diethyl ether in petroleum spirit) yielded 308 
as a clear oil (1.34 g) in 68% yield.                        
1H NMR (CDCl3, 400 MHz) δ: 7.79 (2H, d, J = 8.3 Hz, Ar H), 7.33 (2H, dd, J = 8.5, 
0.4 Hz, Ar H), 4.46 4.44 (1H, m, OCHO), 4.20 4.11 (2H, m, SOCH2CH2), 3.78 3.71 
(2H, m, CH2CH2CH2), 3.48 3.35 (2H, m, OCH2CH2), 2.44 (3H, s, Ar CH3), 1.95 1.88 
(2H, m, CHCH2CH2), 1.63 1.42 (6H, m, Alkyl H).                
13C NMR (CDCl3, 100 MHz) δ: 144.7 (Ar C), 133.2 (Ar C), 129.8 (2x Ar C), 127.9 
(2x Ar C), 98.9 (OCHO), 67.7 (SOCH2CH2), 62.8 (CHOCH2), 62.2 (CH2CH2O), 30.5 
(CHCH2CH2),  29.3  (CH2CH2CH2),  25.4  (OCH2CH2),  21.6  (CH3),  19.4(CHCH2CH2). 
m/z [CI
+ (+ve), isobutane] 231.3 [M+H THP]
+ (100%), 315.5 [M+H]
+ (36%). HRMS 
found 315.1263, C15H23O5S requires 315.1266 [M+H]
+.                
υmax (neat)/cm
 1: 2943, 1597, 1359, 1176, 943. 
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2 Hepta 4,6 diynyloxy tetrahydro pyran, 310.
180 
 
To a stirred solution of 1,4 bis(trimethylsilyl)butadiyne 309 (1 eq) in anhydrous 
tetrahydrofuran (0.2 M) at room temperature was added methyl lithium lithium 
bromide (1.1 eq). The reaction was stirred at room temperature for 5 hours, 
then  cooled  to   78 
oC  at  which  point  hexamethylphosphoramide  (2  eq)  was 
addedTHP ether (1.0 eq) was added slowly over 20 minutes. The reaction was 
stirred for 8 hours and allowed to attain room temperature over that period. 
Once complete by TLC analysis saturated aqueous ammonium chloride solution 
(20 mL) and diethyl ether (20 mL) were added. The organic layer was separated. 
The black  residue  obtained  was  dissolved in  methanol  (0.2  M) and  potassium 
carbonate (1.2 eq) was added. The reaction was stirred for 12 hours then diluted 
with diethyl ether (20 mL) and water (20 mL). The organic layer was separated 
then washed with water (2x 20 mL) then dried over anhydrous sodium sulfate 
and concentrated in vacuo. Purification by flash column chromatography (elution 
with 2 5% diethyl ether in petroleum spirit) yielded 310 as a clear oil. 
Using bromide 307                         
1,4 bis(trimethylsilyl)butadiyne (1.75 g, 9.01 mmol), methyl lithium lithium 
bromide (6.6 mL, 9.91 mmol, 1.5 M in diethyl ether), tetrahydrofuran (45 mL), 
hexamethylphosphoramide (3.14 mL, 18.0 mmol), 2 (3 
bromopropoxy)tetrahydro 2H pyran 311 (2.00 g, 9.01 mmol, 1M in 
tetrahydrofuran) then methanol (45 mL), potassium carbonate (1.49 g, 10.8 
mmol) giving 650 mg of 310 as a clear oil in 38% yield. 
Using Tosylate 308                         
1,4 bis(trimethylsilyl)butadiyne  (787  mg,  4.06  mmol),  methyl  lithium  lithium 
bromide (2.98 mL, 4.74 mmol, 1.5 M in diethyl ether), tetrahydrofuran (20 mL), 
hexamethylphosphoramide  (1.41  mL,  8.12  mmol),  toluene 4 sulfonic  acid  3 
(tetrahydro pyran 2 yloxy) propyl  ester  (1.28  g,  4.06  mmol,  1M  in 
tetrahydrofuran)  then  methanol  (20  mL),  potassium  carbonate  (673  mg,  4.87 
mmol) giving 611 mg of 310 as a clear oil in 78% yield. Chapter 3 – Experimental  
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1H NMR (CDCl3, 400 MHz) δ: 4.58 (1H, d, J = 4.1 Hz, OCHO), 3.87 3.77 (2H, m, 
CHOCH2), 3.52 3.42 (2H, m, CH2CH2O), 2.39 (2H, t, J = 7.0 Hz, CCCH2), 1.95 (1H, 
s,  CCCH),  1.85 1.77  (3H,  m,  CCH2CH2  &  CHCH2CH2),  1.73 1.67  (1H,  m, 
CHCH2CH2), 1.57 1.50 (4H, m, Alkyl H).                   
13C  NMR  (CDCl3,  100  MHz)  δ:  98.8  (OCHO),  77.8  (CCCH2),  68.4  (CCCH2),  65.6 
(HCC),  64.9  (HCC),  64.6  (CH2CH2CH2),  62.2  (CHOCH2),  30.6  (CHCH2CH2),  28.3 
(CH2CH2CH2), 25.5 (OCH2CH2), 19.5 (CHCH2CH2), 16.0 (CCCH2)          
m/z [CI
+ (+ve), isobutane] 193.3 [M+H]
+ (100%). HRMS found 193.1228, C12H17O2 
requires 193.1229 [M+H]
+.                        
υmax (neat)/cm
 1: 2947, 1581, 1182 
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Spirocyclic Pyrans: Towards 
Polymaxenolide  Chapter 4 – Spirocyclic Natural Products   
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4. Introduction 
4.1.  Spirocyclic pyrans 
Spirocyclic  pyrans  and  piperidines  have  been  reported  in  a  number  of  highly 
active  natural  products  and  synthetic/semisynthetic  derivatives,  such  as 
Polymaxenolide, pinnaic acid 335 and a number of spirocyclic saccharides and 
nucleosides 336.
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Figure 4.1. Pinnaic acid 335, spirocyclic glycosides 336, Halichlorine 337. 
 
Polymaxenolide is particularly interesting because of its structural complexity 
that incorporates a novel fusion between uncommon terpene building blocks.  
4.2. Isolation and characterization 
Corals constitute a significant proportion of the tropical reef biomass. One of the 
most abundant soft corals is of the genus Sinularia, which tends to form large 
mono specific  carpets  of  up  to  10  m
2.  Soft  corals  are  a  group  of  cnidarians, 
organisms  possessing  a  cnidocyte,  a  type  of  venomous  cell  that  allows  the 
organism a method of catching prey and the ability to defend themselves against 
predators.  Soft  corals  are  known  to  produce  classes  of  complex  secondary 
metabolites such as sesquiterpenes and diterpenes with a wide variety of carbon 
skeletons and a range of biological activities.
198,199  Chapter 4 – Spirocyclic Natural Products   
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Figure 4.2. Sinularia maxima (left)
200 and Sinularia polydactyla (right).
201  
 
Studies  on  Sinularia  species  secondary  metabolites  highlighted  the 
ichthyotoxicity of the aqueous extracts of some 160 soft corals from all known 
coral  families.
202  The  ichthyotoxicity  for  the  Sinularia  genus  was  63%  (the 
average  across  all  sampled  was  60%),  however  the  Sinularia  species  were 
disproprotionately represented in the most toxic group of extracts (50% of the 
Sinularia  genus  were  amongst  the  most  toxic,  all  fish  treated  with  these 
metabolites were dead within 45 min).
199  
Of  the  secondary  metabolites  characterised  from  the  Sinularia  species, 
Polydactins  A  338  and  B  339  have  been  highlighted  due  to  there  biological 
activities  and  relatively  small  size.  Isolated  from  Sinularia  polydacylya 
(Ehreberg), taken from the South China Sea, the polydactins have moderate to 
weak cytotoxic activity against KB and MCF cell lines. Polydactin A showed the 
stronger activity against both carcinoma cell lines (58 and 63 nM respectively) 
while Polydactin B was much less active against the same targets (16 and 21 mM 
respectively).
203 
 
Figure 4.3. Polydactins A 338 and B 339. 
 
A  further  study  of  the  isolation  and  charcterisation  of  S.maxima  and 
S.polydactyla  secondary  metabolites  by  Kamel  identified  several  new 
cembranoid diterpenes (Figure 4.4).
204 The cytotoxicities of compounds 340 to 
342 were assessed against a variety of carcinomas, 342 strongly inhibited the 
growth of ovarian, breast, pancreatic, colon and cervical cancer cell lines, with Chapter 4 – Spirocyclic Natural Products   
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GI50 (concentration of drug required to inhibit the growth of cells by 50% relative 
to untreated cells) values between 39 nM and 0.58 mM.     
 
Figure 4.4. Cytotoxic diterpenes  
 
Polymaxenolide 343 (Figure 4.5) was similarly isolated from soft corals Sinularia 
maxima  and  Sinularia  polydactyla  in  2004  by  Kamel  and  co workers.
205  The 
molecule  is  important  because  it  is  composed  of  a  rare  fusion  between 
uncommon  terpene  building  blocks.  The  biological  properties/activities  of 
Polymaxenolide have not yet been reported. 
 
Figure 4.5. Polymaxenolide  
 
4.3. Biosynthesis 
Complex  sesquiterpenes  and  diterpenes  are  frequently  encountered  in  the 
extracts of soft corals of the genus Sinularia.
199                   
It is believed Polymaxenolide is a product of hybridisation between 2 terpenes, 
the product of a mixed biosynthetic pathway. It is composed of both cembrane–
type terpene 344 and an africanane sesquiterpene 345 skeleton, joined through 
a  distinct  C,C  bond  linkage.  The  structural  assembly,  is  the  first  recorded 
between these two naturally occurring terpenes.  Chapter 4 – Spirocyclic Natural Products   
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Figure 4.6. Africanane sesquiterpene and cembrane diterpene. 
 
Kamel
205  postulated  a  ‘probable  biogenetic  route’  to  Polymaxenolide  343,  in 
which the C5 enolate of 345 attacks the exo cyclic epoxide methylene carbon of 
344. Nucleophilic attack of the tertiary alkoxide 346 onto the ketone results in 
hemi acetal formation. Elimination of the hydroxyl results in formation of the 
internal E olefin and completes the biosynthesis of Polymaxenolide 343.  
 
Scheme 4.1. The mechanism of formation of Polymaxenolide. R = CO2Me. 
 
Harborne  and  Turner
206  hypothesised  that  the  novel  hybrid  framework  of 
Polymaxenolide (and others) can occur via three different mechanisms            
1)  Interference  with  normal  biosynthetic  pathways  resulting  in  a  build up  of 
intermediates.                            
2) Elaboration of pathways leading to combinations of basic parent skeletons and Chapter 4 – Spirocyclic Natural Products   
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others derived from a second parent                      
3) Regulation or disruption (at a genetic level) following hybridization causing 
shifts in where the compound is produced 
4.4. Structural features 
Polymaxenolide  343  presents  a  highly  complex  architecture,  showcasing  2 
internal Z olefins (tri substituted, C7 C8 and C12 C13) as well as syn (C2' C4') 
and anti (C1' C8') ring junctions. There is also complex cyclic functionality, 6 
different  ring  structures  are  present  including  a  14C  macrocycle, 
cyclopropa[e]azulene ring system and an interesting [5.4] spirocyclic pyran core 
that links Polymaxenloides two terpene components (Figure 4.7
207).  
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Figure 4.7. X ray crystallographic structure of Polymaxenolide . 
 
Rather  than  orientate  as  Figure  4.5  suggests,  the  macrocycle  sits  out  of  the 
plane, creating a hollow space in the center of the molecule (Figure 4.8). The 
africanane terpene component is almost planar, lying in a perpendicular fashion 
to the cembrane diterpene. Chapter 4 – Spirocyclic Natural Products   
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Figure 4.8. Polymaxenolide . Sp = spirocycle 
 
4.5. Spirocyclic pyrans 
There  have  been  many  different  approaches  to  the  synthesis  of  spirocyclic 
piperidines,  including  radical  cyclisations,
208  nitrone  dipolar  cycloadditions,
209 
amine spiroannulations,
210 212 intramolecular Diels Alder,
213 tertiary amine effect 
based approach
214 and Michael additions.
215,216   There  are  far  fewer 
examples for the preparation of functionalized spirocyclic pyrans and none to 
date detailing the synthesis of Polymaxenolide . 
The approaches to the synthesis of spirocyclic pyrans are more limited in scope 
and suitability. 
4.5.1.  Ring closing metathesis 
Olefin metathesis of quaternary alkene ether compounds is a common synthetic 
route in spirocycle generation.   Schmidt has been able to show that spirocyclic 
pyrans  can  be  generated  from  tetrene  ethers.
217  In  Schmidt’s  approach  a 
hydroxy  carboxylic  acid  esters  348  and  349  were  transformed  into  the 
corresponding tetrenes 350 and 351 (Scheme 4.2). Ring closing metathesis of 
the polyenes, gave as single diastereoisomers the spirocyclic pyrans 353 and 354 
in poor to acceptable yields.  Chapter 4 – Spirocyclic Natural Products   
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Scheme 4.2. Schmidt’s’ spirocycle methodology. 
 
Schmidt also reported the synthesis of Menthone 354 and Camphor 358 derived 
spirocycles.
218  The  RCM  precursors  were  made  in  two  steps  from  the 
corresponding ketone that was alkylated and converted to the requisite ether. 
Metathesis reaction of 355 gave spirocycle 356, interestingly a modification of 
the  reaction  conditions  allowed  for  the  generation  of  olefin 
isomerisation/reduction product 357 (Scheme 4.4 and Scheme 4.3). 
   
Scheme 4.3. Synthesis of Menthone derived spirocycles 357 and 356.  
 
Similarly Camphor  357 derived diene  359 could be treated with Grubbs first 
generation  catalyst  to  give  spirocycle  360.  Modifications  to  the  reaction 
conditions resulted in isomerisation of the double bond giving 361 and 362. Chapter 4 – Spirocyclic Natural Products   
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71% 98%
Grubbs I, 5 mol% PhCH3
40 oC, then 2-propanol and
25% NaOH 80 oC
Grubbs I, 2 mol%
CH2Cl2, 40 oC
allylMgBr
96%
NaH, allyl bromide
96%
O
O O O
Grubbs I, 10 mol%
PhCH3, 40 oC, then
NaH (40 mol%) 110oC
98%
OH O
358 359
360 361 362  
Scheme 4.4. Synthesis of Camphor derived spirocycles 360, 361 and 362. 
 
Further enhancements to the ring closing metathesis reactions selectivities were 
observed  by  Shrock  and  Hoyveda.
219  They  achieved  excellent  yields  and 
enantioselectivities of conversion using Molybdenum centered catalysts instead 
of Grubbs ruthenium based equivalent.                        
Hoyveda  details  the  in  situ  generation  of  5  molybdenum  catalysts  and  their 
olefin metathesis applications using THF as solvent and additive. Five catalysts 
were  tested  against  different  achiral  cyclopentenyl  ethers,  generating 
spirocyclic  pyrans  via  a  ring  opening/ring  closing  reaction  sequence.             
(Table  4.1)  shows  results  of  Hoyveda’s  catalyst  screen  against  5  different 
substrates, the results show reasonable levels of enantioselectivity (62 to 88% 
ee) combined with good to excellent yields. Chapter 4 – Spirocyclic Natural Products   
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Reaction  R  Catalyst Catalyst loading Yield e.e.
A H R - 363a 5 mol % 45% 88%
A Me R   363b 9 mol % 75% 80%
B Me R   363c 9 mol % 80% 83%
B TMS S   364a 5 mol % 70% 85%
C   S - 364b 5 mol % 90% 62%
a 363a R1 = iPr, R2 = Ph; 364b R1 = Cl, R2 = Me; 363c R1 = iPr, R2 = Ph
b 364a R1 = Cl, R2 = Me; 364b R1 = Me, R2 = Ph  
Table 4.1. The results of Hoyveda’s catalyst screen 
 
4.5.2.  Spiroannulation 
Alkyllithium  cyclisations  onto  alkenes  or  other  electrophiles  have  been  well 
documented.
220,221 Rychnovsky has shown that alkyllithium spirocyclisations, can 
be performed on a wide selection of electrophile functionality.
222,223 However 
this process is rarely applied to complex natural product targets 
 
Scheme 4.5. Treatment of the nitrile with excess lithium tertbutylbiphenyl causes reduction 
of the nitrile.  
 
Alkenes,  alkynes,  nitriles,  halides,  phosphonates  and  epoxides  have  all  been 
validated against Rychnovsky’s method. It was also shown that more complex Chapter 4 – Spirocyclic Natural Products   
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electrophiles  such  as  allylic  ethers  are  suitable  to  the  reaction  sequence 
(Scheme 4.6). 
 
Scheme 4.6. Rychnovsky’s method. 
 
4.5.3.  Prins cyclisations 
The  Prins  reaction  of  homoallylic  alcohols  (nucleophiles)  and  aldehydes 
producing functionalised tetrahydropyrans is one of the most widely documented 
methods.
224 228 Lewis acids are utilized in the reaction by coordinating to the 
carbonyl oxygen, promoting nucleophilic attack at the electrophilic carbon. In 
2008  several  examples  of  Prins  cyclisations  were  reported,  making  use  of 
different Lewis acid catalysts to achieve the desired THP structures. 
Fuchigami
229 was able to show tetraethylammonium fluoride.hydrogen fluoride 
(Et4NF.5HF) can participate in a Prins cyclisation reaction producing fluorinated 
tertrahydropyrans  367  showcasing  syn  stereochemistry  between  substituents. 
Fuchigami  showed  that  it  was  possible  to  exchange  but 3 en 1 ol  for  the 
equivalent  thiol  and  amine  (and  mono tosylate  derivative),  to  produce 
fluorinated thiacycles and piperidines (selectivity was reduced with sulfur and 
amine derivative as syn and anti fluoro compounds were observed).  
 
Scheme 4.7. Fuchigami’s approach. 
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Fuchigami was also able to show that cyclic ketones could be used to generate 
spirocyclic pyrans under Prins conditions. Hence, treatment of cyclohexanone 
368  with  homoallylic  alcohol  369  and  tetraethylammonium  fluoride.hydrgoen 
fluoride generated fluorinated spirocycle tetrahydropyran 370 (Scheme 4.8). 
 
Scheme 4.8. Synthesis of spirocycle 370. 
 
As part of a Prins Ritter sequence Yadav showed that 4 aminotetrahydropyrans 
can be generated using Bismuth triflate as Lewis acid catalyst.
230       
Several aldehydes were utilized in the sequence from isopropyl and cyclohexyl to 
cinnamyl  and  naphalene.  Three  cyclic  ketones  368,  372  and  374  were 
transformed  into  the  corresponding  spirocyclic  pyrans  by  the  same  method 
(Scheme 4.9). Yadav also altered the nitrile nucleophile, exchanging acetonitrile 
for benzonitrile, phenylacetonitrile or trimethylacetonitrile to introduce further 
functionality to the pyran core.  
 
Scheme 4.9. Prins cyclisations of cyclic ketones. 
 
Yadav was able to generate 4 iodotetrahydropyrans using molecular iodine as 
Lewis acid and nucleophile in the reaction.
231 Using this modified set of reaction 
conditions  4  series  of  spirocycles  were  generated  based  upon  the  starting 
alcohol. The use of alkynes 384 and 385 (series 3 and 4) was significant as it Chapter 4 – Spirocyclic Natural Products   
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allowed  for  the  introduction  of  further  functionality  into  the  spirocycle 
structure. 
 
Scheme 4.10. Series two gave syn diastereoisomers exclusively. 
 
Attempts to identify other iodide sources, such as LiI, tBu4NI and NaI failed to 
produce  the  desired  transformation.  Cerium  trichloride/lithium  iodide  were 
later  reported  by  Yadav  as  a  novel  reagent  system  for  the  synthesis  of  4 
iodotetrahydropyrans.
232  It  was  found  that  under  the  same  conditions  cyclic 
ketones gave higher yields when compared to the acyclic ketones.
233 
4.5.4.  Pauson Khand 
The Pauson Khand reaction has been utilized as a key step in the synthesis of 
many natural products; including Brefeldin A,
234 Incarvilline
235 and Kainic acid.
236 
Due  to  poor  enantioselectivities  of  cyclisations  there  was  a  need  for  chiral 
auxilliaries, leading to the use of Menthol,
237,238 trans 2 phenylcyclohexanol
237,238 
and Camphor derived alcohols.
239 241  
Tanyeli
242 used Camphor derived alkyl ethers as a PKR precursor in the synthesis 
of spirocyclic cyclopentapyrans.  Camphor 358 was treated with allyl magnesium 
bromide, then converted to the corresponding ether 378 upon treatment with 
propargyl  bromide.  Pauson  Khand  reaction  of  the  alkyne olefin  gave  the 
spirocycle 380. Tanyeli was then able to introduce a methyl group at the 4’ Chapter 4 – Spirocyclic Natural Products   
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carbon of 379, by exchanging the allyl group for 2 methylpropene in the first 
Grignard addition step and generating spirocycle 381 as before. It was found the 
products  regioselectivity  could  be  reversed  by  alternating  the  reaction 
sequence,  initially  alkylating  with  a  propargyl  group  then  forming  the 
corresponding ether with allylic bromide. Pauson Khand reaction of the ene ynes 
382 and 383 gave spirocycles 384 and 385 in good yields.  
O
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1) Mg,
2) Mg, HgCl2
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Scheme 4.11. PKR of propargylic ethers. 
 
4.5.5.  Other methods 
Another interesting example of spirocycle generation was reported by Harrity in 
2008, during the synthesis of Rhopaloic acid.
243 The synthesis was based on the 
key  cyclisation  of  diols  R 396  and  S 396  (Scheme  4.13),  which  could  be 
synthesized from organo metallic addition of Grignard 395 to epoxide 394. 
BrMg
OMgBr
O
tBu
+
tBu
OH
OH
tBu
OH
OH
87%
(R:S,66:21)
386 387
S-389
R-388
 
Scheme 4.12. Organomagnesium 387 addition to epoxide 386. 
 
The catalytic palladium/titanium cyclodehydration of diol R 388 gave spirocycle 
390 in acceptable yields. The titanium was shown to be a key participant in the 
reaction  facilitating  alcohol  addition  to  the  Pd  p allyl  complex,  via  a  soft 
titanium alkoxide. Chapter 4 – Spirocyclic Natural Products   
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Scheme 4.13. Spirocyclodehydration reactions of allylic alcohols.  
 
Interestingly the reaction yields were improved when the primary alcohol was 
converted  to  the  acetate,  23%  to  67%  for  the  formation  of  390.  The  reason 
stated for such a large increase in the reaction yields, is that the acetate stops 
the competing dimerisation reaction. 
Finally  an  example  of  spirocycle  generation  by  a  Diels  Alder  approach  was 
reported  by  Singh  in  2008.
244  Singh  took  O qunione  methides  derived  from 
oxidation of phloroglucinol derivatives Jenseone or Grandinol and reacted them 
with terpene derived dienophiles.                            
The biomimetic 3 component reaction involves the Knoevenagel condensation of 
formaldehyde and 2,4 diisovaleryl phloroglucinol followed by [4+2] cycloaddition 
between the resulting diene and dienophiles b pinene 393 or camphene 394 to 
yield complex spirocycles 395 and 396 
 
Scheme 4.14. Synthesis of the S Euglobal derived spirocycles. 
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5. Results and discussion 
5.1. Spirocyclic natural products 
As  part  of  our  studies  towards  the  synthesis  of  spirocycle  containing  natural 
products  (i.e.  Polymaxenolide  343,  Figure  5.1)  we  have  been  interested  in 
developing an easy and efficient method of generating functionalised spirocyclic 
compounds which would complement other methods available to date. 
 
Figure 5.1.Polymaxenolide . 
 
5.1.1.  Initial findings 
Previous  efforts  within  the  Marquez  lab  to  generate  spirocycle  398,
245  were 
centered on a Prins type cyclisation of an olefin onto a pyran derived oxonium 
ion (Scheme 5.1). 
 
Scheme 5.1. Efforts to generate spirocycle 406.  
 
Treatment of lactol 397 (see Scheme 5.4 for synthesis) with boron trifluoride 
diethyl etherate gave 2 products, generated the desired spirocyclic alcohol 398 
and exo olefin 399.  
Mechanistically, spirocycle 399 originates from the nucleophilic attack of the 
terminal  olefin  in  intermediate  400  onto  the  oxonium  (Scheme  5.2),  via  the Chapter 5 – Spirocyclic Natural Products   
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Prins  cyclisation  pathway,  overall  an  intramolecular  6 exo trig  cyclisation  is 
observed. The resulting cation is quenched by the addition of water. 
 
Scheme 5.2. Mechanism of formation of 406. 
 
The formation of the exo olefin molecule 408 is believed to be the result of a 
quicker competing reaction pathway (Scheme 5.3). Intermediate 402 forms as 
expected  but  instead  of  the  internal  cyclisation  event,  deprotonation 
(elimination of a proton) alpha to the oxonium ion is observed, resulting in the 
exo olefin functionality. The overall effect is simply dehydration/elimination.  
 
Scheme 5.3. Synthesis of exo cycle 399. 
 
In  light  of  the  inability  to  favour  the  cyclisation  pathway  (Scheme  5.2)  over 
deprotonation  (Scheme  5.3)  a  new  route  to  spirocycle  398  was  devised  to 
incorporate an allylation/RCM reaction sequence. Chapter 5 – Spirocyclic Natural Products   
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5.1.2.  Retrosynthesis 
In our new approach, bicycle 403 could be obtained through the ring closing 
metathesis reaction of 404, the product of the Sakurai reaction of lactol 405 
with  allyl  trimethylsilane.  The  lactol  405  could  originate  from  the  oxidative 
rearrangement  of  a hydroxyfuran  406  that  could  be  produced  by  a  double 
deprotonation/alkylation sequence of furan 86. 
 
Figure 5.2. Retrosynthesis of the spirocyclic core of Polymaxenolide . 
 
5.1.3.  Synthesizing lactol, 397. 
The  investigation  began  with  furan  86  which  was  deprotonated  with  nbutyl 
lithium and alkylated with 5 bromopentene, giving known alkenyl furan 407
246 in 
good yield. A second deprotonation, followed by trapping with isobutryaldehyde 
(chosen  to  introduce  some  steric  bulk  at  the  C2  position  of  the  eventual 
pyranone) gave racemic alcohol 408 in 62%. Oxidative transformation using the 
Achmatowicz rearrangement,
129 131 of furfuryl alcohol 408 afforded lactol 397 
(Scheme 5.4) in good 96% yield. The stereochemistry at the anomeric center was 
assigned  by  NOe  studies  of  397a a a a  and  397b b b b.  Correlations  where  observed 
between the CH2 of the axial alkyl group and the hydrogen at the C2 position in 
the b anomer, these hydrogen interactions were not observed between the axial 
alkyl and C2 H in the a conformer. Chapter 5 – Spirocyclic Natural Products   
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Scheme 5.4. Conversion of furan 86 to lactol 397. 
 
As expected the a anomer was favoured over the b anomer, in a reproducible 
ratio of 7:1. This result is consistent with the anomeric effect whereby electron 
withdrawing groups occupy the axial (a) position. In the a anomer, there is a 
favourable alignment of orbitals which allows back donation of electrons from 
the ring oxygen into the s* orbital of the C OH bond, the b anomer does not 
have this favourable overlap.  
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a a a a b b b b
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Figure 5.3. a a a a and b b b b anomers of 397 
 
Sakurai reported in 1976 that allylsilanes react with a wide variety of aldehyde 
and ketones in the presence of stoichiometric amounts of titanium tetrachloride 
(later expanded to incorporate a plethora of Lewis acids) to form homo allylic 
alcohols (Scheme 5.5).
247,248 Over time this transformation has been found to be 
highly  regioselective,  can  be  used  with  common  electrophiles  (aldehydes, 
ketones  acetals  and  ketals)
249  and  several  catalytic  protocols  have  been 
developed using TMSOTf,
250 Cp2Ti(OTf)2
251 and Ph3CCIO4.
252 Mechanistically, the 
reaction proceeds by Lewis acid activation of the carbonyl group, which upon 
nucleophilic attack of the terminal olefin results in formation of a carbon carbon 
bond and a silyl stabilized b carbocation, subsequent loss of the TMS group then 
regenerates the terminal olefin. Chapter 5 – Spirocyclic Natural Products   
  147 
 
Scheme 5.5. Formation of homo allylic alcohol. 
 
Treatment the lactol 397 with allyl trimethyl silane in the presence of boron 
trifluoride diethyl etherate gave the diene compound 409. Interestingly the allyl 
group  occupies  the  a position  exclusively  (Scheme  5.6).  This  was  again 
determined by NOe studies of the crude and purified residues. The allylation is 
consistent  with  Woerpel’s  model
253  for  the  addition  of  nucleophiles  to  pyran 
derived  oxonium  ions.  Wherein,  axial  attack  of  the  incoming  nucleophile  is 
favoured over the corresponding equatorial addition. 
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Scheme 5.6. Allylation of oxonium 407. 
 
Diene  409  was  then  treated  with  Grubbs  1
st  generation  catalyst  to  give  the 
desired spirocycle 410 in 65% yield. Interestingly there was very little difference 
in yields when either dichloromethane or dimethylsulfoxide where employed as 
solvent.  The  only  difference  was  the  efficiency  of  the  reaction  as  the  DMSO 
reaction gave an increased amount of side products; it did however give a slight 
increase in yield (66%).  Chapter 5 – Spirocyclic Natural Products   
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Scheme 5.7. Synthesis of spirocycle 410. 
 
5.1.4.  Other ring systems 
Having  synthesized  spirocycle  410,  the  method  was  expanded  to  incorporate 
different sized ring systems. Spirocycle 419 was synthesized using 4 bromobut 1 
ene to alkylate furan while spirocycle 420 was produced from alkylation of furan 
with  5 bromohex 1 ene.  The  reaction  sequence  was  repeated  as  per  the 
synthesis of 410.  
 
Scheme 5.8. Synthesis of spirocycles 419 and 420. 
 
5.1.5.  Synthesis of the [4.5] spirocycle 
When the reaction sequence was directed to the generation of the 5 membered 
ring 429, a significant problem was encountered. Alkylation of allyl furan 421 
using the established procedure failed to give the desired furfuryl alcohol 422. It Chapter 5 – Spirocyclic Natural Products   
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was  concluded  that  the  acidity  of  the  allylic  protons  (Scheme  5.9)  was  too 
closely matched to that for the furan C5 proton (position b), which resulted in 
non selective deprotonation and alkylation products.            
Joule and Mills
254 give the pKa for furan C2/C5 protons to be 35 while Clayden et 
al.
123  give  the  pKa  of  propene  at  approximately  43.  Clearly  exchanging  a 
hydrogen for a furan will increase the acidity of the these protons, providing 
some explanation to 421s unexpected reactivity.  
 
Scheme 5.9. Attempts to alkylate allyl furan 429. 
 
A  modified  synthetic  route  was  devised  in  which  the  alkylation  order  was 
reversed.  Hence  the  furan  anion  was  trapped  with  isobutryaldehyde  as  per 
West’s
255  conditions  giving  secondary  alcohol  423  that  was  protected  as  a 
tertbutyldimethylsilyl ether 424, that could be C5 alkylated with allyl bromide, 
to give 425. Cleavage of the silyl ether with TBAF gave the secondary alcohol 
426. Treatment of 426 with mCPBA according to our established rearrangement 
conditions gave lactol anomers 427 and 428 selectively (7.8:1 ratio of a to b). 
Allylation of the lactol mixture was followed by ring closing metathesis reaction, 
giving spirocycle 429 in 85% yield.  Chapter 5 – Spirocyclic Natural Products   
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Scheme 5.10. Modified route for the synthesis of the spirocycle 429. 
 
Spirocycle  429  was  generated in  43%  overall  yield  from  furan  86  in  7  steps, 
while spirocycles 410, 419 and 420 were generated in 26%, 19% and 7% yield 
respectively. The lower yields are due to the decreased yields observed in the 
ring closing metathesis reactions of 409, 419 and 420. This observation is likely 
due to the increased number of conformations available to longer chain alkyl 
groups,  making  ring  closing  metathesis  less  likely  therefore  increasing  the 
probability of cross metathesis products. 
The  synthesis  has  been  shown  to  be  an  efficient  method  for  generating 
spirocyclic  pyrans  and  has  demonstrated  complete  control  of  the  quaternary 
carbon  stereochemistry.  Harris,
256  Tadano
257  and  others  have  shown  that  an 
enantiopure alcohol can be subjected to Achmatowicz rearrangement conditions 
without  detriment  to  the  enantiomeric  excess  at  that  position.  Their 
observations combined with our method, that features exclusive allyation in the 
a position, allow us complete stereoselectivity over the reaction sequence.  Chapter 5 – Spirocyclic Natural Products   
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5.1.6.  Optimisation of the cyclisation protocol 
It was found that the catalyst ‘life’ could be increased dramatically, particularly 
in  the  longer  reactions  by  darkening  the  reaction  vessel.  When  the  reaction 
vessel was completely covered in aluminium foil the rate at which the ruthenium 
catalyst  was  degraded  was  reduced.  In  the  case  of  spiro  compound  420 
completion could not be achieved without the foil covering.  
Further optimisations were attempted by modifying the heating process and the 
nature of the RCM catalyst. Using microwave heating instead of reflux conditions 
gave only a marginal 1% in reaction yield of spirocycle 419 (Entry 2, Table 5.1)  
Using Grubbs 2
nd generation catalyst under both reflux and microwave conditions 
gave  increased  yields  of  spirocycle  419.  Reflux  conditions  gave  an  enhanced 
yield  of  80%  (an  increase  of  +2%)  while  microwave  conditions  gave  an 
improvement of 7% to 85% isolated yield (Entries 3 and 4, Table 5.1). 
Entry Catalyst Conditions Yield
1 78%
2 79%
3 80%
4 85%
5 No Reaction
PPh3
Ru
PPh3
Ph Cl
Cl
PPh3
Ru
PPh3
Ph Cl
Cl
Ru
PPh3
Ph Cl
Cl
N N Mes Mes
O
O
tBu
tBu
Mo
HN
iPr
iPr
Reflux (40 
oC), 4 
hours
Microwave, 
100 
oC for 4 
minutes
Microwave, 
100 
oC for 4 
minutes
Microwave, 
100 
oC for 4 
minutes
Ru
PPh3
Ph Cl
Cl
N N Mes Mes
Reflux (40 
oC), 4 
hours
 
Table 5.1. Summarising the catalyst screen. 
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When  the  more  reactive  molybdenum  based  Schrock  catalyst  was  used  no 
cyclisation  product  was  obtained,  instead  it  produced  what  appeared  to  be 
traces of homodimer. 
Catalyst  loadings  and  alternate  solvents  were  not  examined  during  the 
optimisation process. 
5.2. Methoxy directed cyclisations 
Having  successfully  developed  an  efficient  approach  to  the  synthesis  of 
spirocyclic  pyrans,  we  turned  our  attention  to  the  generation  of  other  more 
complicated spirocyclic systems. We were particularly keen to explore the use of 
electron rich aromatic phenyl rings as nucleophiles during the cyclisation step. A 
successful cyclisation using aromatic substituents would provide ready access to 
a  new  class  of  spirocyclic  compounds  depending  on  the  aromatic  rings 
substitution pattern (Scheme 5.11).  
Synthetically  it  was  expected  that  incorporating  an  electron  rich  phenyl  ring 
would  sufficiently  increase  electron  availability  and  allow  the  aromatic 
nucleophile  to  react  with  the  oxonium  intermediate  430,  in  the  process 
suppressing the dehydration competition reaction.  
 
Scheme 5.11. Generation of functionalised spirocycles 431 and 432. 
 
It  is believed  that  the  methoxy  group  will  influence the  cyclisation  reaction, 
directing formation of the new ring. In the 4 methoxy example it is believed a 
bis spirocyclic  compound  431  will  be  produced  as  a  result  of  the  electron 
donating  nature  of  the  methoxy  ether  (ortho,  para  direction).  While  the  3 Chapter 5 – Spirocyclic Natural Products   
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methoxy substituted compound will produce a spiro fused ring system 432 (2 
other products could theoretically be produced by this route but it is believed 
that their production will be minimal due to their ring size and conformations). 
These  new  spirocycles  bear  some  resemblance  to  several  important  and 
interesting classes of compound. 5,6 Dihydropyrone derivatives (433) have been 
identified  as  non peptide  HIV  protease  inhibitors  and  anti viral  agents.
258 
Ribasine 434,
259 and derivatives have complex skeletal frameworks and finally 
spirocyclic  steroid  ethers  435  have  been  shown  to  exhibit  anti estrogenics 
properties (Scheme 5.12).
260 
 
Scheme 5.12. Spirocycles 437, 438 and 439 
 
We envisioned the cyclisation precursors 436 to be generated from the oxidative 
rearrangement of furfuryl alcohol 437. 437 could in turn be generated from the 
alkylation  of  protected  furyl  alcohol  438  with  bromide  439  that  could  be 
thought of as having come from anisaldehyde 440. 
 
Scheme 5.13. Generating lactol 436 
 
5.2.1.  First synthetic route  
Bromide  443
261  was  synthesized  from  3 methoxy  benzaldehyde,  that  was 
transformed  to  the  known  a,b unsaturated  ester  442
262  by  Wittig  olefination 
conditions  (carbethoxymethylidene  triphenylphosphorane  in  refluxing Chapter 5 – Spirocyclic Natural Products   
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dichloromethane) as the E olefin exclusively. This reaction was optimised using 
microwave heating that gave slightly reduced yields but greatly reduced reaction 
times, 8 to 10 minutes instead of 5+ hours. Lithium aluminium hydride reduction 
of the ester to the saturated alcohol was achieved in good yield.
263 The alcohol 
was converted to the desired bromide 443 using Appel halogenation conditions. 
Furan was treated with nbutyl lithium and the anion was quenched with bromide 
443 to give compound 444 in 52% yield (Scheme 5.14). 
 
Scheme 5.14  Synthesis of 444. 
 
Alkyl furan 444 was then treated with a second equivalent of nbutyl lithium and 
the anion quenched with isobutryaldehyde. However the desired a hydroxyfuran 
compound  445  was  not  produced.  Further  attempts  to  couple  444  with 
isobutyraldehyde  proved  unsuccessful,  the  base  was  changed  to  lithium 
diisopropylamine (both commercially available and generated in situ from nBuLi 
and iPr2NH), unfortunately failing to generate any of the desired carbinol 445. 
 
Scheme 5.15. The attempted synthesis of alcohol 445. 
 
The 4 methoxy bromide 446 was synthesized in parallel to 443 and this was used 
as coupling partner to previously synthesized TBDMS ether 424, in an effort to 
circumvent  the  problems  encountered  in  Scheme  5.14.  Thus  4 methoxy 
benzaldehyde was olefinated under Wittig conditions to generate the known a,b 
unsaturated ester 447
264 in good yield. Conversion of the ester to the bromide 
449
266  was  conducted  as  per  the  3 methoxy  series  via  known  alcohol  448
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bromide  The  yields  of  conversion  were  consistent  across  both  series, 
interestingly  the  overall  yield  of  the  3  step  transformations  was  51%  in  both 
cases.  
 
Scheme 5.16. 
 
Treatment of bromide 449 with nbutyl lithium then with furan coupling partner 
did not produce any of the desired aromatic bicycle 450. 
 
Scheme 5.17. Attempted synthesis of 450. 
 
A  number  of  different  reaction  conditions  were  explored,  including  different 
equivalents of bromide, different temperatures, different bases as well as the 
use of molecular sieves and tertbutylammonium iodide (TBAI) as a phase transfer 
catalyst. Unfortunately all combinations of reagents and additives failed to alter 
the unsuccessful outcome of the reaction. 
In an attempt to improve the chances of a successful coupling, it was decided to 
switch bromide 449 for the more reactive allylic bromide 453.
267           
452  was  synthesized  from  442
268  by  1,2  reduction  of  the  ester  functionality 
using  a  modification  of  Malony’s  procedure  (diisobutylaluminium  hydride  in 
dichloromethane  instead  of  toluene).
269  The  allylic  alcohol  442  was  then 
transformed  to  allylic  bromide  452  via  Appel  reaction.
177  To  increase  the 
chances of a successful coupling reaction, 442 was also converted into the allylic 
mesylate 453 in acceptable yield.
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Scheme 5.18. Synthesising allylic mesylate 453 and bromide 452. 
 
Unfortunately  attempts  to  couple  TBDMS  protected  furan  424  and  allylic 
bromide 452, proved to be unsuccessful, the number of equivalents of nbutyl 
lithium  where  altered  returning  unreacted  starting  materials  in  each  case. 
Exchanging allylic mesylate 453 for the bromide also failed to produce any of 
the desired coupled material. 
 
Scheme 5.19. Attempts to synthesize 454. 
 
5.2.2.  Palladium cross coupling reactions 
Faced with this complete lack of success it was decided to resort to the use of 
transition metal catalyzed cross coupling reactions reported in the literature.  
The  first  reaction  explored  was  the  Heck  reaction,  as  it  is  known  to  be  an 
accommodating  reaction  that  can  handle  electron  rich,  deficient  or  neutral 
alkenes. A limitation of the reaction is that the halide or triflate cannot contain 
b hydrogens bound to an sp
3 carbon, due to competing b hydride elimination, 
that  could  result.  However  there  have  been  several  protocols  designed  to 
circumvent this issue.
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Scheme 5.20. Heck reaction of alkene. 
 
The mechanism of the Heck reaction is not fully understood and appears to alter 
subtly according to the specific reaction.
272 273 What is known is that the first 
step of the catalytic cycle is an oxidative addition of the aryl halide to the Pd
(0) 
catalyst  affording  s arylpalladium(II)  complex  455.  The  second  step  is  a 
nucleophilic attack (syn addition) on the trans ArPdXL2 456, then a b hydride 
elimination giving the coupled product 457.
274 
Our initial coupling attempts were between previously synthesized allyl furan 
425  and  3  and  4 iodoanisole  were  treated  with  palladium  acetate  catalyst 
(Pd(OAc)2) under both reflux and microwave conditions.
275,276 
 
Scheme 5.21. Heck reaction of 425. 
 
The reflux reactions seemed sluggish with little reactivity between reactants, 
whereas  the  microwave  conditions  were  much  more  productive,  seemingly 
producing desired olefin straight away. However attempts to purify the reaction 
product by flash column chromatography proved unsuccessful, as the compounds 
were  inseparable  from  the  either  of  the  starting  materials.  This  made 
confirmation  of  the  reaction  success  impossible  by 
1H  NMR  spectroscopy. 
Treating the crude compounds with TBAF did not change this as alkyl TBDMS 
ether 425 was also deprotected. Purification by derivatisation though reduction Chapter 5 – Spirocyclic Natural Products   
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of the olefin under either standard conditions (Pd/C, H2) or with the H Cube also 
gave significant degradation of the starting mixture.              
Undeterred by this, a different approach was formulated. 
Careful searches of the literature highlighted a new variant of the traditional 
Suzuki reaction, using ‘unactivated’ alkyl bromides with aryl boronic acids. 
“In  summary,  we  have  described  the  first  palladium  or  nickel 
catalyzed  method  for  coupling  a  diverse  set  of  boronic  acids  and 
unactivated alkyl electrophiles (bromides) that possess b hydrogens.” 
– Gregory Fu
276 
The  coupling  of aryl  bromide  449  and  either commercially  available  furan 2 
ylboronic acid 458 or synthesized TBDMS protected furanyl boronic acid 459 was 
attempted following Fu’s protocol. Unfortunately none of the desired product 
was obtained.  
O
Br
O
O
O B
HO
HO
+ R
R = H, 458
R = CHiPrOTBDMS, 459
Pd(OAc)2, P(tBu)2Me
KOtBu, tert-amylalcohol
O
OTBDMS
1) nBuLi, B(OMe)3, THF
2) 1M HCl
R
449
424
R = H
R = CHiPrOTBDMS
 
Scheme 5.22. Suzuki reaction of bromide 449 and boronic acids. 
 
With  the  inability  to  generate  either  of  the  furan  bicycles,  other  coupling 
reactions were considered. 
At this point we considered the Stille coupling as a feasible alternative to the 
Suzuki coupling because the stannane is more nucleophilic than its corresponding 
boronic acid counterpart (despite the inherent toxicity of tin and tin containing 
compounds).
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The synthesis of stannane 460 began with furan 424, which was treated with 
nBuLi and tributyltin chloride (Scheme 5.23).
279 Regrettably the stannane was 
not formed, under these conditions as indicated by 
1H NMR analysis. 
 
Scheme 5.23. Generating stannane 461. 
 
In  an  attempt  to  discover  the  reason  for  this  failure,  TBDMS  ether  424  was 
deprotonated  with  nBuLi  and  alkylated  with  allyl  bromide  in  excellent  yield 
(71%). This suggested that the reason for the problem lay with the tributyltin 
chloride and not the deprotonation step. We reasoned that the problem was 
likely to be the presence of water in the Bu3SnCl, which therefore quenched the 
furfuryl.  However  despite  obtaining  a  new  source  of  tributyltin  chloride,  the 
reaction was still unsuccessful. 
The  last  obvious  choice  of  palladium  coupling  reaction  was  the  Sonogashira 
coupling. Two possible synthetic routes were considered using this cross coupling 
method.  In  the  first  instance  alkylation  of  silyl  furan  424  with  propargyl 
bromide  would  give  coupling  partner  461  which  could  then  be  reacted  with 
iodoanisole (3  or 4 ) to give the desired bicycle 462. The alternative coupling 
approach, reaction of propargyl alcohol and iodoanisole would give known alkyn 
ol 463.
279 The alcohol functionality could be transformed to a suitable leaving 
group (halide/alkyl sulfone) and displaced with a suitable anion (Scheme 5.24). Chapter 5 – Spirocyclic Natural Products   
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Scheme 5.24. Proposed Sonogashira routes to 462 
 
Initially, the first route was employed but a problem was encountered almost 
immediately. Attempts to synthesize TMS bromide
280 466 that could be used in 
place of propargyl bromide failed. This is not surprising when you considering 
the  alkyne  proton  acidity,  pKa  28.7,
281  it  is  likely  that  the  furan  anion  will 
undergo protonation, before the anion can displace the bromide in the desired 
coupling reaction. 
 
Scheme 5.25. Attempts to alkylate 424. 
 
The second route began with Sonogashira cross coupling reaction between 3 
iodoanisole 464 and propargyl alcohol 465 to give alcohol 463 in good yield. 
Transformation of the alcohol functionality to the corresponding tosylate 467 or 
bromide 468 was achieved in 97% and 46% yield respectively. Chapter 5 – Spirocyclic Natural Products   
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Scheme 5.26. Generating alkyne coupling partners 467 and 468 
 
Unfortunately deprotonation of 424 with nBuLi and treatment with bromide 467 
failed to produce any of the desired bicycle 462. Different bases (LDA, LHMDS, 
KHMDS, NHMDS, KH and NaH) were employed in the reaction with either bromide 
468  or  tosylate  467  as  the  alkylating  agent,  unfortunately  all  combinations 
failed to produce 462.  
5.2.3.  Molybdenum catalyzed allylic substitution 
At this point, we became aware of a method for molybdenum catalyzed coupling 
of electron rich aromatics (and heteroaromatics).
282 Malkov and Kocovsky have 
shown that molybdenum (poly carbonyl)n complexes catalyses the reaction of 
allylic acetates and aromatic compounds. To that end, known acetate 469
283 was 
synthesized from allylic alcohol 442 in the presence of acetic anhydride in 86% 
yield.  However  on  closer  inspection,  the  published  method  suggested  that  it 
would be unsuitable for our purposes; because with the substrates chosen the 
reaction  suffers  from  a  lack  of  regioselectivity.  The  SN2  pathway  is  still  the 
preferred  reaction, however the  reaction mixture  would contain  a  significant 
quantity of the SN2' reaction product as well as low overall yields (~45%).  
 
Scheme 5.27. Substitution of the allylic acetate with furan. 
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Due to the low regioselectivity and product yields, it was decided not to pursue 
this protocol. 
5.2.4.  Original route 
The results thus far were disheartening and abandoning the project was seriously 
considered. However one final coupling reaction was attempted using the same 
conditions as before. Surprisingly, coupling product 450 was produced in 38% 
yield,  as  a  mixture  of  bromide  and  product.  Fluoride  cleavage  of  the  silicon 
protecting  group  gave  secondary  alcohol  470  and  allowed  the  product  to  be 
separated from remaining bromide 449. Transformation of the alcohol 470 to 
the corresponding lactol 471 using our rearrangement conditions proceeded in 
high  yield  and  with  selectivity  comparable  to  those  obtained  in  the  previous 
project. 
 
Scheme 5.28. Synthesis of lactol 471. 
 
5.2.5.  Cyclisation vs dehydration 
When lactol 471 was treated with boron trifluoride diethyl etherate to facilitate 
the nucleophilic attack of the benzene olefin onto the oxonium cation, only the 
dehydrated exo olefin 472 was recovered. The observation is consistent with a 
very  slow  nucleophilic  addition,  so  slow  in  fact  that  deprotonation  a  to  the 
carbon atom of the oxonium ion proceeds rather than the cyclisation (Scheme 
5.29). Chapter 5 – Spirocyclic Natural Products   
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Scheme 5.29. Formation of the dehydration product. 
 
When  the  Lewis  Acid  was  exchanged  for  silicon  tetrachloride  and  ethyl 
aluminium  chloride,  the  exo olefin  472  was  obtained  exclusively.  With  tin 
tetrachloride as the Lewis acid, a small amount of 472 was obtained with larger 
quantities of degradation products in the reaction mixture.  
When triisopropoxytitanium(IV) chloride was used an unexpected product 473 
was  formed.  It  is  believed  that  the  titanium  species  causes  ring  opening  of 
lactol, giving the intermediate 474, through enolisation of the ketone. Electron 
movement opens the ring, giving keto diene 475, that tautomerizes to the 1,2,5 
diketone species 473. 
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Scheme 5.30. Proposed synthesis of the 1,2,5 triketone system. 
 
It did not appear as though the slow nucleophilic attack vs the quick dehydration 
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electron availability for the cyclisation, utilizing a phenolic hydroxyl instead of 
the phenolic methyl ether would provide the desired spirocyclic material. Thus, 
we  decided  to  try  boron  tribromide  as  the  Lewis  acid  to  achieve  the 
demethylation  and  cyclisation  reactions  simultaneously.  Boron  tribromide  is 
widely  accepted  as  a  standard  reagent  for  the  cleavage  of  phenolic  methyl 
ethers,
284,285  although  a  range  of  softer  reaction  conditions  have  been 
reported.
286,287  Mechanistically  it  is  believed  that  the  reaction  proceeds  by 
donation of the ether oxygens lone pair into the empty boron orbital 477, a 
bromide anion is ejected as a result. Nucleophilic attack of the bromide onto the 
methyl carbon and electron movement onto the oxygen gives an oxygen boron 
bond 478 that is cleaved upon acidic workup to give phenol 479 (Scheme 5.31). 
 
Scheme 5.31. The mechanism of BBr3 cleavage of phenolic methyl ethers.  
 
However  treatment  of  lactols  471  with  boron  tribromide  in  dichloromethane 
gave  only  the  exo cycle  472.  It  was  hoped  that  the  methyl  ether  would  be 
cleaved before oxonium formation thus avoiding the troublesome dehydration 
reaction. Unfortunately, this appears not to be the case as only exo cyclic triene 
472 was formed with no deprotected phenol observed. It appears that oxonium 
formation is a very quick process quicker than the cleavage of methyl ethers. 
With  the  end  of  laboratory  work  fast  approaching  one  final  attempt  to  form 
these complex spirocycles was attempted. The synthetic route was as before 
with one extra step included (phenolic methyl ether cleavage). Bicycle 480 was 
generated from freshly distilled silyl ether 424 and bromide 443, as previously 
described although the yield was greatly improved (83%). When boron tribromide 
was added to a solution of furanyl alcohol 480, cleavage of both silyl and methyl Chapter 5 – Spirocyclic Natural Products   
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ether  were  anticipated,  as  there  exist  evidence  of  silyl  ether  cleavage  with 
Lewis acids.
288 291 Unfortunately all that was achieved was extensive degradation 
of the starting materials.  
 
Scheme 5.32. Attempts to synthesize diol 481 
 
Searching  the  literature,  milder  conditions  were  found  utilizing  cyclohexyl 
iodide.
292 Cyclohexyl iodide undergoes thermal decomposition wherein an iodide 
anion  is  eliminated  as  hydrogen  iodide.  Protonation  of  the  oxygens  give  the 
dication  intermediate  483.  Attack  of  the  iodide  onto  the  carbon  and  silicon 
groups causes methyl iodide and tertbutyldimethylsilyl iodide to be ejected from 
intermediate 483 giving diol 482 
 
Scheme 5.33. Demethylation and desilylation of 481. 
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5.3. Future Work 
5.3.1.  Spirocyclic products 
With a method in place for the generation of spirocycles 410, 419, 420 and 429 
it  is intended to apply  it  to  the  synthesis  of  spirocyclic  natural  products.  Of 
particular interest is the complex natural product Polymaxenolide .  
 
Scheme 5.34. Spirocycle 433 and Polymaxenolide 6. 
 
The introduction of the cycloheptane fused ring system could be problematic, 
initially it was expected that isomerisation of the C2 C3 olefin could be achieved 
using Wilkinsons catalyst.
293 The new olefin could participate in a cycloaddition 
reaction building the carbon framework further.    Another  approach  that  is 
being considered is the use of a functionalised allylic bromide to alkylate furan 
86 in the initial stages of the synthesis (Scheme 5.35) to produce 484 that could 
then be carried forward. Tadano,
294 and Oishi
295 have already demonstrated the 
flexibility/tolerance  of  the  Achmatowicz  rearrangement,  accepting  large 
functionality around the furan ring system. 
O
O
H
nBuLi, TMEDA,
bromide, Et2O
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H
H
H
O
R
86 484
485  
Scheme 5.35. Incorporation of the fused ring systems into the methodology.  
 
Finally, a route that is being examined is centered on a modified Sakurai type 
reaction.  It  is  envisioned  that  treatment  of  olefin  486  with  Lewis  acid  will 
induce  a  cyclisation  cascade  via  intermediate  487,  setting  the  5  and  7 
membered rings in one reaction leaving an exo cyclic vinyl group 488 that could 
be further functionalised.  Chapter 5 – Spirocyclic Natural Products   
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Scheme 5.36. Sakurai cascade. 
 
To investigate the feasibility of this approach a model system has been designed, 
it is envisaged that treatment of olefin 489 with Lewis acid will cause oxonium 
formation 490 and subsequent nucleophilic attack of the olefin. The loss of the 
terminal  TMS  group  from  intermediate  491  regenerates  the  olefin  giving  the 
spirocycle 492.  
 
Scheme 5.37. Intramolecular Sakurai reaction 
 
Initial  experiments  attempting  to  introduce  the  allylic  TMS  group  have  been 
unsuccessful. Cross metathesis reactions between allyl TMS and alkene furan 415 
using Gouverneur’s method,
296 Grubbs 2
nd generation catalyst, have not provided 
any of the desired product 493. It is believed that the metathesis product is 
unstable to silica gel and extensive product degradation has been observed.  
 
Scheme 5.38. Cross metathesis of alkene 408.
296 
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In either eventuality much more research and experimentation is required to 
take  the  methodology  described  further  towards  the  synthesis  of 
Polymaxenolide. 
5.3.2.  Methoxy directed cyclisations 
Having  successfully  synthesized  the  lactol  core  491,  increasing  the  electron 
availability of the phenyl ring is the first priority for this project. The synthesis 
of  lactol  499  must  be  altered  slightly,  in  that  an  appropriate  orthogonal 
protecting  group  must  be  introduced  masking  the  phenolic  alcohol.  Thus 
aldehyde 495 will be synthesized from 3 /4 hydroxy benzaldehyde 494, upon 
treatment with trityl chloride (TrCl)
297 or trialkylsilyl chloride (SiR3Cl).
298 495 
will  then  be  olefinated,  reduced  and  converted  to  the  bromide  as  per  the 
previously  established  protocols  (Scheme  5.14).  Coupling  reaction  between 
freshly  distilled  bromide  497  and  silyl  ether  424  will  give  the  bicycle  498, 
cleavage  of  the  protecting  group  will  give  the  rearrangement  precursor  that 
could be converted to lactol 499. Treatment of the lactols 499 with a Lewis acid 
should provide the desired spirocyclic compounds. 
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Scheme 5.39. Future work. 
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6. Experimental 
2 Pent 4 enyl furan, 407.
246 
 
A solution of furan 86 (1.69 mL, 24.9 mmol) in anhydrous THF (125 mL) at 0 
oC 
was treated with nBuLi (10.5 mL, 26.2 mmol, 2.5 M in hexanes) and the resulting 
mixture allowed to warm up to room temperature. The solution was stirred for 
24 hours, at which point 5 bromopent 1 ene (3.09 mL, 26.2 mmol) was added 
slowly. The resulting reaction mixture was then stirred at room temperature for 
a further 24 hours. The reaction was then poured onto ice and the resulting 
mixture diluted with diethyl ether (100 mL). The resulting brown liquid was then 
stirred for 20 minutes after which it was extracted with diethyl ether (2x 30 
mL). The combined organic extracts were washed with water (2x 20 mL), brine 
(20 mL) and then dried over sodium sulfate. Following concentration in vacuo, 
the residue was purified by short path distillation giving 2.11 g of alkene 407 
(62% yield) as clear oil.                         
1H NMR (400 MHz, CDCl3): δ 7.35 (1H, d, J = 1.0 z, Ar H), 6.32 (1H, d, J = 1.8 Hz, 
Ar H), 6.03 (1H, d, J = 2.6 Hz, Ar H), 5.92 5.82 (1H, m, CH2CHCH2), 5.10 5.02 
(2H, m, CH2CHCH2), 2.69 (2H, t, J = 7.6 Hz, CH2CH2CH2), 2.16 (2H, q, J = 7.2 Hz, 
CH2CH2CH2), 2.69 (2H, t, J = 7.6 Hz, CH2CH2CH2).                
13C NMR (100 MHz, CDCl3): δ 156.1 (Ar C), 140.8 (Ar C), 138.2 (CH2CHCH2), 114.9 
(CH2CHCH2),  110.0  (Ar C),  104.8  (Ar C),  33.2  (CH2CH2CH2),  27.3  (CH2CH2CH2), 
27.2 (CH2CH2CH2).                     
m/z [EI
+(+ve)] 136.1 [M]
+ (100%).                              
vmax (neat)/cm
 1. 2092, 1642, 799. 
2 But 3 enyl furan, 411. 
 
A solution of furan 86 (1.49 mL, 22.0 mmol) in anhydrous THF (100 mL) at 0 
oC 
was treated with nBuLi (8.84 mL, 22.1 mmol, 2.5 M in hexanes) and the resulting 
mixture allowed to warm up to room temperature. The solution was stirred for 
24 hours, at which point 4 bromobut 1 ene (2.24 mL, 22.1 mmol) was added 
slowly. The resulting reaction mixture was then stirred at room temperature for Chapter 6 – Experimental   
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a further 24 hours. The reaction was then poured onto ice and the resulting 
mixture diluted with diethyl ether (100 mL). The resulting brown liquid was then 
stirred for 20 minutes and was then extracted with diethyl ether (2x 30 mL). The 
combined organic extracts were washed with water (2x 20 mL), brine (20 mL) 
and  then  dried  over  sodium  sulfate.  Following  concentration  in  vacuo,  the 
residue was purified by short path distillation, giving 2.28 g of alkene 411 in 85% 
yield as clear oil.                            
1H NMR (500 MHz, CDCl3): δ 7.24 (1H, dd, J = 1.8, 0.8 Hz, Ar H), 6.21 (1H, dd, J 
= 3.1, 1.9 Hz, Ar H), 5.93 (1H, dd, J = 3.2, 0.9 Hz, Ar H), 5.82 5.74 (1H, m, 
CH2CH), 5.02 4.91 (2H, m, CH2CH), 2.65 (2H, t, J = 9.1 Hz, CHCH2CH2), 2.36 2.31 
(2H, m, CHCH2CH2).                            
13C NMR (125 MHz, CDCl3): δ 140.4 (Ar C), 137.5 (CH2CH), 117.4 (CH2CHCH2), 
115.2  (Ar C),  110.0  (Ar C),  104.9  (Ar C),  32.1  (CHCH2CH2),  27.5  (CHCH2CH2).  
m/z [EI
+(+ve)] 122.1 [M]
+ (100%).                        
vmax (neat)/cm
 1. 3080, 2959, 1641, 1009, 729. 
2 Hex 5 enyl furan, 412. 
 
A solution of furan 86 (0.99 mL, 14.6 mmol) in anhydrous THF (74 mL) at 0 
oC 
was treated with nBuLi (5.84 mL, 14.6 mmol, 2.5 M in hexanes) and the resulting 
mixture allowed to warm up to room temperature. The solution was stirred for 
24 hours, at which point 6 bromohex 1 ene (1.88 mL, 14.6 mmol) was added 
slowly. The resulting mixture was then stirred at room temperature for a further 
24  hours.  The  reaction  was  then  poured  onto  ice  and  the  resulting  mixture 
diluted with diethyl ether (100 mL). The resulting brown liquid was stirred for 20 
minutes  after  which  it  was  extracted  with  diethyl  ether  (2x  20  mL).  The 
combined organic extracts were washed with water (2x 20 mL), brine (20 mL) 
and  then  dried  over  sodium  sulfate.  Following  concentration  in  vacuo,  the 
residue was purified by short path distillation. Giving 1.89 g (87% yield) of alkene 
412, as clear oil.                            
1H NMR (500 MHz, CDCl3): δ 7.21 (1H, dd, J = 1.8, 0.8 Hz, Ar H), 6.19 (1H, dd, J 
= 3.1, 1.9 Hz, Ar H), 5.89 (1H, dd, J = 3.1, 0.8 Hz, Ar H), 5.77 5.68 (1H, m, 
CH2CHCH2), 4.95 4.86 (2H, m, CH2CH), 2.55 (2H, t, J = 7.6 Hz, CH2CH2Ar), 2.00 
1.98 (2H, m, CHCH2), 1.61 1.55 (2H, m, CH2CH2Ar), 1.36 (2H, quint, J = 7.3 Hz, Chapter 6 – Experimental   
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CHCH2CH2).                             
13C NMR (125 MHz, CDCl3): δ 158.5 (Ar C), 154.8 (Ar C), 138.8 (CH2CH), 114.4 
(CH2CH),  104.8  (Ar C),  104.2  (Ar C),  33.5  (CH2CH2Ar),  28.4  (CH2CHCH2),  27.5 
(CH2CH2CH2), 26.4 (CH2CH2CH2).                    
m/z [EI
+(+ve)] 150.1 [M]
+ (100%).                        
vmax (neat)/cm
 1.2976, 2932, 2858, 1640, 1606, 910, 781. 
2 Methyl 1 (5 pent 4 enylfuran 2 yl) propan 1 ol, 408. 
 
To a solution of alkenyl furan 407 (2.12 g, 15.1 mmol) and TMEDA (2.49 g, 16.6 
mmol) in anhydrous diethyl ether (76 mL) at 0 
oC was added slowly nBuLi (6.4 
mL,  15.9  mmol).  The  resulting  solution  was  allowed  to  warm  to  room 
temperature over a period of 3 hours; at this point, it was cooled to −78 
oC and 
treated  with  isobutyraldehyde  (1.51  mL,  16.6  mmol).  The  reaction  was  then 
stirred for 30 minutes at −78 
oC, after which it was allowed to warm up to 0 
oC 
and stirred for 2 hours. Saturated aqueous ammonium chloride solution (10 mL) 
was  added  before  being  extracted  with  cold  diethyl  ether  (2x  20  mL).  The 
combined organic phases were washed with water (2x  15 ml), brine (15 ml), 
dried  over  sodium  sulfate  and  concentrated  in  vacuo.  The  crude  residue 
obtained  was  then  purified  by  flash  column  chromatography  (silica  gel,  10% 
diethyl ether in petroleum spirit) to give 1.95 g (62% yield) 408 as a clear oil.           
1H NMR (500 MHz, CDCl3): δ 6.06 (1H, d, J = 3.0 Hz, Ar H), 5.87 (1H, d, J = 3.0 
Hz, Ar H), 5.77 (1H, m, CH2CHCH2), 4.99 (1H, dq, J = 17.1, 1.6 Hz, CH2CHCH2), 
4.94 (1H, d, J = 10.2 Hz, CH2CHCH2), 4.24 (1H, d, J = 7.2 Hz, CH(OH)), 2.57 (2H, 
t,  J  =  7.5  Hz,  CH2Ar),  2.15  (1H,  bs,  OH),  2.09–2.00  (3H,  m,  CH2CHCH2  and 
CH(CH3)2),  1.69  (2H,  q,  J  =  7.5  Hz,  CH2CH2CH2),  0.98  (3H,  d,  J  =  6.8  Hz, 
CH(CH3)2), 0.81 (3H, d, J = 6.7 Hz, CH(CH3)2).                  
13C NMR (125 MHz, CDCl3): δ 155.3 (Ar C), 154.3 (Ar C), 138.2 (CH2CH), 114.9 
(CH2CH),  107.0  (Ar C),  105.2  (Ar C),  73.5  (CH(OH)),  33.2  (CH2Ar),  33.1 
(CH2CH2CH2),  27.3  (CH2CH2CH2),  27.2  (CH(CH3)2),  18.8  (CH(CH3)2),  18.4 
(CH(CH3)2).                              
m/z [EI
+(+ve)] 191.1 [M OH]
+ (100%), HRMS found 231.1312, C12H20NaO2 requires 
231.1360 (M
++Na).                            
vmax (neat)/cm
 1. 3438, 2960, 2932, 2871, 1640, 1384, 907. Chapter 6 – Experimental   
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2 Methyl 1 (5 But 3 enylfuran 2 yl) propan 1 ol, 413. 
 
To a solution of alkenyl furan 411 (784 mg, 6.42 mmol) and TMEDA (960 mL, 6.42 
mmol) in anhydrous diethyl ether (32 mL) at 0 
oC was added slowly nBuLi (2.56 
mL, 6.42 mmol, 2.5 M in hexanes). The resulting solution was allowed to warm 
to room temperature over a period of 3 hours; at this point, it was cooled to −78 
oC and treated with isobutyraldehyde (639  mL, 6.42 mmol). The reaction was 
then stirred for 30 minutes at −78 
oC, after which it was allowed to warm up to 0 
oC and stirred for 2 hours. Saturated aqueous ammonium chloride solution (10 
mL) was added before being extracted with cold diethyl ether (2x 20 mL). The 
combined organic phases were washed with water (2x  15 ml), brine (15 ml), 
dried  over  sodium  sulfate  and  concentrated  in  vacuo.  The  crude  residue 
obtained  was  then  purified  by  flash  column  chromatography  (silica  gel,  10% 
diethyl ether in petroleum spirit) to give 1.06 g (85% yield) 413 as a clear oil.         
1H NMR (500 MHz, CDCl3): δ 6.02 (1H, d, J = 3.0 Hz, Ar H), 5.85 (1H, d, J = 2.2 
Hz, Ar H), 5.79 (1H, m, CH2CHCH2), 4.97 (1H, dq, J = 15.4, 1.7 Hz, CH2CHCH2), 
4.91 (1H, d, J = 10.2 Hz, CH2CHCH2), 4.21 (1H, dd, J = 7.0, 3.3 Hz, CHOH), 2.62 
(2H, t, J = 7.6 Hz, ArCH2CH2), 2.34–2.28 (2H, m, CH2CHCH2), 2.01 (1H, sept, J = 
6.9  Hz,  CH(CH3)2),  1.83  (1H,  d,  J  =  2.8  Hz,  OH),  0.94  (3H,  d,  J  =  6.7  Hz, 
CH(CH3)2), 0.77 (3H, d, J = 6.7 Hz, CH(CH3)2).           
 
13C NMR (125 MHz, CDCl3): δ 154.9 (Ar C), 154.3 (Ar C), 137.5 (CHCH2CH2), 115.3 
(CH2CHCH2),  107.1  (Ar C),  105.4  (Ar C),  73.6  (CHOH),  33.3  (CH(CH3)2),  32.1 
(CHCH2CH2), 27.6 (CHCH2CH2), 18.8 (CH(CH3)2), 18.4 (CH(CH3)2).              
m/z [EI
+(+ve)] 177.1 [M
+] (100%).                       
vmax (neat)/cm
 1. 3601, 2960, 2926, 1468, 1014. 
2 Methyl 1 (5 Hex 5 enylfuran 2 yl)propan 1 ol, 414. 
 
To a solution of alkenyl furan 412 (1.39 g, 9.31 mmol) and TMEDA (1.39 mL, 9.31 
mmol) in anhydrous diethyl ether (46 mL) at 0 
oC was added slowly nBuLi (3.72 
mL, 9.31 mmol, 2.5 M in hexanes). The resulting solution was allowed to warm 
to room temperature over a period of 3 hours; at this point, it was cooled to −78 Chapter 6 – Experimental   
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oC and treated with isobutyraldehyde (840  mL, 9.31 mmol). The reaction was 
then stirred for 30 minutes at −78 
oC, after which it was allowed to warm up to 0 
oC and stirred for 2 hours. Saturated aqueous ammonium chloride solution (10 
mL) was added before being extracted with cold diethyl ether (2x 20 mL). The 
combined organic phases were washed with water (2x  15 ml), brine (15 ml), 
dried  over  sodium  sulfate  and  concentrated  in  vacuo.  The  crude  residue 
obtained  was  then  purified  by  flash  column  chromatography  (silica  gel,  10% 
diethyl ether in petroleum spirit) to give 1.55 g 414 as a clear oil in 75% yield.           
1H NMR (500 MHz, CDCl3): δ 6.06 (1H, d, J = 3.1 Hz, Ar H), 5.87 (1H, d, J = 3.0 
Hz, Ar H), 5.77 (1H, m, CH2CHCH2), 4.97 (1H, dq, J = 17.1, 1.9 Hz, CH2CHCH2), 
4.92 (1H, dq, J = 10.1, 0.9 Hz, CH2CHCH2), 4.25 (1H, d, J = 6.8 Hz, CHOH), 2.57 
(2H, t, J = 7.5 Hz, ArCH2CH2), 2.09–1.96 (4H, m, CH2CHCH2, CH(CH3)2, OH), 1.61 
(2H, q, J = 7.6 Hz, CH2CH2), 1.41 (2H, quint, J = 7.8 Hz, CH2CH2), 0.99 (3H, d, J = 
6.7 Hz, CH(CH3)2), 0.82 (3H, d, J = 6.8 Hz, CH(CH3)2). 
13C NMR (125 MHz, CDCl3): 
δ 155.9 (Ar C), 154.5 (Ar C), 138.9 (CH2CH), 114.7 (CH
2CH), 107.3 (Ar C), 105.4 
(Ar C),  77.8  (CHOH),  33.7  (CH2Ar),  33.5  (CH2CHCH2),  28.6  (CH(CH3)2),  28.1 
(CH2CH2), 27.7 (CH2CH2), 19.1 (CH(CH3)2), 18.7 CH(CH3)2).                  
m/z [EI
+(+ve)] 205.1 [M OH]
+ (100%), HRMS found 245.1489, C14H22NaO2 requires 
245.1517 [M + Na]
+.                            
vmax (neat)/cm
 1. 3437, 2959, 2931, 1462, 1011, 910.  
6 Hydroxy 2 isopropyl 6 pent 4 enyl 6H pyran 3 one, 397. 
 
A 0 
oC solution of furfuryl alcohol 408 (1.40 g, 6.74 mmol) in dichloromethane 
(34 mL) was treated with meta chloroperoxybenzoic acid (1.67 g, 7.41 mmol) 
and the resulting opaque solution was stirred at 0 
oC for 1 hour. The mixture was 
allowed to warm up to room temperature and the reaction was stirred for a 
further  2  hours.  The reaction  was  cooled to  0 
oC  and  quenched  by  the  slow 
addition  of  saturated  aqueous  sodium  bicarbonate  (10  mL).  The  resulting 
emulsion was allowed to separate and was then extracted with dichloromethane 
(3x 15 mL). The combined organic extracts were washed with water (10 mL), 
brine  (10  mL)  and  dried  over  anhydrous  sodium  sulfate.  The  solution  was Chapter 6 – Experimental   
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concentrated  in  vacuo  and  the  residue  obtained  purified  by  flash  column 
chromatography (silica gel, 30% diethyl ether in petroleum spirits) to give 1.44 g 
(96% yield) of lactol 397 as a mixture of  anomers (a:b, 8:1).  
Major anomer 397a a a a. 
 
1H NMR (500 MHz, CDCl3): δ 6.76 (1H, d, J = 10.2 Hz, CHCHCO), 6.02 (1H, d, J = 
10.2 Hz, CHCHCO), 5.75 (1H, m, CH2CHCH2), 5.03–4.93 (2H, m, CH2CHCH2), 4.32 
(1H, d, J = 2.7 Hz, COCH(O)CH), 2.89 (1H, bs, OH), 2.42 (1H, m, CH2CHCH2), 
2.05 (2H, m, CH2CHCH2 and CH(CH3)2), 1.84–1.79 (2H, m, CH2C(O)OH), 1.56 (1H, 
m, CH2CH2CH2), 1.47 (1H, m, CH2CH2CH2), 1.00 (3H, d, J = 6.9 Hz, CH(CH3)2), 
0.82 (3H, d, J = 6.8 Hz, CH(CH3)2).                        
13C  NMR  (125  MHz,  CDCl3):  δ  197.0  (CHCHCO),  147.5  (CHCHCO),  138.1 
(CHCHCH2),  127.9  (CHCHCO),  119.5  (CH2CHCH2),  93.9  (C(O)OH),  78.2 
(COCH(O)CH),  41.1  (CH2CHCH2),  33.0  (CH2C(O)OH),  28.7  (CH(CH3)2),  22.8 
(CH2CH2CH2), 19.0 (CH(CH3)2), 16.9 (CH(CH3)2).  
Minor anomer 397β.    
 
1H NMR (500 MHz, CDCl3): δ 6.86 (1H, d, J = 9.9 Hz, CHCHCO), 5.91 (1H, dd, J = 
9.9, 0.4 Hz, CHCHCO), 5.77 (1H, m, CH2CHCH2), 5.05–4.93 (2H, m, CH2CHCH2), 
4.19 (1H, d, J = 4.8 Hz, COCH(O)CH), 2.35 (2H, q, J = 7.4 Hz, CH2CHCH2), 2.24–
2.13 (3H, m, CH(CH3)2 and CH2C(O)OH), 1.75 (1H, m, CH2CH2CH2), 1.25 (1H, m, 
CH2CH2CH2),  0.99  (3H,  d,  J  =  7.0  Hz,  CH(CH3)2),  0.91  (3H,  d,  J  =  6.8  Hz, 
CH(CH3)2).                               
13C  NMR  (125  MHz,  CDCl3):  δ  195.2  (CHCHCO),  147.1  (CHCHCO),  141.9 
(CH2CHCH2),  137.8  (CHCHCO),  121.9  (CH2CHCH2),  85.6  (C(O)OH),  78.2 
(COCH(O)CH),  33.5  (CH2CHCH2),  32.8  (CH2C(O)OH),  31.8  (CH(CH3)2),  24.8 
(CH2CH2CH2), 18.9 (CH(CH3)2), 16.1 (CH(CH3)2).              
m/z  [EI
+(+ve)]  207.1  [M−OH]
+  (100%),  HRMS  found  247.1305,  C13H20NaO3   Chapter 6 – Experimental   
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requires 247.1310 [M+Na]
+.                          
vmax(film)/cm
−1: 3400, 2966, 2930, 1676, 1382, 908. 
6 Hydroxy 2 isopropyl 6 but 3 enyl 6H pyran 3 one, 415.  
 
A 0 
oC solution of furfuryl alcohol 413 (1.71 g, 8.82 mmol) in dichloromethane 
(44 mL) was treated with meta chloroperoxybenzoic acid (2.17 g, 9.70 mmol) 
and the resulting opaque solution was stirred at 0 
oC for 1 hour. The mixture was 
allowed to warm up to room temperature and the reaction stirred for a further 3 
hours.  The  reaction  was  cooled  to  0 
oC  and  quenched  by  slow  addition  of 
saturated  aqueous  sodium  bicarbonate  (15  mL).  The  resulting  emulsion  was 
allowed to separate and was then extracted with dichloromethane (3x 15 mL). 
The combined organic extracts were washed with water (15 mL), brine (10 mL) 
and  dried  over  anhydrous  sodium  sulfate.  The  solution  was  concentrated  in 
vacuo and the residue obtained purified by flash column chromatography (silica 
gel, 20% diethyl ether in petroleum spirits) to give 1.47 g (81% yield)of lactols 
415 as a mixture of  anomers (a:b, 7.8:1).  
Major anomer 415α 
 
1H NMR (500 MHz, CDCl3): δ 6.80 (1H, d, J = 10.2 Hz, CHCHCO), 6.05 (1H, d, J = 
10.2  Hz,  CHCHCO),  5.90  (1H,  m,  CH2CHCH2),  5.11  (1H,  d,  J  =  17.2  Hz, 
CH2CHCH2),  5.04  (1H,  d,  J  =  10.2  Hz,  CH2CHCH2),  4.37  (1H,  d,  J  =  2.7  Hz, 
COCH(O)CH),  3.05  (1H,  bs,  OH),  2.47  (1H,  m,  CH(CH3)2),  2.34  (1H,  m, 
CH2CHCH2), 2.19 (1H, m, CH2CHCH2), 1.97 (2H, m, CH2CH2), 1.06 (3H, d, J = 7.0 
Hz, CH(CH3)2), 0.87 (3H, d, J = 6.8 Hz, CH(CH3)2).                    
13C  NMR  (125  MHz,  CDCl3):  δ  195.2  (CHCHCO),  147.2  (CHCHCO),  135.4 
(CH2CHCH2),  122.3  (CHCHCO),  116.9  (CH2CHCH2),  115.6  (C(O)OH),  85.4 
(COCH(O)CH), 31.8 (CH2CHCH2), 30.9 (CH(CH3)2), 29.7 (CH2CH2), 18.9 (CH(CH3)2), 
16.9 (CH(CH3)2).  Chapter 6 – Experimental   
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Minor anomer 415β                             
 
1H NMR (500 MHz, CDCl3): δ 6.87 (1H, d, J = 10.3 Hz, CHCHCO), 6.07 (1H, d, J = 
10.2  Hz,  CHCHCO),  5.89  (1H,  m,  CH2CHCH2),  5.09  (1H,  d,  J  =  16.9  Hz, 
CH2CHCH2),  5.02  (1H,  d,  J  =  10.1  Hz,  CH2CHCH2),  3.95  (1H,  d,  J  =  4.1  Hz, 
COCH(O)CH),  2.44  (1H,  m,  CH(CH3)2),  2.37  (1H,  m,  CH2CHCH2),  2.23  (1H,  m, 
CH2CHCH2), 1.94 (2H, m, CH2CH2), 1.05 (3H, d, J = 6.9 Hz, CH(CH3)2), 0.95 (3H, 
d, J = 6.7 Hz, CH(CH3)2).                            
13C NMR (125 MHz, CDCl3): δ 194.2 (CO), 146.8 (CHCH), 135.9 (CH2CH), 123.4 
(CHCO),  116.1  (CH2CH),  93.5  (OCOH),  89.1  (COCH),  45.2  (CHCH2CH2),  29.0 
(CH(CH3)2), 21.4 (CHCH2CH2), 18.7 (CH(CH3)2), 18.6 (CH(CH3)2).           
m/z [EI
+(+ve)] 193.1 [M−OH]
+ (85%), HRMS found 233.1148, C12H18NaO3 requires 
233.1153 [M+Na]
+.                           
vmax (film)/cm
−1: 3432, 2967, 2932, 1686, 1041, 910.  
6 Hydroxy 2 isopropyl 6 Hex 5 enyl 6H pyran 3 one, 416. 
 
A 0 
oC solution of furfuryl alcohol 414 (1.46 g, 6.64 mmol) in dichloromethane 
(33 mL) was treated with meta chloroperoxybenzoic acid (1.64 g, 7.30 mmol) 
and the resulting opaque solution was stirred at 0 
oC for 1 hour. The mixture was 
allowed to warm up to room temperature and the reaction stirred for a further 2 
hours.  The  reaction  was  cooled  to  0 
oC  and  quenched  by  slow  addition  of 
saturated  aqueous  sodium  bicarbonate  (10  mL).  The  resulting  emulsion  was 
allowed to separate and was then extracted with dichloromethane (3x 15 mL). 
The combined organic extracts were washed with water (10 mL), brine (10 mL) 
and  dried  over  anhydrous  sodium  sulfate.  The  solution  was  concentrated  in 
vacuo and the residue obtained purified by flash column chromatography (silica 
gel, 30% diethyl ether in petroleum spirits) to give 1.19 g (75% yield) of lactol 
416 as a mixture of  anomers (a:b, 7.9:1).  Chapter 6 – Experimental   
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Major anomer 416α.                             
 
1H NMR (500 MHz, CDCl3): δ 6.76 (1H, d, J = 10.2 Hz, CHCHCO), 6.03 (1H, d, J = 
10.2 Hz, CHCHCO), 5.77 (1H, m, CH2CHCH2), 4.98 (1H, dq, J = 17.1, 1.9 Hz, 
CH2CHCH2),  4.93  (1H,  d,  J  =  10.2  Hz,  CH2CHCH2),  4.32  (1H,  d,  J  =  2.7  Hz, 
COCH(O)CH), 2.42 (1H, m, CH(CH3)2), 2.05 (2H, m, CH2CHCH2), 1.82–1.81 (2H, m, 
CH2C(O)OH), 1.54–1.35 (4H, m, CH2CH2), 1.00 (3H, d, J = 7.0 Hz, CH(CH3)2), 0.83 
(3H, d, J = 6.8 Hz, (CH(CH3)2). 
Minor anomer 416β                             
 
1H NMR (500 MHz, CDCl3): δ 6.82 (1H, d, J = 10.3 Hz, CHCHCO), 6.00 (1H, d, J = 
10.3 Hz, CHCHCO), 5.77 (1H, m, CH2CHCH2), 5.00–4.91 (2H, m, CH2CHCH2), 3.90 
(1H,  d,  J  =  4.1  Hz,  COCH(O)CH),  2.42  (1H,  m,  CH(CH3)2),  2.05  (2H,  m, 
CH2CHCH2), 1.85–1.76 (2H, m, CH2C(O)OH), 1.54–1.37 (4H, m, CH2CH2), 1.00 (3H, 
d, J = 6.9 Hz, CH(CH3)2), 0.90(3H, d, J = 6.8 Hz, CH(CH3)2).                 
m/z [EI
+(+ve)] 221.1 [M−OH]
+ (100%), HRMS found 261.1461, C14H22NaO3 requires 
261.1466 [M + Na]
+.                      
vmax(film)/cm
−1: 3429, 2966, 2931, 1671, 1382, 908.  
6 Allyl 6 (pent 4 enyl) 2 isopropyl 6H pyran 3 one, 409. 
 
A solution of lactol 397 (0.99 g, 4.76 mmol) in anhydrous dichloromethane (23 
mL) was treated with allyltrimethylsilane (1.58 mL, 9.99 mmol) and the resulting 
mixture was cooled to −78 
oC. The reaction mixture was then treated by the 
slow addition of BF3OEt2 (1.78 mL, 14.1 mmol) and the resulting solution was 
stirred for 30 minutes at −78 
oC. The reaction was then allowed to warm to room 
temperature and stirred for a further 2 hours. Once the reaction was complete, Chapter 6 – Experimental   
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as  determined  by  TLC  analysis,  the  reaction  was  quenched  with  saturated 
aqueous  ammonium  chloride  (5  mL)  and  extracted  with  dichloromethane  (2x 
10mL). The combined organic phases were washed sequentially with saturated 
sodium hydrogen carbonate (10 mL), water (2x 10 mL) and brine (10 mL). The 
combined organic extracts were dried over anhydrous sodium sulfate and the 
solvent was removed in vacuo. The crude residue was purified by flash column 
chromatography (silica gel, 8% diethyl ether in petroleum spirits) to afford 945 
mg (80 % yield) of desired bis alkenyl product 409 as a clear oil.     
 
1H NMR (500 MHz, CDCl3): δ 6.75 (1H, d, J = 10.4 Hz, CHCHCO), 5.96 (1H, d, J = 
10.4 Hz, CHCHCO), 5.78–5.65 (2H, m, CH2CHCH2), 5.07–4.85 (4H, m, CH2CHCH2), 
4.02  (1H,  d,  J  =  2.6  Hz,  COCH(O)CH),  2.51  (1H,  ddt,  J  =  8.0,  6.5,  1.0  Hz, 
C(O)CH2CHCH2), 2.34–2.40 (1H, m, CH(CH3)2), 2.32–2.30 (1H, m, C(O)CH2CHCH2), 
2.00–2.01  (2H,  m,  CH2CHCH2),  1.70–1.64  (1H,  m,  CH2CH2),  1.53–1.44  (2H,  m, 
CH2CH2), 1.30–1.22 (1H, m, CH2CH2), 0.95 (3H, d, J = 7.0 Hz, CH(CH3)2), 0.79 
(3H, d, J = 6.8 Hz, CH(CH3)2).                          
13C  NMR  (125  MHz,  CDCl3):  δ  196.7  (CHCHCO),  154.6  (CHCHCO),  138.4 
(CH2CHCH2),  132.6  (CH2CHCH2),  126.6  (CHCHCO),  118.6  (CH2CHCH2),  114.7 
(CH2CHCH2),  78.5  (COCH(O)CH),  75.7  (CHC(O)CH2),  39.7  (CH2CHCH2),  38.0 
(CH2CHCH2), 33.8 (CH2C(O)), 29.1 (CH(CH3)2), 22.7 (CH2CH2CH2), 19.2(CH(CH3)2), 
16.9 (CH(CH3)2).                            
m/z  [EI
+(+ve)]  249.2  [M]
+  (100%),  HRMS  found  249.1849,  C16H25O2  requires 
249.1855 [M + H]
+.                           
vmax (film)/ cm
−1: 2924, 1709, 1381, 911.  
6 Allyl 6 (but 3 enyl) 2 isopropyl 6H pyran 3 one, 417. 
 
A solution of the lactol 415 (1.36 g, 6.45 mmol) in anhydrous dichloromethane 
(32 mL) was treated with allyltrimethylsilane (2.15 mL, 13.54 mmol) and the 
resulting mixture was cooled to −78 
oC. The reaction mixture was then treated 
by the slow addition of BF3OEt2 (2.44 mL, 19.3 mmol) and the resulting solution 
stirred for 30 minutes at −78 
oC. The reaction was then allowed to warm to room 
temperature and stirred for a further 2 hours. Once the reaction was complete, 
as  determined  by  TLC  analysis,  the  reaction  was  quenched  with  saturated Chapter 6 – Experimental   
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aqueous ammonium chloride (10 mL) and extracted with dichloromethane (2x 15 
mL).  The  combined  organic  phases  were  washed  sequentially  with  saturated 
sodium hydrogen carbonate (10 mL), water (2× 10 mL) and brine (10 mL). The 
combined organic extracts were dried over anhydrous sodium sulfate and the 
solvent  was  removed  in  vacuo.  The  crude  residue  was  then  purified  by  flash 
column chromatography (silica gel, 20 50% dichloromethane in petroleum spirits) 
to afford 876 mg (58 % yield) of the desired bisalkenyl product 417.             
1H NMR (500 MHz, CDCl3): δ 6.76 (1H, d, J = 10.4 Hz, CHCHCO), 5.98 (1H, d, J = 
10.4 Hz, CHCHCO), 5.80– 5.68 (2H, m, CH2CHCH2), 5.09–5.02 (2H, m, CH2CHCH2), 
4.94  (1H,  dq,  J  =  17.1,  1.7  Hz,  CH2CHCH2),  4.88  (1H,  dq,  J  =  10.2,  1.6  Hz, 
CH2CHCH2), 4.03 (1H, d, J = 2.5 Hz, COCH(O)CH), 2.51 (1H, dd, J = 14.2, 6.4 Hz, 
CH2CHCH2),  2.39  (1H,  m,  CH(CH3)2),  2.29  (1H,  m,  CH2CHCH2),  2.19  (1H,  m, 
CH2CHCH2),  1.93  (1H,  m,  CH2CHCH2),  1.80  (1H,  ddd,  J  =  13.6,  11.9,  4.7  Hz, 
CH2CH2), 1.54 (1H, ddd, J = 13.6, 11.6, 4.7 Hz, CH2CH2), 0.96 (3H, d, J = 7.0 Hz, 
CH(CH3)2), 0.80 (3H, d, J = 6.8 Hz, CH(CH3)2).                   
13C  NMR  (125  MHz,  CDCl3):  δ  196.7  (CHCHCO),  154.3  (CHCHCO),  138.4 
(CH2CHCH2),  132.5  (CH2CHCH2),  126.7  (CHCHCO),  118.8  (CH2CHCH2),  114.6 
(CH2CHCH2),  78.6  (COCH(O)CH),  75.5  (CHC(O)CH2),  39.8  (CH2CHCH2),  37.8 
(CH2CHCH2), 29.1 (CH(CH3)2), 27.9 (CH2CH2), 19.2 (CH(CH3)2), 16.0 (CH(CH3)2). 
m/z  [EI
+(+ve)]  235.2  [M]
+,  (100%),  HRMS  found  235.1693,  C15H23O2  requires 
235.1698 [M]
+.                           
vmax (film)/ cm
−1: 2964, 2930, 1686, 1061, 910.  
6 Allyl 6 (hex 5 enyl) 2 isopropyl 6H pyran 3 one, 418. 
 
A solution of the lactol 416 (926 mg, 3.88 mmol) in anhydrous dichloromethane 
(20  mL)  was  treated  with  allyltrimethylsilane  (1.29  mL,  8.16  mmol)  and  the 
resulting mixture was cooled to −78 
oC. The reaction mixture was then treated 
by the slow addition of BF3OEt2 (1.48 g, 11.6 mmol) and the resulting solution 
stirred for 30 minutes at −78 
oC. The reaction was then allowed to warm to room 
temperature and stirred for a further 2 hours. Once the reaction was complete, 
as  determined  by  TLC  analysis,  the  reaction  was  quenched  with  saturated 
aqueous ammonium chloride (15 mL) and extracted with dichloromethane (3x 20 Chapter 6 – Experimental   
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mL). The combined organic extracts were washed sequentially with saturated 
sodium hydrogen carbonate (10 mL), water (2x 10 mL) and brine (10 mL). The 
combined  organic  phases  were  dried  over  anhydrous  sodium  sulfate  and  the 
solvent  was  removed  in  vacuo.  The  crude  residue  was  then  purified  by  flash 
column  chromatography  (silica  gel,  7%  diethyl  ether  in  petroleum  spirits)  to 
afford 778 mg (56% yield) of the desired bisalkenyl product 418.                
1H NMR (500 MHz, CDCl3): δ 6.80 (1H, d, J = 10.4 Hz, CHCHCO), 6.02 (1H, d, J = 
10.4 Hz, CHCHCO), 5.75–5.73 (2H, m, CH2CHCH2), 5.13–5.07 (2H, m, CH2CHCH2), 
4.97 (1H, dq, J = 17.1, 1.6 Hz, CH2CHCH2), 4.91 (1H, d, J = 10.2 Hz, CH2CHCH2), 
4.04 (1H, d, J = 2.6 Hz, COCH(O)CH), 2.54 (1H, dd, J = 14.2, 6.3 Hz, CH2CHCH2), 
2.43 (1H, m, CH(CH3)2), 2.32 (1H, dd, J = 14.2, 8.2 Hz, CH2CHCH2), 2.02 (2H, m, 
J = 6.9 Hz, CH2CHCH2), 1.71 (1H, m, CH2CH2CH2), 1.54–1.43 (2H, m, CH2CH2CH2), 
1.41–1.33 (2H, m, CH2CH2CH2), 1.23 (1H, m, CH2CH2CH2), 1.00 (3H, d, J = 7.0 Hz, 
CH(CH3)2), 0.84 (3H, d, J = 6.8 Hz, CH(CH3)2).                            
13C  NMR  (125  MHz,  CDCl3):  δ  196.9  (CHCHCO),  154.7  (CHCHCO),  138.8 
(CH2CHCH2),  132.7  (CH2CHCH2),  126.6  (CHCHCO),  118.6  (CH2CHCH2),  114.5 
(CH2CHCH2),  78.6  (COCH(O)CH),  75.8  (CHC(O)CH2),  39.7  (CH2CHCH2),  38.5 
(CH2CHCH2),  33.6  (CH2CH2CH2),  29.2  (CH(CH3)2),  29.1  (CH2CH2CH2),  22.9 
(CH2CH2CH2), 19.2 (CH(CH3)2), 16.0 (CH(CH3)2).                    
m/z  [EI
+(+ve)]  263.2  [M]
+  (100%),  HRMS  found  263.2007  C17H27O2  requires 
263.2012 [M]
+.                            
vmax (film)/ cm
−1: 3075, 2928, 1686, 1640, 1388, 911. 
2 Isopropyl 1 oxaspiro[5.6]dodeca 4,8 dien 3 one, 410.  
 
A solution of bisalkenyl pyranone 409 (52 mg, 0.21 mmol) in dichloromethane (2 
mL)  in  a  darkened  reaction  vessel  was  treated  with  5  mol%  first  generation 
Grubbs catalyst (8.6 mg, 10.5 mmol). The resulting mixture was then stirred and 
heated to reflux for 15 hours. The resulting black solution was concentrated in 
vacuo  and  the  crude  residue  obtained  was  purified  by  flash  column 
chromatography (silica gel, 7% diethyl ether in petroleum spirits) to give 29 mg 
(65% yield) of spirocycle 410 as a clear oil                      Chapter 6 – Experimental   
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1H NMR (500 MHz, CDCl3): δ 6.98 (1H, d, J = 10.4 Hz, CHCHCO), 5.94 (1H, m, 
CHCHCO), 5.91 (1H, d, J = 10.3 Hz, CHCH), 5.50 (1H, m, CHCH), 3.94 (1H, d, J = 
2.8 Hz, COCH(O)CH), 2.53 (1H, dd, J = 14.9, 5.9 Hz, CHCHCH2), 2.46 (1H, dd, J = 
14.9, 7.1 Hz, CHCHCH2), 2.38 (1H, m, CH(CH3)2), 2.23 (1H, m, CHCHCH2), 2.16 
(1H, m, CHCHCH2), 2.03 (1H, m, CH2CH2), 1.85 (1H, m, CH2CH2), 1.77 (1H, m, 
CH2CH2), 1.57 (1H, m, CH2CH2), 0.99 (3H, d, J = 6.9 Hz, CH(CH3)2), 0.83 (3H, d, J 
= 6.8 Hz, CH(CH3)2).                         
13C NMR (125 MHz, CDCl3): δ 197.4 (CHCHCO), 155.5 (CHCHCO), 134.4 (CHCH), 
125.0  (CHCH),  124.9  (CHCHCO),  78.4  (COCH(O)CH),  72.6  (CHC(O)CH2),  43.2 
(CHCHCH2), 33.4 (CHCHCH2), 28.8 (CH(CH3)2), 28.4 (CH2CH2), 21.3 (CH2CH2), 19.3 
(CH(CH3)2), 16.0 (CH(CH3)2).                      
m/z [EI
+(+ve)] 220.1 [M]
+ (100%).                      
vmax (film)/ cm
−1: 2923, 1648,1368, 912.  
2 Isopropyl 1 oxaspiro[5.5]undeca 4,8 dien 3 one, 419.  
 
Procedure A                      
A solution of bisalkenyl pyranone 417 (128 mg, 0.55 mmol) in dichloromethane 
(10 mL) in a darkened reaction vessel was treated with 5 mol% first generation 
Grubbs catalyst (22.5 mg, 27 mmol). The resulting mixture was then stirred and 
heated to reflux for 4 hours. The resulting black solution was concentrated in 
vacuo  and  the  crude  residue  obtained  was  purified  by  flash  column 
chromatography (silica gel, 40 60% dichloromethane in petroleum spirits) to give 
88 mg (78% yield) of spirocycle 419 as a clear oil                     
Method B                                    
A solution of bisalkenyl pyranone 417 (72 mg, 0.31 mmol) in dichloromethane 
(1.5 mL) was treated with 5 mol% of Grubbs second generation catalyst (13 mg, 
15  mmol).  The  resulting  red  solution  was  placed  in  a  microwave  reactor  and 
heated to 100 
oC for 6 minutes, then cooled to room temperature. The resulting 
black solution was concentrated in vacuo and the crude residue obtained was Chapter 6 – Experimental   
  182 
purified by flash column chromatography (silica gel, 40 60% dichloromethane in 
petroleum spirits) to give 53 mg (85% yield) of spirocycle 419 as a clear oil 
1H NMR(500 MHz, CDCl3): δ 6.84 (1H, d, J = 10.3 Hz, CHCHCO), 5.91 (1H, d, J = 
10.3 Hz, CHCHCO), 5.70 (1H, m, CHCH), 5.52 (1H, m, CHCH), 3.95 (1H, d, J = 2.9 
Hz, COCH(O)CH), 2.37–2.24 (3H, m, CHCHCH2, CHCHCH2 and CH(CH3)2), 2.13 (1H, 
m,  CHCHCH2),  2.03  (1H,  m,  CHCHCH2),  1.80  (1H,  m,  CH2CH2),  1.68  (1H,  m, 
CH2CH2), 0.92 (3H, d, J = 6.9 Hz, CH(CH3)2), 0.80 (3H, d, J = 6.8 Hz, CH(CH3)2). 
13C NMR (125 MHz, CDCl3): δ 197.5 (CHCHCO), 154.2 (CHCHCO), 126.9 (CHCH), 
125.6  (CHCHCO),  122.6  (CHCH),  78.4  (COCH(O)CH),  71.3  (CHC(O)CH2),  32.8 
(CH2CH2),  30.4  (CHCHCH2),  28.8  (CH(CH3)2),  21.9  (CHCHCH2),  19.1  (CH(CH3)2), 
16.1 (CH(CH3)2).                            
m/z  [EI
+(+ve)]  207.1  [M]
+  (100%).  HRMS  found  207.1380,  C13H19O2  requires 
207.1385 [M]
+.                           
vmax (film)/ cm
−1: 2965, 2926, 1687.  
2 Isopropyl 1 oxaspiro[5.7]trideca 4,8 dien 3 one, 420.  
 
A solution of bisalkenyl pyrone 418 (121 mg, 0.46 mmol) in dichloromethane (10 
mL)  in  a  darkened  reaction  vessel  was  treated  with  5  mol%  first  generation 
Grubbs catalyst (18.9 mg, 23 mmol). The resulting mixture was then stirred and 
heated to reflux for 18 hours. The resulting black solution was concentrated in 
vacuo  and  the  crude  residue  obtained  was  purified  by  flash  column 
chromatography (silica gel, 20 60% dichloromethane in petroleum spirits) to give 
28 mg (26% yield) of spirocycle 420 as a clear oil                    
1H NMR (500 MHz, CDCl3): δ 6.92 (1H, d, J = 10.4 Hz, CHCHCO), 5.94 (1H, d, J = 
10.4 Hz, CHCHCO), 5.85 (1H, m, CHCH), 5.49 (1H, m, CHCH), 4.05 (1H, d, J = 2.9 
Hz, COCH(O)CH), 2.52 (1H, dd, J = 13.5, 8.1 Hz, CHCHCH2), 2.44–2.37 (2H, m, 
CHCHCH2,  CH(CH3)2),  2.19–2.14  (2H,  m,  CHCHCH2),  1.88–1.76  (2H,  m, 
CH2CH2CH2),  1.66  (1H,  m,  CH2CH2CH2),  1.61–1.42  (3H,  m,  CH2CH2CH2, 
CH2CH2CH2),  1.02  (3H,  d,  J  =  6.9  Hz,  CH(CH3)2),  0.83  (3H,  d,  J  =  6.8  Hz, 
CH(CH3)2).                                 Chapter 6 – Experimental   
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13C NMR (125 MHz, CDCl3): δ 197.3 (CHCHCO), 155.4 (CHCHCO), 133.4 (CHCH), 
125.9  (CHCHCO),  125.3  (CHCH),  78.8  (COCH(O)CH),  65.9  (CHC(O)CH2),  37.3 
(CHCHCH2),  29.8  (CH(CH3)2),  28.9  (CHCHCH2),  26.8  (CH2CH2CH2),  19.3 
(CH2CH2CH2), 15.9 (CH2CH2CH2), 15.3 (2 × CH(CH3)2).            
HRMS found 257.1512, C15H22NaO2 requires 257.1517 [M+Na]
+.           
vmax (film)/ cm
−1: 3154, 2932, 1685, 1383, 908.  
2 Allylfuran, 421.
246 
 
A solution of furan 86 (1.61 mL, 22.0 mmol) in anhydrous THF (110 mL) at 0 
oC 
was treated with nBuLi (8.84 mL, 22.1 mmol, 2.5 M in hexanes) and the resulting 
mixture allowed to warm up to room temperature. The solution was stirred for 
24 hours at room temperature, at which point the allyl bromide (1.91 mL, 22.1 
mmol)  was  added  slowly.  The  resulting  reaction  mixture  was  then  stirred  at 
room temperature for a further 24 hours. The reaction was then poured onto ice 
and  the  resulting  mixture  diluted  with  diethyl  ether  (100  mL).  The  resulting 
brown liquid was then stirred for 20 minutes after which it was extracted with 
diethyl  ether  (2x  30  mL).  The  combined  organic  extracts  were  washed  with 
water (2× 20 mL), brine (1× 20 mL) and then dried over sodium sulfate. The 
solvent was removed under reduced pressure to give 1.71 g (72% yield) alkene 
421 in as clear oil.                           
1H NMR (500 MHz, CDCl3): δ 7.19 (1H, q, J = 0.9 Hz, Ar H), 6.17 (1H, dd, J = 3.2, 
1.9 Hz, Ar H), 5.89 (1H, dd, J = 3.2, 0.9 Hz, Ar H), 5.85 5.77 (1H, m, CH2CH), 
5.04 4.98  (2H,  m,  CH2CH),  3.27  (2H,  d,  J  =  2.6  Hz,  CHCH2Ar).                          
13C NMR (125 MHz, CDCl3): δ 154.1 (Ar C), 141.5 (Ar C), 134.2 (CH2CH), 117.1 
(CH2CHCH2), 110.5 (Ar C), 105.7 (Ar C), 32.8 (CH2CHCH2).            
m/z [EI
+(+ve)] 108.1 [M]
+ (99%).                              
vmax (neat)/cm
 1. 3076, 2927, 1639, 995, 915. 
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1 Furan 2 yl 2 methyl propan 1 ol, 423.
255 
 
To  a  stirred  solution  of  furan  86  (5.34  mL,  73.4  mmol),  N,N,N′,N′ 
tetramethylethylenediamine (11.01 mL, 73.4mmol) in  anhydrous diethyl ether 
(150  mL)  at  0 
oC  was  added  slowly  nBuLi  (32.3  mL,  80.7  mmol,  2.5  M  in 
hexanes).  The  solution  was  stirred  for  2  hours  then  cooled  to   78 
oC  and 
isobutyraldehyde (7.33 mL, 80.74 mmol) added and stirred for 3 hours. Warmed 
to room temperature, water (50 mL) added and diluted with diethyl ether (50 
mL). The organic layer was separated and washed sequentially with water (2 x 
50 mL) and brine (50 mL) and dried over sodium sulfate. Solvents were removed 
in vacuo and the residue obtained was purified by flash column chromatography 
(30%  ethyl  acetate:  petroleum  spirits)  gave  1 furan 2 yl 2 methyl propan 1 ol 
423 was obtained, 10.3 g in 99% yield.                     
1H NMR(400 MHz, CDCl3): δ 7.37 (1H, dd, J = 2.0, 1.2 Hz, Ar H), 6.33 (1H, dd, J = 
3.2, 2 Hz, Ar H), 6.27 (1H, dd, J = 3.6, 1.0 Hz, Ar H), 4.37 (1H, d, J = 6.8 Hz, 
CHCHOH), 2.17 2.05 (1H, m, CH(CH3)2), 1.94 (1H, bs, OH), 1.02 (3H, d, CH(CH3)2, 
J = 6.8 Hz), 0.86 (3H, d, J = 6.8 Hz, CH(CH3)2).                  
 
13C NMR (100 MHz, CDCl3): δ 156.8 (Ar C), 141.8 (Ar C), 110.3 (Ar C), 106.7 (Ar 
C),  73.7  (CHOH),  33.7  (CH(CH3)2),  18.9  (CH(CH3)2),  18.6  (CH(CH3)2).                 
m/z  [EI
+(+ve)]  140.1  [M]
+  (100%),  HRMS  found  140.0841,  C8H12O2  requires 
140.0837 [M]
+.                                    
vmax (film)/ cm
−1: 3321, 1556, 2941 
tertButyl (1 furan 2 yl 2 methyl propoxy) dimethyl silane, 424. 
 
A  suspension  of  sodium  hydride  (3.67  g,  91.8  mmol)  in  anhydrous 
tetrahydrofuran (100 mL) was cooled to 0 
oC and a solution of 1 furan 2 yl 2 
methyl propan 1 ol 423 (10.3 g, 73.4 mmol) in anhydrous tetrahydrofuran (85 
mL) was added. The reaction was stirred for 30 minutes and then treated with 
tertbutyldimethylsilyl chloride (22.1 g, 146 mmol). The reaction was then stirred Chapter 6 – Experimental   
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for 5 hours until completion, as indicated by TLC analysis. Once complete the 
reaction  was  treated  with  water  (75  mL)  and  diethyl  ether  (75  mL)  and  the 
organic layer was separated and washed sequentially with water (2 x 50 mL) and 
brine (20 mL). The organic phase was concentrated in vacuo and purified by 
flash column chromatography (silica gel, petroleum spirits) to give 17.1 g (92% 
yield) of silyl ether 424 as a clear oil.                        
1H NMR (400 MHz, CDCl3): δ 7.30 (1H, dd, J = 1.6, 0.8 Hz, Ar H), 6.28, (1H, dd, J 
= 3.2, 2.0 Hz, Ar H) 6.12 (1H, dd, J = 3.2, 0.8 Hz, Ar H), 4.30 (1H, d, J = 6.8 Hz, 
CHOSi), 2.00 (1H, m, CH(CH3)2), 0.98 (3H, d, J = 6.8 Hz, CH(CH3)2), 0.85 (9H, s, 
C(CH3)3), 0.72 (3H, d, J = 6.8 Hz, CH(CH3)2), 0.00 (3H, s, CH3Si),  0.16 (3H, s, 
CH3Si).                                              
13C NMR (100 MHz, CDCl3): δ 156.9 (Ar C), 140.9 (Ar C), 109.8 (Ar C), 106.3 (Ar 
C), 74.2 (CHOSi), 31.6 (CH(CH3)2), 26.2 (C(CH3)3), 25.8 (CH(CH3)2), 22.7 (C(CH3)3) 
18.6 (CH(CH3)2),  5.0 (Si(CH3)2),  5.3 (Si(CH3)2).                 
m/z  [EI
+(+ve)]  254.2  [M]
+  (100%),  HRMS  found  254.1698,  C14H26O2Si  requires 
254.1702 [M]
+.                           
vmax (film)/ cm
−1: 3440, 2958, 1637 
[1 (5 Allyl furan 2 yl) 2 methyl propoxy] tertbutyl dimethyl silane, 425. 
 
tertButyl (1 furan 2 yl 2 methyl propoxy) dimethyl silane  424  (2.69  g,  10.5 
mmol) was dissolved in anhydrous tetrahydrofuran (50 mL) and cooled to 0 
oC. 
nBuLi (6.32 mL, 15.8 mmol, 2.5 M in hexanes) was then added and the resulting 
solution was stirred for 2 hours at 0 
oC. The orange/brown solution was treated 
with freshly distilled allyl bromide (1.37 mL, 15.8 mmol) and stirred for 12 hours 
at  room  temperature.  The  reaction  was  quenched  with  water  (50  mL)  and 
diluted with diethyl ether (50 mL). The phases were separated and the organic 
layer was washed with water (2x 50 mL) and brine (20 mL) and concentrated in 
vacuo.  Purification  with  flash  column  chromatography  (silica  gel,  petroleum 
spirits) gave 2.69 g of 425 in 87% yield.                    
1H NMR (400 MHz, CDCl3): δ 6.03 (1H, d, J = 2.8 Hz, Ar H), 5.97 5.87 (1H, m, 
CH2CHCH2), 5.92 (1H, d, J = 3.2 Hz, Ar H), 5.11 (2H, m, CHCH2), 4.25 (1H, d, J = Chapter 6 – Experimental   
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8.8 Hz, CHOSi), 3.36 (2H, d, J = 6.4 Hz, CH2CH), 2.02 1.97 (1H, m, (CH3)2CH), 
0.95 (3H, d, J = 6.8 Hz, CH3CH), 0.87 (9H, s, C(CH3)3), 0.80 (3H, d, J = 6.8 Hz, 
CH3CH), 0.02 (3H, s, CH3Si),  0.13 (3H, s, CH3Si).                
 
13C NMR (100 MHz, CDCl3): δ 155.5 (Ar C), 152.3 (Ar C), 134.3 (CH2CHCH2), 116.5 
(CHCH2),  107.0  (Ar C),  105.8  (Ar C),  74.2  (CHOSi),  34.2  (CH(CH3)2),  32.6 
(ArCH2CH),  25.8  (C(CH3)3),  18.9  (CHCH3),  18.4  (CHCH3),  18.3  (C(CH3)3),   4.87 
(CH3Si),  5.18 (CH3Si).                            
m/z  [EI
+(+ve)]  294.2  [M]
+  (100%),  HRMS  found  294.2019,  C17H30O2Si  requires  
294.2015 [M]
+.                                     
vmax (film)/ cm
−1: 2962, 2097, 1672, 1643, 1078, 835, 777. 
1 (5 Allylfuran 2 yl) 2 methylpropan 1 ol, 426.  
 
To  a  stirred  solution  of  [1 (5 Allyl furan 2 yl) 2 methyl propoxy] tertbutyl 
dimethyl silane 425 (2.68 g, 9.14 mmol) in anhydrous THF (10 mL) at 0 
oC was 
added tetrabutylammonium fluoride (18.3 mL, 18.38 mmol, 1 M in THF). The 
reaction was stirred at 0 
oC for 10 minutes and then at room temperature for a 
further 12 hours. Once complete by TLC analysis, the reaction was diluted with 
diethyl ether (20 mL), water (10 mL) was then added and the biphasic solution 
was stirred for 30 minutes. The organic extracts were washed with water (2x 10 
mL), brine (10 mL), dried over anhydrous sodium sulfate and concentrated in 
vacuo. The crude residue purified via flash column chromatography (5% diethyl 
ether in petroleum spirits) to give 1.59 g (97% yield) alcohol 426 as a clear oil.           
1H NMR (500 MHz, CDCl3): d 6.02 (1H, d, J = 3.0 Hz, Ar H), 5.84 (2H, m, Ar H and 
CH2CHCH2), 5.04 (1H, m, CH2CHCH2), 5.01 (1H, m, CH2CHCH2), 4.20 (1H, d, J = 
7.2 Hz, CHOH), 3.27 (2H, d, J = 6.5 Hz, ArCH2CHCH2), 1.98 (1H, sept, J = 7.0 Hz, 
CH(CH3)2), 0.93 (3H, d, J = 6.7 Hz, CH(CH3)2), 0.76 (3H, d, J = 6.8 Hz, CH(CH3)2). 
13C NMR (125 MHz, CDCl3): d 154.8 (Ar C), 153.9 (Ar C), 133.9 (CH2CHCH2), 116.9 
(CH2CHCH2),  107.3  (Ar C),  105.9  (Ar C),  73.6  (CHOH),  33.2  (CH(CH3)2),  32.6 
(CH2CHCH2), 18.9 (CH(CH3)2), 18.4 (CH(CH3)2).               
m/z [EI
+(+ve)] 163.1 [M OH]
+ (100%), HRMS found 181.0281, C11H17O2 181.1229 
[M]
+.                               
vmax (neat)/cm
 1. 3426, 2965, 1681, 835, 777.  Chapter 6 – Experimental   
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6 Hydroxy 2 isopropyl 6 Allyl 6H pyran 3 one, 427. 
O
O
OH
 
A 0 
oC solution of furfuryl alcohol 426 (801 mg, 4.44 mmol) in dichloromethane 
(15 mL) was treated with meta chloroperoxybenzoic acid (1.08 g, 4.89 mmol) 
and the resulting opaque solution was stirred at 0 
oC for 1 hour. The mixture was 
allowed to warm up to room temperature and the reaction was stirred for a 
further 2 hours. Once the reaction was complete, as determined by TLC analysis, 
the reaction was cooled to 0 
oC and quenched by slow addition of saturated 
aqueous sodium bicarbonate solution (8 mL). The resulting emulsion was allowed 
to  separate  and  was  then  extracted  with  dichloromethane  (3x  20  mL).  The 
combined organic extracts were washed with water (1x 10 mL), brine (1x 10 mL) 
and  dried  over  anhydrous  sodium  sulfate.  The  solution  was  concentrated  in 
vacuo and the residue obtained purified by flash column chromatography (silica 
gel,  10 50%  diethyl  ether in  petroleum  spirits)  to  give  709  mg  (81%  yield)  of 
Lactol 427 as mixture of anomers (7.8:1, a:b) as a clear oil  
Major Anomer 427α                             
 
1H NMR (500 MHz, CDCl3): δ 6.69 (1H, d, J = 10.2 Hz, CHCHCO), 5.95 (1H, d, J = 
10.1 Hz, CHCHCO), 5.81 (1H, m, CH2CHCH2), 5.18–5.12 (2H, m, CH2CHCH2), 4.26 
(1H, d, J = 2.8 Hz, COCH(O)CH), 3.10(1H, bs, OH), 2.58 (1H, dd, J = 13.6, 6.3 Hz, 
CH2CHCH2), 2.43 (1H, dd, J = 13.6, 8.3 Hz, CH2CHCH2), 2.35 (1H, m, CH(CH3)2), 
0.93 (3H, d, J = 7.4 Hz, CH(CH3)2), 0.76 (3H, d, J = 6.8 Hz, CH(CH3)2).              
13C  NMR  (125  MHz,  CDCl3):  δ  197.1  (CHCHCO),  147.4  (CHCHCO),  131.2 
(CH2CHCH2),  127.8  (CHCHCO),  120.7  (CH2CHCH2),  92.8  (C(O)OH),  78.2 
(COCH(O)CH),  45.8  (CH2CHCH2),  28.7  (CH(CH3)2),  19.0  (CH(CH3)2),  16.0 
(CH(CH3)2).  
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Minor anomer 427β 
 
1H NMR (500 MHz, CDCl3): δ 6.75 (1H, d, J = 9.8 Hz, CHCHCO), 5.97 (1H, d, J = 
9.8 Hz, CHCHCO), 5.81 (1H, m, CH2CHCH2), 5.18–5.12 (2H, m, CH2CHCH2), 3.89 
(1H, d, J = 4.4 Hz, COCH(O)CH), 3.32 (1H, bs, OH), 2.61 (1H, m, CH2CHCH2), 
2.42  (1H,  m,  CH2CHCH2),  2.34  (1H,  m,  CH(CH3)2),  0.92  (3H,  d,  J  =  8.2  Hz, 
CH(CH3)2), 0.84 (3H, d, J = 6.0 Hz, CH(CH3)2).                     
13C  NMR  (125  MHz,  CDCl3):  δ  186.4  (CHCHCO),  149.9  (CHCHCO),  130.8 
(CH2CHCH2),  127.5  (CHCHCO),  120.6  (CH2CHCH2),  94.6  (C(O)OH),  82.1 
(COCH(O)C), 41.7 (CH2CHCH2), 29.0 (CH(CH3)2), 18.9 (CH(CH3)2), 16.8 (CH(CH3)2). 
m/z  [EI
+(+ve)]  179.1  [M OH]
+  (100%),  HRMS  found  219.0992,  C11H16NaO3    
219.0997 [M+Na]
+.                         
vmax (film)/ cm
−1: 3403, 2965, 2932, 1691, 1466, 909. 
6,6 Diallyl 2 isopropyl 6H pyran 3 one, 428. 
 
A solution of the lactol 427 (441 mg, 2.24 mmol) in anhydrous dichloromethane 
(11  mL)  was  treated  with  allyltrimethylsilane  (747  mL,  4.70  mmol)  and  the 
resulting mixture was cooled to −78 
oC. The reaction mixture was then treated 
by the slow addition of BF3OEt2 (851 mL, 6.72 mmol) and the resulting solution 
stirred for 30 minutes at −78 
oC. The reaction was then allowed to warm to room 
temperature  and  was  stirred  for  a  further  5  hours.  Once  the  reaction  was 
complete,  as  determined  by  TLC  analysis,  the  reaction  was  quenched  with 
saturated  aqueous  ammonium  chloride  (10  mL)  and  extracted  with 
dichloromethane  (3x  20  mL).  The  combined  organic  extracts  were  washed 
sequentially with saturated sodium hydrogen carbonate (1× 10 mL), water (2× 10 
mL)  and  brine  (1×  10  mL).  The  combined  organic  phases  were  dried  over 
anhydrous  sodium  sulfate  and  the  solvent  was  removed  in  vacuo.  The  crude 
residue was then purified by flash column chromatography (silica gel, 5% ethyl 
acetate  in  petroleum  spirits)  to  afford  452  mg  (81%  yield)  of  the  desired Chapter 6 – Experimental   
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bisalkenyl product 428.                            
1H NMR (500 MHz, CDCl3): δ 6.77 (1H, d, J = 10.4 Hz, CHCHCO), 5.95 (1H, d, J = 
10.4 Hz, CHCHCO), 5.75 (2H, m, CH2CHCH2), 5.11–5.00 (4H, m, CH2CHCH2), 4.04  
(1H, d, J = 2.6 Hz, COCH(O)CH), 2.51 (1H, ddt, J = 14.3, 6.3, 1.3 Hz, CH2CHCH2), 
2.39 (2H, m, CH(CH3)2 and CH2CHCH2), 2.31–2.23 (2H, m, CH2CHCH2), 0.96 (3H, 
d, J = 7.0 Hz, CH(CH3)2), 0.80 (3H, d, J = 6.8 Hz, CH(CH3)2).             
13C  NMR  (125  MHz,  CDCl3):  δ  195.6  (CHCHCO),  153.0  (CHCHCO),  131.9 
(CH2CHCH2),  131.3  (CH2CHCH2),  125.3  (CHCHCO),  117.9  (CH2CHCH2),  117.3 
(CH2CHCH2),  75.7  (COCH(O)CH),  74.4  (CHC(O)CH2),  42.0  (CH2CHCH2),  37.9 
(CH2CHCH2), 28.1 (CH(CH3)2), 18.1 (CH(CH3)2), 14.9 (CH(CH3)2).                   
m/z  [EI
+(+ve)]  221.2  [M]
+  (95%),  HRMS  found  221.1536,  C14H21O2  requires 
221.1542 [M]
+.                            
vmax (film)/cm
−1:2964, 2930, 1690, 1366, 1060.  
7 Isopropyl 6 oxaspiro[4.5]deca 2,9 dien 8 one, 433. 
O
O
 
A solution of bisalkenyl pyrone (58 mg, 0.26 mmol) in dichloromethane (3 mL) in 
a  darkened  reaction  vessel  was  treated  with  5  mol%  first  generation  Grubbs 
catalyst (10.8 mg, 13 mmol). The resulting mixture was then stirred and heated 
to reflux for 3 hours. The resulting black solution was concentrated in vacuo and 
the crude residue obtained purified by flash column chromatography (silica gel, 
5% ethyl acetate in petroleum spirits) to give 44 mg of product 433 (85% yield) 
as a clear oil                              
1H NMR(500 MHz, CDCl3): δ 6.96 (1H, d, J =10.2 Hz, CHCHCO), 5.96 (1H, d, J = 
10.2 Hz, CHCHCO), 5.97 (1H, m, CH2CH), 5.75 (1H, m, CHCH), 3.97 (1H, d, J = 
2.9 Hz CHOC), 2.85 (1H, dquint, = 16.9, 4.0 Hz, CHCHCH2), 2.72 (1H, d, J = 17.2, 
1.9 Hz, CHCHCH2), 2.68 2.63 (1H, dm, CHCHCH2), 2.50 2.45 (1H, d, CHCHCH2), 
2.41 (1H, septd, J = 6.9, 2.9 Hz, CH(CH3)2), 1.00 (3H, d, J = 7.0 Hz, CH(CH3)2), 
0.88 (3H, d, J = 6.9 Hz, CH(CH3)2). .                     
13C NMR (125 MHz, CDCl3): δ 196.9 (CHCHCO), 154.6(CHCHCO), 128.4 (CHCH), 
127.7  (CHCHCO),  124.5  (CHCH),  82.1  (COCH(O)CH),  80.0  (CHC(O)CH2),  46.8 
(CHCHCH2), 40.0 (CHCHCH2), 28.4 (CH(CH3)2), 19.0 (CH(CH3)2), 16.1 (CH(CH3)2).         Chapter 6 – Experimental   
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m/z  [EI
+(+ve)]  193.1  [M]
+  (90%),  HRMS  found  193.1223,  C12H17O2  requires 
193.1229 [M]
+.                                 
vmax (film)/ cm
−1: 2928, 1686, 1476, 1383.  
Methyl (E) 3 (3 methoxyphenyl) acrylate, 442.
262 
 
To a refluxing solution of methyl (triphenylphosphoranylidene) acetate (23.8 g, 
71.0  mmol)  in  anhydrous  dichloromethane  (185  mL)  was  added  3 
methoxybenzaldehyde  441  (4.83  mL,  35.5  mmol).  The  resulting  mixture  was 
refluxed at reflux for a further 10 hours. The reaction mixture was cooled to 
room temperature and concentrated in vacuo and adsorbed directly onto silica. 
Purification  with  flash  column  chromatography  (silica  gel,  elution  with  20% 
diethyl ether in petroleum spirits) afforded 6.20 g (91% yield) of ester 442 as a 
single E isomer.                                  
1H NMR (400 MHz, CDCl3): δ 7.69 (1H, d, J = 16.0 Hz, ArCHCH), 7.32 (1H, t, J = 
8.0, Ar H), 7.15 7.13 (1H, m, Ar H), 7.07 7.06 (1H, m, Ar H), 6.96 (1H, ddd, J = 
8.4, 2.8, 0.8, Ar H), 6.46(1H, d, J = 16.0, ArCHCH), 3.85 (3H, s, OCH3), 3.83 (3H, 
s, CO2CH3).                             
13C NMR (100 MHz, CDCl3): δ 167.4 (CO), 159.9 (Ar C), 144.8 (Ar C), 135.8 (Ar C), 
129.9  (Ar C),  120.7  (Ar C),  118.1  (CHCH),  116.1  (Ar C),  113.0  (CHCH),  55.3 
(OCH3), 51.7 (CO2CH3).                            
m/z [EI
+(+ve)] 192.0 [M]
+ (100%), 161.02 [M OCH3]
+ (26%), HRMS found 192.0785, 
C11H12O3 requires 192.0786 [M
+].                         
vmax (film)/ cm
−1: 1700, 1639, 1434, 783, 679 
3 (3 Methoxyphenyl) propan 1 ol.
263 
 
To a stirred solution of (E) methyl 3 (4 methoxyphenyl) acrylate 442 (5.05 g, 
26.9  mmol)  in  tetrahydrofuran  (270  mL)  at  0 
oC  was  added  slowly  lithium 
aluminium  hydride  solution  (8.07  mL,  8.07  mmol,  1  M  in  diethyl  ether).  The Chapter 6 – Experimental   
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resulting  suspension  was  heated  under  reflux  and  stirred  for  10  hours.  The 
reaction  was  cooled  to  0 
oC  and  diluted  with  diethyl  ether  (200  mL)  and 
sequentially treated with water (2.2 mL), 15% NaOH solution (2.2 mL) and water 
(6.6 mL). To the resulting opaque white suspension was stirred for 30 minutes 
was added anhydrous sodium sulfate and stirred for a further 30 minutes. The 
solids  were  filtered  off  and  washed  with  diethyl  ether  (3x  50  mL)  then 
concentrated  in vacuo. Purification using flash column chromatography (silica 
gel, elution with 30 50% diethyl ether in petroleum spirits), gave 3.26 g (73% 
yield) of the desired saturated alcohol.                       
1H NMR (400 MHz, CDCl3): δ 7.24 (1H, dt, J = 7.7, 0.8 Hz, Ar H), 6.84 6.76 (3H, 
m, Ar H), 3.83 (3H, s, OCH3) 3.71 (2H, t, J = 6.4 Hz, CH2CH2CH2), 2.72 (2H, t, J = 
6.4 Hz, CH2CH2CH2), 1.93 (2H, m, CH2CH2CH2), 1.74 (1H, bs, OH).            
13C NMR (100 MHz, CDCl3): δ 159.7 (Ar C), 143.5 (Ar C), 129.4 (Ar C), 120.9 (Ar 
C), 114.3 (Ar C), 111.1 (Ar C) 62.2 (CH2CH2CH2), 55.2 (OCH3), 34.1 (CH2CH2CH2), 
32.1 (CH2CH2CH2).                        
m/z  [EI
+(+ve)]  166.0  [M]
+  (100%),  HRMS  found  166.0995,  C10H14O2  requires 
166.0994 [M
+].                           
vmax (film)/ cm
−1: 3291, 2861, 1504, 1292 
1 (3 Bromopropyl) 3 methoxybenzene, 443.
261 
 
To  a  solution  of  3 (4 methoxyphenyl)propan 1 ol  (3.16  g,  19.0  mmol)  in 
dichloromethane (190 mL) was added carbon tetrabromide (24.9 g, 76.0 mmol) 
and  triphenylphosphine  (19.9  g,  76.0  mmol).  The  reaction  was  stirred  until 
completion by TLC analysis (3 hours). The solvent was evaporated under reduced 
pressure and the solids formed were adsorbed directly onto silica and purified by 
flash column chromatography (silica gel, 5 % diethyl ether in petroleum spirits) 
to give 3.32 g (77 % yield) of the desired bromide 443.            
1H NMR (400 MHz, CDCl3): δ 7.27 (1H, m, Ar H), 6.82 6.79 (3H, m, Ar H), 3.84 
(3H, s, OCH3), 3.44 (2H, t, J = 6.4 Hz, CH2CH2CH2), 2.80 (2H, t, J = 7.2 Hz, 
CH2CH2CH2), 2.21 (2H, t, J = 6.4 Hz, CH2CH2CH2).         
 
13C NMR (100 MHz, CDCl3): δ 159.8 (Ar C), 142.2 (Ar C), 129.5 (Ar C), 120.9 (Ar 
C), 114.4 (Ar C), 111.5 (Ar C), 55.2 (OCH3), 34.1 (CH2CH2CH2), 33.8 (CH2CH2CH2), Chapter 6 – Experimental   
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33.1 (CH2Br).                            
m/z  [EI
+(+ve)] 
79Br 228.0  [M]
+  (100%),  HRMS  [M
+]  found  228.0151,  C10H13O
79Br 
requires 228.0150. 
81Br 230.0 [M]
+ (97%), HRMS [M
+] found 230.0129, C10H13O
81Br 
requires 230.0129.                         
vmax (film)/ cm
−1: 3016, 3014, 1625, 1503, 832. 
2 (3 (3 Methoxyphenyl)propyl) furan, 444. 
 
Furan 86 (328 mL, 4.52 mmol) in anhydrous tetrahydrofuran (22 mL) was cooled 
to 0 
oC and treated with nBuLi (1.8 mL, 4.52 mmol). The reaction was warmed to 
room temperature and stirred for 20 hours at which time the reaction cooled 
back  down  to  0 
oC  and  a  solution  of  bromide  443  (1.03  g,  4.52  mmol)  in 
anhydrous tetrahydrofuran (10 mL) was added. The reaction mixture was then 
stirred  for  a  further  4  hours.  The  resulting  brown  solution  was  diluted  with 
diethyl ether (15 mL) and water (10 mL) was added and stirred for 30 minutes. 
The  organic  phase  was  washed  with  water  (2x  10  mL),  dried over  anhydrous 
sodium  sulfate  and  concentrated  in  vacuo.  Purification  by  flash  column 
chromatography (silica gel, 4% dichloromethane in petroleum spirits) afforded 
507 mg (52%) of the aromatic compound 444 as a clear oil.                
1H NMR (400 MHz, CDCl3): δ 7.32 (1H, dd, J = 1.7, 0.7 Hz, Ar H), 7.25 7.19 (2H, 
m, Ar H), 6.81 6.74 (1H, m, Ar H), 6.29 (2H, dd, J = 3.1, 1.9 Hz, Ar H), 6.01 (1H, 
dd, J = 3.1, 0.8, Ar H), 3.81 (3H, s, OCH3), 2.66 (4H, q, J = 7.2 Hz, CH2CH2CH2), 
1.99 (2H, quint, J = 7.6 Hz, CH2CH2CH2).                            
13C NMR (100 MHz, CDCl3): δ 159.8 (Ar C), 155.9 (Ar C), 142.2 (Ar C), 140.8 (Ar 
C), 129.5 (Ar C), 120.4 (Ar C), 114.4 (Ar C), 111.1 (Ar C), 110.1 (Ar C), 104.9 
(Ar C), 55.2 (OCH3), 35.3 (CH2CH2CH2), 34.1 (CH2CH2CH2), 27.5 (CH2CH2CH2).        
m/z  [EI
+(+ve)]  216.1  [M]
+  (100%),  HRMS  found  216.1151,  C14H16O2,  requires 
216.1150 [M
+].                           
vmax (film)/ cm
−1: 2938, 1601, 1584, 1261 
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Methyl (E) 3 (4 methoxyphenyl) acrylate, 447.
264 
 
To a refluxing solution of methyl (triphenylphosphoranylidene) acetate (24.5 g, 
73.4mmol)  in  anhydrous  dichloromethane  (185  mL)  was  added  4 
methoxybenzaldehyde  446  (4.99  mL,  36.7mmol).  The  resulting  mixture  was 
refluxed at reflux for a further 10 hours. The reaction mixture was cooled to 
room temperature and concentrated in vacuo and adsorbed directly onto silica. 
Purification  with  flash  column  chromatography  (silica  gel,  elution  with  20% 
diethyl ether in petroleum spirits) afforded 6.41 g (91% yield) of ester 447 as a 
single E isomer.                          
 
1H NMR (400 MHz, CDCl3): δ 7.55 (1H, d, J = 16.0 Hz, ArCHCH), 7.38 (2H, dd, J = 
8.8, 2.0 Hz, Ar H), 6.81 (2H, dd, J = 8.8, 2.0 Hz, Ar H), 6.21 (1H, d, J = 16.0 Hz, 
ArCHCH), 3.74 (3H, s, OCH3), 3.69 (3H, s, CO2CH3).                
13C NMR (100 MHz, CDCl3): δ 167.8 (CO), 161.4 (Ar C), 144.5 (CHCH), 129.7 (2x 
Ar C), 127.1 (Ar C), 115.3 (CHCH), 114.3 (2x Ar C), 55.4 (OCH3), 51.6 (CO2CH3).  
m/z [EI
+(+ve)] 192.1 [M]
+ (100%), 161.1 [M OCH3]
+ (20%), HRMS found 192.0788, 
C11H12O3 requires 192.0786 [M
+].                     
vmax (film)/ cm
−1: 1681, 1599, 1485, 787. 
3 (4 Methoxyphenyl) propan 1 ol, 448.
265 
 
To a stirred solution of (E) methyl 3 (4 methoxyphenyl) acrylate 447 (2.13 g, 
11.1  mmol)  in  tetrahydrofuran  (55  mL)  at  0 
oC  was  added  slowly  lithium 
aluminium hydride solution (15.8 mL, 55.4 mmol, 3.5 M in diethyl ether). The 
resulting  suspension  was  heated  under  reflux  and  stirred  for  10  hours.  The 
reaction  was  cooled  to  0 
oC  and  diluted  with  diethyl  ether  (100  mL)  and 
sequentially treated with water (2.2 mL), 15% NaOH solution (2.2 mL) and water 
(6.6 mL). To the resulting opaque white suspension was stirred for 30 minutes 
was added anhydrous sodium sulfate and stirred for a further 30 minutes. The 
solids  were  filtered  off  and  washed  with  diethyl  ether  (3x  50  mL)  then 
concentrated  in vacuo. Purification using flash column chromatography (silica 
gel, elution with 30 50% diethyl ether in petroleum spirits), gave 1.31 g (71% Chapter 6 – Experimental   
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yield) of the desired saturated alcohol 448.                      
1H NMR (400 MHz, CDCl3): δ 7.15 (2H, d, J = 8.6 Hz, Ar H), 6.87 (2H, d, J = 8.6 
Hz, Ar H), 3.82 (3H, s, OCH3), 3.70 (2H, t, J = 6.4 Hz, CH2CH2CH2), 2.69 (2H, t, J 
= 7.6 Hz, CH2CH2CH2), 1.93 1.86 (2H, m, CH2CH2CH2), 1.35 (1H, bs, OH).          
 
13C NMR (100 MHz, CDCl3): δ 157.3 (Ar C), 133.9 (Ar C), 129.3 (2x Ar C), 113.8 
(2x Ar C), 62.3 (CH2CH2CH2), 55.3 (OCH3), 34.5 (CH2CH2CH2), 31.2 (CH2CH2CH2). 
m/z  [EI
+(+ve)]  166.1  [M]
+  (100%),  HRMS  found  166.0995,  C10H14O2  requires 
166.0994 [M
+].                              
vmax (film)/ cm
−1: 3410, 2871, 1521, 1269 
1 (3 Bromopropyl) 4 methoxybenzene, 449.
266 
 
To  a  solution  of  3 (4 methoxyphenyl)propan 1 ol  448  (1.31  g,  7.89  mmol)  in 
dichloromethane (80 mL) was added carbon tetrabromide (10.3 g, 31.3 mmol) 
and  triphenylphosphine  (8.20  g,  31.3  mmol).  The  reaction  was  stirred  until 
completion by TLC analysis (3 hours). The solvent was evaporated under reduced 
pressure and the solids formed were adsorbed directly onto silica and purified by 
flash column chromatography (silica gel, 5 % diethyl ether in petroleum spirits) 
to give 1.42 g (79 % yield) of the desired bromide 449.               
1H NMR (400 MHz, CDCl3): δ 7.03 (2H, d, J = 8.4 Hz, Ar H), 6.76 (2H, d, J = 8.8 
Hz, Ar H), 3.71 (3H, s, OCH3), 3.30 (2H, t, J = 6.4 Hz, CH2CH2CH2), 2.64 (2H, t, J 
= 7.2 Hz, CH2CH2CH2), 2.05 (2H, quin, J = 6.4 Hz, CH2CH2CH2).            
13C NMR (100 MHz, CDCl3): δ 158.1 (Ar C), 132.6 (Ar C), 129.5 (2x Ar C), 113.9 
(2x Ar C), 55.3 (OCH3), 34.4 (CH2CH2CH2), 33.2 (CH2CH2CH2), 33.1 (CH2CH2CH2). 
m/z  [EI
+(+ve)] 
79Br 228.0  [M]
+  (100%),  HRMS  found  228.0151,  C10H13O
79Br, 
requires 228.0150 [M
+].  
81Br 230.0 (100%), HRMS found 230.0132, C10H13O
81Br 
requires 230.0129 [M
+].                          
vmax (film)/ cm
−1: 3030, 3004, 1612, 1510, 829. 
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(E) 3 (3 Methoxy phenyl) prop 2 en 1 ol, 451.
268 
 
A  stirred  solution  of  (E) 3 (3 Methoxy phenyl) acrylic  acid  methyl  ester  442 
(5.07 g, 26.4 mmol) in anhydrous dichloromethane (130 mL) was cooled to  78 
oC 
and  treated  with  diisobutylaluminium  hydride  (58.1  mL,  58.1  mmol,  1  M  in 
dichloromethane)  and  stirred  for  3  hours.  Warmed  to  0 
oC  and  diluted  with 
diethyl ether (75 mL). The reaction was quenched with water (1.05 mL), 15% 
aqueous  sodium  hydroxide  (1.05  mL)  and  water  (5.75  mL)  sequentially.  The 
cloudy suspension was stirred for 30 minutes and was then treated with sodium 
sulfate and stirred for a further 30 minutes. The solids formed were filtered 
through celite and washed with diethyl ether (3x 100 mL) and the filtrate was 
concentrated  under  reduced  pressure.  Purification  by  flash  column 
chromatography (silica gel, 20 40% diethyl ether in petroleum ether) gave 3.08 g 
(71% yield) of allylic alcohol 451 as a clear oil.                    
1H NMR (400 MHz, CDCl3): δ 7.26 (1H, t, J = 8.0 Hz, Ar H), 7.01 (1H, d, J = 7.6 
Hz, Ar H), 6.95 (1H, t, J = 2.0 Hz, Ar H), 6.84 (1H, ddd, J = 8.0, 2.4, 0.4 Hz, Ar 
H), 6.60 (1H, d, J = 16.0 Hz, ArCHCH), 6.40 (1H, dt, J = 15.9, 5.7 Hz, CHCHCH2), 
4.33 (2H, bs, CH2OH), 3.83 (3H, s, OCH3), 2.21 (1H, bs, OH).              
 
13C NMR (100 MHz, CDCl3): δ 159.8 (Ar C), 138.2 (Ar C), 130.9 (CHCH), 129.6 (Ar 
C), 128.9 (CHCH2), 119.2 (Ar C), 113.3 (Ar C), 111.9 (Ar C), 63.6 (CH2OH), 55.2 
(OCH3).                                   
m/z  [EI
+(+ve)]  164.1  [M]
+  (100%),  HRMS  found  164.0838,  C10H12O2,  requires 
164.0837 [M
+].                           
vmax (film)/ cm
−1: 3161, 2360, 1652.  
(E) 1 (3 Bromoprop 1 enyl) 3 methoxybenzene, 452.
267 
 
To a refluxing solution of (E) 3 (3 methoxy phenyl) prop 2 en 1 ol 451 (967 mg, 
5.89 mmol) in dichloromethane (30 mL) was added carbon tetrabromide (7.72 g, 
23.6  mmol)  and  triphenylphosphine  (6.19  g,  23.6  mmol).  The  reaction  was Chapter 6 – Experimental   
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stirred for 3 hours until completion by TLC analysis. The reaction mixture was 
concentrated  under  reduced  pressure  and  the  solids  formed  were  adsorbed 
directly onto silica and purified by flash column chromatography (silica gel, 5 % 
diethyl ether in petroleum spirits) to give 891 mg (67 % yield) of the desired 
allylic bromide 452.                 
 
1H NMR (400 MHz, CDCl3): δ 7.48 (1H, t, J = 7.5 Hz, Ar H), 7.24 (2H, m, Ar H), 
6.92 (1H, m, Ar H), 6.80 (1H, d, J = 15.1 Hz, ArCHCH), 6.34 (1H, dt, J = 15.7, 5.2 
Hz, ArCHCH2), 3.92 (2H, d, J = 6.2, CH2OH), 3.83 (3H, s, OCH3).            
 
13C NMR (100 MHz, CDCl3): δ 160.9 (Ar C), 138.9 (Ar C), 132.9 (CHCH), 129.1 (Ar 
C), 122.7 (CHCH2), 119.7 (Ar C), 113.6 (Ar C), 113.4 (Ar C), 55.2 (OCH3), 36.1 
(CH2Br).  
(E) 3 (3 Methoxyphenyl) allyl methanesulfonate, 453.
270 
 
To a stirred solution of (E) 3 (3 methoxy phenyl) prop 2 en 1 ol, 451 (499 mg, 
3.05 mmol) in tetrahydrofuran (20 mL) at 0 
oC was added mesyl chloride (344 mL, 
4.57 mmol). The resulting solution was stirred for 10 minutes and then treated 
with triethylamine (848 mL, 6.09 mmol) for a further 2 hours. The mixture was 
diluted with diethyl ether (20 mL) and 10% aqueous hydrochloride acid solution 
(5 mL) was added. The phases were separated and the organic layer was washed 
with saturated sodium bicarbonate solution (5 mL) and brine (10 mL), then dried 
over anhydrous sodium sulfate and concentrated in vacuo. The crude residue was 
taken on to the next step without further purification. 
3 (Methoxy phenyl) prop 2 yn 1 ol, 463.
279 
 
3 Iodoanisole 464 (6.53 g, 54.8 mmol) in acetonitrile (270 mL) was treated with 
Bis(triphenylphosphine)palladium(II)  dichloride  (4.81  g,  6.85  mmol),  copper 
iodide (2.61 g, 13.7 mmol) and triethylamine (38.5 mL, 274 mmol). The resulting Chapter 6 – Experimental   
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yellow solution was treated with propargyl alcohol 465 (3.94 mL, 65.8 mmol) 
and the reaction was heated to reflux and stirred for 10 hours. Once complete, 
by TLC analysis, the solids were filtered off and washed with diethyl ether (2x 50 
mL), the filtrate was evaporated and the residue obtained was purified by flash 
column chromatography (30% ethyl acetate in petroleum) to give 7.37 g (83% 
yield) of the desired alkyne 463 as a brown oil.           
 
1H NMR (400 MHz, CDCl3): δ 7.22 (1H, dd, J = 8.0, 0.8 Hz, Ar H), 7.04 (1H, dt, J = 
7.6, 0.8 Hz, Ar H), 6.98 (1H, dd, J = 2.4, 1.2 Hz, Ar H), 6.89 (1H, ddd, J = 8.4, 
2.8, 0.6 Hz, Ar H), 4.49 (2H, s, CH2OH), 3.79 (3H, s, OCH3), 1.70 (1H, s, OH).   
13C NMR (100 MHz, CDCl3): δ 159.3 (Ar C), 129.4 (Ar C), 124.2 (Ar C), 123.5 (Ar 
C),  116.5  (Ar C),  115.1  (Ar C),  87.0  (CC),  85.7  (CCH2),  55.3  (OCH3),  51.7 
(CH2OH).                            
m/z  [EI
+(+ve)]  162.1  [M]
+  (100%),  HRMS  found  162.0679,  C10H10O2,  requires 
162.0681 [M
+].                           
vmax (film)/ cm
−1: 3374, 3002, 2938, 2227, 1603, 855, 782, 687. 
3 (3 Methoxyphenyl)prop 2 ynyl 4 methylbenzenesulfonate, 467.
 
 
A solution of alkyne alcohol 463 (509 mg, 3.14 mmol) in diethyl ether (20 mL) 
was treated with 4 methylbenzenesulfonyl chloride (628 mg, 3.30 mmol) and the 
solution  was  cooled  to  0 
oC  and  stirred  for  30  minutes.  Powdered  potassium 
hydroxide (881 mg, 15.7 mmol) was added in 3 portions over 20 minutes and the 
heterogeneous mixture stirred for a further 2 hours. Water (10 mL) and diethyl 
ether (20 mL) were added and the biphasic mixture was stirred for 30 minutes. 
The organic phase was washed with water (2x 10 mL), brine (10 mL), dried over 
anhydrous sodium sulfate and concentrated in vacuo to yield 972 mg (97% yield) 
of tosylate 467.                                  
 
1H NMR (400 MHz, CDCl3): δ 7.75 (2H, d, J = 8.4 Hz, Ar H), 7.22 (2H, d, J = 8.0 
Hz, Ar H), 7.08 (1H, t, J = 7.9 Hz, Ar H), 6.79 6.74 (2H, m, Ar H), 6.68 (1H, dd, J 
= 1.3 Hz, Ar H), 4.84 (2H, s, CCH2O), 3.67 (3H, s, OCH3), 2.29 (3H, s, ArCH3).    
13C NMR (100 MHz, CDCl3): δ 159.2 (Ar C), 145.2 (Ar C), 133.3 (Ar C), 130.3 (Ar Chapter 6 – Experimental   
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C), 129.8 (Ar C), 129.4 (Ar C), 128.2 (Ar C), 127.0 (Ar C), 124.2 (Ar C), 122.4 
(Ar C), 116.9 (Ar C), 115.4 (Ar C), 88.9 (CCCH2), 80.4 (CCCH2), 58.6 (OCH3), 55.3 
(CCCH2), 21.6 (ArCH3).                        
m/z  [EI
+(+ve)]  316.1  [M]
+  (100%),  HRMS  found  316.0772,  C17H16O4S,  requires 
316.0769 [M
+].                           
vmax (film)/ cm
−1: 2852, 2233, 1595, 1319, 1176, 759. 
1 (3 Bromo prop 1 ynyl) 3 methoxy benzene, 468. 
 
To a solution of 3 (Methoxy phenyl) prop 2 yn 1 ol 463 (367 mg, 2.26 mmol) in 
dichloromethane (15 mL) was added carbon tetrabromide (2.99 g, 9.05 mmol) 
and triphenylphosphine (2.37 g, 9.05 mmol). The reaction was stirred for 3 hours 
until  completion  by  TLC  analysis,  solvent  was  evaporated  under  reduced 
pressure. Crude solids were adsorbed directly onto silica and purified by flash 
column  chromatography  (silica  gel,  5  %  diethyl  ether  in  petroleum  spirits), 
affording 232 mg (46% yield) of 468 as a brown oil.                 
1H NMR (400 MHz, CDCl3): δ 7.16 (1H, dd, J = 7.6, 0.6 Hz, Ar H), 6.97 (1H, d, J = 
7.6 Hz, Ar H), 6.90 6.89 (1H, m, Ar H), 6.84 6.82 (1H, Ar H), 4.09 (2H, s, CH2Br), 
3.73 (3H, s, OCH3).                          
13C NMR (100 MHz, CDCl3): δ 160.2 (Ar C), 130.5 (Ar C), 122.9 (Ar C), 115.8 (Ar 
C), 115.1 (Ar C), 114.0 (Ar C), 85.7 (CCCH2), 80.9 (CCCH2), 55.2 (OCH3), 12.2 
CCH2Br. 
(E) 3 (3 methoxyphenyl) allyl acetate, 469.
283 
 
A solution of (E) 3 (3 Methoxy phenyl) prop 2 en 1 ol 451 (5.49 g, 33.5 mmol) 
was dissolved in dichloromethane (100 mL) at 0 
oC. Triethylamine (6.99 mL, 50.2 
mmol)  and  dimethylaminopyridine  (409  mg,  3.45  mmol)  were  added  and  the 
reaction mixture was stirred for 30 minutes, then treated with acetic anhydride Chapter 6 – Experimental   
  199 
(4.45  mL,  50.2  mmol).  The  mixture  was  stirred  for  a  further  12  hours  until 
completion, monitored by TLC analysis. Water (20 mL) and dichloromethane (50 
mL) were added and the organic phase was washed with water (2x 20 mL). The 
combined  organic  extracts  were  dried  over  anhydrous  sodium  sulfate  and 
concentrated  in  vacuo.  Purification  with  flash  column  chromatography  (silica 
gel,  20%  diethyl  ether  in  petroleum  ether)  gave  5.94  g  (86%  yield)  of  allylic 
acetate 469.                      
1H NMR (400 MHz, CDCl3): δ 7.15 (1H, t, J = 7.9 Hz, Ar H), 6.90 (1H, d, J = 7.7 
Hz, Ar H), 6.84 (1H, t, J = 2.0 Hz, Ar H), 6.74 (1H, ddd, J = 8.2, 2.5, 0.7 Hz, Ar 
H),  6.54  (1H,  d,  J  =  15.8  Hz,  CHCHCH2),  6.19  (1H,  dt,  J  =  15.8,  6.4  Hz, 
CHCHCH2), 4.64 (2H, d, J = 6.4 Hz, CHCH2), 3.73 (3H, s, OCH3), 2.02 (3H, s, 
COCH3).                             
13C NMR (100 MHz, CDCl3): δ 170.9 (COCH3), 159.8 (Ar C), 137.7 (Ar C), 134.1 
(CHCH), 129.6 (Ar C), 123.5 (Ar C), 119.3 (CHCH), 113.8 (Ar C), 111.8 (Ar C), 
65.0 (CHCH2), 55.2 (OCH3), 21.0 (COCH3).              
m/z  [EI
+(+ve)]  206.1  [M]
+  (100%),  HRMS  found  206.0945,  C12H14O3,  requires 
206.0943 [M
+].                               
vmax (film)/ cm
−1: 2941, 2835, 1735, 1490, 1259, 775. 
tertButyl (1 (5 (3 (4 methoxyphenyl)propyl)furan 2 yl) 2 methylpropoxy) 
dimethylsilane, 450. 
 
To a stirred 0 
oC solution of tertButyl (1 furan 2 yl 2 methyl propoxy) dimethyl 
silane 424 (992 mg, 3.89 mmol) in anhydrous tetrahydrofuran (10 mL) was added 
slowly nBuLi (1.16 mL, 5.84 mmol, 2.5 M solution in hexanes). The solution was 
stirred at 0 
oC for 10 minutes and the yellow solution was allowed to attain room 
temperature over an hour. Cooled to  78 
oC the now brown solution was treated 
with a solution of bromide 449 (10 mL, 5.07 mmol, 0.5 M in tetrahydrofuran) 
and stirred for 1 hour, then for a further 12 hours at room temperature. The 
mixture was diluted with diethyl ether (10 mL) and  quenched with saturated 
ammonium chloride solution (5 mL) and the layers separated. The organic phase Chapter 6 – Experimental   
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was washed with water (2x 10 mL), dried over anhydrous sodium sulfate and 
concentrated in vacuo. Purification by flash column chromatography (silica gel, 
petroleum ether) gave 1.03 g of silyl ether bicycle 450 (38% yield) as clear oil 
that was inseparable from remaining bromide 449.                   
1H NMR (400 MHz, CDCl3): δ 7.09 (2H, d, J = 9.2 Hz, Ar H), 6.85 (2H, d, J = 9.4 
Hz, Ar H), 6.01 (1H, d, J = 3.0 Hz, Ar H), 5.89 (1H, d, J = 3.0 Hz, Ar H), 4.24 
(1H,  d,  J  =  7.0  Hz,  CHOSi),  3.79  (3H,  s,  OCH3),  2.59  (4H,  t,  J  =  7.7  Hz, 
CH2CH2CH2), 2.05 1.98 (1H, m, CH(CH3)2), 1.94 1.87 (2H, m, CH2CH2CH2), 0.96 
(3H, d, J = 6.7 Hz, CH(CH3)2), 0.87 (9H, s, SiC(CH3)3), 0.79 (3H, d, J = 6.8 Hz, 
CH(CH3)2), 0.02 (3H, s, SiCH3),  0.13 (SiCH3).                  
13C NMR (100 MHz, CDCl3): δ 158.1 (Ar C), 155.0 (Ar C), 154.5 (Ar C), 132.4 (Ar 
C), 129.4 (2x Ar C), 113.9 (2x Ar C), 106.9 (Ar C), 105.3 (Ar C), 74.3 (CHOSi), 
55.3  (OCH3),  34.4  (CH2CH2CH2),  33.2  (CH2CH2CH2),  30.2  (CH(CH3)2),  27.5 
(CH2CH2CH2), 25.9 (C(CH3)3), 18.8 (CH(CH3)2), 18.6 (CH(CH3)2), 18.3 (C(CH3)3),  
4.8 (SiCH3),  5.2 (SiCH3).                      
m/z  [EI
+(+ve)]  402.3  [M]
+  (100%),  HRMS  found  402.2594,  C24H38O3Si,  requires 
402.2590 [M
+].                           
vmax (film)/ cm
−1: 2955, 2932, 2856, 1512, 1247 
1 (5 (3 (4 Methoxyphenyl)propyl)furan 2 yl) 2 methylpropan 1 ol, 470. 
 
To a stirred solution of tertButyl(1 (5 (3 (4 methoxyphenyl)propyl)furan 2 yl) 2 
methylpropoxy)dimethylsilane, 450 (595 mg, 1.48 mmol) in tetrahydrofuran (4 
mL) at 0 
oC was added tetrabutylammonium fluoride (2.96 mL, 2.96 mmol) and 
the resulting solution was stirred for 48 hours. Water (5 mL) and diethyl ether 
(10 mL) were added and the phases were separated. The organic layer was then 
washed with water (2x 5 mL), brine (5 mL) and dried over anhydrous sodium 
sulfate. The solution was concentrated in vacuo to afford 418 mg (98% yield) of 
alcohol 470 that was used without further purification.                          
1H NMR (400 MHz, CDCl3): δ 6.99 (2H, d, J = 8.6 Hz, Ar H), 6.73 (2H, d, J = 8.6 
Hz, Ar H), 6.01 (1H, d, J = 3.1 Hz, Ar H), 5.82 (1H, d, J = 3.0 Hz, Ar H), 4.19 
(1H,  dd,  J  =  7.1,  5.2,  CHOH),  3.69  (3H,  s,  OCH3),  2.50  (4H,  q,  J  =  7.5  Hz, Chapter 6 – Experimental   
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CH2CH2CH2),  2.03 1.95  (1H,  m,  CH(CH3)2),  1.82  (2H,  quint,  J  =  5.6  Hz, 
CH2CH2CH2), 1.69 (1H, d, J = 5.2 Hz, OH), 0.92 (3H, d, J = 6.7 Hz, CH(CH3)2), 
0.75 (3H, d, J = 6.8 Hz, CH(CH3)2).                    
 
13C NMR (100 MHz, CDCl3): δ 157.8 (Ar C), 155.3 (Ar C), 154.5 (Ar C), 134.0 (Ar 
C), 129.4 (2x Ar C), 113.8 (2x Ar C), 107.1 (Ar C), 105.3 (Ar C), 73.7 (CHOH), 
55.3  (OCH3),  34.3  (CH2CH2CH2),  33.3  (CH2CH2CH2),  29.9  (CH2CH2CH2),  27.5 
(CH(CH3)2), 18.8 (CH(CH3)2), 18.4 (CH(CH3)2).             
m/z  [EI
+(+ve)]  288.2  [M]
+  (100%),  HRMS  found  288.1729,  C18H24O3  requires 
288.1725 [M
+].                           
vmax (film)/ cm
−1: 3432, 1613, 1511, 1244, 1035. 
6 Hydroxy 2 isopropyl 6 (3 (4 methoxyphenyl)propyl) 2H pyran 3(6H) one, 
469. 
 
To  a  stirred  solution  of  1 (5 (3 (4 Methoxyphenyl)propyl)furan 2 yl) 2 
methylpropan 1 ol, 470 (452 mg, 1.56 mmol), in dichloromethane (9 mL) at 0 
oC 
was  added  3 chloroperoxybenzoic  acid  (423  mg,  1.72  mmol).  The  white 
suspension was stirred for 30 minutes at 0 
oC then a further 4 hours at room 
temperature until completion TLC analysis. The reaction was cooled to 0 
oC and 
diluted with dichloromethane (10 mL) then quenched by the slow addition of 
saturated sodium hydrogen carbonate solution (5 mL) and stirred for a further 30 
minutes. The resulting emulsion was allowed to separate and was then extracted 
into dichloromethane (3x 10 mL). The organic layer was washed with water (2x 5 
mL),  dried  over  anhydrous  sodium  sulfate  and  concentrated  in  vacuo. 
Purification  by  flash  column  chromatography  (silica  gel,  30%  diethyl  ether  in 
petroleum spirits) afforded 306 mg (65% yield) of lactol 469 as a mixture of 
anomers (7:1, a to b) and as clear oil  
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6 α Hydroxy 2 isopropyl 6 (3 (4 methoxyphenyl)propyl) 2H pyran 3(6H) one, 
469a a a a.  
 
1H NMR (400 MHz, CDCl3): δ 7.09 (2H, d, J = 8.6 Hz, Ar H), 6.84 (2H, d, J = 8.7 
Hz, Ar H), 6.74 (1H, d, J = 10.2 Hz, CHCH), 6.04 (1H, d, J = 10.2 Hz, CHCO), 4.34 
(1H, d, J = 2.7 Hz, COCH), 3.79 (3H, s, OCH3), 2.64 2.59 (2H, m, CH2CH2CH2), 
2.67 2.43 (2H, m, CH2CH2CH2), 1.88 1.81 (2H, m, CH2CH2CH2), 1.79 1.68 (1H, m, 
CH(CH3)2), 1.59 (1H, bs, OH), 1.03 (3H, d, J = 7.0 Hz, CH(CH3)2), 0.92 (3H, d, J = 
6.8 Hz, CH(CH3)2).                           
13C NMR (100 MHz, CDCl3): δ 196.8 (CO), 157.9 (Ar C), 147.3 (Ar C), 133.8 (Ar C), 
129.3 (Ar C), 127.9 (Ar C), 113.9 (Ar C), 94.0 (OCO), 78.2 (COCH), 55.3 (OCH3), 
41.2  (CH2CH2CH2),  34.7  (CH2CH2CH2),  28.7  (CH(CH3)2),  25.4  (CH2CH2CH2),  19.1 
(CH(CH3)2), 16.2(CH(CH3)2). 
6 β Hydroxy 2 isopropyl 6 (3 (4 methoxyphenyl)propyl) 2H pyran 3(6H) one, 
469b b b b.    
 
1H NMR (400 MHz, CDCl3): δ 7.09 (2H, d, J = 8.6 Hz, Ar H), 6.84 (2H, d, J = 8.7 
Hz, Ar H), 6.81 (1H, d, J = 9.8 Hz, CHCH), 6.00 (1H, d, J = 10.3 Hz, CHCO), 3.85 
(1H, d, J = 4.7 Hz, COCH), 3.79 (3H, s, OCH3), 2.64 2.59 (2H, m, CH2CH2CH2), 
2.67 2.43 (2H, m, CH2CH2CH2), 1.88 1.81 (2H, m, CH2CH2CH2), 1.79 1.68 (1H, m, 
CH(CH3)2), 1.26 (1H, bs, OH), 1.01 (3H, d, J = 6.8 Hz, CH(CH3)2), 0.88 (3H, d, J = 
6.8 Hz, CH(CH3)2).                          
13C NMR (100 MHz, CDCl3): δ 204.3 (CO), 167.0 (Ar C), 150.3 (Ar C), 133.8 (Ar C), 
129.3 (Ar C), 127.4 (Ar C), 155.1 (Ar C), 81.9 (OCO), 77.2 (COCH), 55.3 (OCH3), 
41.2  (CH2CH2CH2),  34.7  (CH2CH2CH2),  28.7  (CH(CH3)2),  24.8  (CH2CH2CH2),  19.1 
(CH(CH3)2), 16.2(CH(CH3)2).                    
m/z [CI
+ (+ve), (isobutane)] 305.2 [M+H]
+ (100%), HRMS found 305.1756, C18H25O4 
requires 305.1753 [M+H]
+.                        
vmax (film)/ cm
−1: 3431, 1675, 1613, 1511. Chapter 6 – Experimental   
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2 isoPropyl 6 (3 (4 methoxyphenyl)propylidene) 2H pyran 3(6H) one, 472. 
 
A  solution  of  6 Hydroxy 2 isopropyl 6 (3 (4 methoxyphenyl)propyl) 2H pyran 
3(6H) one 471 in dichloromethane (0.1 M with respect to lactol) was cooled to  
78 
oC. The solution was treated with Lewis acid (see below for specific reagents) 
and stirred for 2 hours at  78 
oC. The reaction was diluted diethyl ether (5 mL) 
and quenched with water (2 mL). The phases were separated and the organic 
layer was washed with water (2x 2 mL), dried over anhydrous sodium sulfate and 
concentrated in vacuo. Purification by flash column chromatography (silica gel, 
20% diethyl ether in petroleum spirits) gave 472 as a clear oil.         
With boron trifluoride diethyl etherate               
Lactol  (51  mg,  0.17  mmol),  dichloromethane  (1.7  mL),  BF3.OEt2  (43  mL,  0.34 
mmol) gave 31 mg 472 in 64% yield.                         
With silicon tetrachloride                       
Lactol (46 mg, 0.15 mmol), dichloromethane (1.5 mL), SiCl4 (452 mL, 0.45 mmol, 
1 M in dichloromethane) gave 33 mg 472 in 76% yield.             
With ethyl aluminium chloride                 
Lactol (49 mg, 0.16 mmol), dichloromethane (1.6 mL), SiCl4 (478 mL, 0.48 mmol, 
1 M in hexanes) gave 13 mg 472 in 29% yield.                   
1H NMR (400 MHz, CDCl3): δ 7.05 (2H, d, J = 8.6 Hz, Ar H), 6.79 (2H, d, J = 10.3 
Hz, Ar H), 6.76 (1H, d, J = 6.5 Hz, CHCH), 5.86 (1H, d, J = 9.8 Hz, CHCO), 5.02 
(1H, t, J = 7.5 Hz,CH2CHCH), 4.13 (1H, d, J = 4.7 Hz, COCH),3.72 (3H, s, OCH3), 
2.63 (2H, t, J = 7.5 Hz, CH2CH2CH), 2.49 (2H, q, J = 7.6 Hz, CH2CH2CH), 2.18 
2.12 (1H, m, CH(CH3)2), 0.96 (3H, d, J = 6.9 Hz, CH(CH3)2), 0.84 (3H, d, J = 6.8 
Hz, CH(CH3)2).                          
13C  NMR  (100  MHz,  CDCl3):  δ  195.2  (CO),  157.9  (Ar C),  151.1  (CHC),  147.1 
(CHCH), 141.1 (Ar C), 133.6 (Ar C), 129.3 (CHCO), 122.1 (Ar C), 119.3 (Ar C), 
113.8 (Ar C), 85.4 (CH2CHC), 77.3 (CHCO), 55.3 (OCH3), 34.2 (CH2CH2CH), 31.7 
(CH(CH3)2), 27.6 (CH2CH2CH), 18.9 (CH(CH3)2), 16.8(CH(CH3)2).           
m/z  [EI
+(+ve)]  286.1  [M]
+  (100%),  HRMS  found  286.1566,  C18H22O3  requires 
286.1569 [M]
+.                           
vmax (film)/ cm
−1: 2966, 1685, 1612, 830. Chapter 6 – Experimental   
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10 (4 methoxyphenyl) 2 methyldecane 3,4,7 trione, 473. 
 
6 Hydroxy 2 isopropyl 6 (3 (4 methoxyphenyl)propyl) 2H pyran 3(6H) one  471 
(46 mg, 0.149 mmol) in dichloromethane (1.5 mL) was cooled to  78 
oC. The 
solution was treated with chloro triisopropoxytitanium (IV) (449 mL, 0.45 mmol) 
and stirred for 2 hours. The reaction was diluted with diethyl ether (5 mL) and 
quenched then water (2 mL). The phases were separated and the organic layer 
was  washed  with  water  (2x  2  mL),  dried  over  anhydrous  sodium  sulfate  and 
concentrated in vacuo. Purification by flash column chromatography (silica gel, 
20% diethyl ether in petroleum spirits) gave 24 mg (55% yield) of 473 in as a 
green oil.                              
1H NMR (400 MHz, CDCl3): δ.7.08 (2H, d, J = 8.6 Hz, Ar H), 6.82 (2H, d, J = 8.6 
Hz, Ar H), 3.78 (3H, s, OCH3), 3.35 (1H, sept, J = 6.9 Hz, CH(CH3)2), 2.94 (2H, t, 
J = 6.1 Hz, COCH2CH2), 2.74 (2H, t, J = 6.2 Hz, COCH2CH2), 2.56 (2H, t, J = 7.5 
Hz, CH2CH2CH2), 2.45 (2H, t, J = 7.4 Hz, CH2CH2CH2), 1.88(2H, quint, J = 7.4 Hz, 
CH2CH2CH2), 1.11 (6H, d, J = 6.9 Hz, CH(CH3)2).                 
13C  NMR  (100  MHz,  CDCl3):  δ.208.6  (CH2COCH2),  202.8  (COCOCH),  198.9 
(CH2COCO), 157.9 (Ar C), 133.5 (Ar C), 129.4 (2x Ar C), 113.8 (2x Ar C), 55.3 
(OCH3), 41.6 (CH2CH2CH2), 36.2 (COCH2CH2), 34.1 (CH2CH2CH2), 33.8 (CH(CH3)2), 
30.6 (COCH2CH2), 25.5 (CH2CH2CH2), 17.4 (2x CH(CH3)2).              
m/z  [EI
+(+ve)]  304.2  [M]
+  (100%),  HRMS  found  304.1673,  C18H24O4  requires 
304.1674 [M
+].                                   
vmax (film)/ cm
−1: 2067, 1704, 1613, 831. Chapter 6 – Experimental   
  205 
tertButyl(1 (5 (3 (3 methoxyphenyl)propyl)furan 2 yl) 2 methylpropoxy) 
dimethylsilane, 481. 
 
A  solution  of  tertButyl (1 furan 2 yl 2 methyl propoxy) dimethyl silane  424 
(1.95 g, 7.66 mmol) in anhydrous tetrahydrofuran (40 mL) at 0 
oC was treated 
slowly with nBuLi (3.44 mL, 8.42 mmol, 2.45 M solution in hexanes). The solution 
was stirred for 10 minutes at 0 
oC and the yellow solution was allowed to attain 
room temperature over an hour. The resulting brown solution was cooled to  78 
oC and treated with a solution of freshly distilled  bromide 443 (20 mL, 8.42 
mmol, 0.4 M in tetrahydrofuran) and stirred for 1 hour, then for a further 12 
hours at room temperature. The reaction mixture was diluted with diethyl ether 
(20 mL) and quenched by the slow addition of saturated ammonium chloride 
solution (5 mL). The layers were separated and the organic phase was washed 
with water (2x 10 mL), dried over anhydrous sodium sulfate and concentrated in 
vacuo.  Purification  by  flash  column  chromatography  (silica  gel,  petroleum 
spirits)  gave  as  an  oil  an  inseparable  mixture  of  desired  silyl  ether  481  and 
bromide 443 (2.77 g, 87:13 silyl ether:bromide).                 
1H NMR (400 MHz, CDCl3): δ 7.21 7.18 (1H, m, Ar H), 6.81 6.73 (3H, m, Ar H), 
6.02 (1H, d, J = 3.0 Hz, Ar H), 5.89 (1H, d, J = 3.0 Hz, Ar H), 4.24 (1H, d, J = 7.0 
Hz, CHOSi), 3.79 (3H, s, OCH3), 2.62 (4H, t, J = 7.4 Hz, CH2CH2CH2), 2.05 1.99 
(1H,  m,  CH(CH3)2),  1.96 1.90  (2H,m  ,CH2CH2CH2),  0.96  (3H,  d,  J  =  6.7  Hz, 
CH(CH3)2), 0.87 (9H, s, SiC(CH3)3), 0.79 (3H, d, J = 6.8 Hz, CH(CH3)2), 0.02 (3H, s, 
SiCH3),  0.13 (3H, s, SiCH3).                      
13C NMR (100 MHz, CDCl3): δ 160.6 (Ar C), 151.4 (Ar C), 151.2 (Ar C), 142.1 (Ar 
C), 129.8 (Ar C), 120.6 (Ar C), 115.2 (Ar C), 113.2 (Ar C), 108.7 (Ar C), 104.3 
(Ar C),  74.3  (CHOSi),  55.2  (OCH3),  35.3  (CH(CH3)2),  34.3  (CH2CH2CH2),  29.8 
(CH2CH2CH2),  27.2  (CH2CH2CH2),  25.9  (C(CH3)3),  18.8  (CH(CH3)2),  18.6 
(CH(CH3)2),18.5 (C(CH3)3)  4.8 (SiCH3),  5.2 (SiCH3).                       
m/z  [EI
+(+ve)]  288.2  [M]
+  (100%),  HRMS  found  288.1730,  C18H24O3  requires 
288.1725 [M
+].                           
vmax (film)/ cm
−1: 3432, 1613, 1511, 1244, 1035 Chapter 7 – Appendices   
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7. Appendices 
7.1.  Appendix 1 - Reaction of diene 208 and dienophile 198 
 
Equivalent's Diene Solvent
a
Lewis Acid Temperature
1.1 CH2Cl2   Reflux
1.1 CH2Cl2   Reflux (sealed tube)
1.1 Benzene   Reflux
1.1 Benzene   Reflux (sealed tube)
2.0 Toluene   Reflux
2.0 Xylene   Reflux
1.15 CH2Cl2 Me3Al Reflux
1.2 CH2Cl2 AlCl3 Reflux
1.2 CH2Cl2 Et2AlCl Reflux
1.15 CH2Cl2 Me3Al Reflux (sealed tube)
1.15 Benzene Me3Al Reflux
1.15 Benzene Et2AlCl Reflux
1.15 Benzene Me3Al Reflux (sealed tube)
2.0 Toluene AlCl3 Reflux
2.0 Xylene AlCl3 Reflux  
a Reactions were run at concentrations of 0.2 M with respect to dienophile 198.  
 Chapter 7 – Appendices   
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7.2.  Appendix 2 - Reaction of modified dienes 202 and 206 
 
 
a Reactions were run for at least 24 hours and at 0.2 M with respect to dienophile and with 
1.1 equivalents of diene and monitored by TLC. 
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7.3.  Appendix 3 - Microwave conditions. 
 
 
a Number of diene equivalents  
b       m m m mW conditions were applied temperatures and durations, 
pressures increased as a result up to 5 bar with the toluene and diphenyl ether experiments. 
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7.4.  Appendix 4 - Neat Diels Alder series. 
 
Number of diene equivalents in parentheses. 
 
7.5.  Appendix 5 – X-ray data for 198 
Table 1.  Crystal data and structure refinement for 198. 
Identification code      198  
Empirical formula      C15 H25 N O4 
Formula weight       283.36 
Temperature        293(2) K 
Wavelength        0.71073 A 
Crystal system, space group    ?,  ? 
Unit cell dimensions      a = 10.3366(15) A   alpha = 90 deg. 
b = 10.3366(15) A    beta = 90 deg. 
c = 27.883(6) A   gamma = 120 deg. 
Volume         2580.0(7) A
3 
Z, Calculated density      7,  1.277 Mg/m
3 
Absorption coefficient      0.092 mm
 1 
F(000)          1078 
Crystal size        ? x ? x ? mm 
Theta range for data collection   3.16 to 27.48 deg. 
Limiting indices       13<=h<=13,  13<=k<=13,  35<=l<=36 
Reflections collected / unique    36960 / 3940 [R(int) = 0.2909] 
Completeness to theta = 27.48    99.9 % 
Absorption correction      None 
Refinement method      Full matrix least squares on F
2 
Data / restraints / parameters    3940 / 1 / 186 
Goodness of fit on F
2      0.943 
Final R indices [I>2sigma(I)]    R1 = 0.0906, wR2 = 0.1864 
R indices (all data)      R1 = 0.2407, wR2 = 0.2395 
Absolute structure parameter    1(3) 
Largest diff. peak and hole    0.192 and  0.180 e.A
 3 
 
Table 2.  Atomic coordinates ( x 10
4) and equivalent isotropic displacement parameters (A
2 x 
10
3) for 198. 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________ 
                                x                 y                 z           U(eq) 
________________________________________________________________ 
O(1)         7440(5)       8896(5)         62(1)         70(1) 
O(2)         5622(6)       7224(6)        379(2)        98(2) 
O(3)        12589(4)      10529(5)        158(1)       76(1) 
O(4)        11797(5)      10698(5)        908(1)       74(1) 
N(1)        10611(5)      10764(5)        244(1)       59(1) 
C(1)         6291(8)       7505(9)          2(3)          77(2) 
C(2)         5972(9)       6463(8)        377(3)        93(2) 
C(3)         6900(10)      6715(10)       731(3)      114(3) 
C(4)         8237(8)       8184(8)        788(2)        85(2) 
C(5)         8040(7)       9366(8)        547(2)        67(2) 
C(6)         9439(6)      10873(7)        492(2)       60(2) 
C(7)        11694(7)      10690(7)        471(2)       63(2) Chapter 7 – Appendices   
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C(8)        13977(8)      10632(9)        325(2)      76(2) 
C(9)        14561(9)      10326(10)       133(2)      109(3) 
C(10)       14954(8)      12113(9)        537(2)       88(2) 
C(11)       13630(9)       9328(9)        683(3)      100(2) 
C(12)       9125(7)      12038(7)        258(2)       73(2) 
C(13)       10111(11)     13587(9)        411(4)      121(3) 
C(14)       11663(9)      14151(10)       427(4)      131(4) 
C(15)        9682(13)     14617(10)       152(4)      153(4) 
________________________________________________________________ 
Table 3.  Bond lengths [A] and angles [deg] for 198. 
________________________________________________________________ 
O(1) C(1)                     1.341(8) 
O(1) C(5)                     1.466(6) 
O(2) C(1)                     1.221(7) 
O(3) C(7)                     1.342(7) 
O(3) C(8)                     1.461(7) 
O(4) C(7)                     1.223(6) 
N(1) C(7)                     1.321(7) 
N(1) C(6)                     1.448(7) 
C(1) C(2)                     1.417(10) 
C(2) C(3)                     1.310(10) 
C(3) C(4)                     1.463(11) 
C(4) C(5)                     1.494(9) 
C(5) C(6)                     1.513(8) 
C(6) C(12)                    1.540(8) 
C(8) C(10)                    1.471(10) 
C(8) C(9)                     1.513(9) 
C(8) C(11)                    1.569(9) 
C(12) C(13)                   1.467(10) 
C(13) C(14)                   1.408(11) 
C(13) C(15)                   1.524(12) 
C(1) O(1) C(5)              118.2(5) 
C(7) O(3) C(8)              119.8(5) 
C(7) N(1) C(6)              122.8(4) 
O(2) C(1) O(1)              117.2(6) 
O(2) C(1) C(2)              125.0(7) 
O(1) C(1) C(2)              117.9(7) 
C(3) C(2) C(1)              122.4(7) 
C(2) C(3) C(4)              120.4(7) 
C(3) C(4) C(5)              110.9(6) 
O(1) C(5) C(4)              110.6(5) 
O(1) C(5) C(6)              106.0(4) 
C(4) C(5) C(6)              115.9(5) 
N(1) C(6) C(5)              112.0(5) 
N(1) C(6) C(12)             111.7(5) 
C(5) C(6) C(12)             112.4(5) 
O(4) C(7) N(1)              123.4(5) 
O(4) C(7) O(3)              125.9(5) 
N(1) C(7) O(3)              110.6(5) 
O(3) C(8) C(10)             110.0(6) 
O(3) C(8) C(9)              101.3(5) 
C(10) C(8) C(9)             114.7(6) 
O(3) C(8) C(11)             110.2(6) 
C(10) C(8) C(11)            112.4(5) 
C(9) C(8) C(11)             107.5(6) 
C(13) C(12) C(6)            115.3(5) 
C(14) C(13) C(12)           119.2(9) 
C(14) C(13) C(15)           113.3(8) 
C(12) C(13) C(15)           109.8(7) 
________________________________________________________________ 
  
Symmetry transformations used to generate equivalent atoms: 
  Chapter 7 – Appendices   
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 Table 4.  Anisotropic displacement parameters (A
2 x 10
3) for 198. 
The anisotropic displacement factor exponent takes the form: 2 p^2 [ h^2 a*^2 U
11 + ... + 2 h k a* 
b* U
12 ] 
_________________________________________________________________ 
              U
11         U
22         U
33         U
23         U
13        U
12 
_________________________________________________________________ 
O(1)     66(3)      93(3)      36(2)       3(2)       0(2)      30(3) 
O(2)     91(4)      90(4)      71(3)      10(3)       9(3)      14(3) 
O(3)     67(3)     121(4)      44(2)       9(2)       7(2)      50(3) 
O(4)     77(3)     108(3)      43(2)       4(2)       1(2)      51(3) 
N(1)     61(3)      80(3)      34(2)       4(2)       0(2)      34(3) 
C(1)     46(4)      84(5)      78(5)       0(4)      14(4)      14(4) 
C(2)     71(5)      75(5)      96(5)      15(4)      15(5)       9(4) 
C(3)     85(6)     109(7)     115(6)      49(5)       8(5)      23(6) 
C(4)     91(5)      84(5)      62(4)      20(3)       0(3)      30(5) 
C(5)     59(4)      98(5)      40(3)      10(3)       6(3)      37(4) 
C(6)     68(4)      85(5)      35(3)       2(3)       4(3)      45(4) 
C(7)     63(4)      91(5)      40(3)       1(3)       4(3)      42(3) 
C(8)     76(5)     103(6)      64(4)       8(4)       1(3)      56(5) 
C(9)    106(6)     177(9)      83(5)       3(5)      19(4)     101(7) 
C(10)    78(5)     113(6)      88(5)      20(5)       6(4)      58(5) 
C(11)   114(6)     111(6)      91(5)      24(4)       8(4)      69(5) 
C(12)    67(4)      84(5)      65(4)      12(3)      14(3)      36(4) 
C(13)   131(8)      87(6)     132(7)      10(5)      55(6)      44(6) 
C(14)    75(6)      84(6)     213(11)     16(6)      26(6)      24(5) 
C(15)   180(10)     93(7)     173(9)      16(6)      64(8)      58(7) 
 
Table 5.  Hydrogen coordinates ( x 10
4) and isotropic displacement parameters (A
2 x 10
3) for 
198. 
_________________________________________________________ 
                             x                y              z           U(eq) 
_________________________________________________________________ 
H(1A)       10603         10746          64          70 
H(2A)        5069          5566           371         111 
H(3A)        6709          5956           948         137 
H(4A)        9090          8167           650         102 
H(4B)        8435          8415          1126         102 
H(5A)        7315          9505           734          81 
H(6A)        9809         11234           817          71 
H(9A)       14386         10818           396         163 
H(9B)       14054          9269           192         163 
H(9C)       15614         10695           103         163 
H(10A)      15146         12873           304         132 
H(10B)      15880         12186           633         132 
H(10C)      14473         12245           811         132 
H(11A)      13301          9516           984         149 
H(11B)      14517          9267           733         149 
H(11C)      12859          8402           552         149 
H(12A)       9211         11986            87          88 
H(12B)       8102         11769           328          88 
H(13A)       9832         13604           746         145 
H(14A)      11889         13655           677         196 
H(14B)      12165         15205           492         196 
H(14C)      11995         13980           125         196 
H(15A)      10156         15577           306         230 
H(15B)       8617         14194           164         230 
H(15C)      10002         14731           176         230 
 
7.6.  Appendix 6 – X-Ray data for 244 
Table 1.  Crystal data and structure refinement for 244. Chapter 7 – Appendices   
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Identification code      244 
Empirical formula      C12 H13 O3 
Formula weight       205.22 
Temperature        293(2) K 
Wavelength        0.71073 A 
Crystal system, space group    P21/n 
Unit cell dimensions      a = 6.2961(11) A   alpha = 90 deg. 
b = 8.7626(18) A    beta = 90.705(5) deg. 
c = 18.718(3) A   gamma = 90 deg. 
Volume         1032.6(3) A
3 
Z, Calculated density      4,  1.320 Mg/m
3 
Absorption coefficient      0.094 mm
 1 
F(000)          436 
Crystal size        0.1 x 0.1 x 0.4 mm 
Theta range for data collection   3.18 to 27.48 deg. 
Limiting indices        8<=h<=8,  11<=k<=11,  24<=l<=24 
Reflections collected / unique    13411 / 2353 [R(int) = 0.0612] 
Completeness to theta = 27.48    99.7 % 
Absorption correction      None 
Refinement method      Full matrix least squares on F
2 
Data / restraints / parameters    2353 / 0 / 192 
Goodness of fit on F
2      1.119 
Final R indices [I>2sigma(I)]    R1 = 0.0444, wR2 = 0.1050 
R indices (all data)      R1 = 0.0674, wR2 = 0.1257 
Largest diff. peak and hole    0.232 and  0.258 e.A
 3 
 
Table 2.  Atomic coordinates ( x 10
4) and equivalent isotropic displacement parameters (A
2 x 
10
3) for 244. 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________ 
                               x                  y                  z             U(eq) 
__________________________________________________________ 
O(3)        11708(2)       4056(1)       1987(1)       31(1) 
O(1)         5333(2)       4401(1)       1092(1)       32(1) 
O(2)         7225(2)       4751(1)       2064(1)       29(1) 
C(8)        10919(3)       5579(2)       2013(1)       26(1) 
C(9)         8900(3)       5588(2)       2443(1)        26(1) 
C(10)        9004(3)       4852(2)       3179(1)       28(1) 
C(6)         8465(3)       5880(2)        968(1)        26(1) 
C(11)       10736(3)       5581(2)      3635(1)       33(1) 
C(5)         7959(3)       6375(2)        280(1)        30(1) 
C(7)         6899(3)       4975(2)       1364(1)       26(1) 
C(4)         9446(3)       7194(2)        101(1)        31(1) 
C(2)        11903(3)       7008(2)        883(1)       29(1) 
C(1)        10437(3)       6188(2)       1275(1)       26(1) 
C(12)        6858(3)       4994(2)       3540(1)       35(1) 
C(3)        11409(3)       7508(2)        200(1)       31(1) 
________________________________________________________________ 
  
 
Table 3.  Bond lengths [A] and angles [deg] for 244. 
_____________________________________________________________ 
O(3) C(8)                     1.425(2) 
O(1) C(7)                     1.213(2) 
O(2) C(7)                     1.338(2) 
O(2) C(9)                     1.461(2) 
C(8) C(1)                     1.508(2) 
C(8) C(9)                     1.513(2) 
C(9) C(10)                    1.521(2) 
C(10) C(11)                   1.518(3) 
C(10) C(12)                   1.523(3) 
C(6) C(1)                     1.388(2) 
C(6) C(5)                     1.392(2) Chapter 7 – Appendices   
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C(6) C(7)                     1.472(2) 
C(5) C(4)                     1.385(3) 
C(4) C(3)                     1.380(3) 
C(2) C(3)                     1.383(2) 
C(2) C(1)                     1.387(2) 
C(7) O(2) C(9)              120.20(13) 
O(3) C(8) C(1)              111.51(13) 
O(3) C(8) C(9)              108.58(13) 
C(1) C(8) C(9)              108.94(14) 
O(2) C(9) C(8)              110.19(13) 
O(2) C(9) C(10)             104.48(13) 
C(8) C(9) C(10)             116.90(14) 
C(11) C(10) C(9)            110.75(15) 
C(11) C(10) C(12)           110.52(15) 
C(9) C(10) C(12)            109.80(15) 
C(1) C(6) C(5)              120.96(16) 
C(1) C(6) C(7)              119.90(15) 
C(5) C(6) C(7)              119.12(16) 
C(4) C(5) C(6)              119.36(17) 
O(1) C(7) O(2)              117.67(16) 
O(1) C(7) C(6)              123.91(16) 
O(2) C(7) C(6)              118.41(15) 
C(3) C(4) C(5)              120.02(17) 
C(3) C(2) C(1)              120.59(17) 
C(2) C(1) C(6)              118.74(16) 
C(2) C(1) C(8)              122.67(16) 
C(6) C(1) C(8)              118.57(15) 
C(4) C(3) C(2)              120.33(17) 
_____________________________________________________________ 
  
Symmetry transformations used to generate equivalent atoms 
 
Table 4.  Anisotropic displacement parameters (A
2 x 10
3) for 244. 
The anisotropic displacement factor exponent takes the form:  2 p
2 [ h
2 a*
2 U
11 + ... + 2 h k a* b* 
U
12 ] 
______________________________________________________________ 
                        U
11        U
22           U
33        U
23        U
13        U
12 
______________________________________________________________ 
O(3)     30(1)      30(1)      34(1)       4(1)       4(1)       5(1) 
O(1)     28(1)      35(1)      32(1)       2(1)       3(1)       3(1) 
O(2)     28(1)      33(1)      26(1)       1(1)       2(1)       4(1) 
C(8)     27(1)      26(1)      26(1)       1(1)       2(1)       2(1) 
C(9)     27(1)      24(1)      26(1)       1(1)       3(1)       1(1) 
C(10)    32(1)      25(1)      27(1)       0(1)       0(1)       2(1) 
C(6)     27(1)      25(1)      26(1)       2(1)       0(1)       0(1) 
C(11)    37(1)      33(1)      28(1)       1(1)       3(1)       0(1) 
C(5)     31(1)      30(1)      28(1)       2(1)       3(1)       0(1) 
C(7)     28(1)      24(1)      27(1)       2(1)       1(1)       2(1) 
C(4)     37(1)      32(1)      24(1)       2(1)       1(1)       1(1) 
C(2)     31(1)      26(1)      28(1)       2(1)       2(1)       1(1) 
C(1)     29(1)      23(1)      26(1)       2(1)       0(1)       2(1) 
C(12)    38(1)      36(1)      30(1)       0(1)       4(1)       2(1) 
C(3)     35(1)      28(1)      30(1)       1(1)       4(1)       2(1) 
 
Table 5.  Hydrogen coordinates ( x 10
4) and isotropic displacement parameters (A
2 x 10
3) for 
244.  
________________________________________________________________ 
                               x                 y                 z           U(eq) 
________________________________________________________________ 
H(10)       10430(30)      6670(30)      3688(11)      40(6) 
H(4)         6590(30)      6110(20)        79(9)          25(5) 
H(8)         8390(30)      6670(20)       2482(9)         20(4) 
H(6)        11960(30)      6290(20)      2264(9)        25(5) Chapter 7 – Appendices   
  214 
H(9)         9320(30)      3750(20)       3092(9)         27(5) 
H(13)        6500(30)      6060(30)      3578(10)      35(5) 
H(12)       10730(30)      5120(20)     4132(12)      36(5) 
H(3)         9090(30)      7520(20)       584(10        30(5) 
H(2)        12460(30)      8110(20)       68(10)        39(5) 
H(1)        13330(30)      7260(20)      1097(10)      36(5) 
H(15)        5700(40)      4480(20)      3250(12)      41(6) 
H(14)        6910(40)      4500(30)      4035(13)      46(6) 
H(11)       12190(40)      5450(30)      3429(12)      52(6) 
H(7)        12900(50)      4080(30)      1723(14)      67(8) 
________________________________________________________________  
 
7.7.  Appendix 7 – X- Ray data for 261 
Table 1.  Crystal data and structure refinement for 261. 
Identification code      261 
Empirical formula      C15H18O3 
Formula weight       246.31 
Temperature        100 K 
Wavelength        0.71073 A 
Crystal system, space group    Monoclinic,  P 1 21/c 1 
Unit cell dimensions      a = 19.150(13) A   alpha = 90 deg. 
b = 5.058(3) A    beta = 97.09(2) deg. 
c = 12.838(10) A   gamma = 90 deg. 
Volume         1234.0(15) A
3 
Z, Calculated density      4,  1.326 Mg/m
3 
Absorption coefficient      0.091 mm
 1 
F(000)          528 
Crystal size        0.20 x 0.08 x 0.08 mm 
Theta range for data collection   3.198 to 23.255 deg. 
Limiting indices        21<=h<=21,  5<=k<=5,  14<=l<=14 
Reflections collected / unique    7318 / 1765 [R(int) = 0.207] 
Completeness to theta = 22.790   99.5 % 
Absorption correction      None 
Refinement method      Full matrix least squares on F
2 
Data / restraints / parameters    1765 / 1 / 166 
Goodness of fit on F
2      0.8991 
Final R indices [I>2sigma(I)]    R1 = 0.0771, wR2 = 0.1382 
R indices (all data)      R1 = 0.1909, wR2 = 0.1766 
Largest diff. peak and hole    1.00 and  1.12 e.A
 3 
 
Table 2.  Atomic coordinates ( x 10
4) and equivalent isotropic  displacement parameters (A
2 x 
10
3) for 261. 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
____________________________________________________________ 
                             x                 y                 z            U(eq) 
____________________________________________________________ 
O(1)         3398(2)      10491(9)       3782(3)       41 
O(5)         2372(2)      11354(8)       1944(3)       33 
C(8)         3898(3)       9640(12)       564(5)       32 
C(9)         2871(3)      11639(13)      1291(5)       31 
C(13)        1096(3)       9815(13)      2763(5)       37 
O(16)        2785(2)      13508(8)        674(3)       38 
C(19)        3470(3)       9779(11)      1361(5)       29 
C(23)         542(3)      10050(13)      3513(5)       41 
C(28)        4581(3)       6205(13)      1512(5)       37 
C(37)        4450(3)       7840(12)       634(5)       36 
C(48)         519(3)       7620(12)      4207(5)       43 
C(50)        2383(3)       8912(12)      2596(5)       35 
C(57)        3595(3)       8150(12)      2243(5)       29 
C(62)        4157(3)       6348(12)      2303(5)       40 
C(65)        1817(3)       6911(12)      4074(5)       37 Chapter 7 – Appendices   
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C(68)        3131(3)       8388(12)      3085(5)       36 
C(72)        1828(3)       9304(11)      3355(5)       30 
C(76)        1244(3)       7100(13)      4816(5)       42 
 
 
Table 3.  Bond lengths [A] and angles [deg] for 261. 
____________________________________________________________ 
O(1) C(68)                    1.442(7) 
O(1) H(2)                     0.89(4) 
O(5) C(9)                     1.355(7) 
O(5) C(50)                    1.491(7) 
C(8) C(19)                    1.388(8) 
C(8) C(37)                    1.390(8) 
C(8) H(81)                    0.950 
C(9) O(16)                    1.231(7) 
C(9) C(19)                    1.478(8) 
C(13) C(23)                   1.522(8) 
C(13) C(72)                   1.533(7) 
C(13) H(131)                  0.950 
C(13) H(132)                  0.950 
C(19) C(57)                   1.397(8) 
C(23) C(48)                   1.522(8) 
C(23) H(231)                  0.950 
C(23) H(232)                  0.950 
C(28) C(37)                   1.396(8) 
C(28) C(62)                   1.377(9) 
C(28) H(281)                  0.950 
C(37) H(371)                  0.950 
C(48) C(76)                   1.530(8) 
C(48) H(481)                  0.950 
C(48) H(482)                  0.950 
C(50) C(68)                   1.515(7) 
C(50) C(72)                   1.541(8) 
C(50) H(501)                  0.950 
C(57) C(62)                   1.405(8) 
C(57) C(68)                   1.488(9) 
C(62) H(621)                  0.950 
C(65) C(72)                   1.524(8) 
C(65) C(76)                   1.541(9) 
C(65) H(651)                  0.950 
C(65) H(652)                  0.950 
C(68) H(681)                  0.950 
C(72) H(721)                  0.950 
C(76) H(761)                  0.950 
C(76) H(762)                  0.950 
C(68) O(1) H(2)             108(4) 
C(9) O(5) C(50)             118.2(5) 
C(19) C(8) C(37)            119.9(6) 
C(19) C(8) H(81)            119.4 
C(37) C(8) H(81)            120.7 
O(5) C(9) O(16)             115.5(6) 
O(5) C(9) C(19)             119.8(6) 
O(16) C(9) C(19)            124.7(7) 
C(23) C(13) C(72)           111.5(5) 
C(23) C(13) H(131)          110.1 
C(72) C(13) H(131)          109.2 
C(23) C(13) H(132)          108.9 
C(72) C(13) H(132)          107.7 
H(131) C(13) H(132)         109.5 
C(9) C(19) C(8)             120.7(6) 
C(9) C(19) C(57)            118.6(6) 
C(8) C(19) C(57)            120.7(6) 
C(13) C(23) C(48)           112.3(5) Chapter 7 – Appendices   
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C(13) C(23) H(231)          108.7 
C(48) C(23) H(231)          107.8 
C(13) C(23) H(232)          109.1 
C(48) C(23) H(232)          109.3 
H(231) C(23) H(232)         109.5 
C(37) C(28) C(62)           120.1(6) 
C(37) C(28) H(281)          120.3 
C(62) C(28) H(281)          119.7 
C(28) C(37) C(8)            119.9(7) 
C(28) C(37) H(371)          119.7 
C(8) C(37) H(371)           120.4 
C(23) C(48) C(76)           110.3(5) 
C(23) C(48) H(481)          110.5 
C(76) C(48) H(481)          110.6 
C(23) C(48) H(482)          107.8 
C(76) C(48) H(482)          108.2 
H(481) C(48) H(482)         109.5 
O(5) C(50) C(68)            109.0(5) 
O(5) C(50) C(72)            106.6(5) 
C(68) C(50) C(72)           116.8(5) 
O(5) C(50) H(501)           108.3 
C(68) C(50) H(501)          108.4 
C(72) C(50) H(501)          107.5 
C(19) C(57) C(62)           118.7(6) 
C(19) C(57) C(68)           118.9(6) 
C(62) C(57) C(68)           122.4(6) 
C(57) C(62) C(28)           120.7(6) 
C(57) C(62) H(621)          119.3 
C(28) C(62) H(621)          120.0 
C(72) C(65) C(76)           112.9(5) 
C(72) C(65) H(651)          109.1 
C(76) C(65) H(651)          110.4 
C(72) C(65) H(652)          106.7 
C(76) C(65) H(652)          108.1 
H(651) C(65) H(652)         109.5 
C(50) C(68) C(57)           109.4(5) 
C(50) C(68) O(1)            111.9(5) 
C(57) C(68) O(1)            108.2(5) 
C(50) C(68) H(681)          109.1 
C(57) C(68) H(681)          109.1 
O(1) C(68) H(681)           109.1 
C(50) C(72) C(13)           111.6(5) 
C(50) C(72) C(65)           110.1(5) 
C(13) C(72) C(65)           110.7(5) 
C(50) C(72) H(721)          108.5 
C(13) C(72) H(721)          108.2 
C(65) C(72) H(721)          107.6 
C(65) C(76) C(48)           111.4(5) 
C(65) C(76) H(761)          108.8 
C(48) C(76) H(761)          108.6 
C(65) C(76) H(762)          109.2 
C(48) C(76) H(762)          109.4 
H(761) C(76) H(762)         109.5 
 
Symmetry transformations used to generate equivalent atoms: 
 
Table 4.  Anisotropic displacement parameters (A
2 x 10
3) for 261. 
The anisotropic displacement factor exponent takes the form:  2 p
2 [h
2 a
2 U
11 + 2 h k a* b* U
12 ] 
________________________________________________________________ 
                        U
11         U
22        U
33          U
23        U
13        U
12 
________________________________________________________________ 
O(1)     50(3)      40(3)      33(3)       1(3)       5(2)       2(2) 
O(5)     40(3)      29(3)      29(3)       2(2)       4(2)       6(2) Chapter 7 – Appendices   
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C(8)     33(4)      31(4)      30(4)       3(3)       1(3)       2(3) 
C(9)     31(4)      26(4)      35(4)       2(4)       6(4)       4(3) 
C(13)    33(4)      40(4)      38(4)       3(4)       2(3)       3(3) 
O(16)    44(3)      35(3)      33(3)       4(2)       3(2)       2(2) 
C(19)    28(4)      25(4)      32(4)       4(3)       6(3)       2(3) 
C(23)    46(5)      33(4)      43(5)       6(3)       6(4)       8(4) 
C(28)    32(4)      36(4)      43(5)       2(4)       3(4)       2(3) 
C(37)    38(4)      36(4)      35(4)      11(3)       5(3)       1(3) 
C(48)    53(5)      37(4)      42(5)       2(3)      17(4)       3(4) 
C(50)    25(4)      31(4)      46(5)       8(4)       5(3)       4(3) 
C(57)    31(4)      28(4)      28(4)      10(3)       1(3)       1(3) 
C(62)    47(4)      31(4)      38(5)       6(3)       2(4)       5(4) 
C(65)    40(4)      33(4)      37(4)       3(3)       2(4)       6(3) 
C(68)    47(5)      28(4)      31(4)       0(3)       2(4)      11(3) 
C(72)    37(4)      23(4)      31(4)       2(3)      10(3)       3(3) 
C(76)    61(5)      31(4)      35(4)       2(3)       6(4)       4(4) 
 
Table 5.  Hydrogen coordinates ( x 10
4) and isotropic displacement parameters (A
2 x 10
3) for 
261. 
________________________________________________________________ 
                             x               y                z           U(eq) 
________________________________________________________________ 
H(81)        3806         10774            27          47 
H(131)       1108         11388          2362          49 
H(132)        981          8359          2307          49 
H(231)        652         11532          3958          58 
H(232)         94         10303          3118          58 
H(281)       4958          4974          1564          53 
H(371)       4743          7731            90          52 
H(481)        176          7836          4675          59 
H(482)        397          6146          3762          59 
H(501)       2233          7470          2149          45 
H(621)       4246          5231          2899          58 
H(651)       2267          6707          4467          46 
H(652)       1717          5417          3633          46 
H(681)       3143          6777          3467          48 
H(721)       1958         10798          3785          49 
H(761)       1357          8517          5292          57 
H(762)       1232          5492          5196          57 
H(2)         3180(30)     10410(130)     4360(40)      50 
 
 
7.8.  Appendix 8 – X-Ray data for 264 
Table 1.  Crystal data and structure refinement for 264 
Identification code       264 
Empirical formula       C17H16O3 
Formula weight       268.30 
Temperature         100(2) K 
Wavelength         0.71073 Å 
Crystal system        Monoclinic 
Space group         Pc 
Unit cell dimensions      a = 12.826(5) Å a= 90°. 
          b = 7.712(2) Å  b= 91.105(19)°. 
          c = 6.916(3) Å  g = 90°. 
Volume         683.9(4) Å3 
Z          2 
Density (calculated)      1.303 Mg/m3 
Absorption coefficient      0.089 mm 1 
F(000)          284 Chapter 7 – Appendices   
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Crystal size        0.20 x 0.20 x 0.08 mm3 
Theta range for data collection   1.59 to 29.97° 
Index ranges         18<=h<=17,  10<=k<=9,  9<=l<=9 
Reflections collected      11845 
Independent reflections      3782 (R(int) = 0.0465) 
Observed reflections (>2sigma(I))  3011  
Completeness to theta = 29.97°   100.0 %  
Absorption correction      Semi empirical from equivalents 
Max. and min. transmission    0.9929 and 0.9825  
Refinement method      Full matrix least squares on F2 
Data / restraints / parameters    3782 / 2 / 185 
Goodness of fit on F2      1.023 
Final R indices (I>2sigma(I))    R1 = 0.0463, wR2 = 0.1051 
R indices (all data)      R1 = 0.0646, wR2 = 0.1149 
Absolute structure parameter     0.9(10) 
Largest diff. peak and hole    0.334 and  0.165 e.Å 3 
 
Table 2.  Atomic coordinates  and equivalent  isotropic displacement parameters (Å2) for 264 
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
_________________________________________________________________ 
             x         y                   z        U(eq) 
_________________________________________________________________ 
O(1)    0.67391(11)    1.14513(16)   0.21976(19)    0.0244(3) 
O(2)    0.56260(10)    0.93766(16)   0.28384(17)    0.0214(3) 
O(3)    0.53289(11)    0.67266(18)   0.02699(19)    0.0279(3) 
C(1)    0.83906(14)    0.9027(3)   0.1581(3)    0.0259(4) 
C(2)    0.91110(15)    0.7787(3)   0.1035(3)    0.0296(4) 
C(3)    0.87838(16)    0.6092(3)   0.0635(3)    0.0281(4) 
C(4)    0.77443(16)    0.5625(3)   0.0824(3)    0.0257(4) 
C(5)    0.70136(14)    0.6854(2)   0.1382(2)    0.0211(4) 
C(6)    0.73436(15)    0.8547(3)   0.1754(3)    0.0214(4) 
C(7)    0.65680(14)    0.9895(2)   0.2268(2)    0.0203(4) 
C(8)    0.58683(15)    0.6453(2)   0.1529(3)    0.0225(4) 
C(9)    0.54193(14)    0.7526(2)   0.3149(3)    0.0206(4) 
C(10)    0.42548(14)    0.7342(3)   0.3422(3)    0.0236(4) 
C(11)    0.38640(15)    0. 8493(3)   0.5064(3)    0.0294(4) 
C(12)    0.27748(15)    0.8039(2)   0.5677(3)    0.0234(4) 
C(13)    0.19026(15)    0.8675(3)   0.4681(3)    0.0278(4) 
C(14)    0.09075(15)    0.8264(3)   0.5285(3)    0.0379(6) 
C(15)    0.07723(19)    0.7218(3)   0.6883(3)    0.0419(6) 
C(16)    0.1631(2)    0.6567(3)   0.7863(4)    0.0451(6) 
C(17)    0.26268(18)    0.6990(3)   0.7279(3)    0.0340(5) 
 
 
Table 3.   Bond lengths [Å] and angles [°] for  264. 
_____________________________________________________  
O(1) C(7)       1.221(2) 
O(2) C(7)       1.339(2) 
O(2) C(9)       1.468(2) 
O(3) C(8)       1.428(2) 
O(3) H(1)       1.03(4) 
C(1) C(2)       1.387(3) 
C(1) C(6)       1.400(3) 
C(1) H(1A)       0.9500 
C(2) C(3)       1.399(3) 
C(2) H(2A)       0.9500 
C(3) C(4)       1.390(3) 
C(3) H(3A)       0.9500 
C(4) C(5)       1.393(3) 
C(4) H(4A)       0.9500 
C(5) C(6)       1.395(3) 
C(5) C(8)       1.507(3) Chapter 7 – Appendices   
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C(6) C(7)       1.486(3) 
C(8) C(9)       1.516(3) 
C(8) H(8A)       1.0000 
C(9) C(10)       1.516(2) 
C(9) H(9A)       1.0000 
C(10) C(11)       1.534(3) 
C(10) H(10A)       0.9900 
C(10) H(10B)       0.9900 
C(11) C(12)       1.509(3) 
C(11) H(11A)       0.9900 
C(11) H(11B)       0.9900 
C(12) C(17)       1.388(3) 
C(12) C(13)       1.392(3) 
C(13) C(14)       1.387(3) 
C(13) H(13A)       0.9500 
C(14) C(15)       1.382(4) 
C(14) H(14A)       0.9500 
C(15) C(16)       1.377(4) 
C(15) H(15A)       0.9500 
C(16) C(17)       1.385(3) 
C(16) H(16A)       0.9500 
C(17) H(17A)       0.9500 
C(7) O(2) C(9)      119.98(14) 
C(8) O(3) H(1)      100(2) 
C(2) C(1) C(6)      119.08(19) 
C(2) C(1) H(1A)     120.5 
C(6) C(1) H(1A)     120.5 
C(1) C(2) C(3)      119.93(18) 
C(1) C(2) H(2A)     120.0 
C(3) C(2) H(2A)     120.0 
C(4) C(3) C(2)      120.57(18) 
C(4) C(3) H(3A)     119.7 
C(2) C(3) H(3A)     119.7 
C(3) C(4) C(5)      120.09(19) 
C(3) C(4) H(4A)     120.0 
C(5) C(4) H(4A)     120.0 
C(4) C(5) C(6)      119.00(17) 
C(4) C(5) C(8)      122.74(17) 
C(6) C(5) C(8)      118.21(16) 
C(5) C(6) C(1)      121.31(17) 
C(5) C(6) C(7)      119.76(16) 
C(1) C(6) C(7)      118.89(17) 
O(1) C(7) O(2)      117.96(16) 
O(1) C(7) C(6)      123.77(17) 
O(2) C(7) C(6)      118.27(16) 
O(3) C(8) C(5)      111.55(15) 
O(3) C(8) C(9)      112.26(15) 
C(5) C(8) C(9)      108.82(14) 
O(3) C(8) H(8A)     108.0 
C(5) C(8) H(8A)     108.0 
C(9) C(8) H(8A)     108.0 
O(2) C(9) C(8)      110.52(14) 
O(2) C(9) C(10)     106.88(14) 
C(8) C(9) C(10)     115.48(15) 
O(2) C(9) H(9A)     107.9 
C(8) C(9) H(9A)     107.9 
C(10) C(9) H(9A)    107.9 
C(9) C(10) C(11)    112.01(15) 
C(9) C(10) H(10A)    109.2 
C(11) C(10) H(10A)    109.2 
C(9) C(10) H(10B)    109.2 
C(11) C(10) H(10B)    109.2 
H(10A) C(10) H(10B)    107.9 Chapter 7 – Appendices   
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C(12) C(11) C(10)    113.03(15) 
C(12) C(11) H(11A)    109.0 
C(10) C(11) H(11A)    109.0 
C(12) C(11) H(11B)    109.0 
C(10) C(11) H(11B)    109.0 
H(11A) C(11) H(11B)    107.8 
C(17) C(12) C(13)    118.67(18) 
C(17) C(12) C(11)    120.09(19) 
C(13) C(12) C(11)    121.23(18) 
C(14) C(13) C(12)    120.4(2) 
C(14) C(13) H(13A)    119.8 
C(12) C(13) H(13A)    119.8 
C(15) C(14) C(13)    120.3(2) 
C(15) C(14) H(14A)    119.8 
C(13) C(14) H(14A)    119.8 
C(16) C(15) C(14)    119.7(2) 
C(16) C(15) H(15A)    120.2 
C(14) C(15) H(15A)    120.2 
C(15) C(16) C(17)    120.3(2) 
C(15) C(16) H(16A)    119.9 
C(17) C(16) H(16A)    119.9 
C(16) C(17) C(12)    120.7(2) 
C(16) C(17) H(17A)    119.6 
C(12) C(17) H(17A)    119.6 
 
Symmetry transformations used to generate equivalent atoms:  
 
 Table 4.   Anisotropic displacement parameters  (Å2) for 264.   
The anisotropic displacement factor exponent takes the form:   2p2[ h2 a*2 U11 + ...  + 2 h k a* 
b* U12 ] 
_________________________________________________________________ 
      U11  U22   U33  U23  U13  U12 
O(1)  0.0306(7)  0.0226(7)  0.0199(6)   0.0010(6)  0.0003(5)   
0.0034(5) 
O(2)  0.0236(6)  0.0195(6)  0.0210(7)   0.0006(5)   0.0004(5)   0.0001(5) 
O(3)  0.0326(7)  0.0303(8)  0.0207(7)   0.0018(6)   0.0020(6)    
 0.0055(6) 
C(1)  0.0255(10)  0.0344(11)  0.0180(9)    0.0016(8)  0.0005(7)    
 0.0039(8) 
C(2)  0.0236(9)   0.0450(12)  0.0201(10)    0.0018(9)  0.0007(8)   0.0004(8) 
C(3)  0.0303(10)   0.0327(11)  0.0214(9)   0.0008(8)  0.0038(8)   0.0101(8) 
C(4)  0.0336(10)   0.0259(10)  0.0176(9)   0.0016(8)  0.0019(7)   0.0055(8) 
C(5)  0.0279(9)   0.0227(10)  0.0129(8)   0.0028(7)  0.0035(7)   0.0008(7) 
C(6)  0.0249(8)   0.0257(10)  0.0138(8)    0.0006(7)   0.0006(7)   0.0016(7) 
C(7)  0.0251(9)   0.0242(9)  0.0114(7)    0.0012(7)   0.0023(7)    
 0.0008(7) 
C(8)  0.0291(9)   0.0208(9)  0.0177(8)    0.0018(7)  0.0017(7)    
 0.0021(7) 
C(9)  0.0249(9)   0.0199(8)  0.0170(8)   0.0012(7)  0.0007(6)    
 0.0012(7) 
C(10)  0.0236(9)   0.0241(9)  0.0231(9)    0.0036(8)  0.0015(7)    
 0.0036(7) 
C(11)  0.0217(9)   0.0339(11)  0.0327(11)    0.0100(9)  0.0046(8)    
 0.0043(8) 
C(12)  0.0242(9)   0.0237(9)  0.0222(9)    0.0057(8)  0.0028(7)    
 0.0010(7) 
C(13)  0.0312(10)   0.0313(10)  0.0209(10)    0.0017(8)  0.0003(8)   0.0001(8) 
C(14)  0.0227(10)   0.0575(15)  0.0335(12)    0.0172(11)   0.0024(9)   0.0019(9) 
C(15)  0.0366(12)   0.0501(14)  0.0397(13)    0.0197(11)  0.0171(10)    
 0.0204(11) 
C(16)  0.0699(18)   0.0333(13)  0.0330(12)   0.0011(10)  0.0215(12)    
 0.0127(11) Chapter 7 – Appendices   
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C(17)  0.0441(12)   0.0292(11)  0.0288(11)   0.0035(9)  0.0021(9)   0.0069(9) 
 
Table 5.   Atomic coordinates  and isotropic displacement parameters (Å2) for 264. 
_________________________________________________________________  
                     x                  y            z               U(eq) 
_________________________________________________________________  
H(1A)     0.8605    1.0186    0.1835    0.031 
H(2A)     0.9826    0.8089    0.0931    0.035 
H(3A)     0.9276    0.5253    0.0232    0.034 
H(4A)    0.7532    0.4466    0.0572    0.031 
H(8A)    0.5797    0.5201    0.1881    0.027 
H(9A)    0.5779    0.7174    0.4384    0.025 
H(10A)    0.4090    0.6116    0.3711    0.028 
H(10B)    0.3884    0.7659    0.2203    0.028 
H(11A)    0.4346    0.8380    0.6193    0.035 
H(11B)    0.3876    0.9719    0.4638    0.035 
H(13A)    0.1989    0.9394    0.3580    0.033 
H(14A)    0.0316    0.8703    0.4597    0.045 
H(15A)    0.0090    0.6949    0.7304    0.050 
H(16A)    0.1541    0.5825    0.8944    0.054 
H(17A)    0.3215    0.6557    0.7983    0.041 
H(1)    0.584(3)  0.756(5)   0.093(6)  0.099(12) 
 
7.9.  Appendix 9 – X-ray data for 276 
Table 1.  Crystal data and structure refinement for 276. 
Identification code      276 
Empirical formula       C13 H16 O3 
Formula weight       220.27 
Temperature        293 K 
Wavelength        1.54180 A 
Crystal system, space group     Monoclinic,  P 1 21/n 1 
Unit cell dimensions      a = 7.5397(8) A   alpha = 90 deg. 
b = 15.2598(13) A   beta = 99.298(6) deg. 
c = 10.2955(11) A  gamma = 90 deg. 
Volume         1169.0(2) A
3 
Z, Calculated density      4,  1.251 Mg/m
3 
Absorption coefficient      0.716 mm
 1 
F(000)          472 
Crystal size        0.30 x 0.10 x 0.08 mm 
Theta range for data collection   6.619 to 65.288 deg. 
Limiting indices        8<=h<=7,  14<=k<=17,  12<=l<=11 
Reflections collected / unique    4172 / 1859 [R(int) = 0.025] 
Completeness to theta = 65.288   93.3 % 
Absorption correction      Semi empirical from equivalents 
Max. and min. transmission     0.94 and 0.62 
Refinement method      Full matrix least squares on F
2 
Data / restraints / parameters    859 / 0 / 148 
Goodness of fit on F
2       0.9186 
Final R indices [I>2sigma(I)]     R1 = 0.0578, wR2 = 0.1541 
R indices (all data)      R1 = 0.0839, wR2 = 0.1765 
Largest diff. peak and hole    0.48 and  0.34 e.A
 3 
 
Table 2.  Atomic coordinates ( x 10
4) and equivalent isotropic displacement parameters (A
2 x 
10
3) for 276. 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________ 
                              x                y                z           U(eq) 
________________________________________________________________ 
C(1)         6864(4)        755(2)       3996(3)       47 Chapter 7 – Appendices   
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C(2)         5997(4)        657(2)       2710(3)       46 
C(3)         5233(4)       1428(2)       1963(4)       51 
O(4)         5029(3)       2172(1)       2624(2)       54 
C(5)         5237(5)       2139(2)       4061(3)       49 
C(6)         6949(5)       1657(2)       4605(3)       52 
O(7)         8525(3)       2074(2)       4304(3)       64 
C(8)         5108(5)       3096(2)       4537(3)       56 
C(9)         5110(6)       3110(2)       6014(4)       69 
C(10)        5335(7)       4011(3)       6617(5)      101 
C(11)        3427(6)       3533(3)       3797(4)       86 
O(12)        4803(4)       1442(2)        773(2)       66 
C(13)        5927(5)        163(2)       2096(3)       58 
C(14)        6749(5)        879(2)       2769(4)       62 
C(15)        7635(5)        777(2)       4039(4)       64 
C(16)        7686(5)         27(2)       4667(4)       56 
 
Table 3.  Bond lengths [A] and angles [deg] for 276. 
________________________________________________________________ 
C(1) C(2)                     1.387(4) 
C(1) C(6)                     1.509(4) 
C(1) C(16)                    1.399(4) 
C(2) C(3)                     1.471(4) 
C(2) C(13)                    1.399(4) 
C(3) O(4)                     1.344(4) 
C(3) O(12)                    1.216(4) 
O(4) C(5)                     1.464(4) 
C(5) C(6)                     1.512(4) 
C(5) C(8)                     1.549(4) 
C(5) H(51)                    0.994 
C(6) O(7)                     1.426(4) 
C(6) H(61)                    0.963 
O(7) H(1)                     0.89(3) 
C(8) C(9)                     1.521(5) 
C(8) C(11)                    1.522(5) 
C(8) H(81)                    1.015 
C(9) C(10)                    1.506(5) 
C(9) H(91)                    1.020 
C(9) H(92)                    0.958 
C(10) H(101)                  0.978 
C(10) H(102)                  1.011 
C(10) H(103)                  0.973 
C(11) H(111)                  0.993 
C(11) H(112)                  1.005 
C(11) H(113)                  0.939 
C(13) C(14)                   1.385(5) 
C(13) H(131)                  0.965 
C(14) C(15)                   1.378(6) 
C(14) H(141)                  0.922 
C(15) C(16)                   1.384(5) 
C(15) H(151)                  0.909 
C(16) H(161)                  0.964 
C(2) C(1) C(6)              118.5(3) 
C(2) C(1) C(16)             119.2(3) 
C(6) C(1) C(16)             122.2(3) 
C(1) C(2) C(3)              119.7(3) 
C(1) C(2) C(13)             120.4(3) 
C(3) C(2) C(13)             119.8(3) 
C(2) C(3) O(4)              118.6(3) 
C(2) C(3) O(12)             123.9(3) 
O(4) C(3) O(12)             117.5(3) 
C(3) O(4) C(5)              118.7(2) 
O(4) C(5) C(6)              109.7(3) 
O(4) C(5) C(8)              106.6(2) Chapter 7 – Appendices   
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C(6) C(5) C(8)              115.8(3) 
O(4) C(5) H(51)             107.6 
C(6) C(5) H(51)             106.8 
C(8) C(5) H(51)             110.1 
C(5) C(6) C(1)              108.3(3) 
C(5) C(6) O(7)              113.2(3) 
C(1) C(6) O(7)              107.3(3) 
C(5) C(6) H(61)             107.0 
C(1) C(6) H(61)             110.2 
O(7) C(6) H(61)             110.9 
C(6) O(7) H(1)              114(2) 
C(5) C(8) C(9)              109.8(3) 
C(5) C(8) C(11)             110.1(3) 
C(9) C(8) C(11)             111.1(3) 
C(5) C(8) H(81)             109.9 
C(9) C(8) H(81)             109.3 
C(11) C(8) H(81)            106.5 
C(8) C(9) C(10)             114.0(4) 
C(8) C(9) H(91)             110.3 
C(10) C(9) H(91)            107.1 
C(8) C(9) H(92)             107.4 
C(10) C(9) H(92)            105.7 
H(91) C(9) H(92)            112.2 
C(9) C(10) H(101)           110.7 
C(9) C(10) H(102)           114.9 
H(101) C(10) H(102)         111.0 
C(9) C(10) H(103)           104.2 
H(101) C(10) H(103)         105.8 
H(102) C(10) H(103)         109.7 
C(8) C(11) H(111)           112.2 
C(8) C(11) H(112)           107.5 
H(111) C(11) H(112)         113.7 
C(8) C(11) H(113)           107.1 
H(111) C(11) H(113)         107.0 
H(112) C(11) H(113)         109.2 
C(2) C(13) C(14)            119.9(3) 
C(2) C(13) H(131)           117.9 
C(14) C(13) H(131)          122.2 
C(13) C(14) C(15)           119.6(3) 
C(13) C(14) H(141)          120.6 
C(15) C(14) H(141)          119.8 
C(14) C(15) C(16)           121.1(3) 
C(14) C(15) H(151)          117.6 
C(16) C(15) H(151)          121.3 
C(1) C(16) C(15)            119.7(3) 
C(1) C(16) H(161)           121.5 
C(15) C(16) H(161)          118.7 
 
  
Symmetry transformations used to generate equivalent atoms: 
  
Table 4.  Anisotropic displacement parameters (A
2 x 10
3) for 276. 
The anisotropic displacement factor exponent takes the form: 2 p
2 [h
2 a*
2 U
11 + ... + 2 h k a* b* 
U
12 
________________________________________________________________ 
                       U
11          U
22          U
33         U
23        U
13        U
12 
________________________________________________________________ 
C(1)     52(2)      42(2)      47(2)       3(1)       6(2)       2(2) 
C(2)     49(2)      43(2)      45(2)       1(1)       3(2)       0(1) 
C(3)     53(2)      51(2)      45(2)       0(2)       1(2)       2(2) 
O(4)     68(2)      47(1)      43(1)       1(1)       3(1)       4(1) 
C(5)     57(2)      45(2)      45(2)       0(1)       6(2)       2(2) 
C(6)     62(2)      49(2)      42(2)       1(1)       2(2)       3(2) Chapter 7 – Appendices   
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O(7)     56(2)      54(1)      78(2)      15(1)       1(1)       5(1) 
C(8)     62(2)      46(2)      57(2)       1(2)       6(2)       5(2) 
C(9)     88(3)      61(2)      61(3)      14(2)      18(2)       0(2) 
C(10)   107(4)      98(4)     100(4)      23(3)      22(3)       2(3) 
C(11)    93(3)      67(3)      90(3)      14(2)       7(2)      33(2) 
O(12)    86(2)      66(2)      42(2)       2(1)       2(1)      13(1) 
C(13)    66(2)      54(2)      51(2)       7(2)       6(2)       6(2) 
C(14)    71(3)      40(2)      77(3)       3(2)      17(2)       3(2) 
C(15)    66(2)      43(2)      82(3)      12(2)      13(2)       8(2) 
C(16)    61(2)      51(2)      54(2)       9(2)       1(2)       5(2) 
 
 
Table 5.  Hydrogen coordinates ( x 10
4) and isotropic displacement parameters (A
2 x 10
3) for 
276. 
_________________________________________________________________ 
                             x                y               z           U(eq) 
_________________________________________________________________ 
H(51)        4226          1786          4295          62 
H(61)        6988          1612          5542          64 
H(81)        6169          3449          4329          71 
H(91)        6130          2731          6486          90 
H(92)        3954          2910          6161          90 
H(101)       5204          3991          7546         117 
H(102)       6478          4324          6495         117 
H(103)       4300          4336          6176         117 
H(111)       3274          4139          4109          99 
H(112)       2381          3137          3869          99 
H(113)       3577          3573          2911          99 
H(131)       5278           209          1211          72 
H(141)       6716          1422          2372          72 
H(151)       8160          1258          4456          81 
H(161)       8329            75          5554          66 
H(1)         8870(40)      2540(20)      4810(30)      50 
 
  
7.10. Appendix 10 – X-ray data for 289 
Table 1.  Crystal data and structure refinement for 289. 
Identification code      289 
Empirical formula      C16 H17 N1 O4 
Formula weight       287.32 
Temperature        150 K 
Wavelength        0.71073 A 
Crystal system, space group    Monoclinic,  P 1 21/n 1 
Unit cell dimensions       a = 8.3707(4) A   alpha = 90 deg. 
b = 7.7537(3) A    beta = 94.832(2) deg. 
c = 22.1213(10) A   gamma = 90 deg. 
Volume         1430.66(11) A
3 
Z, Calculated density      4,  1.334 Mg/m
3 
Absorption coefficient      0.096 mm
 1 
F(000)          608 
Crystal size        0.35 x 0.20 x 0.15 mm 
Theta range for data collection   1.848 to 27.476 deg. 
Limiting indices        10<=h<=10,  10<=k<=8,  28<=l<=26 
Reflections collected / unique    9665 / 3251 [R(int) = 0.0679] 
Completeness to theta = 27.476   99.6 % 
Absorption correction      None 
Refinement method      Full matrix least squares on F
2 
Data / restraints / parameters    3251 / 0 / 193 
Goodness of fit on F
2      0.9678 
Final R indices [I>2sigma(I)]    R1 = 0.0560, wR2 = 0.1112 Chapter 7 – Appendices   
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R indices (all data)      R1 = 0.1063, wR2 = 0.1332 
Largest diff. peak and hole    0.65 and  0.75 e.A
 3 
 
Table 2.  Atomic coordinates ( x 10
4) and equivalent isotropic displacement parameters (A
2 x 
10
3) for 289. 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
_______________________________________________________________ 
                         x             y             z           U(eq) 
_______________________________________________________________ 
O(1)         1640(2)       4218(2)       2217(1)       29 
C(2)         1633(2)       6022(3)       2087(1)       24 
C(3)           18(2)       6812(3)       2218(1)       23 
O(4)         1098(2)       6271(2)       1763(1)       24 
C(5)          582(2)       6214(3)       1166(1)       24 
O(6)         1575(2)       5990(2)        808(1)       33 
C(7)         1158(2)       6406(3)        993(1)       23 
C(8)         2250(2)       6367(3)       1439(1)       24 
C(9)         3879(3)       6521(3)       1261(1)       30 
C(10)        4406(3)       6687(3)        655(1)       35 
C(11)        3320(3)       6712(3)        217(1)       35 
C(12)        1695(3)       6571(3)        384(1)       30 
C(13)         856(2)       6289(3)       2830(1)       24 
C(14)        2496(3)       7166(3)       2929(1)       32 
C(15)        3528(2)       6493(3)       3466(1)       25 
N(16)        5040(2)       7236(2)       3623(1)       25 
C(17)        5601(2)       6416(3)       4105(1)       25 
O(18)        4607(2)       5177(2)       4287(1)       31 
C(19)        3293(2)       5254(3)       3866(1)       29 
C(20)        7129(3)       6697(3)       4483(1)       31 
C(21)         217(3)       6730(3)       3337(1)       37 
 
Table 3.  Bond lengths [A] and angles [deg] for 289. 
________________________________________________________________ 
  
O(1) C(2)                     1.428(3) 
O(1) H(1)                     0.87(3) 
C(2) C(3)                     1.517(3) 
C(2) C(8)                     1.505(3) 
C(2) H(21)                    1.000 
C(3) O(4)                     1.470(2) 
C(3) C(13)                    1.525(3) 
C(3) H(31)                    0.983 
O(4) C(5)                     1.355(2) 
C(5) O(6)                     1.208(2) 
C(5) C(7)                     1.482(3) 
C(7) C(8)                     1.401(3) 
C(7) C(12)                    1.390(3) 
C(8) C(9)                     1.392(3) 
C(9) C(10)                    1.382(3) 
C(9) H(91)                    0.946 
C(10) C(11)                   1.383(3) 
C(10) H(101)                  0.939 
C(11) C(12)                   1.383(3) 
C(11) H(111)                  0.934 
C(12) H(121)                  0.938 
C(13) C(14)                   1.531(3) 
C(13) C(21)                   1.533(3) 
C(13) H(131)                  0.974 
C(14) C(15)                   1.502(3) 
C(14) H(141)                  0.999 
C(14) H(142)                  0.983 
C(15) N(16)                   1.408(3) 
C(15) C(19)                   1.333(3) Chapter 7 – Appendices   
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N(16) C(17)                   1.295(3) 
C(17) O(18)                   1.354(2) 
C(17) C(20)                   1.483(3) 
O(18) C(19)                   1.381(3) 
C(19) H(191)                  0.934 
C(20) H(201)                  0.973 
C(20) H(202)                  0.955 
C(20) H(203)                  0.968 
C(21) H(211)                  0.963 
C(21) H(212)                  0.980 
C(21) H(213)                  0.982 
C(2) O(1) H(1)              109.9(18) 
O(1) C(2) C(3)              112.09(16) 
O(1) C(2) C(8)              111.02(17) 
C(3) C(2) C(8)              110.16(17) 
O(1) C(2) H(21)             107.2 
C(3) C(2) H(21)             108.5 
C(8) C(2) H(21)             107.7 
C(2) C(3) O(4)              110.88(16) 
C(2) C(3) C(13)             113.95(17) 
O(4) C(3) C(13)             105.59(16) 
C(2) C(3) H(31)             109.0 
O(4) C(3) H(31)             107.3 
C(13) C(3) H(31)            109.9 
C(3) O(4) C(5)              120.89(15) 
O(4) C(5) O(6)              117.60(18) 
O(4) C(5) C(7)              118.30(18) 
O(6) C(5) C(7)              124.1(2) 
C(5) C(7) C(8)              120.06(19) 
C(5) C(7) C(12)             119.35(19) 
C(8) C(7) C(12)             120.56(19) 
C(2) C(8) C(7)              118.84(18) 
C(2) C(8) C(9)              122.28(19) 
C(7) C(8) C(9)              118.7(2) 
C(8) C(9) C(10)             120.5(2) 
C(8) C(9) H(91)             119.6 
C(10) C(9) H(91)            119.9 
C(9) C(10) C(11)            120.4(2) 
C(9) C(10) H(101)           120.2 
C(11) C(10) H(101)          119.4 
C(10) C(11) C(12)           120.2(2) 
C(10) C(11) H(111)          120.7 
C(12) C(11) H(111)          119.1 
C(7) C(12) C(11)            119.7(2) 
C(7) C(12) H(121)           118.6 
C(11) C(12) H(121)          121.7 
C(3) C(13) C(14)            110.41(17) 
C(3) C(13) C(21)            109.63(17) 
C(14) C(13) C(21)           111.67(18) 
C(3) C(13) H(131)           107.6 
C(14) C(13) H(131)          108.2 
C(21) C(13) H(131)          109.1 
C(13) C(14) C(15)           114.10(19) 
C(13) C(14) H(141)          108.5 
C(15) C(14) H(141)          109.1 
C(13) C(14) H(142)          107.7 
C(15) C(14) H(142)          107.0 
H(141) C(14) H(142)         110.4 
C(14) C(15) N(16)           119.93(18) 
C(14) C(15) C(19)           132.0(2) 
N(16) C(15) C(19)           108.08(19) 
C(15) N(16) C(17)           105.02(18) 
N(16) C(17) O(18)           113.77(18) Chapter 7 – Appendices   
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N(16) C(17) C(20)           128.8(2) 
O(18) C(17) C(20)           117.36(19) 
C(17) O(18) C(19)           104.15(16) 
O(18) C(19) C(15)           108.98(18) 
O(18) C(19) H(191)          120.0 
C(15) C(19) H(191)          131.0 
C(17) C(20) H(201)          109.3 
C(17) C(20) H(202)          109.5 
H(201) C(20) H(202)         109.0 
C(17) C(20) H(203)          109.3 
H(201) C(20) H(203)         111.6 
H(202) C(20) H(203)         108.1 
C(13) C(21) H(211)          110.7 
C(13) C(21) H(212)          110.3 
H(211) C(21) H(212)         107.4 
C(13) C(21) H(213)          110.6 
H(211) C(21) H(213)         109.0 
H(212) C(21) H(213)         108.8 
 
Symmetry transformations used to generate equivalent atoms: 
  
Table 4.  Anisotropic displacement parameters (A
2 x 10
3) for 289. 
The anisotropic displacement factor exponent takes the form: 2 p
2 [h
2 a*
2 U
11 + ... + 2 h k a* b* 
U
12 ] 
______________________________________________________________ 
                       U
11         U
22         U
33          U
23        U
13         U
12 
_______________________________________________________________ 
O(1)     32(1)      30(1)      26(1)       0(1)       5(1)       5(1) 
C(2)     25(1)      24(1)      23(1)       2(1)       5(1)       2(1) 
C(3)     27(1)      22(1)      21(1)       5(1)       1(1)       3(1) 
O(4)     22(1)      30(1)      21(1)       2(1)       2(1)       0(1) 
C(5)     25(1)      24(1)      23(1)       1(1)       1(1)       3(1) 
O(6)     27(1)      46(1)      26(1)       0(1)       6(1)       2(1) 
C(7)     25(1)      21(1)      25(1)       0(1)       1(1)       2(1) 
C(8)     24(1)      20(1)      26(1)       2(1)       0(1)       1(1) 
C(9)     24(1)      32(1)      34(1)       1(1)       2(1)       3(1) 
C(10)    25(1)      36(1)      44(2)       1(1)       9(1)       0(1) 
C(11)    37(1)      36(1)      28(1)       4(1)      11(1)       3(1) 
C(12)    31(1)      32(1)      26(1)       1(1)       1(1)       3(1) 
C(13)    27(1)      23(1)      22(1)       1(1)       1(1)       1(1) 
C(14)    32(1)      32(1)      29(1)       1(1)       5(1)       5(1) 
C(15)    27(1)      25(1)      23(1)       2(1)       0(1)       1(1) 
N(16)    25(1)      27(1)      23(1)       1(1)       2(1)       1(1) 
C(17)    24(1)      27(1)      23(1)       1(1)       4(1)       3(1) 
O(18)    28(1)      35(1)      29(1)       8(1)       2(1)       1(1) 
C(19)    25(1)      26(1)      37(1)       2(1)       2(1)       2(1) 
C(20)    27(1)      41(1)      25(1)       1(1)       1(1)       4(1) 
C(21)    35(1)      51(2)      26(1)       8(1)       0(1)      12(1) 
 
Table 5.  Hydrogen coordinates ( x 10
4) and isotropic displacement parameters (A
2 x 10
3) for 
289. 
__________________________________________________________________ 
                               x              y                z           U(eq) 
__________________________________________________________________ 
H(21)        2383          6587          2355          28 
H(31)          73          8074          2194          25 
H(91)        4630          6514          1558          34 
H(101)       5507          6779           536          43 
H(111)       3669          6825           193          42 
H(121)        937          6563            94          35 
H(131)       1023          5047          2822          28 
H(141)       2326          8430          2981          38 
H(142)       3073          6946          2568          38 Chapter 7 – Appendices   
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H(191)       2432          4502          3897          30 
H(201)       7721          5618          4520          37 
H(202)       6906          7077          4878          37 
H(203)       7739          7591          4301          37 
H(211)        359          6584          3729          49 
H(212)        561          7937          3304          49 
H(213)       1172          5989          3311          49 
H(1)         1160(30)      3660(40)      1944(13)      50 
 
 
7.11. Appendix 11 – X-ray data for 298 
Table 1.  Crystal data and structure refinement for 298. 
Identification code      298 
Empirical formula      C18 H20 O4 
Formula weight       1201.36 
Temperature        150(2) K 
Wavelength        0.71073 A 
Crystal system, space group    ?,  ? 
Unit cell dimensions      a = 6.6229(12) A   alpha = 90 deg. 
b = 10.6758(14) A   beta = 98.058(6) deg. 
c = 22.750(3) A   gamma = 90 deg. 
Volume         1592.7(4) A
3 
Z, Calculated density      1,  1.253 Mg/m
3 
Absorption coefficient      0.088 mm
 1 
F(000)          640 
Crystal size         ? x ? x ? mm 
Theta range for data collection   3.11 to 27.48 deg. 
Limiting indices        8<=h<=8,  13<=k<=13,  29<=l<=29 
Reflections collected / unique    20004 / 3649 [R(int) = 0.1898] 
Completeness to theta = 27.48    99.9 % 
Refinement method      Full matrix least squares on F
2 
Data / restraints / parameters    3649 / 0 / 279 
Goodness of fit on F
2      0.931 
Final R indices [I>2sigma(I)]    R1 = 0.0679, wR2 = 0.1409 
R indices (all data)      R1 = 0.1864, wR2 = 0.1920 
Largest diff. peak and hole    0.198 and  0.209 e.A
 3 
 
Table 2.  Atomic coordinates ( x 10
4) and equivalent isotropic displacement parameters (A
2 x 
10
3) for 298. 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________ 
                              x                y                 z              U(eq) 
________________________________________________________________ 
O(1)         3165(4)       7540(2)       1893(1)       40(1) 
O(2)         1331(4)       5138(2)       2233(1)       48(1) 
O(3)         4994(4)       4162(2)       1245(1)       43(1) 
O(4)         1587(5)       5971(3)       2432(1)       74(1) 
C(1)         2591(5)       6993(3)        910(1)       33(1) 
C(2)         2386(5)       8305(3)        955(1)       37(1) 
C(3)         2536(6)       9069(4)        468(2)       46(1) 
C(4)         2973(6)       8506(4)         57(2)       51(1) 
C(5)         3203(6)       7227(4)         91(2)       50(1) 
C(6)         2983(5)       6433(3)        390(1)       38(1) 
C(7)         2016(6)       8564(3)       1585(1)       40(1) 
C(8)         2212(5)       6537(3)       1512(1)       34(1) 
C(9)         2872(6)       5325(3)       1840(1)       36(1) 
C(10)         255(6)       5977(3)       2120(2)       51(1) 
C(11)          88(5)       6747(3)       1573(2)       41(1) 
C(12)        3121(5)       4108(3)       1505(1)       38(1) 
C(13)        4891(6)       3344(3)       1756(2)       39(1) 
C(103)       1860(7)       8937(4)       1304(2)       58(1) Chapter 7 – Appendices   
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C(104)        172(6)       8197(3)       1676(2)       46(1) 
C(105)       1672(6)       6270(4)       1061(2)       51(1) 
C106)       1300(7)       3553(4)       1126(2)       58(1) 
C(107)       5085(8)       1961(4)       1656(2)       50(1) 
 
Table 3.  Bond lengths [A] and angles [deg] for 298. 
________________________________________________________________ 
C(1) C(7)                     1.455(4) 
O(1) C(8)                     1.463(4) 
O(2) C(10)                    1.377(4) 
O(2) C(9)                     1.463(4) 
O(3) C(12)                    1.449(4) 
O(3) C(13)                    1.463(4) 
O(4) C(10)                    1.207(4) 
C(1) C(6)                     1.382(4) 
C(1) C(2)                     1.412(5) 
C(1) C(8)                     1.508(4) 
C(2) C(3)                     1.391(5) 
C(2) C(7)                     1.514(4) 
C(3) C(4)                     1.401(5) 
C(3) H(1)                     1.00(4) 
C(4) C(5)                     1.378(5) 
C(4) H(2)                     1.01(4) 
C(5) C(6)                     1.408(5) 
C(5) H(3)                     0.95(4) 
C(6) H(4)                     1.05(3) 
C(7) C(104)                   1.542(5) 
C(7) H(5)                     1.01(3) 
C(8) C(9)                     1.526(4) 
C(8) C(11)                    1.565(5) 
C(9) C(12)                    1.527(4) 
C(9) H(13)                    1.06(4) 
C(10) C(11)                   1.510(5) 
C(11) C(105)                  1.541(6) 
C(11) C(104)                  1.568(5) 
C(12) C(13)                   1.476(5) 
C(12) C(106)                  1.502(5) 
C(13) C(107)                  1.502(5) 
C(13) H(16)                   1.02(3) 
C(103) C(104)                 1.524(6) 
C(103) H(9)                   0.95(4) 
C(103) H(7)                   1.02(4) 
C(103) H(8)                   1.08(5) 
C(104) H(6)                   0.98(3) 
C(105) H(10)                  0.95(4) 
C(105) H(11)                  1.09(4) 
C(105) H(12)                  1.03(4) 
C(106) H(15)                  1.04(5) 
C(106) H(14)                  1.00(5) 
C(106) H(20)                  1.00(4) 
C(107) H(18)                  1.00(4) 
C(107) H(17)                  1.11(4) 
C(107) H(19)                  0.99(4) 
C(7) o(1) C(8)               96.5(2) 
C(10) o(2) C(9)             112.1(2) 
C(12) o(3) C(13)             60.9(2) 
C(6) C(1) C(2)              121.5(3) 
C(6) C(1) C(8)              135.5(3) 
C(2) C(1) C(8)              103.0(3) 
C(3) C(2) C(1)              120.4(3) 
C(3) C(2) C(7)              133.3(3) 
C(1) C(2) C(7)              106.3(3) 
C(2) C(3) C(4)              118.2(3) Chapter 7 – Appendices   
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C(2) C(3) H(1)              120(2) 
C(4) C(3) H(1)              122(2) 
C(5) C(4) C(3)              120.8(3) 
C(5) C(4) H(2)              120(2) 
C(3) C(4) H(2)              119(2) 
C(4) C(5) C(6)              121.8(4) 
C(4) C(5) H(3)              120(2) 
C(6) C(5) H(3)              119(2) 
C(1) C(6) C(5)              117.2(3) 
C(1) C(6) H(4)              122.1(17) 
C(5) C(6) H(4)              120.6(17) 
O(1) C(7) C(2)              100.0(3) 
O(1) C(7) C(104)            100.5(3) 
C(2) C(7) C(104)            111.1(3) 
O(1) C(7) H(5)              112.5(19) 
C(2) C(7) H(5)              116.0(17) 
C(104) C(7) H(5)            114.6(19) 
O(1) C(8) C(1)              100.8(2) 
O(1) C(8) C(9)              105.1(2) 
C(1) C(8) C(9)              130.2(3) 
O(1) C(8) C(11)             100.8(2) 
C(1) C(8) C(11)             108.8(3) 
C(9) C(8) C(11)             107.1(3) 
O(2) C(9) C(12)             108.8(3) 
O(2) C(9) C(8)              103.8(3) 
C(12) C(9) C(8)             121.5(3) 
O(2) C(9) H(13)             105.0(18) 
C(12) C(9) H(13)            109.1(19) 
C(8) C(9) H(13)             107.6(19) 
O(4) C(10) o(2)             119.2(3) 
O(4) C(10) C(11)            129.2(4) 
O(2) C(10) C(11)            111.5(3) 
C(10) C(11) C(105)          108.8(3) 
C(10) C(11) C(104)          114.0(3) 
C(105) C(11) C(104)         113.9(3) 
C(10) C(11) C(8)            100.3(3) 
C(105) C(11) C(8)           117.0(3) 
C(104) C(11) C(8)           102.1(3) 
O(3) C(12) C(13)             60.1(2) 
O(3) C(12) C(106)           116.5(3) 
C(13) C(12) C(106)          122.3(3) 
O(3) C(12) C(9)             109.2(3) 
C(13) C(12) C(9)            114.4(3) 
C(106) C(12) C(9)           119.2(3) 
O(3) C(13) C(12)             59.06(19) 
O(3) C(13) C(107)           116.8(3) 
C(12) C(13) C(107)          124.3(4) 
O(3) C(13) H(16)            110.5(18) 
C(12) C(13) H(16)           114.9(18) 
C(107) C(13) H(16)          116.9(18) 
C(104) C(103) H(9)          112(3) 
C(104) C(103) H(7)          105(3) 
H(9) C(103) H(7)            107(3) 
C(104) C(103) H(8)          111(3) 
H(9) C(103) H(8)            112(4) 
H(7) C(103) H(8)            110(3) 
C(103) C(104) C(7)          115.1(3) 
C(103) C(104) C(11)         117.9(4) 
C(7) C(104) C(11)           100.2(3) 
C(103) C(104) H(6)          111.9(19) 
C(7) (104) H(6)            103(2) 
C(11) C(104) H(6)           106.8(18) 
C(11) C(105) H(10)          109(2) Chapter 7 – Appendices   
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C(11) C(105) H(11)          110(2) 
H(10) C(105) H(11)          110(3) 
C(11) C(105) H(12)          109(2) 
H(10) C(105) H(12)          109(3) 
H(11) C(105) H(12)          111(3) 
C(12) C(106) H(15)          114(3) 
C(12) C(106) H(14)          113(3) 
H(15) C(106) H(14)          103(4) 
C(12) C(106) H(20)          106(2) 
H(15) C(106) H(20)          109(3) 
H(14) C(106) H(20)          112(4) 
C(13) C(107) H(18)          109.3(19) 
C(13) C(107) H(17)          110.4(19) 
H(18) C(107) H(17)          104(3) 
C(13) C(107) H(19)          109(2) 
H(18) C(107) H(19)          114(3) 
H(17) C(107) H(19)          111(3) 
 
Symmetry transformations used to generate equivalent atoms: 
Table 4.  Anisotropic displacement parameters (A
2 x 10
3) for 298. 
The anisotropic displacement factor exponent takes the form: 
 2 p
2 [ h
2 a*
2 U
11 + ... + 2 h k a* b* U
12] 
_________________________________________________________________ 
                        U
11         U
22           U
33          U
23        U
13         U
12 
_________________________________________________________________ 
O(1)     48(2)      36(1)      34(1)       4(1)       2(1)       2(1) 
O(2)     58(2)      44(2)      46(1)      15(1)      22(1)      13(1) 
O(3)     49(2)      40(1)      42(1)       1(1)      16(1)       2(1) 
O(4)     80(2)      71(2)      83(2)      26(2)      57(2)      22(2) 
C(1)     31(2)      34(2)      32(2)       2(1)       2(2)       1(2) 
C(2)     36(2)      40(2)      36(2)       1(2)       7(2)       0(2) 
C(3)     52(3)      40(2)      47(2)       7(2)       8(2)       1(2) 
C(4)     64(3)      48(3)      44(2)       7(2)      16(2)       1(2) 
C(5)     52(3)      64(3)      35(2)       1(2)      10(2)       3(2) 
C(6)     41(2)      42(2)      30(2)       0(2)       6(2)       1(2) 
C(7)     50(3)      31(2)      40(2)       0(2)       5(2)       5(2) 
C(8)     37(2)      35(2)      28(2)       5(1)       5(2)       1(2) 
C(9)     43(2)      37(2)      30(2)       1(2)      11(2)       2(2) 
C(10)    57(3)      43(2)      57(2)      12(2)      23(2)      12(2) 
C(11)    35(2)      44(2)      47(2)       5(2)      14(2)       8(2) 
C(12)    37(2)      38(2)      40(2)       3(2)       9(2)       0(2) 
C(13)    46(2)      34(2)      37(2)       4(2)       9(2)       5(2) 
C(103)   57(3)      50(3)      69(3)       9(2)      16(2)      16(2) 
C(104)   54(3)      44(2)      44(2)       3(2)      18(2)       9(2) 
C(105)   29(2)      52(3)      72(3)       7(2)       3(2)       1(2) 
C(106)   51(3)      49(3)      69(3)      16(2)       5(2)       3(2) 
C(107)   62(3)      41(2)      47(2)       5(2)       9(2)       9(2) 
 
Table 5.  Hydrogen coordinates ( x 10
4) and isotropic displacement parameters (A
2 x 10
3) for 
298. 
_________________________________________________________________ 
                                  x                 y                 z              U(eq) 
_________________________________________________________________ 
H((6)          180(50)      8320(30)      2102(15)      38(9) 
H((4)         3160(50)      5460(30)       354(14)      46(10) 
H((18)        4340(50)      1740(30)      1257(16)      41(9) 
H((10)        2990(70)      6510(40)      1136(16)      65(12) 
H((1)         2340(60)      9990(40)       499(15)      60(12) 
H((16)        5730(50)      3710(30)      2125(15)      39(9) 
H((17)        4270(60)      1420(40)      1969(17)      67(12) 
H((2)         3160(60)      9050(40)       405(18)      75(13) 
H((19)        6550(70)      1740(30)      1710(16)      60(12) 
H((9)         1800(70)      8850(40)       890(20)      77(15) Chapter 7 – Appendices   
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H((11)        1370(60)      6680(40)       644(19)      72(12) 
H((7)         1560(70)      9860(40)      1407(18)      77(14) 
H((13)        4250(60)      5510(30)      2128(16)      58(11) 
H((3)         3520(60)      6860(40)       450(18)      67(12) 
H((5)         2480(50)      9410(30)      1752(14)      43(9) 
H((12)        1610(60)      5310(40)      1043(16)      67(12) 
H((15)        1590(70)      2700(40)       940(20)      89(15) 
H((14)         800(80)      4090(50)       770(20)     100(17) 
H((8)         3340(80)      8690(40)      1420(20)     104(17) 
H((20)         240(70)      3440(40)      1397(18)      73(14) Chapter 8 – References   
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